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Abstract 
 
Impact of nitric oxide in the regulation of blood flow in the microcirculation: 
 A Computational Analysis 
Patrick L Kirby 
Dov Jaron, Ph.D. 
	  
Nitric oxide (NO) is historically known as a vasodilator. A clear role for NO in metabolic 
autoregulation within the microcirculation and its relationship to both blood flow and local O2 
concentrations has yet to have been established. As NO production from endothelial cells is 
limited under hypoxic conditions, increased vascular tone and a subsequent decrease in vascular 
diameter develop. This decrease in vascular diameter is expected to trigger a decrease in the 
amount of O2 transported to the surrounding tissue. In terms of the local flow mediated response, 
this decrease in vessel diameter will also lead to an increase in hydraulic resistance, which should 
theoretically lead to a decrease in blood flow through the vasculature (and thereby reducing O2 
transport to the tissue).   
Experimental studies have shown that at bifurcations an unequal distribution of red blood cells 
will flow into the larger of the two daughter vessels, in a fashion not proportional to the bulk fluid 
distribution in the two daughter branches(1). Therefore, in relation to NO, a decrease in vessel 
diameter will lead to a decrease in red blood cell flux to the hypoxic tissue.  This decrease in red 
blood cells could be beneficial in terms of CNO by reducing the presence of NO scavangers, 
thereby increasing CNO in and around the vessel wall and promoting vessel dilation. Yet, this 
increase in blood flow will also immediately allow for a greater influx of red blood cells into the 
region and lead to a greater scavenging of NO. Theoretically this would lead to a decrease in 
vessel diameter, and make this means of autoregulatory control unstable. 
xxiv	  
	  
It is the desire of this work to explore a role of NO in the autoregulatory control of arteriole 
diameter and subsequent blood flow to connected vessels.  Ideally a pathway is sought, which 
would allow for a steady increase in CNO around a resistive vessel until relationship stable 
equilibrium between the vasculature and its surrounding tissue is resumed To define the role of 
NO in the metabolic signaling leading to the autoregulation of local blood transport, this study 
computationally examines the relationship between NO and O2 within a vascular network.   
Specifically, this work explores if a decrease in local PO2 can lead to an increase in local CNO 
around the arteriole wall. In addition, this thesis models the relationship between CNO and 
changes in the vessel diameter to determine their influence on the resultant distribution of blood.  
Finally, this work examines the pathway most commonly associated with NO production; the 
shear mediated NO production by endothelial cells. A fuller understanding of the mechanisms of 
NO production and its relationship to blood transport within the vasculature is expected to 
provide insight into the metabolic auto-regulatory system and future potential therapeutic avenues 
for metabolic dysfunction.  
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Chapter 1: Introduction: Nitric Oxide, Insight into an important molecule 
Drs. Furchgott, Ignarro, and Murad were all awarded the Nobel Prize in 1998 for work identifying NO as 
an endothelial derived factor responsible for relaxing smooth muscle. Nitrogen monoxide (NO) is a 
simple molecule that is involved in many processes vital for proper immune responses, neurological 
signaling, and cardiovascular function. Yet, within the story of the biological function of NO there 
remain a great many paradoxes. 
 
The fundamental goal of this thesis is to explore the role NO plays in the immediate regulation of the 
microcirculation in response to changes in the local tissue environment to maintain normal physiological 
function.  As microcirculation is the site of oxygen transport to tissue (2-4) and the control point for local 
regulation of blood flow (5-10), it appears logical to begin the mathematical analysis of the interaction 
between NO and O2 in a microcirculatory computational domain. Starting from existing computational 
models of O2 (5, 11) and NO (12) transport in similar microcirculatory networks a base structure is 
developed, using which we delve further into the interaction between these two molecules and how they 
control local blood flow.  There exist multiple pathways, which can be explored linking local partial 
pressure of O2 (PO2) to NO release to change in vessel diameter and then to a new local PO2 in response 
to changes in local metabolic demand.  This particular study has latched on to a pathway making use of 
red blood cells (RBCs) as O2 sensors, triggering the release of ATP from the RBCs traversing the 
vasculature, which then contributes to an increase in arteriole NO concentration (CNO).  The increase in 
CNO triggers an increase in arteriole diameter and alters the blood flow to better accommodate the 
changes in metabolic demand. A complete analysis of this potential connection between NO and O2 
requires the study of: 
 
 
2	  
	  
1. NO production from endothelial cells (ECs) 
a. Influence of hemodynamics 
b. Influence of nucleotide transport 
2. NO transport through microvascular domains 
a. Role of capillaries and venules on CNO in the proximity of the arteriole 
b. Role of vessel architecture 
c. Interaction between NO and O2 within the vessel and within the surrounding tissue 
3. NO influence on vascular tone in surrounding vascular smooth muscle (VSM). 
Oxygen is assumed to be transported from the arteriole tree and NO is thought to travel in a manner 
dependent upon concentration gradient (Figure 1). The transport of both O2 and NO is dependent upon 
distribution of blood flow, which in itself is dependent upon the design of the vasculature (Figure 1B).  
ATP released through channels and from RBCs is considered to play an important role in integrating the 
transport of O2 with that of NO.   
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Figure 1: Illustration of mechanisms of interest for NO dependent control of microcirculatory blood flow 
originating from terminal arterioles. (A)The diffusion of oxygen O2(blue dots) and NO(green dots) from 
neighboring vascular components is considered to play an important role in the NO-dependent regulation of 
O2 supply to the surrounding tissue.  (B) As RBCs separate in bifurcating branches the transport of NO and 
O2 shall be greatly influenced. This influence shall alter the concentration of NO diffusing from the VECL 
(vascular endothelial cell layer) to the VSM and therefore the diameter of the arteriole branch.   
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Key Characters of our Story 
1.1.1 Nitric Oxide 
At times a significant enough increase in tissue metabolic rate occurs to trigger an increase of a nearby 
arteriole diameter, or dilation. This increase in vessel diameter allows for an additional supply of blood 
to enter the vessel and distribute additional quantities of nutrients and O2 to the tissue and promote the 
removal of metabolic waste. In hamster cremaster muscles Satio et al (13) applied 2,4-Dintrophenol 
(DNP) to increase the local metabolic rate and found that the diameter of the arteriole increased 
significantly (13). This response was modulated when the paired venule was occluded, preventing the 
transport of metabolites.  This observation suggested that diffusion of substances between the arteriole 
and paired venule plays an important role in regulating blood flow via transport of various metabolites. 
Amongst metabolites reported to participate in the venule contribution to arteriole dilation is NO (14).  
NO can be obtained from dietary sources, but the majority of NO is produced within the body. Produced 
by the enzyme nitric oxide synthase (NOS), requiring O2, the amino acid L-arginine and other essential 
co-factors (15, 16), nitric oxide can be found in many different cell types and can be produced through a 
variety of mechanisms. NOS has 3 major isoforms, all of which correspond to a location in which they 
are typically found:  eNOS (type III) found in endothelial cells (ECs), nNOS (type I) found in NO 
producing neurons, and inducible iNOS (type II) found in macrophages.  
	  
Both eNOS and nNOS are constitutive enzymes whose activation is primarily dependent upon their 
binding to the calcium (Ca2+)-calmodulin (CaM) complex. This binding process enables electron transfer 
from NADPH to oxygenase domain of the enzyme containing L-arginine binding sites (17) (18). This 
process is initiated by increases in Ca2+ levels which promote binding of Ca2+ to CaM and consequent 
displacement of caveolin to begin producing NO (19). While there is a certain level of agreement with 
regards to the existence of the Ca2+-dependent pathway previously discussed, it has also been reported 
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that there exists Ca2+-independent pathway, due to studies showing that the basal NO production is 
maintained even if Ca2+ levels are depleted (20) (21).   
Changes in the phosphorylation of proteins has also been demonstrated to influence the activity of eNOS 
(22-30). The binding of calmodulin and the flux of electrons from the reductase to the oxygenase domain 
of the enzyme are all dependent upon the phosphorylation which occurs on the serine, threonine and 
tyrosine residues (29). The application of fluid shear stress to endothelial cells results in the activation of 
the phosphatidylinositol 3-kinase and the subsequent activation of the serine kinases Akt and protein 
kinase A (PKA), which phosphorylate eNOS on Ser1177 and increase eNOS activity (26, 27, 31). While 
this process is described as being calcium-independent the chelation of intracellular calcium will also 
abolish the shear stress induced eNOS activation. Furthermore, a decrease in the calcium response is also 
found to decrease the shear stress dependent NO production (32). These findings suggest that the 
increase in eNOS activity remains calcium dependent but the enzyme can now be activated at resting 
calcium levels (26). Nitric Monoxide can also be released through neurohumoral mediators activating 
specific endothelial receptors (33). While there clearly exists other sources for stimulation of NO 
production, blood flow-induced wall shear stress (WSS) is known to influence endothelial cell function, 
morphology, and gene expression (34, 35) and therefore commonly revered as the chief factor for NO 
production.   
Expanding upon the earlier study conducted by Satio et al. (13), a separate study involving the occlusion 
of a branch of a venular bifurcation was demonstrated to cause a dilatory response in a paired arteriole 
(36). The occlusion of the venular branch increases the blood flow and shear rate in the non-occluded 
venule.The dilatory response was diminished greatly by applying NG-monomethyl-L-arginine (L-
NMMA), a NO synthase inhibitor indicating the importance of NO in the signal transferred from the 
venule to its paired arteriole.  
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The influence of capillaries on the transport of NO remains undefined. Depending upon the rate of NO 
production within these vessels they can either act as a source for NO, as appears to be the case for 
venules in certain situations or a sink. A study conducted by Mitchell and Tyml (37) used intravital 
microscopy to observe the capillary response to local application of L-NAME, a NO synthase inhibitor, 
and bradykinin (BK, a NO synthase stimulator). The authors were able to determine that NO is released 
from capillaries and affects arteriole tone. The application of L-NAME reduced the RBC flux and 
velocity within the capillaries but had no effect on the feeding arteriole and the draining venule.  
Meanwhile the increase in capillary NO production due to BK increased arteriolar dilation. Capillaries 
and venules appear to play integral roles in the change in arteriole tone and therefore blood flow 
respectively. The importance of each of these vascular components in the O2-dependent generation of 
NO signal so as to maintain homeostasis within the vasculature requires further examination of NO-O2 
interplay in a biological sense.  
 
The relationship between O2 and NO and the influence that this relationship has on the control of the 
vascular tone is not fully elucidated.  Oxygen is required for the generation of NO from the guanidine-
nitrogen terminal of L-arginine during the catalysis of NOS (38).  Both in vivo and in vitro experiments 
have shown that variation of O2 availability within the physiological range can result in significant 
changes in NO synthesis in vascular endothelial cells (39, 40). Additionally the relationship between NO 
and O2 extends out of the endothelial cell and the vessel and into the peripheral tissue where O2 
competes with NO for the binding site of cytochrome-c-oxidase in the mitochondria, affecting the 
respiratory chain (41, 42).  The interaction between these molecules extends beyond this brief review, 
but first it appears appropriate to further describe O2 transport, as well as other important characters of 
this story.  
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1.1.2 Oxygen 
As explained by Pittman, approximately 95% of all the oxygen consumed within the tissues is due to 
mitochondrial respiration at cytochrome c oxidase site (41). These mitochondria appear to be able to 
sustain normal function until the local O2 concentration falls below a certain critical value approximated 
around 1mm Hg (43) or 2 mm Hg (44). In many cases the oxygen levels in living tissue is well above 
this range. The main function of the microcirculation is to ensure that all cells and organs have an 
adequate supply of oxygen (6). Air is inhaled and transported from the lungs to the vasculature where it 
is primarily transported via the red blood cells (RBCs).  In many instances the design of the vasculature 
is created to handle the metabolic demand of the tissue, which it is located within. Krogh (45) 
demonstrated  that the reasons for which capillary density is greater in tissues with higher consumption 
rates is the diffusion limitation on tissue oxygenation. New capillaries which had been closed are opened 
during muscular work and while tissue PO2 may be low, in working muscle PO2 approaches levels close 
to that observed within blood (45). As oxygen travels along the arteriole tree up to two-thirds of the 
molecule have been lost by the time it reaches the capillary bed (46-48).  Some of the oxygen which 
leaves the system can be recaptured downstream by RBCs via diffusion and travel to other regions of the 
body (49). Due to geometric properties of the vasculature, such as bifurcations, the distribution of 
oxygen is highly heterogeneous. Also, blood related phenomena such as plasma skimming and the 
Fahreaus effect prevent blood flow itself from being a good indication of oxygen supply to tissue, due to 
their contribution to the heterogeneity of its distribution(1, 41, 50-53). Furthermore, the oxygen 
concentration is extremely heterogeneous within the bulk blood flow; with measured values of 35 mmHg 
within the red blood cells and 10 mmHg within the plasma (54). The plasma PO2 will be lower than that 
within the erythrocytes, not because of consumption within the blood, but because of consumption in the 
wall and the surrounding tissue since free O2 is more readily diffusible than oxygen carried by the RBCs. 
Mathematical models examining the transport of O2 around parallel vessels and vascular networks can 
be found much more readily than those describing NO transport. Sharan and Popel et al.(55) examined 
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O2 transport around paired arterioles and venules without capillaries in a mathematical model.  Within 
their model they showed that under normal conditions, the change in PO2 along the axial direction of the 
venule is small as long as the ratio of venular flow to arteriolar flow is not very small. Secomb and Hsu 
(11) demonstrated that the O2 concentrations found inside the capillaries are closely correlated with those 
from the nearby arterioles. Diffusion from the arterioles accounts for approximately 85% of oxygen 
consumption and 46% of this oxygen diffuses into the capillaries and is transported elsewhere within the 
tissue (11).   Diffusion as well as the transport of O2 via RBCs are the key modes of oxygen transport 
through and from the cardiovascular system.  The question remains though if an NO-dependent signal 
could exert a significant influence on this transport of O2?   
1.1.3 Nucleotides 
The nucleotide adenosine 5’-triphosphate (ATP) is considered to be the major energy source within a 
cell.  The cell makes use of the high-energy content of the ATP molecule for a multitude of functions 
including its requirement as a cofactor for active transport of molecules across the plasma membrane and 
actin-myosin cross bridge cycling during muscle contraction. While studies have been ongoing for over 
50 years with regards to purinergic signaling a great deal of investigation continues.  Much of the current 
research revolves around determination of the manner in which ATP is released from endothelial cells, 
whether it be through vesicular exocytosis, ABC transporters, Plasma membrane F, F0-ATPase, 
Connexin hemichannels, or Pannexin channels (56).   
Under normal conditions, concentrations of ATP and related nucleotides in the plasma are maintained at 
around 10-7M by the action of extracellular enzymes such as ectophosphoesterhydrolases and 
ectonucleotidases located on the plasma membranes of endothelial cells (EC), erythrocytes, leukocytes 
and platelets.  The extracellular presence of the adenine nucleotides ATP and ADP stimulates the 
production of vasoactive agents and mobilizes intracellular calcium in vascular endothelial cells (57, 58). 
These responses are modulated by fluid mechanical shear stress on the cell surface (59-62).  The 
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concentration of ATP (CATP) at the endothelial surface increases with the magnitude of applied shear 
stress (63, 64). Experimental studies on ECs demonstrating the release of ATP in response to shear stress 
act as the motivation for mathematical studies (65).  As ADP is as potent as ATP in mobilizing EC 
intracellular calcium, the modeling of nucleotide transport has been extended to include ADP and 
demonstrated that the combined nucleotide cell-surface concentration varies slightly over a wide range 
of shear stresses (66). 
ECs are not the lone cell type known to release ATP.  Bergfeld and Forester were the first to demonstrate 
that red cells exposed to hypoxia released ATP (67).  This ATP, which would be released in the 
resistance vessel, is conducted along arterioles indicating the presence of purinergic receptors P2y1 and 
P2y2(68, 69).  The binding of ATP to these receptors on vascular endothelium causes vasodilation by 
release of NO (70). 
The mechanisms involved in the pathway for the release of ATP from erythrocytes experiencing 
conditions of low oxygen tension have been described (71).  Activation of the heterotrimeric G-protein 
Gi and subsequently the activation of adenylyl cyclase (AC) result in increases in intracellular cyclic 
adenosine monophosphate (cAMP).  This increase in intracellular cAMP brings about activation of 
protein kinase A (PKA) as well as the cystic fibrosis transmembrane conductance regulator (CFTR).  
Pannexin 1 is the final agent responsible for ATP release in response to the stimulus of low oxygen 
tension, Figure 2. 
Arciero created a model that was applied to test the hypothesis that saturation dependent ATP release by 
red blood cells triggers a conducted response and upstream vasodilation (72).  This was a compartment 
model composed of a flow pathway connected in series, consisting of an upstream artery, a large 
arteriole, a small arteriole, a capillary compartment, a small venule, a large venule, and finally a 
downstream vein.  Only the large and small arterioles are assumed to be vasoactive. The study provides a 
mechanism for metabolic flow regulation. 
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The theory behind this study can be traced to three points laid out by Ellsworth (73).  First of all when 
exposed to low oxygen red blood cells have been shown to release an increased amount of ATP.  Second 
in a study conducted by Collins et al. when ATP is administered intraluminally to collecting venules an 
increase in upstream arteriole vessel diameters is observed(74).  Thirdly, when measured as oxygen is 
decreased both diameter and ATP concentration ([ATP]) were found to increase only in vessels 
containing red blood cells.   
 
Figure 2:  Schematic of ATP release via the Pannexin-1 channels due to changes in oxygen tension. The 
green small molecule is the ATP molecule.  Activation of the heterotrimeric G-protein Gi and subsequently 
the activation of adenylyl cyclase (AC) result in increases in intracellular cyclic adenosine monophosphate 
(cAMP).  This increase in intracellular cAMP brings about activation of protein kinase A (PKA) as well as 
the cystic fibrosis transmembrane conductance regulator (CFTR).  Pannexin 1 is the final agent responsible 
for ATP release in response to the stimulus of low oxygen tension. Image is modification of that previously 
presented by Goldman (71). 
 
1.1.4 Microcirculation 
The average adult has approximately 1011 blood vessels with the vast majority of them being capillaries 
(75). Ranging in diameters from a few hundred microns down to just a few microns the vascular 
components of the microcirculation are the smallest blood vessels found in the body. The vessels are 
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known to be densely spaced allowing for a large surface area for the diffusion of various physiological 
species to their respective targets.  The three categories of micro-vessels located within the various tissue 
types of the body are arterioles (whose job it is to carry oxygenated blood from the arteries), capillaries 
(which are the smallest and perhaps one of the most important vessels in the body connecting arterioles 
to venules), and venules (which carry de-oxygenated blood to the veins). 
Overall it has been observed that each micro-vascular network has its own characteristics, but as laid out 
by Schmid-Schonbein there exist general unifying features (75).  Arteries or arterioles are known to form 
networks, which come to be known under a number of names such as arcades, plexuses, collaterals, or 
bifurcating trees. Venules are known to form similar arrangements as arterioles. Several input arteries 
supply blood to the various networks. These input arteries are connected to different central arteries. The 
typical vascular network drains into several central veins. The functional grouping of capillaries, 
terminal arteriole, and draining venule has come to be known as a micro-vascular unit (MVU) (76).  
Others have defined a grouping of capillaries fed by a single arteriole as a tissue module (5, 77).   
Regardless of terminology, the MVU or tissue module is the smallest functional unit for control of blood 
flow and consists of the capillaries which are fed by a single terminal arteriole (78). As defined by Segal 
the typical MVU consists of a terminal arteriole that gives rise to 12-20 capillaries, each approximately 
500 to 1000 um long, in both directions along muscle fibers and terminating in respective collecting 
venules (76).   This description applies to tissues such as those found in the hamster tibialis anterior (79, 
80) and retractor (81).   
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Figure 3: Micro-vascular casts in mouse gluteus maximus muscle (76) . The vasculature is cast using 
Microfil and muscle fibers are cleared in glycerin.  A third-order arteriole (A) and its paired venule (V).  
Close proximity of respective arteriole, venule branches as network branches to terminal segments that 
supply and drain the micro-vascular units. 
 
 
.  
 
 
Table 1: Reproduction of Table 1 from Hutchins, Bond, and Green(82) describing the categorization of the 
vessels inside the microvasculature. In particular, this table categorizes the different types of arterioles 
within the rat cremaster muscle. 
Terminal arterioles being the smallest arterioles found in  
Vessel	  Type
Average	  
Diameter	  (um)
Diameter	  Range	  
(um)
Precapillary	  Sphincter 5.7 4.0-­‐7.5
Terminal	  Arteriole 6.1 3.4-­‐9.3
Metarteriole 9.4 4.9-­‐15.0
Areteriole	  1 9.1 5.1-­‐12.2
Areteriole	  2 13.6 12.5-­‐14.8
Arteriole	  3 16.9 15-­‐19.25
Arteriole	  4 26.7 20-­‐39.5
Arteriole	  5 51.4 41-­‐63
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Table 1 are directly connected to the capillaries, which as defined by Fry are vessels whose diameters are 
less than 8µm(83).These feeding terminal arterioles and capillaries then drain into the venule, which as 
described by Segal are capable of providing feedback to nearby arterioles regarding the metabolic state 
of the tissue via transport phenomena (76). 
Importance of Study 
1.2.1 Pathological Significance of NO-mediated Dilation 
In many forms of vascular disease, there exists an imbalance amongst the steps involved with the 
NO/cGMP pathway (84, 85). Dysfunctions related to NO transport have been linked as either causes or 
symptoms of diseases such as: essential hypertension, atherosclerosis, sepsis, glaucoma, renal failure, 
diabetes mellitus, and neurodegenerative disorders (86-88). Interestingly, endothelium-dependent 
relaxation is impaired in established diabetes, yet early stages of the disease include an increased release 
of nitric oxide (89). This fascinating behavior demonstrates the dynamic nature of health and pathology 
and the role which the signaling molecule NO has in the maintenance of each.   
Studies have unveiled that blood transfusions are associated with adverse cardiovascular events, leading 
to transfusion related organ damage and even mortality (90). Approximately 85 million units of human 
blood are collected each year for therapeutics but may be causing more harm than good. Stored blood 
show low levels of S-nitrosohemoglobin (SNO-Hb). SNO-Hb has been proposed to regulate blood flow 
and tissue oxygenation. The binding and release of O2 from hemes are intimately linked to binding and 
release of NO from cysteine residues in Hb that in turn controls vasodilation and constriction. Further,  
renitrosylation of blood restores the ability of transfused blood to deliver adequate O2 and nutrients to 
tissue, making a clear case for the importance of NO in this process (90). The mechanisms implicated in 
returning the functionality of O2 transport to blood are associated with the release of S-nitrosothiols 
(SNOs) into the blood. This highlights the importance of understanding the role of NO in controlling 
blood flow and subsequent O2 delivery (91-93) in normal healthy vasculature. 
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As 50-80% of all vascular resistance occurs within the microcirculation (95), the smaller vessels found 
within the cardiovascular system demand adequate consideration when studying blood flow and nutrient 
transport. In silico studies have examined local regulation of blood flow within the microcirculation (72, 
96-101). Vascular smooth muscle (VSM) tone refers to the state of constriction of a vessel, differs by 
location and size of the vessel, and exerts a significant influence on local control of blood flow and 
nutrient delivery (102).  The local regulation of blood flow and control of local vascular tone is broken 
down into specific response types.  The myogenic response, which is associated with defining the basal 
(or resting state) vascular tone for the vessel (102, 103). The myogenic response of blood vessels is 
related to  trans mural pressure, and independent of neural, metabolic, and hormonal influence (104).  
Flow-induced dilation is also thought to occur independent of neural and humoral influences, as well as 
extrinsic factors from parenchymal cells (105-108). As wall shear stress (WSS) is the primary 
hemodynamic determinant of endothelial release of nitric oxide (NO) (18, 26, 109-117), models 
considering the role of NO in regulation of vascular tone associate NO with the flow mediated response 
(97).   
The underlying theory of the metabolic response involves the limited resource of O2 within the living 
system. A biochemical process must occur in an oxygen dependent manner that produces one or more 
chemical messengers as the system approaches hypoxia(118).  As the metabolic demand increases there 
is a proportional release of vasodilator metabolites into the interstitial spaces. Vasodilation at the level of 
the microcirculation rises or ascends into the ‘feed’ arteries controlling blood flow (74), is another 
modality of local blood flow regulation labeled aptly as the conducted response.   
Of the studies examining the local control of blood flow within the microcirculation, few consider the 
influence of NO (96, 97). As nitric oxide is associated with the flow mediated modulation of the 
myogenic response (95, 119-121) and subsequent decrease in smooth muscle vascular tone, the 
concentration of NO (CNO) is assumed to depend upon shear stress stimulation alone. When incorporated 
in the model a balance was observed between upstream flow-dependent dilation due to NO and 
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downstream constriction with metabolism (96). The transport and therefore influence of oxygen is not 
considered in either of these models (96, 97). As the metabolic response is largely driven by a response 
to changes in local O2 levels(118, 122) it seems imperative that models of regulation of blood flow 
should incorporate O2 transport (118, 122). Furthermore, models, which omit the transport of O2 when 
considering the transport of NO, are neglecting a very intricate relationship. Oxygen is an essential 
substrate for nitric oxide production (38, 123), and oxygen levels are also known to influence the 
metabolism of nitric oxide in the perivascular region as NO and O2 have been found to competitively 
bind to cytochrome c oxidase (124-128). There exists other means by which the biological functioning of 
NO and O2 intersect, Umbrello, Dyson, Feelisch, and Singer have discussed many of which in their 
review of the role of NO in hypoxic regulation(94).   
Local oxygen levels have been incorporated in later modeling attempts along with flow-dependent, and 
myogenic responses (72, 101). In particular an oxygen-dependent conducted response is considered in 
multiple works, which operates via ATP release from red blood cells (72, 101). Both the flow-dependent 
and myogenic responses were found to oppose the mechanism of metabolic (oxygen-dependent) flow 
regulation. The greatest metabolic signals were found to originate within the venules and vein of the 
network considered and found to positively correlate with an increase in oxygen demand within the 
tissue.  In a later study the location from which the metabolic signal originates was examined (101). The 
conducted response, as well as the signals generated due to shear stress and wall tension were all 
incorporated in the model (101).  It should be noted that as the conducted response depends upon O2 
metabolism, it is considered for the sake of these referenced simulations a contributor to the metabolic 
response.  It was concluded that the heterogeneous flow, commonly observed in the microcirculation, a 
wall-derived signal may prove to provide better regulation via matching the oxygen demand of the 
surrounding tissue. 
Studies have also examined the influence of the myogenic, shear-dependent, and metabolic responses on 
a single vessel (96).  As opposed to the other models the myogenic response is assumed to be a function 
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of the wall tension rather than being directly related to pressure.  As noted by the authors the model 
suffers from some limitations as it neglects the role of diffusive exchange between capillaries and 
arterioles when considering oxygen delivery.   
Returning to the consideration of flow regulation for a single vessel due to various stimuli, Carlson and 
Beard (7) build off of an earlier mathematical model constructed by Carlson and Secomb(130) to 
determine which of the VSM stress sensitive channels is most likely responsible for the myogenic 
response.  The model also incorporates the change in smooth muscle tension due to calcium dynamics 
previously modeled by Kapela, Bezerianos, and Tsoukias(131). The Kapela model eloquently 
incorporates both the NO-sGC-cGMP pathway as well as NO’s influence on the large-conductance, 
Ca2+-activated K+ (BKCa) channel.  With this said, only two concentrations of NO were considered in the 
study, 0 nM and1 µM. The 1 µM is a saturating concentration, unlikely to be observed physiologically. 
NO was found to hyperpolarize the plasma membrane and decrease intracellular Ca2+, both of which 
were altered due to various concentrations of norepinephrine ( NE) administration to the computational 
vessel. 
The microvasculature must adapt to changes in the metabolic demand and blood flow (6). The response 
of the microvasculature to changing conditions must be assimilated across the vascular bed (76, 132).  
Both hemodynamic forces  and metabolically derived signals can combine to alter the properties and 
structure of the vascular system.  In the first half of last century Cecil Murray(133) came up with a 
theory which stated that the overall energy “cost” of the many different aspects of blood flow are 
minimized when the blood flow in each of the many segments which make up the vascular system is 
proportional to the cube of that particular vessels diameter.  The governing mechanism for diameter 
change of the vasculature would be to maintain a constant wall shear stress value, an idea that is still 
debated (134). 
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This dissertation assumes that the control of the vessel diameter is indeed the result of numerous signals 
originating from different sources.  In particular, O2 is considered to play a vital role in determination of 
the signal strength and therefore blood flow.  As hypoxic vasodilation has been studied for over one-
hundred years it proves interesting that the sensing mechanisms and effector signaling mechanisms 
require further elucidation (135).  Nitric oxide (NO) is a known vasodilator and is another important 
signaling factor.  Nitric oxide is also known to be both dependent upon as well as play an influential role 
in the consumption of oxygen (O2) within the tissue as well as the vascular wall.  For this and various 
other reasons it is proposed that there exists a nitric oxide - oxygen pathway that controls the dilation of 
the vessels as well as other vascular processes.  Recently a model has been proposed linking NO to the 
local regulation of blood flow in an oxygen dependent manner (118).  This “on/off” model considers that 
muscle contraction and active hyperemia are the physiologically normal state of the arteriole.  An 
increase in superoxide (O2- ) brought on by an abundance of oxygen and glucose results in a turning 
“off” of the NO-dependent signal.  Commentaries on this model have largely been unfavorable, in 
particular stating that the regulation of blood flow is far too important to be associated with only one 
mechanism(136)   
 
While the focus of this dissertation is NO and the potential role it may play in control of blood flow and 
oxygen transport, it is not believed that this is the only means by which blood flow is correlated with 
oxygen demand.   It is believed that making use of three-dimensional vascular models a role for NO in 
the regulation of O2 supply and demand at the smallest most intimate level of O2 and nutrient transport 
can be determined.  Furthermore, consideration of the interaction between blood flow, O2, ATP, ADP, 
NO, and vessel architecture will provide greater detail in the relationship between O2 and NO and how 
this interaction influences blood flow and normal biological function of tissue.  The concentration of NO 
will change at critical locations of blood flow control depending upon local oxygen transport.  The 
responsibility for regulating the local CO2 does not fall solely upon the cells located in and traveling 
through the arterioles, but also the red blood cells and endothelial cells found in the capillaries and 
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venules of the network.  The endothelial derived NO from the capillaries or venules is proposed to 
diffuse from the source vasculature to the arteriole wall and trigger an oxygen dependent dilatory 
response as the increase in NO production is caused by an increase in oxygen-dependent ATP release 
from RBCs.  NO and O2 are transported from the different vascular components via both diffusion 
through the tissue and convection downstream the vasculature,  
Figure 4.  Nucleotide transport, vascular geometry, hemodynamics, and other traits are considered to 
play important roles in the control of NO release from vascular endothelial cells resulting in a viable 
manner of oxygen dependent blood flow control. These physiological mechanisms require proper 
investigation in an attempt to get a grasp and attempt to find long term solutions to many pathological 
issues. 
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Figure 4:  Schematic of key processes involved with chief hypothesis. Within each vascular component, 
blood flow, shear stress, RBC flux, and local PO2 are sensed by the ECs arterioles lining the respective vessel.  
Accordingly a certain concentration of nucleotide is released which coupled with the other factors influences 
the CNO. Depending upon the gradient of NO, diffusion occurs through the tissue influencing the CNO in the 
respective vascular component. 
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1.2.3 Specific Aims: 
The fundamental goal of this project is to explore the role of NO in the regulation of blood flow in the 
microcirculation in response to changes in tissue oxygen (O2). A series of computational studies have 
been completed in attempt to further examine the relationship between O2 and NO in the 
microcirculation. These studies are designed in compliment to previous experimental studies completed 
in our lab and also those described in literature. The particular software packages applied in our analysis 
are COMSOL and FlexPDE, both of which being finite element analysis, FEA, packages. The specific 
aims of this project are: 
1. Model the influence of vascular design on the coupled transport of NO and O2. 
Hypothesis 1:  Vessel architecture greatly impacts the transport of NO and O2 in the 
microcirculation. This impact of vessel architecture influences the location of potential 
metabolic signal generation in response to changes in O2 demand in the tissue. 
Hypothesis 2: Vessel architecture greatly influences the flow of blood, which is the most 
important modeling characteristic. 
 
2. Develop a model describing an O2-dependent pathway regulating NO concentration. 
Hypothesis 1: O2 and NO transport in the microvasculature is very codependent.  
Hypothesis 2: There exists a mechanism that an increase in NO can occur in response to an 
increase in O2 demand in the tissue. 
 
3. Simulate the increase in arteriole diameter and subsequent changes in blood flow in an 
MVU due to increases in NO concentration. 
Hypothesis: An increase in the terminal arteriole will result due to the predicted increase in NO 
around the arteriole. This increase in arteriole diameter will promote red blood cell flux into the 
terminal arteriole and downstream vasculature. 
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Chapter 2: Geometries, mathematical equations and key concepts 
A key concept focused on throughout this thesis is that of heterogeneity. Cells found in different tissues 
behave differently, different vessel types have different behaviors, etc. ‘The microvascular beds of all 
organs are not the same.’(137) As demonstrated by Kashiwagi et al., the expression of eNOS differs in 
arterioles, capillaries, and venules (138). Other studies have verified the findings of Kashiwagi in rat 
mesentery endothelial cells (139). In particular eNOS was found to be significantly greater in rat 
mesenteric venular endothelial cells (RMVECs) vs. rat mesenteric arteriole endothelial cells (RMAECs). 
Contrasting studies concerning cultured ECs from bovine aorta and vena cava found that these cells 
released similar amounts of nitric oxide in response to bradykinin (140). Stimulation of NO release from 
the jugular vein and nearby carotid artery were found to elicit a lower release of NO from the jugular 
vein in comparison to the nearby carotid artery (141). These heterogeneous findings signify the need to 
take caution when applying experimental or computational findings from specific tissue types to defining 
global laws in reference to NO transport. These findings could also provide an explanation for the large 
observed discrepancies with regards to the CNO range for which soluble guanylate cyclase (sGC)-cyclic 
guanosine monophosphate (cGMP) dependent dilation demonstrates sensitivity, along with differences 
in experimental techniques.  
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Author CNO [nM] Vessel Diameter [µm] Experimental Notes 
Tsai et al. (142) 200 58 Hamster Retractor 
Muscle 
Tsai et al. (143) 600-1200 50-60 Hamster Retractor 
Muscle-high viscosity 
plasma 
Zani and Bohlen(144) 545±144 53 Spraque Dawley rats 
intestine arteries 
Nase et al. (40) 397±26 52 Intestine arterioles 
Malinski et al. (145) 1300 Adult New Zealand 
Rabbit thoracic aorta 
Ex vivo-stimulated by 
bradykinin 
Table 2: Experimentally observed [NO] (nM) per respective vessel diameter (in vivo conditions unless 
otherwise noted).   
	  
Author EC50 [nM] Experimental Notes 
Stone and Marletta(146) ≤ 250 In vitro purified sGC 
Russwurm(147) 690 In vitro purified sGC 
Bellenny(148) 20 In vitro purified sGC in cerebellar 
cells 
Artz(149) 1600 In vitro purified sGC using NO 
donors 
Condorelli and George(150) 23 In silico computation of kinetics 
Bellenny(151) 3.9 In vitro brain tissue 
Roy and Garthwaite(152) 2.9 In vitro tetracycline inducible HEK-
293 cells 
Yan et al.(153) 9.7 Ex vivo 
Bellenny and Garthwaite(154) 20-45 Cerebellar cell suspensions 
Griffiths and Garthwaite (155) 2 Cerebellar cell suspensions 
Table 3: Experimental measurement of the half activation constant of sGC with respect to [NO]. Various 
distinguishing characteristics of each experiment are provided in the experimental notes column.   
 
As indicated, the large discrepancies observed in experimental reports could be due to a large amount of 
heterogeneity present in the circulatory system. The endothelial cells and other constituents of the 
vascular system have adapted and been designed to respond to certain stimuli in a manner unique for 
their particular environment. Stimuli such as shear stress have been shown to change the alignment 
(156), release of certain signaling molecules (157), and changes in gene expression (111, 158) of ECs. 
At this current juncture, it is desired to express the observance of heterogeneity with respect to NO 
transport and function to illustrate the need for caution when interpreting the results of this and other 
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related studies. Chapter 5 shall explore the NO-sGC-cGMP pathway and its influence on vessel 
diameter, in which the topic of heterogeneity in the pertinent experimental and computational results is 
revisited. The existence of heterogeneity in biological functions indicates the need for improvements and 
the usage of multiple computational models to develop a more general understanding of the role NO can 
play in PO2 sensitive regulation of blood flow.  
2.1 Micro-vascular Computational Domains 
Due to the significance placed upon heterogeneity in blood flow we decided to consider multiple 
computational vascular structures within this dissertation. The first structure is inspired by a hamster 
cheek pouch retractor muscle (49) and has previously been made use of in computational studies 
undertaken by Ellsworth and Secomb (159) and Chen et al. (12).  As shown in  
Figure 5, we consider a rectangular volume of tissue is with the dimensions of 100µm x 500µm x 75µm. 
This particular volume of tissue consists of 15 vessels. There is one arteriole (A1) that is directly 
connected to two capillary branches (C2 and C3). Positioned approximately 100µm away from A1 is a 
bifurcating arteriole (A2). This parent branch of A2 divides into two daughter vessels (A2b and A2c). 
Arranged in a parallel pattern around the two arterioles are eleven capillaries (C1 and C4-C12).  The 
dimensions of these vascular components are described within Table 6: Descriptive parameters of blood flow 
for the bifurcating network geometry.	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Figure 5: Microvascular tissue block model of the dimensions 100 um x 500 um x 75 um. Subfigures 
illustrating the bifurcating arteriole network tissue block model from different perspectives. Subfigures (A) 
and (C) indicate the location of the two arterioles (A1 and A2). Subfigure (B) illustrates the locations of the 
each of the twelve capillaries from the distributed capillary network. As described in Chen et al. (12) the 
parent arteriole A1 has a singular daughter arteriole (A1a) and two branching capillaries (C2 and C3). 
Meanwhile, parent arteriole A2 bifurcates to two daughter branches (A2a and A2b). Outlet A2b is the larger 
of the daughter bifurcations, while of course the branching arteriole A2c is the smaller of the daughter 
branches. 
	  
The network model,  
Figure 5, is composed of two arteriole branches. A large degree of focus is placed upon the bifurcating 
arteriole (A2) in this study, as we are interested in studying the influence of the bifurcation on the 
distribution of blood flow and subsequent transport of signaling molecules. The parent branch of A2 
bifurcates into two daughter branches, one is the same diameter as the parent and the other is 4/5 the 
diameter of the parent arteriole. The other arteriole branch (A1), of the paired bifurcating arteriole 
system, clearly feeds two capillary branches extending from the middle of the vessel. The inlet velocity 
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into each of the arterioles and the outlet pressures for the different branches along with other 
physiological parameters was assigned from various publications as was done previously(12).  
Parameter Numerical Value Source 
Average Capillary Length 1 mm (11) 
Average Arteriole Length 2 mm (160) 
Average Arteriole Pressure 26.7 mmHg (161) 
Average Capillary Pressure 17.4 mmHg (161) 
Table 4: Physiological Properties used to determine blood flow in bifurcating arteriole network model. 
 
The outlet pressures at the different capillary locations were set to 22.6, 24.5, and 29 torr (mmHg) 
respectively (12). The outlet pressure of the arterioles was set to 29 mmHg. These boundary conditions 
refer to the bifurcating arteriole model and have previously been described in the corresponding 
published work (12). Previous simulations considering an arteriole venule pairing(162) have 
demonstrated that the venules have the potential to play an important role in the transport of NO in a 
micro-vascular unit structure. Also as discussed above in describing the heterogeneous nature of NO 
production, venule eNOS expression has been found to be greater than that observed in the arteriole(138, 
139). To consider the impact of chemical transport through a collecting venule, as well as to expand 
upon the potential contribution of capillaries in the regulation of NO transport and blood flow, a new 
network structure is considered. So to connect the capillaries to the arterioles we step away from the 
geometry studied by Chen et al. (12) and Secomb and Hsu (11).   
The complexity of the micro-vascular geometry and hemodynamics (41), as well as blood transport 
properties (163, 164) play a large role in the transport of O2 throughout the network. Due to the large 
number of interactions between O2 and NO within a physiological entity, the complex structure of a 
physiological network structure will also greatly influence the transport of NO.  
The new network geometry considered is not based upon an experimentally studied network. Instead, the 
new micro-vascular network borrows aspects of the microcirculatory network from studies conducted by 
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Tsoukias (5) and experimental measurements by the likes of Hutchins et al. (82) and Davis et al. (161). 
As described by Goldman and Popel (165), the capillaries found in muscle fibers are not straight and 
uniform, but instead have a degree of tortuosity and a series of cross connections (anastomoses) which 
are found to greatly influence oxygen transport within the network(165).  For this reason the capillaries 
included in the network structure illustrated in Figure 6 are mostly curved and irregularly shaped to a 
much greater degree than the capillary network included in the bifurcating vessel model,  
Figure 5. This network contains capillaries (13 in number), supplying arterioles (2 arteriole inlets), 
draining venule (1 venule outlet), and is largely based upon the morphological parameters for the 
hamster cheek pouch retractor muscle (161). 
A 64-bit operating system with an Intel® Xeon™ Processor with 3.40 GHz CPU was made use of for 
the majority of the simulations. When solving three-dimensional models, simulations in which the 
number of elements in the mesh approached 2 x 106 proved to be very challenging for the computational 
power of the machine. This is a good reason to limit the complexity of the model geometry. Also before 
examination of larger more complex networks, it proves useful to properly model and analyze the 
intricacies of the transport of NO and O2 in the vascular network structure considered within this study. 
The number of capillaries found in the new network is based largely upon computational limits. So to 
maintain a sense of order and also to limit the mesh so to allow for the solution of the transport in the 
vascular system, we limit our MVU design to 13 capillaries. 
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Figure 6: Schematic of connected vascular network inspired by that studied by Tsoukias (5). Blood flows 
into the arteriole branches (labeled 1-8, designating the different parts of the arteriole) in a diameter 
dependent fashion, through the capillaries (labeled c1-c13), and out of the venule (labeled V1).The 
vasculature is surrounded by a block of tissue as has been the case with all of the three dimensional models 
considered in this study. Furthermore, the capillary network structure has been simplified to a degree from 
that which inspired the geometric alterations. 
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Figure 7: Lumped network circuit representation of the vascular network represented in Figure 7. A 
diagram of this nature can be made use of to determine flow and hemodynamic properties within the 
network structure. Ra1-Ra8 represents the flow resistance due to the 8 sections that make up the arteriole 
considered in the simulation. Rc1-Rc13 are the flow resistances in each of the capillaries which empty into 
the resistive venule. The resistance of the venule is not considered in this diagram and therefore is not 
shown. 
 
2.2 Solution Algorithm 
The general algorithm for solving for the mass transport within our system begins with the definition of 
input parameters (viscosity, ratio of RBCs to total blood (Hct), and vessel dimensions). These input 
parameters are then applied to an equivalent hydraulic circuit, representative of either of the two multi-
vessel vascular structures considered in this study. The hydraulic network geometry allows for us to 
solve for the approximated pressure driven flow and define the flow dependent viscosity and Hct in each 
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of the vessels of the model. These parameters are solved for in an iterative fashion, using the values from 
literature as initial guesses. The flow dependent viscosity and Hct are then applied in the multi-vessel 
models along with the appropriate inputs from literature. The Navier-Stokes equations are	   solved	   to	  
determine	  the	  blood	  velocity	  and	  profile.	  The	  solution	  for	  blood	  flow	  is	  then	  coupled	  to	  determine	  the	  
transport	  of	  NO,	  O2,	  ATP,	  and/or	  ADP	  in	  our	  network.	  	  
	  
	  
Figure 8: General solution algorithm for multi-vessel models. 
 
Amongst the steps of the solution process described in 	  
Figure 8, the importance of solving for the distribution of red blood cells cannot be over-stated. RBCs are 
known to be key transporters of O2 and also play an integral role in the transport of NO. 
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2.3 Modeling/Calculating Blood Flow 
The vascular geometry will greatly influence the fluid transport in said network. Likewise, blood flow is 
known to exert a grand influence over the transport of NO. Convective transport, shear stress dependent 
NO production, RBC dependent NO scavenging, and potentially RBC dependent NO production (166, 
167) are several examples of the pathways by which blood flow can influence NO transport. Mechanical 
forces, pressure gradients, and vascular resistances drive the flow of blood within the circulation. As the 
blood enters the microcirculation the oscillatory behavior observed in the larger vessels is neglected and 
the flow is assumed to be steady and governed by the change in pressure of the vasculature as well as the 
variety in vascular resistances through the bifurcations.  
Simplified Navier Stokes Equations are solved making use of the internal computational power of the 
simulation software COMSOL®. Prior to application of the finite element software it is necessary to 
approximate the blood flow through the considered networks, as previously discussed. This need exists 
as the hematocrit and viscosity within each of the vessels within the computational network must be 
defined prior to running COMSOL®. The approximation of blood flow and related properties will 
prevent computational costs due to the need to iteratively solve for the viscosity and Hct in each of the 
vascular components in the model as the solution converges. Furthermore, there will be instances in 
which additional vessels either upstream or downstream of the computational domain are considered due 
to their influence on the transport within the model domain. As these components are not actual parts of 
the computational domain in COMSOL®, it would be difficult to approximate the influence of changing 
descriptive parameters of the non-present vascular components, i.e. feeding arteriole. 
For these approximations the steady motion of blood through the vasculature is considered to be an 
incompressible viscous fluid. It is also assumed flow is unidirectional along the vessel (we define this as 
the x-axis).  The Navier-Stokes equations then reduce to a singular equation: 
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  ................................................................................................................... Equation 1 
 
The value u is the velocity component in the axial direction of the vessel and is independent of x. The 
continuity equation is then satisfied and the pressure gradient will then be a constant and   Equation 1 can 
then be written in the following form: 
  .................................................................................................................. Equation 2 
 
Where ΔP is the pressure difference along the length (L) of the vessel considered within the model.  The 
velocity profile of the flowing blood is assumed to be parabolic. At the vascular wall a no slip boundary 
condition is assumed, along with the assumption that blood flow is symmetric about the center of the 
vessel.  
  .................................................................................................................... Equation 3 
 
Assuming steady flow, the radial and the swirl components of the flow are assumed to be 0 and the flow 
is also assumed to be axisymmetric. The radius of the vessel (r) raised to the forth power along with π 
divided by the product of 8 and the viscosity of the fluid is equivalent to 1/R, with R being the equivalent 
resistance of the vascular component. So what we are left with is an equation describing pressure driven 
flow within our vascular component. 
  ......................................................................................................................... Equation 4 
 
  Equation 4 is the equivalent of Ohm’s law for electrical circuits in terms of a hydraulic circuit. 
With R being the resistance, equivalent to   Equation 5. 
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  ......................................................................................................................... Equation 5 
 
The hydraulic resistance is the ratio of eight times the dynamic viscosity and the length of the pipe and 
the product of π times the radius of the tube raised to the forth power. L is the length over which the 
pressure drop occurs and r is the radius of the vascular branch in question. These approximations 
adequately describe the flow of blood through the microcirculation due to low Womersley and Reynolds 
numbers. Further assumptions applied so to make use of the Hagen-Poiseuille relation include neglecting 
the influence of entrance effects and assuming that R/L << 1 and R/L <<<1/Re (Re is the Reynolds 
number). This approximation allows for us to take the necessary step in solving for the viscosity and Hct 
in each of the vessels found within the model without the need to use COMSOL®. Without this 
approximation it would be necessary to solve for the viscosity and the distribution of red blood cells with 
an iterative algorithm in the FAE program, dramatically increasing the computational demand of our 
model.  
 As it has been demonstrated that the hydraulic circuit is analogous to the electrical circuit, Kirchoff 
circuit laws can be applied in order to deduce the flux of blood and eventually red blood cells through a 
particular vascular component. For the initial network of the shear stress dependent NO production 
computational model the connected hydraulic network is not extremely advanced, Figure 9.  For this 
simulation set the approximated network of the pressure driven flow is used to determine the hematocrits 
and viscosities within the two daughter branches. The lumped resistance network for the connected 
arteriole/venule network has already been illustrated in Figure 7. There exist clear connections between 
the arteriole and the capillaries of the vascular structure. In a similar tone, all of the later generations of 
simulations making use of the bifurcating arteriole computational structure assume that the arterioles are 
likewise connected to capillaries and therefore make use of a different set of boundary conditions than 
those applied in the original three dimensional model considered in this work(12).   
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Figure 9: Basic hydraulic network structure for bifurcating arteriole. The boxes denoted with Rx are 
hydraulic resistances experienced in the parent and two daughter vessels.  The inlet boundary condition is 
the average velocity defined at the inlet of the bifurcating arteriole and the outlet boundary condition is the 
outlet pressure associated with the end of the length of each of the two daughter branches computationally 
considered. The current network consists of the two daughter branches in parallel and their respective 
equivalent resistance in series with the resistance of the parent branch. 
 
To alter the boundary conditions logically away from those for the model considered in Figure 9 and 
(12) several approximations with regards to the vasculature outside of the computational structure are 
made. The smallest vascular unit consists of a single terminal arteriole which feeds 20-25 capillaries and 
supplies a region of muscle tissue ~100 x 200 m in cross section with a length of 500 um (168). Using 
this knowledge and the data from Table 4 a fluid circuit was created for each of the two respective 
arterioles of our bifurcating arteriole network model. The inlet pressure of each arteriole is set to 
26.7torr, corresponding with the pressure in the 4A arteriole type of the hamster cheek pouch as 
described by Davis (161). In the case of the first arteriole branch the fluid is assumed to travel the 
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average length of the arteriole and then break up and either enter one of the two capillary outlets or finish 
its journey to the conclusion of the arteriole. At the end of the arteriole, as previously indicated it is 
assumed that the arteriole divides into 20 capillaries, each with an outlet pressure of 17.6 mmHg(161). 
Meanwhile the second arteriole is composed of a parent branch, which then divides into two daughter 
branches.  The first of the two daughter branches is the same size as the parent arteriole, while the 
second daughter branch is 4/5 the diameter of the parent arteriole. The network model is based upon 
other models and experimental networks examined by Ellsworth and Secomb(11, 49) and previously 
applied by Chen(12). Therefore, applying the conservation of mass each of the respective capillaries will 
have 1/40 the total flow entering the terminal arteriole, as we have two terminal arterioles assumed to be 
feeding 20 capillaries apiece. Using these approximations and solving for the fluid flow we can 
determine the fluid driven parameters of the blood viscosity and hematocrit throughout our different 
computational domains.  
To review briefly there are three primary three-dimensional computational domains that are considered 
within this study. The initial domain makes use of the same boundary conditions applied in the published 
study of NO transport in a three dimensional bifurcating arteriole completed by our lab (12). Using the 
same computational domain, but approximating the upstream and downstream vasculature of the original 
tissue block model, new boundary conditions are made use of and a second more connected 
computational network is constructed. The vessels in this network are more interdependent as the flow 
into the capillaries is a function of that out of the arterioles, and the vessels further down stream 
influence the flow of the arterioles. The third computational domain is that of the described connected 
arteriole/venule model. Consideration of these geometries and their respective boundary conditions 
allows for us to approximate the hematocrit and viscosity that we require so to solve our three 
dimensional COMSOL ® model. 
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2.3.1 Calculation of parameter dependent viscosity 
In their analysis of blood flow resistance in micro-vessels Pries et al. (169) rely upon the usage of 
experimental observations of fluid velocity and pressure in male Wistar rats to develop a series of 
empirical viscosity equations dependent upon such parameters as vessel diameter and blood Hct.  
Amongst the parameters fit by Pries et al. (169) are C and ƞ0.45. C describes the sensitivity of blood 
viscosity on Hct. Meanwhile, η0.45 is the diameter dependence of viscosity in tube flow, accounting for 
the Fahraeus-Lindqvist effect (170, 171).  Ƞ0.45 is also the viscosity of blood at a fixed discharge 
hematocrit of 0.45. The variable D found below is the diameter of the vessel in question. The tube 
hematocrit is represented with the variable HD. 
 .............................................. 
 Equation 6 
 
  .............................................................. Equation 7 
 
  ............................. Equation 8 
 
It is important to calculate the change in viscosity as throughout the various vascular components, not 
only to describe the flow of blood appropriately, but also to adequately describe the change in shear 
stress. As previously mentioned, shear stress is known to play an important role in the production of NO 
from ECs(106, 172). With this said in the diameter range from 5-15µm the apparent blood viscosity is 
only slightly greater than that of the suspending plasma and does not exhibit a strong dependence on 
hematocrit (51, 169, 173-175).  The viscosity of plasma is set to equal 1.2cp (137).  
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2.2.3 Determination of the Distribution of Red Blood Cells throughout a micro-vascular network 
 
Throughout the vasculature there are numerous locations in which a single parent vessel branches out 
into numerous daughter branches to better provide essential nutrients to the tissue found throughout the 
body.  As blood encounters a bifurcation the distribution of erythrocytes would be so that the smaller of 
the two daughter branches will receive a lower fraction of the RBCS in proportion to the total fluid flow 
than the larger of the two daughter branches. Pries et al. have studied this physiological behavior on 
numerous occasions and have derived empirical formulas to mathematically describe this 
phenomena(99, 176).    
For the following equations we consider a singular arteriole bifurcation. There is a parent branch (Bp), 
which supplies two daughter branches (Bα and Bβ). The flow rates through each of the respective 
branches are Qp,Qα, and Qβ. The diameters of each of the various branches are DP, Dα, and Dβ. In each of 
the following equations the subscripts p, α, and β refer to the calculated or defined value for the parent 
branch or either of the two daughter branches. FQE is a general term representative of fractional 
erythrocyte flow into each of the daughter branches α and β. FQB is the general representation of the 
fractional volumetric flow of blood into either of the two daughter branches. 
 
Figure 10:  Flow encountering a bifurcation leading to dissimilar quantities of blood and red blood cells in 
the two daughter branches (α and β). The flow of blood (Q) and the flux of red blood cells (q) does not 
necessarily have to differ in daughter branches. This will depend upon the diameters of the two daughter 
branches. 
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  ..................................................................... Equation 9 
 
  ........................................................................... Equation 10 
 
  .................................................................................................... Equation 11 
 
 ......................................................................................................................... 
 Equation 12 
 
In making use of the correlations and fits deduced by Pries several characteristics of the descriptive 
empirical formulas were discovered. If the fractional blood flow calculated to enter a particular daughter 
vessel is less than X0 then no red blood cells shall be flowing into this branch. This would make the 
hematocrit of this branch 0. For this reason X0 defines the minimal fractional blood flow required to 
promote RBC entry into a respective daughter branch.  In a related manner if the fractional blood flow 
entering a daughter branch is equivalent or greater than 0.94 then all of the red blood cells from the 
parent branch shall enter this particular daughter branch and the hematocrit in this branch shall be 
equivalent to that of the parent. The other daughter branch shall therefore experience a lack in RBC flow. 
With the use of this information and the empirical formulas derived by Pries et al. (1, 50, 177) one can 
calculate the distribution of blood and erythrocyte flow throughout a vascular network.   
The relationship between the daughter vessels is controlled by the flow split and by the calculated 
parameter A. If daughter vessels have the same diameter then A is 0, and the vessel with the larger flow 
fraction will get the higher Hct. If not, the hematocrit is biased towards the smaller daughter. However, 
the smaller daughter usually has lower fractional flow that leads to lower Hct instead of this bias. This 
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last statement helps to explain why in certain situations one could get greater Hct in one of the daughter 
branches than in the parent branch.   
Similar to what has been applied by Goldman (165) a two-phase continuum flow model is used to 
approximate the total blood flow and erythrocytes. In reference to the branching of the vessels only 
bifurcations are considered, therefore allowing each node to be connected to as most as three other 
nodes.  At each node it is verified that conservation of mass is observed in reference to both the flux of 
blood as well as the red blood cell flux,   Equation 13. 
  ............................................................................................................. Equation 13 
 
An iterative procedure is completed so to determine the viscosity and the hematocrit in each of the 
daughter bifurcations, and connected capillaries (depending upon the computational network of 
concern).  Initially the viscosity is calculated in each of the branches assuming a value equivalent to the 
discharge hematocrit entering the inlet arteriole branch, in many cases this is 0.2. This viscosity in each 
of the branches is then used in determination of the vascular resistances in each of the daughter branches,  
 Equation 4. Using this recalculated blood flow distributions updated Hcts in each of the daughter 
branches are calculated. These Hcts are then used to calculate the viscosities in each of the branch until 
the % difference between iterations is less than 0.1%. Typical simulations were found to converge very 
quickly.   
2.3.3 Coupled solving of blood and signaling molecule transport 
The initial calculations completed to determine the viscosity and the hematocrit inputs for the different 
network models considered make use of a great many simplifications upon the governing Navier-Stokes 
equations. When we calculate the blood flow through the various vascular networks, once more 
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simplified Navier-Stokes Equations are applied. Yet, these simplifications aren’t quite as numerous as 
when the Hagen-Poiseuille relation was applied. If one were to make the following assumptions: 
1. Blood has a constant density 
2. Blood flow is laminar throughout the vasculature 
3. Blood is Newtonian 
4. Blood Flow is incompressible 
A more general form of the flow governing equations can be obtained describing the conservation of 
momentum and mass,   Equation 14. U and p are the desired calculated outputs and all variables and 
parameters are defined in Table 5. 
  ....................................................... Equation 14 
 
 
 
Variable Description Value 
ρ Blood Density 1060 kg/m3 
u Fluid Velocity Vector Calculated in Simulation 
µ Dynamic Viscosity Calculated Input 
F Body Forces acting on Fluid Calculated in Simulation 
Table 5: Variables of incompressible Navier-Stokes Equations 
 
Blood within the arteriole trees of all models is approximated even further with the Stokes equations ( 
 Equation 15), which is appropriate due to the low Reynolds numbers observed in each of the 
simulations (and laminar flow approximations). 
  ......................................................................................................... Equation 15 
 
This simplification of the Navier-Stokes equations relies upon the viscosity of blood (ƞ), the Laplacian 
of the blood velocity (v), and the gradient of the pressure. The blood flow is assumed to have a parabolic 
profile. WSS in each of the arterioles were calculated using the velocity gradient in each blood vessel: 
( )( )[ ] Fuupluu T +∇+∇+−⋅∇=∇⋅ µρ )(
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  ............................................................................................. Equation 16 
 
 Where n is the normal vector to the vascular wall and is the transpose of the velocity gradient.  
Non-slip boundary conditions are applied at the vessel walls. Within the capillaries considered in the 
bifurcating arteriole geometry network models, we chose not to solve for the blood flow in COMSOL®. 
Instead flowrates and other related parameters are defined based upon previously completed 
experimental analysis on microvascular network from which this model is based (178).  In these vessels 
for which the flowrate (Q= UA, where U is the average blood velocity and A is the cross sectional area 
of the vessel) and radius(r) are defined the WSS is calculated using   Equation 17. 
  ................................................................................................................. Equation 17 
 
This approximation allows for us to once more decrease the computational demand of our model, by 
eliminating the need to solve for the flow through the capillaries surrounding the bifurcating and non-
bifurcating arterioles. In solving for the fluid transport of blood in the bifurcating network the parameters 
described in  
Table 6 are applied. When the connected arteriole/venule model is considered the defining parameters 
differ from those required for the bifurcating arteriole,  
Table 7. In comparing  
Table 6 and  
Table 7 it is clear that the connected network model requires less input parameters, due in large part to 
solving for the blood flow through the connecting capillaries and allowing for the distribution of blood 
and red blood cells to be defined by the empirical relations put forward by Pries and Secomb (1). 
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Parameter Value Units Reference 
Inner radius of A1 5 µm  
Inner radius of A1a 5 µm  
Inner radius of C2 and C3 3 µm  
Inner radius of A2 5 µm  
Inner radius of A2b 5 µm  
Inner radius of A2c 4 µm  
Inner radius of C1 and C4-11 2 µm  
Inlet Hct 20 % (179) 
Hct in C1 43.3 % (179) 
Hct in C2 8.3 %  
Hct in C3 8.0 %  
Hct in C4-C11 39.5 %  
Outlet Blood Pressure 29 mmHg (161) 
Average blood velocity at arteriole inlets 1505 µm/s (179) 
Blood Pressure at C2 outlet 27.8 mmHg  
Blood Pressure at C3 outlet 28.7 mmHg  
Blood velocity in C1 51 µm/s  
Blood velocity in C4-C12 93.6 µm/s (178) 
Blood viscosity in A1 and A2 3.16 cp  
Blood viscosity in C1 6.25 cp  
Blood viscosity in C4-C12 5.81 cp  
 
Table 6: Descriptive parameters of blood flow for the bifurcating network geometry. 
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Parameter Parameter Value Parameter Source/ Inspiration 
Inlet Hct 0.2  
Capillary diameters (µm) 
c1-c13 3-6 (5, 12, 82) 
Venule Diameter (µm) 18 (5, 82, 161) 
Inlet Arteriole Diameter 
(µm) 
a1 and a2 
10 (5, 82, 161) 
Pressure at Arteriole Inlet 26.7 mmHg (161) 
Pressure at Venule Outlet 17.4 mmHg (161) 
 
Table 7: Dimensions and inputs for the connected network model with exact sources/ inspirational source 
for model parameters. 
 
2.4 General Mass Transport Equations 
The transport of the various chemical species can be modeled with the general mass transport equations, 
in which the rate of change of a particular chemical is equal to the amount in-amount out+the amount 
generated-the amount consumed.  Using the outputs of the laminar flow we are then able to deduce the 
steady state concentration profile of the molecule of interest assuming constant density,   Equation 18. 
  ............................................................................... Equation 18 
 
The inputs variables and parameters of   Equation 18 can be found in  
Table 8. 
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Variable Description Value 
Di General Diffusive Coefficient (DC) - 
DNO DC for NO 3300 [(um)2/s] 
DO2 DC for O2 2800 [(um)2/s] 
DATP DC for ATP 240 [(um)2/s] 
DADP DC for ADP 240 [(um)2/s] 
Ci Molecule Concentration Calculated in Simulation 
u Fluid Velocity Vector Calculated Input 
Ri Chemical Reaction Terms Specified in Simulation 
 
Table 8: Parameters describing the mass transport of the general convection-diffusion equation. 
 
2.4.1 Governing Equations Relating to O2 
The techniques applied to model oxygen transport have been previously applied in other mathematical 
models concerning the transport of oxygen in simplified three-dimensional singular vessels (180, 181).  
Assuming steady-state conditions the transport of O2 in blood follows the following form: 
 ................................. 
 Equation 19 
 
The solubility of oxygen (αO2) in the tissue and within the blood is assumed to be the same.  A similar 
approximation is made in reference to the diffusion coefficient of oxygen (DO2).  As described above 
PO2 is the partial pressure of oxygen, calculated using Henry’s Law.  The product of the O2-carrying 
capacity of blood (CmaxO2), the slope of the oxy-hemoglobin equilibrium curve dS(PO2)/d(PO2), and the 
blood velocity describes the transport of oxygen due to red blood cells.  The slope of the oxy-
hemoglobin curve is calculated from a modified Easton model(182). 
 
  ............................................................ Equation 20 
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As described by Chen in his doctoral dissertation(183) the parameters Sm=96.01%, k=4.091 1/torr, 
p*=0.3675 torr, and S0=Sm/(1-eexp(kp*)) for human blood at standard conditions (T=370C, PCO2=40 torr, 
pH=7.4) (183).  In    Equation 20, p* is a characteristic partial pressure which can be a function of 
pH, temperature and other factors.  However, we assume that these factors are held constant and 
therefore our p* remains constant. The O2-carrying capacity of blood depends upon the hematocrit and is 
therefore scaled by the quotient of microcirculatory hematocrit and 0.45 (which is a typical value 
assigned for systemic hematocrit).  For larger vessels it is typical to assume a parabolic blood flow 
profile. With this said we are primarily concerned with vessels whose diameters are only slightly greater 
than that of the red blood cells traveling through them. For this reason a parabolic distribution of red 
blood cells may not be completely accurate, but one should still include regions of zero Hct along the 
vascular walls due to the presence of the glycocalyx as well as the Fahraeus effect (180). 
The bifurcating arteriole network model previously described is based upon other models and 
experimental networks examined by Ellsworth and Secomb(159). The study completed by Secomb and 
Hsu (11) examined the distribution of oxygen within the same network as that illustrated in  
Figure 5.  The mathematical model predicted PO2 values of 40.9 torr in arteriole tree A1 and A2, 33.8 
torr in the capillaries, and 31.8 torr in tissue as discussed by Chen (12).  In their model consumption, 
diffusivity, and solubility of oxygen are assumed to be uniform and constant throughout the tissue, and 
blood flow is assumed to be steady.  In the consideration of non-hypoxic tissue Fick’s Law and the 
conservation of mass leads to an equation which incorporates the product of the diffusive coefficient for 
oxygen (DO2) and the solubility of oxygen in tissue (αO2), and the Laplacian of the partial pressure of 
oxygen (PO2).  The product of these terms is set to equal to the oxygen consumption in tissue (M).  
Similar assumptions and approximations shall be used within this dissertation when modeling O2 
transport in the tissue. 
  .......................................................................................... Equation 21 
 
MPOD OO =∇ 2
2
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Instead of constant oxygen consumption rate the loss of oxygen due to a variety of metabolic processes 
is modeled as being a function of nitric oxide and the concentration of oxygen itself. As modeled by 
Secomb and Hsu the consumption rate was set to a value of 0.89 cm3O2 100 g-1 min-1 for resting muscle 
(11, 49). In additional studies concerned with exercising muscle the oxygen consumption is increased by 
a factor of 10 to a value of 8.9 cm3O2 100 g-1 min-1, from 0.56-5.6µM/s.  Other studies interested in the 
nature by which blood flow is altered in response to changes in metabolism explores a range of 1 to 25 
cm3 O2·100 cm−3·min−1 pertaining to oxygen consumption in tissue, this range in tissue O2 demand 
corresponds to ~0.6-15µM/s.  When the oxygen demand was set to 1 cm3 O2·100 cm−3·min−1 it was 
assumed that the tissue was under resting conditions, with a consumption rates of 8 and 20 cm3 O2·100 
cm−3·min−1 corresponding to levels of moderate and heavy exercise (72).  Previous studies conducted by 
our lab group has used maximal O2 consumption rates of 10, 20, 50 µM/s in tissue and1, 2, and 5µM/s in 
the vascular wall (162, 180, 181).  Our lab defines a maximal O2 consumption rate instead of a constant 
oxygen consumption because in these models the consumption of oxygen in both the tissue and the 
vascular wall is modeled as a modified Michaelis-Menten O2 consumption rate (181). Rather than a 
constant M we instead define M as a function of both oxygen and nitric oxide concentrations,  
 Equation 22. 
  .................................................................................. Equation 22 
 
Qmax is the aforementioned maximal O2 consumption rate. The parameter AppKm is the apparent 
Michaelis constant, at which 50% of the O2 consumption occurs. Nitric oxide has been shown to bind 
cytochrome oxidase, causing an inhibition of O2 consumption (126, 184, 185).  Thomas et al. (186) made 
use of a similar linear relationship when modeling nitric oxide dependent oxygen respiration in tissue as 
one progresses away from a theoretical vessel source.  A nonlinear relationship has been proposed 
describing the relationship between oxygen respiration by the mitochondria and nitric oxide in 
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experimental studies and review articles (38, 187).  Following the precedent set by Chen and Lamkin-
Kennard a linear model shall be applied describing the phenomena of NO inhibition of oxygen 
respiration in the tissue and the vascular wall (162, 180, 181). Assuming that the Michaelis constant is 
equivalent to 1 torr in the absence of NO(181) the apparent constant will take the form of  
 Equation 23 (38). 
  ............................................................................... Equation 23 
 
The maximal consumption rate of oxygen in the tissue will differ from that observed in the vascular 
wall.  Previous theoretical models of arteriole transport have assumed an O2 consumption rate in the 
vascular wall similar to that of resting muscle (188), while others have assumed that this sink for oxygen 
is negligible (189-191).  There also exists some which believe that the consumption of oxygen in the 
vascular wall is two orders of magnitude greater than that in the surrounding tissue (48, 192).  As 
indicated above, our lab has operated under the idea that oxygen consumption in the vascular wall is less 
than that in the surrounding tissue.   For this reason we have assumed that the consumption of nitric 
oxide in the vascular wall is 10% of that in the surrounding tissue.  
The boundary conditions concerning oxygen will vary from model to model, depending upon the 
computational domain considered.  Pertaining to the capillaries, when the connected arteriole/venule 
domain is considered the inlet boundary conditions of the capillaries will be directly connected to the 
concentration exiting the arteriole.  Likewise, the outlet boundary condition will be equivalent to the 
inlet of the venule. Unlike the connected arteriole/venule model, it is necessary to define the boundary 
conditions pertaining to oxygen transport in the capillaries for the bifurcating arteriole model.  In the 
bifurcating arteriole model each of these capillaries is also assumed to be supplied oxygen by the 
arterioles.  This link of the arterioles to the capillaries allows for the capillaries to be dependent upon the 
change in flow conditions brought on by the oxygen environment in the microvascular unit.  Each of the 
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three arteriole outlets is assumed to feed three of the capillaries included in the computational model.  
Therefore, at the inlet of each of the groups of three capillaries a concentration of oxygen is specified, 
which happens to be a function of the outlet oxygen concentration of the respective arteriole that the 
capillary group is associated with. At this current juncture the PO2 inlet boundary condition for the 
capillaries is set to be 10/12th the average outlet concentration of the associated arteriole.  This is done 
since the partial pressure of oxygen reported by Tsai et al in the terminal arterioles is 24 mmHg 
compared to 20 mmHg within the capillaries (48).   
The boundary conditions for O2 change from model to model. Changes in boundary conditions will be 
dependent upon the model purpose. In particular the arteriole inlet boundary condition chosen for PO2  
shall be a focus and a cause for discussion of simulations considered.  As it is via nucleotide transport 
that PO2 state and NO are linked, the transport of nucleotides shall be closely related to the boundary 
conditions chosen for O2 transport.  
2.4.2 Governing Equations Relating to Nucleotides 
This is not the first model linking nucleotide concentration to the production of NO. A previous study 
completed by Comerford et al. (193) examined the activation of eNOS in response to shear and calcium 
dependent signaling in the arterial wall. The two nucleotides of interest in this dissertation are ATP and 
ADP.  The general form describing the transport of ATP and ADP takes the form of   Equation 24 
and   Equation 25. 
  ....................................................... Equation 24 
 
  .................................................... Equation 25 
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As all chemical species considered in this study the time dependent change of ATP and ADP is modeled 
as being a function of the diffusive transport of each nucleotide (the product of the diffusive coefficient 
and the Laplacian of the concentration), the convective transport of each nucleotide (the product of the 
velocity vector and the divergence of the concentration), and the reactions of each nucleotide (dependent 
upon the compartment of interest).  There are many potential reactions that may occur in reference to 
each of the two nucleotides, yet there are two that are of particular interest for this dissertation. The two 
imperative reactions are the oxygen dependent release of ATP from red blood cells, and the release of 
ATP from endothelial cells. RATP and RADP are volumetric reaction terms occurring within the vessel. For 
the purine nucleotide ATP this term will incorporate the release of ATP from RBCs. All of the reactions 
regulating the control of ADP are incorporated into the flux of the nucleotide from the ECs. 
Modeling the Release of ATP from the red blood cells 
The release of ATP from circulating red blood cells in response to alterations of oxygen saturation has 
been considered in previous mathematical models (72, 101). Making use of a linear fit of experimental 
measurements (67) interested with the release of ATP from human erythrocytes under conditions of 
hypoxia and normoxia provides us with the following function describing the ATP release in red blood 
cells as a function of saturation: 
 
  ..................................................................... Equation 26 
 
 ............................................................................. Equation 27 
	   
 
R0 and R1 are constants set at 1.4 e-9 mol/(s1cm3) and 0.891 respectively (67). The value describing the 
rate of ATP degradation kd is a set value of 2e-4 cm/s (67). S(PO2) is the saturation of blood modeled as a 
)]S(PO R-[1 R=)] R[S(PO  2102
RATPRBC = HctR0 1− R1S PO2( )"# $%
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function of oxygen concentration (partial pressure). Hct is the spatially dependent hematocrit with the 
vascular network and Dia is the diameter of the respective vessel. 
There have been findings that ADP is capable of activating a negative feedback pathway for ATP to be 
released from human RBCs via the purinergic receptor P2Y13 (194). Yet at this current juncture this 
potential pathway of ATP regulation in reference to red blood cells is not incorporated in the model.  In 
the future it may prove useful to incorporate this negative feedback pathway of ATP regulation to gain a 
better understanding of the role ATP plays in the auto regulation of the circulation. ADP has also been 
mentioned to be released from red blood cells, nevertheless there does not appear to be either 
experimental or mathematical data describing said mechanism(195). 
NO concentration has also been demonstrated to influence ATP release from red blood cells (196).  This 
direct means of NO modulation of ATP release is also not considered in this model, and may prove 
useful to examine in future studies.  With that said due to the mechanisms by which NO influences O2 
transport and the direct link between blood oxygen saturation and ATP release, NO will still modulate 
red blood cell release within the model in a more indirect manner. 
Nucleotide release from endothelial cells 
There have been many other models created examining the transport of ATP along the surface of cells 
either in a flow chamber (65, 197-200), or in a more physiological environment (193, 201).  In their 
study examining the influence of flow on the concentration of ATP and ADP at the endothelial surface 
within a flow chamber John and Barakat (65) make use of two different representations of flow 
dependent ATP release, relying upon experimental data gathered by Milner et al. (202). The first of the 
phenomenological relationships used to relate shear stress and ATP release is a linear model, which 
holds the reference shear stress (τo) to be 10 dynes/cm2 (𝑆!"# 𝑧 = 𝑆!"# !! !!! ). The distance along the 
surface of the cell is represented with the variable z, and τw(z) is the spatially dependent shear stress.  
Using data collected by Milner(202), John and Barakat (65) assign a Smax value of 10-9mol/(m2s).  The 
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investigators (John and Barakat) (65) also make use of what one would believe to be a more 
physiologically relevant sigmoidal relationship between shear stress and ATP release from the 
endothelial surface.  
  ............................................................ Equation 28 
 
The majority of the models previously discussed also incorporate hydrolysis of ATP near the endothelial 
surface in the form of a Michaelis-Menton type equation. The flux at the arteriole wall 
𝐅𝐀𝐓𝐏     =     𝐒𝐀𝐓𝐏 𝛕𝐰 −     𝐕𝐦𝐚𝐱,𝐀𝐓𝐏  𝐂𝐀𝐓𝐏𝐊𝐦,𝐀𝐓𝐏!𝐂𝐀𝐓𝐏   ........................................................................ Equation 29 
 
consists of the balance between ATP released due to shear stress and the hydrolysis of ATP to ADP. The 
uptake of ATP (kd) is set to 1.68 x 10-6 m/s and the diffusion coefficient of ATP (DATP) is 2.4 x 10-10 
m2/s. The flux of ADP from the endothelial surface layer is modeled in a fashion similar to the ATP flux 
from the ECs lining the vessel. The flux of ADP is a balance between the ADP produced due to the 
hydrolysis of ATP and the degradation of ADP to AMP. 
𝐅𝐀𝐃𝐏     = 𝐕𝐦𝐚𝐱,𝐀𝐓𝐏  𝐂𝐀𝐓𝐏𝐊𝐦,𝐀𝐓𝐏!𝐂𝐀𝐓𝐏   −     𝐕𝐦𝐚𝐱,𝐀𝐃𝐏  𝐂𝐀𝐃𝐏𝐊𝐦,𝐀𝐃𝐏!𝐂𝐀𝐃𝐏   ..................................................................... Equation 30 
 
Other models of ATP release from endothelial cells (203) shall be considered in this study for the sake of 
comparison and the desire to provide a fuller understanding of nucleotide transport and the manner it 
may relate to NO transport. 
The transport of NO is not described in general in this section.  Due to the specific aspects of NO 
transport considered in each individual model, when NO transport is considered a model specific 
description of governing equations and boundary conditions shall be provided.  Application of the 
equations, computational domains, and theories described in this section we shall now describe studies 
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whose intention is to link an increase in NO around the arteriole to changes in the metabolic demand for 
O2.   In particular we shall examine: 
1. The influence of hemodynamic factors on NO transport  
2. The interplay between NO and O2 in a vascular environment 
3. The influence of NO on diameter and the subsequent changes in blood flow 
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Chapter 3: Relationship between blood flow and NO production from ECs 
 (Flow-Dependence of Endothelial NO production) 
Blood flow is known to influence the transport of NO in numerous manners. Convective transport, shear 
stress dependent NO production, red blood cell dependent NO scavenging, and potentially red blood cell 
dependent NO production are several examples of the pathways by which blood flow can influence the 
life of NO. The primary hemodynamic determinant of endothelial release of nitric oxide (NO) and 
subsequent vasodilatation is WSS (18, 26, 109-117). The continuous supply of NO produced due to the 
viscous drag over the endothelial cells (ECs) has been demonstrated to depend upon calcium 
mechanisms(18, 117, 204), post translational mechanisms (such as endothelial nitric oxide synthase 
(eNOS) phosphorylation(20, 22, 26, 27, 29), and promotional activity of eNOS expression (22). There 
remains a challenge to determine the rate of nitric oxide release from endothelial cells due to shear stress 
and the exact roles that specific mechanisms play in this release.  Some of the difficulty comes from the 
fact that a variety of direct and indirect measurements have been used to determine the release of nitric 
oxide due to shear stress, these shortcomings have been previously reviewed (116). Furthermore, a 
determinant of wall shear stress is the blood viscosity. As has been previously shown blood viscosity is 
dependent upon the local Hct (51, 205). 
Unless incorporating new mechanisms previously ignored (162, 180, 206), red blood cells are 
established scavengers of NO. NO is known to react with deoxy-and oxy-hemoglobin at a very high rate 
to form nitrosyl-hemoglobin and methemoglobin (207, 208). This reaction is thought to put NO in an 
inactive state and has been mathematically demonstrated to greatly reduce the concentration of NO in the 
vascular lumen (209-211) and subsequently throughout the surrounding vascular components. Currently 
the pure scavenging role of red blood cells is being challenged in this study and also those previously 
cited discussing the role of red blood cells in releasing NO in a SNO- dependent manner (212-214). 
Others have indicated that RBCs may actually generate NO as well via eNOS (167). For the simulations 
to follow only the scavenging role of red blood cells shall be considered pertaining to red blood cells 
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direct influence on NO.  The influence of red blood cells on shear stress shall also be considered as we 
seek to determine, which of the two characteristics of red blood cells exerts a greater influence over NO 
transport.  Scavenging of NO overcomes any additional production of NO due to increased WSS, yet we 
still desire to delve deeper in the mechanisms involved in shear stress dependent NO production from 
ECs and turn to a more simplified computational geometry. 
To examine further the manner that WSS influences NO production in ECs we turn to a computational 
model of a parallel plate flow chamber. Described in detail in a recent publication from our lab, this 
apparatus proves capable of direct in vitro real time measurement of nitric oxide and allows for a 
quantified measurement of the manner CNO changes with alterations in flow (116). Experimental data 
recorded from the parallel plate flow chamber apparatus is expected to reveal the relationship between 
blood flow and ECs production of NO when analyzed with the use of a computational model.  It is also 
the desire of this model to uncover the manner that nucleotide transport alters NO transport within the 
chamber and in particular NO production from the ECs. 
3.1 Consideration of Shear Dependent Nitric Oxide Production in a 3D Tissue Block Domain 
3.1.1Background and Methods 
The release of nitric oxide from the endothelial cells is assumed to be proportional to the shear stress 
encountered on the surface of the endothelial cells lining the intraluminal portion of the vessels 
considered within the model.  The production (RNO) of NO is modeled as being linearly dependent upon 
the ratio of the wall shear stress (WSS) to a reference shear stress (τref) value previously applied in a 
mathematical study conducted by Kavida and Popel so to provide a 100 nM concentration of nitric oxide 
in the smooth muscle surrounding the vascular endothelial cells (172).  RNOref is chosen to be equivalent 
to that made use of in previous models completed by our lab(159) and to provide CNO in the tissue 
similar to those reported experimentally (215).  
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 ...................................................................................................................  Equation 31 
 
As in this model the production of NO at the EC surface will be modeled as a flux, 
  Equation 31 shall be multiplied by the thickness of the endothelial layer in the 
model. 
𝐹!"!!!!"!!"# 	  ........................................................................................................	  Equation 32	  
 
Rather than computationally solving the convective and diffusive transport of NO within the arterioles 
and capillaries, an analytical solution is applied (209).  This approximation has previously been validated 
via a computational model (211).  The radial dependent concentration of NO can be modeled in the form  
 Equation 33. 
  .......................................................................................... Equation 33 
 
Ce is the concentration of NO at the endothelial surface where r=re.  This concentration shall be 
calculated within the simulation. I0 is the zero order modified Bessel function of the first kind with and 
argument b=(λbHct/0.45DNO)1/2. To describe the flux of NO from the endothelium to the bloodstream the 
following equation is made use of: 
 .....................................................................................  Equation 34 
 
We differentiate   Equation 33 and apply it to evaluate   Equation 34 and along with the shear 
stress dependent nitric oxide production can combine to define the boundary condition along the 
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vascular wall.  As demonstrated in the term b (from   Equation 33), the concentration of nitric oxide 
within the vessel lumen is a function of the hematocrit. For this reason the influence of such phenomena 
such as phase separation and the Fahraeus effect will influence the nitric oxide concentration within the 
blood. 
Within the capillaries a single file passage of red blood cells is assumed.  The hematocrit in C2 and C3 is 
calculated making use of the following equation, described by House and Lipowsky (179): 
  .............................................................................. Equation 35 
 
The frequency of RBC passage is represented with the term frbc and has the units of RBC/s.  MCV is the 
mean corpuscular volume (µm3) and Vrbc is the velocity of the red blood cells through the capillaries 
(µm/s).   Values for the frequency of RBC passage and the velocity of red blood cells are collected from 
various experimental and computational studies concerning a similar network structure(49). 
Governing Equations/Parameters Describing NO Transport in Tissue 
The primary mechanisms governing nitric oxide transport within the tissue is the diffusion of the 
molecule along with consumption of nitric oxide for various metabolic processes. 
  .................................................................................. Equation 36 
 
All of the parameters found in   Equation 36 have been previously discussed and can be found in  
Table 9.  The parameter λt described the rate of NO metabolism within the tissue of the computational 
domain, which is assumed to take the form of a first order reaction.  
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Parameter Value Units Description Reference 
DNO 3300 µm2/s NO Diffusion Coefficient  
re 5 µm Intraluminal Radius of Arteriole  
fRBC 4,6.8 RBC/s Frequency of RBC passage (49) 
MCV 69.3 µm3 Mean Corpuscular Volume (216) 
VRBC 51,96 µm/s Red Blood Cell Velocity (49) 
λt 1 1/s Scavenging Rate of NO in Tissue (181, 186, 
217) 
λb 382.5 1/s Scavenging Rate of NO by RBCs (218) 
Hct 20 % - (179) 
Hct in C1 43.3 % - (179) 
Hct in C2 8.3 % -  
Hct in C3 8.0 % -  
Hct in C4-
C11 
39.5 % -  
τref 24 dyn/cm2 Reference Shear Stress (161) 
 
Table 9:  Parameters descriptive of the shear stress dependent NO release from ECs model in three-
dimensional bifurcating arteriole network model. 
Computational Model Boundary Conditions  
The boundary conditions in reference to the flow within the arterioles have been described previously.  
The diffusion equation describing the steady state nitric oxide transport shall have the following 
boundary conditions applied: 
1. CNO = 100 nM at z=75 µm.  This will represent an average tissue NO background (211). 
2. At the inlet of the arterioles it is assumed that the concentration of nitric oxide is 0 nM. 
3. The flux from the endothelial surface to the red blood cells is described in   Equation 34 
and the flux from the endothelial cells to the surrounding tissue is the shear stress dependent 
nitric oxide production ( Equation 31) sans the flux to the red blood cells. 
4. Zero flux boundary conditions are applied at the remainder of boundaries. 
Procedure of Study  
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While indeed it is useful to examine the nature that NO can potentially distribute in a section of vascular 
tissue, this model may prove even more useful in that it allows for one to examine the strong relationship 
between blood flow and nitric oxide transport.  In order to do so the influence of varying certain input 
parameters was examined on the spatial distribution of nitric oxide within the model and in particular in 
and around the bifurcating arteriole.  To better examine the relationship between blood flow and NO the 
inlet hematocrit into the arterioles was altered.  Inlet Hct was set to either 10%, 20% (baseline levels), or 
30%.  Changes in WSS, NO flux, and local [NO] was evaluated at 5 different locations of the bifurcating 
arteriole. The locations of evaluation and comparison are illustrated in Figure 11. 
 
Figure 11: Illustration of arteriole labeled as A2 by Chen et al. (12) in a previous study.  This particular 
figure designates various points of interest.  Point 1 is located at the inlet of the branching arteriole.  Points 2 
and 3 are designated at the branching points between the parent branch and the two daughter branches.  
Point 5 is located on the vessel wall at the outlet of the smaller of the two daughter branches and Point 4 is 
found at a similar location on the larger daughter branch.  In this particular study the diameters of the 
arteriole parts are 8 um for the parent branch and the larger of the two daughter branches and 6 um in the 
smaller of the daughter branches. 
 
Numerical Methods of Solution 
COMSOL 3.3 (COMSOL, Inc.) is the software package made use of to solve the partial differential 
equations used to define the flow and transport of chemical species within our computational network.  
The commercially available finite element software is also applied to create the mesh and create the 
three dimensional vascular network considered within this study.  The user has the choice of numerous 
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solvers, yet for these particular simulations the GMRES solver and incomplete LU pre-conditioner were 
applied.  The Lagrange-P3P2 element type was chosen to solve the blood flow within the arterioles and 
the quadratic element type was applied in the solving process of the transport of nitric oxide.  The two 
physics applied in this model are coupled via velocity and fluid dependent shear forces encountered by 
the vascular walls contributing to the mass transport and production of NO respectfully. 
Relying upon COMSOL’s user-friendly meshing tool a three dimensional mesh is created consisting of 
216,893 elements, with extra mesh refinement around the arterioles.  The simulations are performed on a 
personal computer making use of a 64 bit Windows XP Professional operating system with relative 
accuracy of 5 x 10-4 for the numerical solutions. 
3.1.2 Results 
Local WSS and Hct inversely influence CNO  
Wall shear stress is greatest at the inlets of the two parent arterioles. The locations of greatest WSS 
unsurprisingly correspond to the locations of greatest blood velocity. 
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Figure 12: Bifurcating arteriole network model of shear stress dependent NO production with the 
consideration of NO scavenging by RBCs, Chen 2011. (A) NO concentration profiles along different 
intersecting planes of the 3D structure. (B) Wall shear stress distribution along the arteriole branches. (C) 
Influence of increasing the inlet Hct (HD) on the distribution of RBCs in the two daughter branches and the 
consequent transport of NO. (D) Plane intersecting the arterioles illustrating the modeled NO concentrations 
and local shear stress values (Black numbers) when HD is equal to 0.2. 
 
Our lab has previously examined the transport of NO in a bifurcating arteriole network (Chen, 2011). 
The concentration profiles of Figure 12(A) simulate greater concentrations of NO around the arteriole. 
The wall shear stress around the arteriole is also modeled in Figure 12(B). As blood flow is distributed 
amongst the two daughter branches we take note that the greater WSS occur within the larger of the two 
daughter branches. Branch A2C is smaller than A2b, which is set to be the same diameter as the parent 
arteriole A2. The shear stress observed along the vessel wall of A2C (6µm in diameter) is modeled as 
being less than that of A2b (10µm) in Figure 12(D) as well.   
Tissue CNO are predicted to range from 100 to 150 nM in regions located a substantial distance away 
from either of the arteriole branches.  The concentration of nitric oxide close to the arteriole surface is 
much greater than that observed in the surrounding tissues. When the inlet Hct was set to 0.2 the greatest 
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[NO] observed was greater than 700 nM near the bifurcation of the arteriole A2.  In contrast a 
concentration of NO around 330 nM is predicted around the vascular wall of the smaller of the two 
daughter branches of A2. 
Returning the discussion to the shear stress we note that the greatest WSS is observed on the surface of 
inlet (or parent) arteriole A2, Figure 12.  The value of this WSS is 49 dyn/cm2.  On the other end of the 
spectrum the lowest shear stress observed in the model was 23.5 dyn/cm2 and occurred on the surface of 
the smaller daughter branch (A2c). Yet we find that the concentrations of NO are greater in the smaller 
of the two daughter branches. The contour plots of NO concentration around the bifurcating arteriole 
branch also simulate a decrease in NO around the arteriole as HD is increased. Overall the role of RBCs 
as a scavenger of NO is more dominant than their contribution to shear stress dependent NO production. 
3.1.3 Discussion 
The heterogeneous shear stress and red blood cell distributions within the bifurcating vascular network 
have a great influence on the distribution of NO throughout the network and tissue. Daughter branches 
receiving a lower flux of RBCs shall theoretically experience a decrease in shear stress dependent RNO 
brought on by a decrease in shear stress due to the blood viscosity dependence upon RBC flux(51).  
Simultaneously the lower Hct experienced in the vessel exposed to lower shear stresses will result in a 
lesser scavenging of NO.  As the CNO in these regions is greater in comparison to simulations in which 
the Hct is increased in these very same regions, and also in comparison to regions of greater Hct it can be 
taken that the scavenging role of Hct plays a much stronger role in determination of local CNO than the 
contribution that increased Hct may play in shear stress mediated NO production.   
Regions experiencing low WSS are more prone to cardiovascular disease as CNO will be lower in these 
regions (193, 219, 220), yet this is more commonly the case with larger vessels. Other than regulating 
vascular tone, NO is also known to inhibit platelet aggregation and adhesion molecule expression, as 
well as preventing vascular smooth muscle cell proliferation(221). Many of the referenced studies 
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consider larger vessels than those examined in this study. What is predicted in this study is that within 
the microvasculature vessels the lower shear stresses brought on due to lower RBC flux will actually 
contribute to CNO and its vaso-protective properties. Therefore, while shear stress may contribute to an 
increase in CNO a subsequent increase in Hct would prove counterproductive. 
3.2  Characterization of Shear-dependent transport of NO in parallel plate flow chamber 
This section largely comes from the paper “Mathematical Model for Shear Stress Dependent NO and 
Purine Nucleotide Production from Endothelial Cells”. Both the author of this dissertation and Dr. 
Donald Buerk contributed sizably to the work for this section.  
3.2.1 Introduction regarding NO Production from ECs:  
Mathematical Modeling of Shear Stress Dependent NO production 
Wall shear stress (τw) is the primary hemodynamic determinant of endothelial release of nitric oxide 
(NO) produced by endothelial nitric oxide synthase (eNOS) in endothelial cells (ECs) with subsequent 
effects on vascular tone (18, 26, 109-117).  It is well known that the NO produced due to viscous drag 
over ECs depends upon Ca2+ (18, 117, 204), eNOS phosphorylation (222-225), and eNOS expression 
(225). The importance of purinergic signaling in the vasculature at the cellular scale (both EC and 
smooth muscle cells) is also recognized (226, 227). Purine nucleotides (ATP, ADP) are known to 
modulate the rate of NO production (RNO) by ECs (228-231), where RNO is expressed as the rate of NO 
produced per volume of cells (10-9 mol/liter/s or nM/s). However, it is difficult to investigate specific 
mechanisms involved in NO release, since it is technically challenging to quantify τw-dependent RNO 
from ECs as there are numerous shortcomings for direct and indirect measurements of NO, especially 
under in vivo conditions. To address this problem, we had previously designed a parallel-plate flow 
chamber apparatus (Figure 13) capable of direct in vitro real time measurement of NO released by ECs 
in response to changes in flow (116), which we have used for additional NO measurements (232, 233).  
Here, we further develop a computational mass transport model that allows quantitative analysis of in 
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vitro experimental data obtained with parallel-plate flow chambers that could provide insight into the 
relationship between blood flow and production of NO by ECs under in vivo conditions.  
 
 
 
 
 
 
 
Figure 13.  Diagram of parallel-plate flow apparatus used in experiments to measure NO produced from 
cultured ECs (Andrews et al. (116, 232, 233)). The computational domain used in the mass transport 
model simulations is based upon chamber geometry, where L = length, H = height, and U = fluid 
velocity. The NO electrode location in the upper chamber is indicated. 
 
 Models for τw-Dependent RNO 
Fadel et al. (234) and Plata (235) developed mass transport models which predict the spatial distribution 
of NO produced by ECs cultured in a parallel-plate flow chamber, based on linear and non-linear 
empirical functions to represent the increase in RNO with increased flow and τw. More recently, Andrews 
et al. (116) found that a hyperbolic function, 𝑅!" =   𝑅!"#"$ + 𝑅!"# !!!!!!    .................................................................................. Equation 37 
       
where A = 35 dyne/cm2; Rmax = 457.5 nM/s; and Rbasal = 2.13 nM/s, provided the best fit for RNO 
calculated from experimental steady-state NO measurements with bovine aortic ECs at different values 
of τw in our parallel-plate flow chamber. As an alternative to using an instantaneous step increase in RNO 
for an instantaneous step increase in τw at t = t1, we can use a ramp function to generate a gradual, linear 
increase in NO production over the time period from t1 to t2 
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to more closely match experimental observations (116, 232, 233) for the dynamic NO response. 
Models for Purine Nucleotide Transport and τw-Dependent Release 
Computational and bench-top studies demonstrate the importance of purine nucleotides in endothelial 
biology (59-62), and mass transport models for parallel-plate geometry have been developed. The mass 
transport model by Nollert et al. (63, 64) predicts that, when ATP is in the perfusing media, convection 
can increase ATP concentration at the EC surface and affect intracellular Ca2+. Since ADP is also potent 
in mobilizing EC intracellular Ca2+, Shen et al. (66) extended the model by including ADP, and 
demonstrated that the combined nucleotide EC surface concentration in a parallel-plate flow chamber 
varies over a wide range of τw (0.1 to 30 dyn/cm2).  
Similar to Boileau et al. (236) we are motivated to examine the influence of applying different models of 
shear stress dependent endothelial release of ATP. As the experimental studies conducted by Andrews et 
al. (32, 116) do not incorporate the measurement of nucleotide concentration, we wish to examine 
multiple models for ATP release so to gather a more thorough understanding of the manner nucleotide 
transport will be influenced by different experimental inputs. The confidence with which we can present 
our results will depend largely upon the comparison of nucleotide transport determined by the two 
models.  
Mathematical models have also been developed to describe the tw-dependent endogenous release of 
purine nucleotides from ECs. The model originally developed by John and Barakat (237) (Model A), has 
been used by many others (193, 199, 203, 238). Another model (Model B) was developed by Qin et al. 
(203) by fitting experimental results obtained by Yamamoto et al. (239). In the current report, we 
compare predicted concentrations obtained with these two different ATP-release models and analyze 
recent experimental data from our laboratory (232, 233). Boileau et al. (236) modify both Model A and 
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Model B in their study. The exact reasoning behind their modifications is not known, but is evident upon 
examination of the new models with those motivating Model A and Model B. 
 Model A 
ATP production with increasing τw is represented by a sigmoidal function   𝑆!"# 𝜏! =   𝑆!"# 1 −   𝑒!(!!!! ) ! ............................................................................ Equation 39 
 
where τ0  is a reference shear stress, and Smax is the maximum ATP production rate ( 
Table 10: Definitions and values for parallel-plate chamber model parameters.). Using the same criteria as Choi 
et al. (238), τ0 was set to 4 dyn/cm2 (198), based upon experiments by Bodin and Burnstock (240), 
assuming that Smax occurs at τw = 25 dynes/cm2. The value for Smaxwas estimated by John and Barakat 
(237), based on experiments by Milner et al. (241) with ECs cultured on micro-carrier beads. 
Symbol Value Units Definition 
DADP 257  µm2/s Diffusion coefficient for ADP 
DATP 236  µm2/s Diffusion coefficient for ATP 
DNO 3300 µm2/s Diffusion coefficient for NO 
KADP 155  µM Michaelis constant for ADP 
KATP 475 µM Michaelis constant for ATP 
kauto 2 x 10-8  (nM x s)-1 Pseudo-second order reaction rate for auto-oxidation of NO 
µ 0.00696 dyn x s/cm2 Dynamic viscosity of water at 37º C 
Vmax,ATP 0.1 x 10-6  mol/(m2 x s) Maximum enzyme reaction velocity for ATP hydrolysis 
Vmax,ADP 0.8 x 10-6  mol/(m2 x s) Maximum enzyme reaction velocity for degradation of ADP 
Smax 1 x 10-9  mol/(m2 x s) Maximum release rate of ATP from ECs 
 
Table 10: Definitions and values for parallel-plate chamber model parameters. 
 
Model B 
Parallel-plate flow chamber studies by Yamamoto et al. (239) demonstrated that, following a step 
increase in τw, ATP produced by ECs reaches a maximum, then slowly decreases with time as the higher 
τw is sustained. Qin et al. (203) modified the John and Barakat (237) model, using the product of two 
state variables to better represent experimentally observed dynamic behavior. The first state (p1) 
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represents the effects of τw and the probability of open states of all possible ATP production pathways. 
The second state (p2) represents activation levels of ATP production pathways and includes the 
phenomenon of “receptor desensitization” (a reduction in the response with a longer stimulus). As 
described in Xiang et al. (242), the desensitization phenomenon is a ubiquitous feature of cells that are 
exposed to a constant stimulus. The τw-dependent production of ATP from ECs is given by 
 𝑆!"# 𝜏! , 𝑡 =   𝑝!𝑝! .................................................................................................. Equation 40 
        
where p1 and p2 satisfy the following ordinary differential equations 
 !"!!" = 𝑓 𝜏! −   !!!!  ..................................................................................................... Equation 41 
       
and 𝒅𝒑𝟐𝒅𝒕 = −   𝒑𝟐𝒕𝟐  ................................................................................................................ Equation 42 
         
where t1 and t2 are time delay constants. The function in 
!"!!" = 𝑓 𝜏! −   !!!!  Equation 41 is  
 𝑓 𝜏! = 𝑎! +    !!!!!!!  !! ............................................................................................... Equation 43 
       
where coefficients (a1, a2, a3) were determined from experimental data (239). Time-dependent changes in 
state variables after exposing the EC monolayer to a single step change in τw are 
 
𝑝! 𝑡 = 𝑡!  𝑓 𝜏!! 1 −   𝑒!! !! ;                                                                                                                                       0   ≤ 𝑡   <   𝑇!𝑡!  𝑒!! !!    𝑓 𝜏!! 𝑒!! !! − 1 + 𝑓 𝜏!! 𝑒! !! − 𝑒!! !! ;     𝑇!   ≤ 𝑡   <   𝑇!  Equation 44 
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And 
 𝑝! 𝑡 =     𝑒!  ! !! ....................................................................................................... Equation 45 
     
Coefficients for Model B ( 
Table 11 Definitions and parameter values for ATP production by endothelial cells (𝑆!"# 𝜏! , 𝑡 =   𝑝!𝑝!
 Equation 40𝑝! 𝑡 =     𝑒!  ! !! Equation 45) from Qin et al. (203) and Li et al. (243).) were 
determined by Qin et al. (203) by fitting Yamamoto’s data (239), where τw1 and τw2 correspond to the 
two different τw steps that ECs were exposed to. Recently, Li et al. (243) used this model to describe 
effects of ATP on Ca2+ dynamics, with corrected units for the coefficients a1 and a2 (mol/m2/s). With 
respect to the current simulation, the baseline NO is obtained at the first shear stress (τw1), then flow is 
increased to expose ECs to a second, final shear stress (τw2). The time T1 is for the initial step and T2 is 
for the final time.  
Symbol Value Units Definition 
a1 0.65 x 10-13  mol/(m2 x s) Dynamic model parameter 
a2 2.79 x 10-10  mol/(m2 x s) Dynamic model parameter 
a3 69.6 dyn/cm2 Dynamic model parameter 
t1 17.4 s Time delay constant 
t2 218.9 s Time delay constant 
 
Table 11 Definitions and parameter values for ATP production by endothelial cells (𝑆!"# 𝜏! , 𝑡 =   𝑝!𝑝!
 Equation 40𝑝! 𝑡 =     𝑒!  ! !! Equation 45) from Qin et al. (203) and Li et al. (243). 
 
Net Release of ATP and ADP 
ATP is hydrolyzed according to an irreversible Michaelis-Menten reaction to form ADP via 
ectonucleotidases located at the EC surface (193, 200, 203, 237, 238). The net flux for ATP release 
(FATP) is given by 
 
68	  
	  𝐹!"#     =     𝑆!"# 𝜏! −     !!"#,!"#  !!"#!!,!"#!!!"#  ....................................................................... Equation 46 
     
The net flux for ADP release (FADP) is the summation of ADP degraded at the EC surface and the rate of 
ADP production due to ATP hydrolysis.   
 𝑭𝑨𝑫𝑷     = 𝑽𝒎𝒂𝒙,𝑨𝑻𝑷  𝑪𝑨𝑻𝑷𝑲𝒎,𝑨𝑻𝑷!𝑪𝑨𝑻𝑷   −     𝑽𝒎𝒂𝒙,𝑨𝑫𝑷  𝑪𝑨𝑫𝑷𝑲𝒎,𝑨𝑫𝑷!𝑪𝑨𝑫𝑷  .................................................................... Equation 47 
       
Rate constants for the conversion of ATP and ADP have been determined previously (244-246). The 
above mass fluxes are converted to volumetric reaction rates (RATP, RADP), multiplying each flux by the 
area and dividing by the volume of ECs. 
Relationship between RNO and Purine Nucleotides 
It is reported that NO produced by ECs is dependent upon both ATP (228, 247-250) and ADP (230). 
However, the empirical relationship (𝑅!" =   𝑅!"#"$ + 𝑅!"# !!!!!!    Equation 37𝑅!" =   𝑅!"#"$ +𝑅!"#    𝑟𝑎𝑚𝑝 𝑡!, 𝑡! !!!!!!   Equation 38) that fits our experimental data (116) does not explicitly 
model this dependence. The majority of previous experimental studies relating purine nucleotide 
concentrations and NO are based upon increases in eNOS activity (228, 230). Other studies use 
diaminofluorescein (DAF) fluorescence to detect changes in NO (249, 250) or to evaluate changes in 
eNOS expression (251). Since no direct correlation exists between these measurements and RNO, it is 
difficult to obtain a quantitative relationship for the change in RNO with purine nucleotide concentrations 
as a function of τw. 
 
Andrews et al. (232, 233) examined the influence of purine nucleotides on τw-dependent RNO in our 
parallel-plate flow chamber, although ATP and ADP were not directly measured. Instead, NO was 
measured at different τw before and after adding 1 U/mL of apyrase (Sigma Aldrich) to the media to alter 
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purine nucleotide concentrations. In the presence of apyrase, a smaller increase in NO with τw was 
observed from ECs, especially in the lower τw range, consistent with a decrease in RNO. In the current 
report, we quantified the change in τw-dependent RNO with apyrase using our modified model. 
3.2.2.6  Characterization of Apyrase Activity 
Apyrase is a Ca2+-activated plasma membrane-bound enzyme that catalyzes the conversion of ATP to 
ADP, followed by conversion of ADP to AMP and inorganic phosphate. The reaction with apyrase 
 𝐴𝑝𝑦𝑟𝑎𝑠𝑒 + 𝐴𝑇𝑃   ⇌   𝐴𝑝𝑦𝑟𝑎𝑠𝑒 ∗ 𝐴𝑇𝑃   ⇌     𝐴𝑝𝑦𝑟𝑎𝑠𝑒 + 𝐴𝐷𝑃   ................................ Equation 48 
    
affects ATP and ADP concentrations with degradation rates of 
  𝑹𝑨𝑻𝑷,𝒂𝒑𝒚𝒓𝒂𝒔𝒆 = −  𝑪𝑨𝑻𝑷  𝑪𝒂𝒑𝒚𝒓𝒂𝒔𝒆    𝒌𝒄𝒂𝒕𝑲𝒎!  𝑪𝑨𝑻𝑷  ............................................................ Equation 49 
    𝑹𝑨𝑫𝑷,𝒂𝒑𝒚𝒓𝒂𝒔𝒆 = −  𝑪𝑨𝑫𝑷  𝑪𝒂𝒑𝒚𝒓𝒂𝒔𝒆      𝒌𝒄𝒂𝒕𝑲𝒎!  𝑪𝑨𝑫𝑷  .......................................................... Equation 50 
 
Apyrase used in these experiments (232, 233) was derived from potatoes (S. tuberosum). According to 
the manufacturer (Sigma Aldrich), the specific activity varies from batch to batch, ranging between 3.0-
40.0 U/mg protein. There are at least two isoenzymes in different varieties of S. tuberosum. Since the 
exact composition of apyrase used experimentally was not specified, we focused our attention on two 
isoenzymes that have been previously characterized. The first isoenzyme, Pimpernel, catalyzes 
hydrolysis of the γ-phosphoryl group of ATP ten times faster than the β-phosphoryl group of ADP (244, 
245). The other isoenzyme, Desiree, has a lower ATPase/ADPase ratio, and converts ADP to AMP at a 
rate similar to the conversion rate of ATP to ADP. Each isoenzyme has the same molecular weight of 49 
kDa (244).  
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Mass Transport Model for Parallel-plate Flow Chamber Model 
The computational domain for the modified model is based on the specific geometry of our parallel-plate 
flow apparatus (Figure 13) as described by Andrews et al. (116) (see their first two figures for more 
detailed diagrams). ECs are grown to confluence on the bottom surface of a 10 µm thick membrane, 
which is then placed at the top of the main flow chamber, exposing ECs to fluid flow. A second chamber 
allows the tip of a NO electrode to be positioned on the membrane immediately above the midpoint of 
the EC monolayer, physically separated from fluid flow. Dimensions of the flow channel (in cm) are W 
= 4.57, L = 12.19, H = 0.025. The EC monolayer is modeled as a thin sheet he = 5 µm thick and 2.4 cm 
long (the same length as the diameter of the membrane). The EC cell surface is defined at y = 0 with the 
bottom of the flow chamber located at y = H. 
 
Each simulation reflects the protocols that were used experimentally (116, 232, 233). The perfusing 
media in the lower chamber was maintained at constant temperature 37º C and is assumed to have the 
same dynamic viscosity as water (µ=0.00696 dyn-s/cm2). Initially, a low flow rate with τw = 0.1 dyn/cm2 
was maintained for a sufficient time (typically t > 400 s) to generate a steady-state baseline NO at the 
electrode tip. A step change in pump flow was then applied to increase τw. Four different step changes in 
τw from the baseline were simulated (0.1 to 1, 0.1 to 6, 0.1 to 10, and 0.1 to 20 dyn/cm2). 
Model Assumptions 
1. The flow chamber is treated as being infinitely wide (W >> H), simplifying the model to two 
dimensions. 
2. Fully developed Poiseuille flow is assumed throughout the chamber. 
3. There is no NO dissolved in the culture medium entering the chamber (NO = zero at the 
entrance). 
4. Excess substrates are available for NO synthesis (L-arginine, O2), and O2 consumption by ECs is 
negligible (234). 
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5. The model neglects any influence of negative feedback by NO on RNO, and any influence of 
ATP feedback on ATP release. 
6. The hyperbolic representation of tw-dependent RNO determined by Andrews et al. (116) was 
modified to reflect a time lag between the increase in τw and the corresponding increase in RNO, 
as suggested experimentally. 
7. The concentration of ATP = 0 at the inlet of the chamber, with concentrations of ATP and ADP 
in the flowing media originating solely from ECs.   
8. The ATP production rate depends upon the magnitude of τw (239), which can be represented by 
a single term, and intracellular ATP stores are not depleted. 
Governing Equations 
The mathematical model for the parallel-plate flow chamber includes transport of three chemical species 
(NO, ATP, and ADP). Since some NO may be lost due to auto-oxidation in an oxygenated aqueous 
solution (252) 
 4𝑁𝑂 +   𝑂! + 2𝐻!𝑂   → 4𝐻! + 4𝑁𝑂!! ..................................................................... Equation 51 
      
we include a second order reaction with rate constant kauto = 2 . 10-6 nM-1s-1 (253) to describe auto-
oxidation of NO within the chamber (kautoC2NO). 
Flowing Region (Lower Chamber) 
Within the flowing media, the transport of NO is described by the general time-dependent 
convection/diffusion/reaction equation, including removal by auto-oxidation, with model parameters as 
defined in Table 1. 
!!!"!"   =     𝐷!"∇!𝐶!" −   𝑘!"#$𝐶!"! − 𝑢 𝑦 !!!"!"  ...................................................................................... Equation 52 
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Equations for transport of ATP and ADP can be described similarly but do not require an auto-oxidation 
term: 
𝝏𝑪𝑨𝑻𝑷𝝏𝒕   =     𝑫𝑨𝑻𝑷𝛁𝟐𝑪𝑨𝑻𝑷 −   𝒖 𝒚 𝝏𝑪𝑨𝑻𝑷𝝏𝒛  ............................................................................................................. Equation 53 !!!"#!"   =     𝐷!"#∇!𝐶!"# −   𝑢 𝑦 !!!"#!"  ..................................................................... Equation 54 
      
where u(y) defines the parabolic velocity profile for laminar flow: 
𝑢 𝑦 = 4𝑈     !  ! −    !! !  .......................................................................................... Equation 55 
        
The derivative of the velocity profile is used to calculate τw at the EC surface (y=0).  
 
𝜏! = µμ   !"!" ⃒!!!     = !"!!  ........................................................................................... Equation 56 
 
The volumetric flow rate that determines the midstream maximum velocity U at y = H/2 is based on the 
values of τw used experimentally (116, 232, 233). 
Effect of Apyrase 
When apyrase is present in the medium, degradation reactions 
(𝑹𝑨𝑻𝑷,𝒂𝒑𝒚𝒓𝒂𝒔𝒆 = −  𝑪𝑨𝑻𝑷  𝑪𝒂𝒑𝒚𝒓𝒂𝒔𝒆    𝒌𝒄𝒂𝒕𝑲𝒎!  𝑪𝑨𝑻𝑷  Equation 
49𝑹𝑨𝑫𝑷,𝒂𝒑𝒚𝒓𝒂𝒔𝒆 = −  𝑪𝑨𝑫𝑷  𝑪𝒂𝒑𝒚𝒓𝒂𝒔𝒆      𝒌𝒄𝒂𝒕𝑲𝒎!  𝑪𝑨𝑫𝑷  Equation 50) are added to the nucleotide mass 
transport equations  
 
!!!"#!"   =     𝐷!"#∇!𝐶!"# −   𝑢 𝑦 !!!"#!" +   𝑅!"#,!"#$!%&  ..................................................................... Equation 57 
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 Endothelial Cell Monolayer 
As there is no fluid flow within the EC monolayer, convective transport can be neglected, and governing 
equations for each chemical species are: 
!!!"!"   =     𝐷!"∇!𝐶!" −   𝑘!"#$𝐶!"! +   𝑅!"  ................................................................................................... Equation 59 
     
!!!"#!"   =     𝐷!"#∇!𝐶!"# +   𝑅!"# ............................................................................... Equation 60 
        
!!!"#!"   =     𝐷!"#∇!𝐶!"! +   𝑅!"#  ........................................................................................................................... Equation 61 
      
where CNO, CATP, and CADP are concentrations of NO, ATP, and ADP, and RNO, RATP and RADP are the 
overall reaction rates for each chemical species. 
 Membrane and Upper Chamber 
The governing equations require only diffusion for each chemical species within the membrane layer and 
the upper chamber, with only one reaction (auto-oxidation of NO). 
 
!!!"!"   =     𝐷!"∇!𝐶!" −   𝑘!"#$𝐶!"!  ........................................................................... Equation 62 
       
!!!"#!"   =     𝐷!"#∇!𝐶!"#  ................................................................................................................................................... Equation 63 
        
!!!"#!"   =     𝐷!"#∇!𝐶!"# ............................................................................................ Equation 64 
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Initial and Boundary Conditions: 
The initial and boundary conditions applied in the parallel-plate model are identical to those used by 
Fadel et al. (234) with continuity of concentrations and mass fluxes between compartments. At the inlet 
of the lower chamber (z=0), the initial and boundary concentrations for NO, ATP, and ADP are set to 0. 
Mass fluxes at the bottom (y=H) and entrance (z=0) of the chamber are set to zero for all chemical 
species. 
 
!"!" ⃒!!! =    !"!" ⃒!!!   = 0   ......................................................................................... Equation 65 
        
There is negligible mass flux through the membrane into the upper chamber. 
	  
Dimensionless Governing Equations 
Defining dimensionless variables C* = C/Cref, y* = y/H, z* = z/L, t* = H2/D, u* = u(y)/U, and R/Rmax, 
the governing partial differential equations are converted into dimensionless form 
 
!!∗!!∗   =    !!!∗!!∗! +   (!!)!   !!!∗!!∗! − (!!!!" )  𝑢∗ !!∗!!∗ +    !!!!"#!!!"# 𝑅∗ ....................................... Equation 66 
     
 where the dimensionless velocity profile is  𝑢∗ = 4𝑦∗(1 − 𝑦∗) .................................................................................................... Equation 67 
         
For the NO simulations, the dimensionless auto-oxidation loss term - k*C*2 is added to Equation 30, 
where the dimensionless rate constant is 
 
𝑘∗ = !!!!!"#!   ............................................................................................................ Equation 68 
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3.2.3 Results 
Dimensionless partial differential equations for all species in each region of the flow chamber were 
solved by the finite element method using commercial software (FlexPDE 4™), which allows for 
adaptive mesh refinement to guarantee an accuracy of 0.0001. Changes in the concentrations of NO, 
ATP, and ADP for τw ranging from 0.1 to 30 dyn/cm2 were computed throughout the chamber. Results 
are shown for values predicted at the midpoint of the EC monolayer (z = 12 mm) near the NO electrode 
position. 
3.2.3.1  Dynamic Changes in NO at EC Surface 
Predicted changes in NO at the EC surface are shown in Figure 14A for the four step changes in τw used 
experimentally. RNO was computed from 𝑅!" =   𝑅!"#"$ + 𝑅!"# !!!!!!    Equation 37 using values for 
Rbasal, Rmax and A that provided the best fit to the steady-state experimental NO data (squares) 
determined by Andrews et al. (116). For the smallest step change in τw (0.1 to 1 dyn/cm2), the final 
steady-state NO is below the baseline value, due to a convective washout effect. With larger increases in 
τw, there is a sufficient increase in RNO to increase NO above baseline. The NO value at the midpoint (z = 
12 mm) is not the highest value on the EC surface, which occurs downstream at the lower edge of the EC 
monolayer (z = 24 mm). For example, the midpoint NO = 70.4 nM for the largest τ, τw = 20 dyn/cm2, but 
at the downstream edge NO = 89.3 nM. 
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Figure 14: (A) Changes in NO concentration at the endothelial surface predicted for different step changes 
in wall shear rate (τw) by increasing the rate of fluid flow at t = 200 s (baseline τw = 0.1 dyn/cm2) and steady 
state experimental values from Andrews et al. (116) (squares). (B) Comparison of experimental NO 
measurement (circles) with dynamic simulation using a step increase in RNO (dashed line) or a 60 s duration 
ramp increase in RNO (solid line). 
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The dynamic NO response that is predicted for the simulation using a simultaneous step change in τw and 
RNO (dashed line) at t = 0 s is much faster than observed experimentally (circles). Using a ramp function 
(𝑅!" =   𝑅!"#"$ + 𝑅!"#    𝑟𝑎𝑚𝑝 𝑡!, 𝑡! !!!!!!   Equation 38) with a 60 s period for the increase in RNO 
causes a slower increase in NO (solid line) following the instantaneous step change in τw at t = 0 s. 
Consequently, there is a transient decrease in NO after increasing flow, which can be attributed to 
convective washout of NO until RNO reaches a higher value.  
3.2.3.2 Dynamic Changes in ATP and ADP at EC Surface  
Predicted dynamic changes in nucleotide concentrations at the EC surface following step changes in τw 
at t = 1 min for both Model A and Model B are shown for ATP in Figure 15, and for ADP in Figure 16. 
For Model A, both ATP (Figure 15A) and ADP (Figure 16A) increase rapidly, reaching 90% of steady-
state within 5 – 6 s after the increase in τw. In contrast, Model B predicts a much slower and smaller 
increase, reaching peak concentrations (open circles) at t ~ 45 s for ATP (Figure 15B) and ~ 50 s for 
ADP (Figure 16B) after the step increase in τw, which is then followed by a slow decline, falling to ½ of 
the peak (closed circles) at t ~ 4.6 min, or 3.6 min after the step increase in τw, due to the equations 
representing “receptor desensitization” included in this model. In addition to the difference in time 
responses, another major difference between the two ATP-release models is the lower concentrations of 
ATP and ADP at the EC surface simulated for Model B, compared with Model A. Differences between 
the two models over a wide range of τw are shown in Figure 15C for ATP and Figure 16C for ADP. At 
the midpoint of the EC monolayer (z = 12 mm) close to the NO electrode, Model A predicts that the 
surface ATP = 1.32 µM is highest for τw ~ 14 dyn/cm2 and the highest ADP = 0.190 µM is for τw ~ 12 
dyn/cm2.  At higher τw, both RATP and RADP continue to increase for both Models A and B, but the 
increased convective transport out of the chamber causes both ATP and ADP to decrease.  
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Figure 15: Dynamic change in ATP concentration at the endothelial surface predicted by model A (A) and 
predicted by model B (B) for different step changes in τw above baseline of 0.1 dyn/cm2. (C) Comparison of 
maximum ATP reached for both models as a function of the final τw above baseline. 
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Figure 16: Dynamic change in ADP concentration at the endothelial surface predicted by model A (A) and 
predicted by model B (B) for different step changes in τw above baseline of 0.1 dyn/cm2. (C) Comparison of 
maximum ADP reached for both models as a function of the final τw above baseline. 
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However, Model B does not predict this biphasic response, as both RATP and RADP and the resulting 
nucleotide concentrations progressively increase over the entire τw range investigated. 
 
Additional detail for the ATP simulation for Model A with τw = 14 dyn/cm2 is shown in Figure 17 (not to 
scale, since y << z), with a color map of ATP concentrations in the flow chamber next to the EC 
monolayer (A), the change in ATP on the EC surface from 0 < z < 24 mm (B), and the ATP gradient into 
the flow stream at 2 locations (C). The majority of ATP is transported in a relatively thin layer near the 
EC surface. The predicted ATP at the EC surface increases progressively, reaching 1.32 µM at the 
midpoint of the EC monolayer (z = 12 mm), with the highest concentration (1.60 µM) located farther 
downstream at z ~ 22 mm, about 0.28 µM higher than at the midpoint location. The ATP concentration 
then decreases to ~ 1.35 µM at the downstream edge of the EC monolayer (z = 24 mm). The ATP 
concentration falls below < 1 nM at y ~ 40 µm from the surface, and is negligible in the middle and outer 
flow regions. Qualitatively similar predictions for the spatial distribution of ADP were found. It should 
be recognized that the actual flow chamber extends farther upstream and downstream beyond the region 
that was modeled (directly next to the EC monolayer), and ATP and ADP concentrations exiting the 
chamber will be very low due to dilution as they mix into the bulk flow. 
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Figure 17: (A) Color map of ATP concentration profile in flowing fluid near the EC monolayer predicted by 
model A with τw = 14 dyn/cm2. (B) ATP concentration along the EC surface from proximal to distal edge (0 
< z < 24 mm) of the EC monolayer, with symbols for the predicted midpoint value (at z = 12 mm) and the 
highest predicted value (at z ~ 22 mm). (C) ATP gradients out into the flowing fluid near the EC monolayer 
at the midpoint and near the end of the EC monolayer. 
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3.2.3.3 Effect of apyrase on ATP and ADP concentrations 
We performed simulations to evaluate the effect of constant apyrase concentration = 1 U/mg protein in 
the media using different parameters (Km, kcat;  
Table 12) and different ATPase and ADPase activities for each isoenzyme (Table 4). The ATP and ADP 
concentrations were computed at the midpoint of the endothelial surface under the location where the 
NO electrode is positioned.  
Isoenzyme Substrate Km (mM) kcat (s-1) 
Pimperal ATP 0.172 920.74 
 ADP 0.264 105 
Desiree ATP 0.0635 2202.5 
 ADP 0.31 2076.3 
 
Table 12: Reaction constants for the rate of conversion of purine nucleotides for 2 different isoenzymes of 
apyrase at 37°C. 
	  
 
Isoenzyme 
 ATPase activity 
(U/mg protein) 
[ATPase] 
(mol/m3) 
[ADPase] 
(mol/m3) 
Pimpernel A 40 5.10 x 10-4 5.10 x 10-3 
Pimpernel B 30 1.02 x 10-3 1.02 x 10-2 
Desiree A 40 5.10 x 10-4 5.10 x 10-4 
Desiree B 20 1.02 x 10-3 1.02 x 10-3 
Desiree C 3 6.80 x 10-3 6.80 x 10-3 
 
Table 13: Parameters for 5 simulations using different isoenzymes of apyrase and corresponding 
concentrations of ATPase and ADPase within the range of specific activities specified by the manufacturer 
(Sigma Aldrich). 
 
As expected, apyrase reduced ATP concentrations simulated for all τw with both models, as summarized 
in  
Table 14 and compared with ATP results without apyrase (first column). Reductions in ATP with 
apyrase are compared with the maximum (Model A) or peak ATP (Model B) without apyrase in Figure 
15A and Figure 15B for each ∆τw range. For both models, the lowest ATP concentrations are predicted 
with parameters for Desiree C, whereas Pimpernel A and B had the smallest effect on ATP. At the 
lowest ∆τw range (0.1 to 1 dyn/cm2), there is a 99.7% reduction in the final ATP for Desiree C compared 
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with the final ATP without apyrase in the media. The changes in ADP are compared with the maximum 
(Model A) or peak ADP (Model B) without apyrase in Figure 16A and Figure 16B for each Dtw range. In 
all cases, there is a large increase in ADP above the value predicted without apyrase, with the largest 
increases for Pimpernel A and B, and smaller increases for Desiree A, B, and C. Further downstream 
from the EC monolayer (not modeled), the exiting ATP and ADP concentrations will be very low since 
there is more time for further degradation reactions catalyzed by apyrase in the media as well as dilution 
due to mixing into the bulk flow. 
Model A No apyrase Pimperal A Pimperal B 
Dtw ATP (µM) ADP (µM) ATP (µM) ADP (µM) ATP (µM) ADP (µM) 
0.1 to 1 0.0389 0.0007 0.0066 0.0225 0.0038 0.0186 
0.1 to 6 0.9001 0.0136 0.3396 0.5410 0.2232 0.5701 
0.1 to 10 1.2506 0.0183 0.6000 0.6450 0.3739 0.7934 
0.1 to 20 1.2430 0.0175 0.7088 0.5306 0.5159 0.6775 
 Desiree A Desiree B Desiree C 
Dtw ATP (µM) ADP (µM) ATP (µM) ADP (µM) ATP (µM) ADP (µM) 
0.1 to 1 0.0014 0.0052 0.0007 0.0030 0.0001 0.0006 
0.1 to 6 0.1282 0.2383 0.0723 0.0030 0.0281 0.0689 
0.1 to 10 0.2121 0.3898 0.1342 0.2802 0.0516 0.1161 
0.1 to 20 0.2680 0.4790 0.1702 0.3732 0.0693 0.1510 
 
Model B No apyrase Pimperal A Pimperal B 
Dtw ATP (µM) ADP (µM) ATP (µM) ADP (µM) ATP (µM) ADP (µM) 
0.1 to 1 0.1284 0.0022 0.0280 0.1066 0.0194 0.2166 
0.1 to 6 0.4172 0.0028 0.1730 0.2603 0.1157 0.3087 
0.1 to 10 0.5625 0.0082 0.2701 0.3025 0.1963 0.3809 
0.1 to 20 0.7916 0.0111 0.4612 0.3414 0.3441 0.4626 
 Desiree A Desiree B Desiree C 
Dtw ATP (µM) ADP (µM) ATP (µM) ADP (µM) ATP (µM) ADP (µM) 
0.1 to 1 0.0087 0.0204 0.0051 0.0144 0.0004 0.0019 
0.1 to 6 0.0660 0.1116 0.0385 0.0833 0.0103 0.0333 
0.1 to 10 0.1078 0.1742 0.0715 0.1335 0.0207 0.0510 
0.1 to 20 0.1695 0.3021 0.1355 0.2148 0.0431 0.0952 
 
Table 14 Predicted maximum (Model A) or peak (Model B) ATP and ADP concentrations with and without 
apyrase for step changes in τw used experimentally. 
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Figure 18: Effects of apyrase for 5 different parameter sets  
Table 13 on (A) maximum ATP and ADP for model A, and (B) peak ATP and ADP for model B. Predictions 
for the lowest Δτw (0.1 to 1 dyn/cm2) are shown at expanded scale in left panels. 
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3.3.3.4 Effect of apyrase on RNO 
The values for RNO calculated from experimental NO data (232, 233) measured with (solid cicrlces) and 
without apyrase (open circles) in the media are shown in Figure 19A as a function of τw. The hyperbolic 
relationship (𝑅!" =   𝑅!"#"$ + 𝑅!"# !!!!!!    Equation 37) for RNO was fit to both sets of 
experimental data (control RNO = 4.1 + 532 x τ/(τ + 32.9) nM/s; apyrase RNO = 0 + 602 x τ/(τ + 44.6) 
nM/s) using the previous analysis for the chamber described by Andrews et al. (116). The apyrase curve 
(dashed line) falls below the control curve (solid line) without apyrase by 41%, 21%, 18%, and 13% for 
τ = 1, 6, 10 and 20 dyn/cm2 respectively.  
 
To model the effects of apyrase, we hypothesize that a component of RNO at a given τw is directly 
proportional to the total nucleotide concentration (ATP+ADP), as  
 𝑅!",!"#$%&'()%* = 𝛽 𝐴𝑇𝑃 + 𝐴𝐷𝑃 ! ......................................................................... Equation 69 
 
To examine whether this relationship can describe our experimental results, we determined the 
proportionality constant β (units: nM/s NO production per µM nucleotide concentration), which provides 
the best match (smallest rot mean square error, rms) for each simulation fitted to the apyrase curve. 
Simulations were performed for both Model A and Model B using parameters for each isoenzyme ( 
Table 12 and  
Table 13). Values for β with the lowest rms are summarized in Table 15. Realistic matches could not be 
made for the Pimperal isoenzyme, which had very small differences in (ATP + ADP). Very high β 
values were estimated for simulations with Model A using parameters for the Pimperal isoenzyme, 
which would generate RNO,nucleotides values higher than the experimental control curve. For Model B, 
nonphysiological negative β values were estimated. Very good matches were obtained for the 
simulations with all 3 parameter sets for the Desiree isoenzyme. Simulations for Desiree with parameter 
set B, which had changes in total nucleotide concentration between parameter sets A and C (  
Table 14 and Figure 18), are shown for Model A (Figure 19B) and Model B (Figure 19C). The simulation 
for Model B  (Figure 19C) with parameter set B for Desiree provided the closest match (rms = 0.0356 
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nM/s) to the experimental apyrase curve (dashed line). The predicted component (RNO,nucleotides) is shown 
as a function of τw at the bottom of Model A (Figure 19B) and Model B (Figure 19C) along with the 
estimated values for β. In general, the match for the simulation with Model B was closer than that 
determined with Model A for all 3 parameter sets for the Desiree isoenzyme. The poorest match was 
determined from the simulation for Model A using parameter set A for the Desiree isoenzyme. 
 
Table 15: Estimated values for the RNO,nucleotides proportionality constant (β, nM/s per µM) in Equation 
33 that provides best match (lowest root mean square error) to experimental apyrase curve for simulations 
with different parameters for the Desiree isoenzyme  
Table 13. 
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Figure 19 (A) Variation in the NO production rate (RNO) with τw determined from NO measurements for 
parallel-plate flow experiments by Andrews et al. (23, 24) (solid line, no apyrase in media, experimental data 
shown by open circles; dashed line, 1 U/mg protein apyrase in media, experimental data shown by solid 
circles). (B) Predicted effects of apyrase isoenzyme Desiree with parameter set B (Table 4) on the 
RNO,nucleotide components (no apyrase, solid symbols; apyrase, open symbols; match to apyrase curve, 
open triangles) based on Equation 33 using Model A, and (C) using Model B.  
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3.3.4 Discussion 
Andrews et al. (233) propose that the mechanism for τw-induced NO production is in part due to the 
release of ATP in nM-to-µM concentrations (consistent with concentration ranges predicted by our 
simulations), with subsequent activation of purinergic receptors in the plasma membrane and changes in 
intracellular Ca2+. To our knowledge, Andrews et al. (233) are the first to report on the role of capacitive 
Ca2+ entry (CCE) in the mechanism of the acute τw-induced NO response. ATP stimulates a Ca2+ 
response through both the release from endoplasmic reticulum (ER) stores as well as influx through 
store-operated channels (SOCs). Studies of purinergic receptor with human umbilical vein ECs 
(HUVEC) found an EC50 for ATP around 3.05 µM for peak Ca2+ responses (254). Our predicted ATP 
responses for both release models would be in the lower 20% of the Ca2+ response curve reported for 
HUVECs. Raqeeb et al. (56) This study also found that 2 µM ATP caused an approximately 27% 
increase in DAF fluorescence, consistent with an increase in RNO. If a linear extrapolation between 
changes in RNO and DAF fluorescence can be made, this suggests that there could be a modest increase 
in RNO that can be attributed to increased ATP with higher τw since predicted ATP values for Model A 
are above 1 µM when τw  > 7 dyn/cm2 (Figure 3C). However, our previous experimental data (116) 
demonstrates much larger τw-dependent changes in RNO, which might be completely independent from 
changes in ATP. More experimental data on changes in RNO with ATP is needed to develop a more 
quantitative relationship, and quantitative experimental data are currently lacking for changes in RNO 
with ADP. 
 
In addition to the studies showing reduced RNO with apyrase, Andrews et al. (233) also conducted a 
study blocking purinergic receptors with suramin (200 µM for 10 min), which attenuated the τw-
dependent NO response by 60% following a step change in τw from 0.1 to 10 dyn/cm2 compared with the 
response for untreated ECs. Andrews et al. (233) also inhibited SOCs using SKF-96365, which caused a 
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40% reduction in NO responses to τw =10 dyn/cm2. When apyrase was added to the medium, the degree 
of RNO inhibition was greater at lower τw, which can be explained by the diffusion limited reaction of 
apyrase with ATP. Also, there are higher rates of ATP release at higher shear stresses. Suramin, which 
would not be diffusion limited, showed greater attenuation of the NO response at 10 dyn/cm2 than seen 
with apyrase.  
 
A reduction in EC NO production following exposure to apyrase has also been reported by Kiefmann et 
al. (255) from in vivo studies in rat lung. They showed that lung expansion augments Ca2+ oscillations 
and increased ATP release from the pulmonary vasculature. Microinjections of ATP directly into lung 
alveoli caused localized Ca2+ oscillations. Intra-alveolar infusion of apyrase (50 U/ml) completely 
blocked cytosolic Ca2+ oscillations and significantly attenuated EC NO production (evaluated by DAF 
fluorescence). However, increased NO with ATP was also seen under Ca2+-free conditions, suggesting 
no role for CCE. A quantitative relationship between ATP and RNO is not possible with these 
observations. 
 
Phosphorylation of eNOS was also measured by Andrews et al. (232, 233) which provides further 
insight into the relationship between ATP and NO. Under control conditions (no apyrase), there was a 
statistically significant increase in eNOS phosphorylation in ECs exposed to τw for 3 minutes, but not for 
ECs exposed for a shorter time (1 min). Flow caused a 20% increase in eNOS phosphorylation for 
control ECs while degradation of endogenous ATP with apyrase showed a 15% decrease in eNOS 
phosphorylation after 3 min of τw. However, the mechanisms by which ATP influences RNO are not well 
understood. ATP has been demonstrated to increase eNOS phosphorylation at the Ser1177 site (228). ADP 
appears to also trigger an increase in eNOS phosphorylation at Ser1177 and Ser635 as well as 
dephosphorylation at Ser116 (230). In cultured fetal bovine aortic ECs, extracellular ATP in the media 
during laminar τw was found to significantly increase NO-dependent signaling (113). However, this may 
not necessarily be due to τw-dependent RNO, but may involve another activation pathway (231).  
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Other mechanisms that increase RNO have been identified (256, 257), although they may not necessarily 
be independent of adenine nucleotides. Kumar et al. (258) report that protein kinase C-δ (PKCδ) and 
catalase are two previously unidentified signaling molecules that are important in regulating tw-mediated 
NO signaling in pulmonary artery ECs. They found that acute increases in τw stimulate NO generation 
through the inhibition of PKCδ signaling. The decrease in PKCδ in turn leads to a decrease in 
phosphorylation of eNOS at Thr495 and an increase in eNOS phosphorylation at Ser1177. There is 
evidence that phosphorylation at Ser633 increases NO production (257), but this can occur without the 
need for an increase in intracellular Ca2+ (259, 260), as would occur with increased purine nucleotide 
concentrations. 
 
A number of studies suggest that red blood cells (rbcs) release ATP, especially in response to hypoxic or 
hypercapnic conditions in vivo (261, 262), and may therefore play a role in modulating NO and blood 
flow. This mechanism is controversial, since a recent study suggests that the source of ATP and ADP 
from rbcs is due to hemolysis and release of internal contents (263). However, another study using rbcs 
incubated with hydroxyurea, the FDA approved therapy for sickle cell disease, contends that ATP 
release from rbcs is due to mechanisms other than hemolysis (264). This study reports that rbcs 
incubated with hydroxyurea had an over two-fold greater release rate for ATP compared with normal 
rbcs, and caused 1.34 higher rate of NO production from cultured ECs, compared with measurement 
using normal rbcs. The actual concentrations of ATP (determined by luciferin–luciferase assay) and NO 
(determined by DAF fluorescence) in this study are not known, so it is not possible to obtain a 
quantitative relationship between ATP and RNO. Hemolysis appears to account for significant 
measurement errors in determining human plasma ATP (265), since rbcs normally contain high 
concentrations of ATP (mM levels). Gorman et al. (265) report than normal ATP levels in human blood 
plasma are 28 nM, much lower than the ~ 1 µM levels (or higher) that are reported in other studies (see 
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their Table 1). However, ATP levels at the endothelial surface can be in the µM range, as our simulation 
predicts. 
 
It should be noted that we have focused only on the endogenous production of ATP by ECs to model its’ 
potential effects on NO production in a simple, in vitro system. More complicated modeling would be 
necessary for in vivo models of blood vessels, especially for dynamic models that include changing 
diameters and τw with vascular regulation by NO. The release of ATP by sympathetic nerves as a co-
transmitter with noradrenaline, or other vasoactive substances produced by ECs, such as endothelium-
derived relaxing factor, or the interaction of the purine nucleotides with their receptors would also need 
to be considered (227). Effects of pulsatile and steady-state flow on nucleotide transport have been 
modeled in realistic geometries for branching arteries (266, 267), and a model incorporating eNOS has 
been developed that predicts where tw is low and NO may be deficient in the vascular wall, especially at 
locations in bifurcations and bends (193). These regions were also predicted to have lower values for 
ATP and ADP at the EC surface. However, the eNOS activation model by Comerford et al. (193) lacked 
experimental CNO data to compare with predicted results. While the parallel-plate flow chamber may 
have limitations, it remains a useful experimental tool for studying different mechanisms for tw-
dependent RNO. 
3.3.5  Model Limitations 
We used simplified relationships to model the increase in EC RNO with τw in this study. Koo et al. (117) 
developed a much more complex, integrated model for RNO incorporating major mechanisms of τw-
dependent eNOS activation, including transcriptional regulation by key proteins, eNOS phosphorylation 
by key kinases, and interactions with protein partners (e.g., caveolin, calmodulin, heat shock proteins). 
They computed a relative increase in cumulative RNO, and relative contributions from each mechanism 
were shown. It would be necessary to couple this model with geometry-specific mass transport to 
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quantify the concentration of NO in a biological system. They did not model the effects of purine 
nucleotides. 
 
Although O2 is required by eNOS to produce NO, O2 transport was not included in our model, since 
Fadel et al. (234) previously demonstrated that O2 consumption by ECs in their model did not influence 
the spatial distribution of NO in the chamber. However, O2 transport is an important consideration for O2 
transport with in vivo models, where the nonlinear oxyhemoglobin reaction must be used. The viscosity 
of blood also requires more complex modeling to represent variation in τw in a network of blood vessels.  
3.3.6  Conclusions 
Knowledge of how shear stress influences CATP and CADP at the endothelial surface is important for 
understanding the shear stress regulation of vasoregulatory processes, in particular the regulation of 
nitric oxide. As studies have demonstrated the release of ATP and ADP from red blood cells and 
endothelial cells in response to hypoxic conditions (67, 72, 74, 268), understanding of the manner by 
which this signaling alters the production of nitric oxide becomes even more intriguing and important. 
Our simulations for τw-dependent purine nucleotide production at the EC surface using either Model A 
or Model B suggest that the effect of increasing ATP and ADP on RNO would be greater in the low τw 
range < 6 dyn/cm2, compared with effects at higher τw. Predicted values are higher for Model A, but 
there are relatively smaller changes in ATP and ADP for the higher τw ranges. Convective effects in the 
chamber help maintain relatively constant ATP and ADP at higher τw, despite further small increases in 
the rates of ATP and ADP production. Although predicted values are lower for Model B, there is more 
gradual increase in concentrations over the entire range of τw studied in the chamber. However, there is a 
nearly 3.5 fold higher increase in ATP for τw < 5 dyn/cm2 compared with the rate of ATP increase for τw 
> 10 dyn/cm2. This is also consistent with having a larger effect on RNO in the lower τw range. Although 
we were not able to quantify the effect of altering purine nucleotide concentrations with apyrase on RNO, 
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the simulations predicted much larger decreases in ATP with apyrase at lower τw. However, even though 
there was a predicted increase in ADP, the sum of both ATP and ADP for a given ∆τw will be smaller 
due to continuing degradation reactions with apyrase than the predicted sum of ATP and ADP without 
apyrase in the medium. The experimental studies with apyrase showing a greater effect on RNO at lower 
τw also appears to be consistent with the modeling results.	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Chapter 4: Relationship between NO and O2 in the Microcirculation 
4.1 Introduction 
4.1.1 General introduction 
The only current three dimensional network model of nitric oxide transport in the microcirculation has 
several limitations (12).  The first of the limitations is the neglect of the convective transport of NO in 
the vessel lumen.  A second limitation of the referenced model is the omission of O2 transport, which 
could become an issue at very low blood flow rates or during other conditions that may limit the 
production of NO via eNOS due to lack of the essential substrate oxygen. Since NO is a known 
vasodilator (255-258) and a chief role of the microcirculation is to transport O2 to the surrounding tissue 
(2-4), computational models examining the cross-talk between the two molecules could prove to be an 
important tool in development of interventions of various cardiovascular diseases. 
The functions of NO and O2 in the microvasculature are intricately related. The current model of NO 
transport in a three dimensional computational network does not consider oxygen transport, and 
therefore a connection cannot be made between changes in oxygen demand and NO-mediated change in 
vessel diameter. As oxygen is a known essential substrate for NO production inclusion of this 
mechanism is a logical point from which the interaction between NO and O2 can be explored in a 
computational microvasculature unit (MVU). The transport of O2 in MVUs (or at least a representative 
vascular unit structure) has previously been considered (5, 49).  Additional computational models have 
also considered the interaction between NO and O2 in the microvasculature (161, 179, 180, 259). These 
models considering the interaction between NO and O2 do not consider the influence which O2 has on 
the metabolism of NO within the microcirculation, they do consider the influence that NO has on O2 
metabolism, such as preventing the consumption of O2 via cellular respiration (161, 179, 180). As the 
inhibition of NO inactivation via low tissue O2 proves to be an important route in which NO and O2 
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interact it should also be considered in the computational model. The role played by scavengers of NO in 
the transport in a microcirculatory environment appears to be substantial. As demonstrated in the 
previous chapter, RBCs are strong scavengers of NO and play a large role in local CNO. Furthermore, the 
distribution of RBCs has been described as being heterogeneous. The influence of this heterogeneity 
could prove useful in the signal required for NO-mediated dilation, and is therefore a focus of later 
models, as regions in which RBCs are lacking will be regions of lower NO scavenging. This indicates a 
“non-active” manner that vessels lacking adequate oxygen could increase their CNO to promote dilation 
and an increase in O2 delivery.  
Beyond its role as a scavenger of NO and a carrier of O2 RBCs serve a role in the transport of other 
molecules vital to the regulation of blood flow, in particular ATP (61, 67, 68, 72, 73, 246, 260, 261). As 
ATP has been demonstrated to be released in an O2 dependent manner (67, 262, 263) and endothelial 
dependent NO release has been found to be a function of local CATP (192, 229, 230, 245, 264, 265) a 
potential means of O2 control on endothelial NO production becomes evident. There exists the desire and 
the need to determine if modeling the described manners of NO/O2 interplay in a computational network 
can reveal a pathway by which changes in metabolic demand trigger an increase in CNO so as to alter the 
arteriole diameter, blood flow, and oxygen supply. As the transport of O2 and nucleotides has already 
been described, we turn our attention to the molecule of great focus, NO. 
4.1.2 NO transport dependence on local PO2 
Produced by the enzyme nitric oxide synthase (NOS), requiring oxygen (O2), the amino acid L-arginine, 
and other essential co-factors (15, 16) nitric oxide can be found in many different cell types and can be 
produced through a variety of mechanisms. Studies have shown that the intracellular L-arginine level is 
higher than necessary for optimal NO production (215); and therefore NO production rate is mainly 
determined by O2 once eNOS is fully activated (266). Both in vivo and in vitro experiments have shown 
that variation of O2 availability within the physiological range can result in significant changes in NO 
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synthesis in vascular endothelial cells (158). Additionally the relationship between NO and O2 extends 
out of the endothelial cell and the vessel and into the peripheral tissue where O2 competes with NO for 
the binding site of cytochrome-c-oxidase in the mitochondria, affecting the respiratory chain (158).   
As discussed by Fraisl (267) there are several implications of  this ongoing competition between O2 and 
NO. The first implication is a decreased gradient of oxygen away from the vessel with increased oxygen 
concentration in the tissue (268). The other implication of the competition between NO and O2 is an 
increase in the generation of mitochondrial reactive oxygen species (ROS) (269). It appears as if this 
outcome of competition may lead to up-regulation of eNOS and via this up-regulation increase the 
production of NO in the mitochondria and therefore improve overall O2 delivery.   
The bifurcating arteriole network model previously described is based upon other models and 
experimental networks examined by Ellsworth and Secomb (158). As the oxygen consumption in the 
tissue is increased to levels 12 times that of the resting state, the partial pressure of oxygen in the tissue 
decreases by approximately 10 torr. While, the main focus of the work of Secomb and Hsu was to 
determine the manner by which oxygen was transported to the capillaries, the discussion in reference to 
an increased metabolic state proves very useful and interesting.   
Mathematical studies have examined the synthesis of NO from various isoforms of nitric oxide synthase.  
Amongst said mathematical models are that conducted by Lamkin-Kennard in which the concentration 
of oxygen is considered for mitochondrial NOS (mtNOS), endothelial NOS (eNOS), and inducible NOS 
(iNOS) (180).  The half activation constant for mtNOS is assumed to be ~ 5, which is reported to be on 
the low end for eNOS.  The half activation constants (Km) as reported by Rengasamy and Johns (270) are 
found in Table 16.  While there does exist a slight discrepancy in the parameter values made use of for 
the mathematical model and those reported experimentally the story with regards to the sensitivity of 
each isoform of NOS to oxygen appears to be consistent. Neuronal NOS is most sensitive to oxygen 
concentration, making it appear that it is imperative to maintain adequate levels of oxygen in the brain.  
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The importance of keeping the brain well-oxygenated is already well known for reasons other than NO 
production.  Both eNOS and iNOS appear to be much less sensitive to changes in oxygen concentration.  
This would seem to be the case as long as one avoids what could be defined as hypoxic conditions, a 
definition that can vary.  For the range of oxygen consumptions considered in the study by Secomb and 
Hsu (11) the production of nitric oxide should not be influenced due to a limitation of the substrate 
oxygen. 
NOS 
Isoform 
Mathematical 
Model Half 
Activation Partial 
Pressure (Km) 
[torr](180) 
Rengasmy and 
Johns exp. 
Half 
Activation 
Partial 
Pressure (Km) 
[torr](270) 
eNOS 4.7 7.7±1.6 
iNOS 3.8 6.3±0.9 
nNOS 15 23.2±2.8 
Table 16: Parameters describing the sensitivity of each nitric oxide synthase to partial pressure of oxygen as 
applied in the mathematical study conducted by Lamkin-Kennard(180) and experimental analysis of 
purified NOS(270). 
	  
The production rate of nitric oxide influenced by oxygen has been modeled in numerous other studies.  
As explained by Buerk (38), if we assume that nitric oxide production follows Michealis-Menton 
kinetics the production of nitric oxide as a function of oxygen will take the form of  
  ................................................................................................................................ Equation 70 
 
If nitric oxide production was solely a function of oxygen, the production of NO would be the product of 
a maximal nitric oxide production rate (RNOmax) and RNOO2. This type of relationship, accounting for the 
oxygen dependent nitric oxide production, has been used in previous mathematical models by our lab 
group (161, 179, 180, 259, 271).  It is the interest of this particular project to incorporate the influence of 
m
ONO KPO
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=
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both oxygen and shear stress on nitric oxide transport within a three dimensional network. A corollary 
would be to analyze the manner that nitric oxide transport and oxygen interact within the network and 
the surrounding tissue. 
4.1.3 Intravascular transport of NO 
As explained by Chen et al. (179) the majority of the endothelium-derived NO is believed to be 
scavenged by hemoglobin within the flowing red blood cells and only a fraction diffuses into the 
surrounding tissue. In an earlier generation of simulation the transport of nitric oxide within the vessel 
lumen was not simulated (12). Instead of solving for the distribution of NO within the vessel making 
using of COMSOL’s finite element analysis, CNO within the vessel is approximated and the flux of NO 
from the vascular wall to the blood is accounted for.  This approximation is derived from the assumption 
that NO will only diffuse radially within the vessel (209).  More recent studies of nitric oxide production 
in flow chambers and mathematical models of the afferent arteriole of the kidney demonstrate that axial 
transport and convection also play an important role in determining the nitric oxide concentration at the 
vessel wall (222, 223, 272). To progress the model towards a tool that will better predict the transport of 
nitric oxide, related chemical species and subsequent physiological processes, we choose to model the 
transport of NO within the vascular lumen.  Within the lumen the transport of NO takes a form similar to 
that observed in description of oxygen transport within the vascular lumen.  
  ............................................................................. Equation 71 
 
The modes of transport of NO inside of the vessel are diffusion of NO, convection, and scavenging of 
NO by red blood cells. The diffusion of nitric oxide throughout the blood stream is modeled with the 
product of the diffusion coefficient of NO (DNO) and the Laplacian of the concentration of NO. The 
convective transport of NO is accounted for with the product of the velocity vector and the gradient of 
CNO.The final term of our convection-diffusion equation accounts for any reactions that may be 
DNO∇2CNO − v∇CNO + RNO = 0
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occurring within the vessel. For the current model the reactions occurring within the blood is the 
scavenging of NO by the hemoglobin within the red blood cells. The scavenging of nitric oxide by red 
blood cells is modeled as being a first order reaction, where the parameter λb is the NO scavenging rate 
for blood at the systemic hematocrit (45%).  Previous mathematical models completed by our group 
have chosen a variety of values for the hemoglobin scavenging (λb) (180), based upon  experimental 
studies conducted by Carlsen and Comroe (218). As explained by Lamkin-Kennard et al. (180) there 
exists a great deal of variability in reported and applied values for λb ranging from 100 s-1(273) to 1000 s-1 
(210). The majority of the mathematical studies conducted by our group (161, 179) have decided to use 
the higher parameter value representing the hemoglobin scavenging of the range originally considered 
(180).  The incorporation of the scavenging of NO by red blood cells allows for Equation 72 to take the 
following form: 
 ...................................................................................... 
 Equation 73 
 
The reaction between hemoglobin and nitric oxide is a fascinating one as the affinity of NO for 
hemoglobin is tremendous (1800 times that of carbon monoxide and approximately 400,00 times that of 
oxygen(218)).   
4.1.4 NO production from endothelial cells in an oxygen dependent manner 
Previous simulations considered the production of nitric oxide due to shear stress, yet fail to incorporate 
the influence of oxygen on the release of NO from the endothelial cells. This shall be remedied in this 
study. To do so we shall incorporate an O2-dependent term (RNOO2) that scales the reference NO 
production rate, RNOref.. This scaling term shall take a form similar to that previously applied to define O2 
dependent NO production (161, 179, 180, 259) 
  ......................................................................................... Equation 74 
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This is the first equation that incorporates the influence of both oxygen and shear stress on the production 
and transport of nitric oxide through a vascular network.  The applied mathematical model considers NO 
production as a flux occurring on the vascular wall rather than a reaction occurring within a volume.  To 
transform into a boundary condition the production of NO is multiplied by the thickness of the 
endothelial layer, which is a function of the radius of the vessel (δrel). The reaction occurring in the 
volume is transformed to a flux by multiplying each flux by the volume and dividing by the area of ECs. 
This leaves us with the thickness of the EC layer, for which we assume that the volume is conserved 
with regards to the radius of the vessel. 
  𝛿!"# = 𝛿!"# !!!"#  ............................................................................................................ Equation 75 
 
The reference thickness of the endothelial layer for terminal arterioles is approximated to be 1µm, and 
the reference radius is typically 5µm(but depends upon the vessel of interest). The flux of nitric oxide 
from the vascular wall can then be modeled as being the product 
𝐹!" = 𝛿!"#𝑅!"  ............................................................................................................... Equation 76 
 
4.1.4 O2 transport boundary conditions 
 
In our models the consumption of oxygen at the vascular wall is implemented as a flux occurring at the 
interface between the vasculature and the tissue. At the wall boundary we consider the metabolic 
consumption of O2 as well as the usage of O2 for NO production. The general oxidation reaction that 
occurs during a NOS active cycle to synthesize NO involves the oxidation of L-arginine to L-citrulline 
and NO,   Equation 77. 
  ................................................................. Equation 77 
 
L − arginine+ 2O2→ L − citrulline+ NO
102	  
	  
For every one NO molecule produced two O2 molecules are required.  Therefore, the consumption of 
oxygen due to the production of nitric oxide in the endothelium can be modeled as   Equation 78 
  ............................................................................................................ Equation 78 
 
The consumption of oxygen within the vascular wall can be calculated with an equation similar to that 
used to describe the consumption of oxygen in the tissue surrounding the vasculature, as in previous 
chapter. Yet as explained previously it seems likely that the consumption of oxygen in the vascular wall 
will be less than that in the surrounding tissue.  For this reason Qwall<Qmax, in particular the parameter of 
Qwall is set to be 1/10 of Qmax. 
  .................................................................................. Equation 79 
 
The entire boundary condition at the vascular wall is expressed with the following equation by 
combining the influence of both means of oxygen metabolism considered.  With this said due to the 
manner by which the mathematical model is constructed, the consumption of oxygen within the vascular 
wall must be expressed as a flux and therefore we incorporate the influence of thickness of the vascular 
wall.  The parameter δ is the assumed thickness of the endothelial cell and is set to 1 µm. Depending 
upon the diameter of the vessel it is assumed that the thickness of the endothelial cell layer will change 
accordingly, forcing our boundary condition to take the form  
𝐹!! = 𝛿!"# 𝑀!"## + 𝑅!!!"   .......................................................................................... Equation 80 
 
The outlets of the vessel are specified as having a zero flux boundary condition specified normal to the 
outlet.  Two different boundary conditions are applied at the inlet of the arterioles. For some simulations 
we turn to the results of a meta-analysis of nearly 265 experiments, which allowed for the following 
correlation to be created relating partial pressure of oxygen and fluid velocity (2). 
NONOO
RR 22 =
m
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 ................................................................................... Equation 81 
    
Umean is the average inlet velocity of the respective arterioles, and to be used in the above formula must 
be described in the units of mm/s. Another option at times applied is the usage of a constant inlet partial 
pressure of oxygen. A previous modeling effort by our group has made use of constant inlet partial 
pressure of oxygen (58.59 torr (161)). Studies examining the transport of NO in a microcirculatory 
network have used lower inlet partial pressures of O2 as they consider lower and higher generation 
arterioles as the initiation point of their computational domains. Secomb and Hsu assumed an inlet PO2 
at the beginning of the arteriole of 50 mmHg, corresponding to an oxygen saturation of 76% (11).  The 
control simulation considered by Tsoukias et al. chose an inlet PO2 of 41mmHg (5). Furthermore, as 
illustrated in a study by Golub and Pittman the oxygen concentration is extremely heterogeneous within 
the blood as well; with average measured values of 35torr within the red blood cells and 10torr within 
the plasma (54). If one were to use the approximated inlet velocity an inlet partial pressure of 33.75torr 
is calculated. Other studies of vascular transport in tissue have made use of a similar range when 
describing the partial pressure of oxygen at the terminal arteriole inlet (189) .  
As explained in Chapter 2, using the calculated flow rates into the capillary outputs of the arterioles the 
fluid velocity in each of the 20 capillaries fed by each arteriole can then be calculated.  The 
computational domain originally considered consisted of nine capillaries, and it is assumed that each of 
the arterioles feeds three of the nine capillaries. This link of the arterioles to the capillaries allows for the 
capillaries to be dependent upon the change in flow conditions brought on by the oxygen environment in 
the microvascular unit. Therefore, at the inlet of each of the groups of three capillaries a concentration of 
oxygen is specified, which happens to be a function of the outlet oxygen concentration of the respective 
arteriole that the capillary group is associated with. At this current juncture the PO2 inlet boundary 
condition for the capillaries is set to be 10/12th the average outlet concentration of the associated 
arteriole. This is done since the partial pressure of oxygen reported by Tsai et al. in the terminal 
( ) ( )torr
s
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arterioles is 24 mmHg compared to 20 mmHg within the capillaries (48). No flux boundary conditions 
are specified at the remainder of the boundary walls  
It should be noted that the transport of nitric oxide and oxygen in the capillaries is modeled as being 
similar to that of the arterioles.  The main difference is the thickness of the endothelial layer lining the 
capillaries compared to that of the arterioles; Table 17 describes each along with other parameters 
considered. 
Parameter Value Units Reference 
Endothelial thickness 
of Arterioles (δ) 
1 µm - 
Endothelial thickness 
of capilaries (δref) 
1/3 µm - 
Solubility coefficient 
(αO2) 
1.34 µM/torr - 
Diffusion coefficient of 
O2 (DO2) 
2800 µm2/s - 
O2 consumption in 
tissue (Qmax) 
10-100 µM/s - 
O2 consumption in 
tissue (Qwall) 
Qmax/10 µM/s - 
Hemoglobin 
scavenging (λb) 
382.5 1/s (161) 
rref 5 µm - 
Table 17: Values and parameters describing the transport of oxygen within the vascular unit structure. 
 
4.2 Simulation methods/results/discussions illustrating the strong physiological relationship 
between NO and O2 
4.2.1 The synthesis of NO from eNOS is not sensitive to changes in tissue O2 metabolic demand. 
Secondly, capillary PO2 is a good representation of the metabolic demand in surrounding tissue 
 
The bifurcating arteriole network considered in this study concerns arterioles whose parent branches are 
of the diameter of 8µm. The greatest PO2 is predicted in and around the arterioles.  This is expected, as 
the arterioles are the source of O2 to the system modeled in the computational domain. The oxygen 
profile illustrated in Figure 20 makes use of the velocity dependent inlet oxygen boundary condition.  As 
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the oxygen demand modeled for this particular simulation is relatively great, the PO2 in the tissue 
dramatically decreases with an increase in distance from the feeding arterioles. As can be expected the 
lower the oxygen demand in the tissue, the greater the PO2 predicted throughout the domain, Figure 21 
and Figure 22. 
 
 
Figure 20:  Profiles of partial pressure of oxygen within the bifurcating arteriole microvascular network.  
The partial pressure profiles are illustrated along 5 slices through the network structure. The surfaces are 
designated with S1(z=25um),S2(x=80um),S3(x=20um),S4(y=400um), and S5(y=100um). The range of oxygen 
partial pressures predicted goes from 0 to 35 torr. In this particular simulation set the maximal 
consumption of oxygen within the tissue is 10 µM/s, which corresponds to highly active tissue.  The inlet 
partial pressure of oxygen is set to 33.75 torr. 
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Figure 21:  Partial pressure of oxygen profiles along surfaces 1 and 5 as tissue oxygen demand is altered.  
The surfaces are defined within Figure 20.  The brighter, lighter colors represent greater partial pressures of 
oxygen and the darker colors represent the lower levels of oxygen, typically predicted under conditions of 
greater oxygen demand. The partial pressure of oxygen within each surface ranges from 0-35 torr. 
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Figure 22: Oxygen partial pressure [PO2] profiles for surfaces S2 and S3, as the surfaces are defined in 
Figure 20. The range of oxygen predicted in the accompanying color bar is from 0-35 torr. 
	  
As has been described above, the local PO2 must decrease to near hypoxic levels before NO production 
via eNOS is affected (180). Considering the weak coupling of NO and O2 used in this modeling iteration, 
the weak link between CNO and O2 metabolism is not surprising.  This lack of influence of O2 demand is 
further described in Table 18. If the demand for oxygen in the surrounding tissue increases beyond the 
levels considered in the referenced figures, the results in Table 18 lead us to expect a decrease in CNO 
throughout the domain as the eNOS production of NO becomes affected by low local PO2. 
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Figure 23:  NO profiles for surface S3, S4, and S5 for different levels of O2 consumption ranging from low 
levels of oxygen demand, to moderate levels of oxygen, to high levels of oxygen demand. As illustrated in the 
accompanying color bar the range of nitric oxide predicted in this study were from 0-400nM. 
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Figure 24:NO profile on surface S1 and S2 cutting through our network.  The surfaces are identified in 
Figure 20. The range of nitric oxide considered is from 0-400 nM. 
 
The data presented in Table 18 provides information beyond the observed decrease in CNO. The 
saturation of oxygen within the vasculature is observed to decrease significantly as the metabolic 
demand is increased. Analysis of the average oxygen saturation in the arterioles compared to the 
saturation through the capillaries demonstrates an increased sensitivity of the capillaries to changes in 
tissue metabolic demand than the arterioles (comparison of Figure 25 to Figure 26). 
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Table 18: Influence of oxygen consumption on various other defining quantities of Vascular Network Model.  
Diameter (µm) is the diameter of the vessel. Consumption (µM/s) is the maximal oxygen consumption rate 
within the tissue surrounding the vasculature.(High Sat) and (Low Sat) are respectively the high and low 
blood saturation levels within the arteriole branches (A1 and A2). PO2(torr) defines the average tissue 
oxygen value while Notis(nM) is the corresponding NO concentration. Noves (nM) is the average vessel wall 
nitric oxide concentration.  Finally %diff sat is the measurement of the percent difference in average vessel 
oxygen saturation compared to the baseline diameter with a maximal oxygen consumption of 1(µM/s). 
 
 
Figure 25: Plot of average vessel saturation versus maximal tissue consumption (µM/s) of oxygen for an 
arteriole vessel diameter of 8 µm.   
 
Diameter	  (um)Consumption	  (uM/s) High	  Sat Low	  Sat	   Ave	  Sat PO2(torr) Notis(nM) Noves(nM) %diff	  sat
8 1 0.65 0.62 0.5971 28.8602 288.864913 369.453092 0.00%
8 11 0.65 0.58 0.4998 18.96975 259.775122 363.834325 6.45%
8 21 0.65 0.5 0.4533 14.51779 227.678762 358.913697 19.35%
8 31 0.65 0.4 0.4218 11.79028 208.679005 354.074862 35.48%
8 41 0.65 0.4 0.3993 9.89743 193.152295 349.192311 35.48%
8 51 0.65 0.38 0.3821 8.555213 180.417698 344.518105 38.71%
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Figure 26: Predicted data along two capillaries running parallel to one another within the vascular block 
model (C5, left panel; C8, right panel).  For each capillary both nitric oxide concentration (top) and partial 
pressure of oxygen (bottom) are plotted with respect to the length of the capillary as it travels along the 
vessel block.  Three maximal rates of O2 consumption are considered a moderate metabolic state (0.01 
mM/s,dark blue line), a heavy active state (0.05 mM/s, light blue line), and an extremely heavy state of 
exercise (0.1 mM/s, red line). The region in which the capillaries come into close proximity with the 
arterioles is labeled and stretches from 200µm to 360µm. 
When the concentration of NO and the PO2 are modeled along two parallel capillary branches both 
outputs become more sensitive to an increase in tissue O2 demand. This is sensitivity is most evident in 
Figure 26 as the portions of the capillary further away from the arterioles is considered. This model 
indicates that an O2 dependent signal leading to an increase in NO production and bioavailability may be 
produced within the capillaries and tissue found further away from the arterioles. 
4.2.2 Oxygen determines the Nitric Oxide Metabolism in Tissue 
To further our understanding of the relationship between oxygen and nitric oxide within the 
microcirculation we return to a model whose previous purpose was to investigate the effect of the 
presence of red blood cells in the plasma layer adjacent to the arteriole wall (179). It is with this two-
dimensional geometry (Figure 27) that we have decided to begin our exploration of the relationship 
between NO and O2 in the vascular wall and tissue surrounding the vessel.  
112	  
	  
	  
Figure 27:Single arteriole model used previously by Chen et al 2006. A tissue layer (flesh colored) surrounds 
a single arteriole (red). 
 
The manner in which NO and O2 interact in a biological entity has not yet been explored in the 
computational domain considered here. Numerous studies have indicated that the metabolism of NO at 
the Cytochrome C Oxidase (CcO, complex IV of the mitochondrial electron transport chain) is 
dependent upon local CO2 (124, 126, 127, 274, 275). Other studies have also demonstrated a link 
between perivascular metabolism of nitric oxide and oxygen (185), as well as a change in sGC 
sensitivity to NO at lower levels of O2 (276).  Yet no study to this point has examined this mechanism of 
NO/O2 interaction in a computational model considering multiple modes of molecule transport. This 
means of interplay between the two molecules has not been explored within any three dimensional 
vascular network models, as there exists a paucity of three dimensional mathematical models 
considering the transport of NO and O2. 
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Figure 28: NO metabolism pathway as a function of O2. Change in redox state of CcO leads to a decrease in 
the metabolism of NO in the perivascular tissue. 
 
In cells generating low CNO respiring toward low PO2 the redox state of CcO changes from oxidized to 
reduced, leading to a decrease in NO inactivation(124), Figure 28.  CcO is known to convert NO to nitrite 
(NO2-) when the binuclear center is predominantly oxidized and the enzyme is in turnover (277-280). 
The oxygen dependent cellular nitric oxide consumption has previously been studied experimentally and 
modeled mathematically in isolated rat hepatocytes(185). 
  ..................................................................................... Equation 82 
 
CCell is the approximated concentration of cells in a particular tissue type.  As modeled by Thomas et al. 
(185) two different cell densities, considering different tissue types with either high or low cellular 
concentrations, are considered in mathematical modeling the transport of NO in the perivascular cells.  
The reaction rate constant kobs was calculated as being 5.38.±0.3 x 10-4M-1s-1(Cell/ml)-1 (185).  Previous 
modeling efforts conducted by our group have assumed a first order dependence of NO consumption in 
perivascular cells taking the form 
CellNOOobs
NO CCCk
dt
dC
2=
−
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  ..................................................................................................... Equation 83 
 
The consumption rate makes use of a constant λw,t.  The subscript w is used to define the rate of NO 
inactivation in the vascular wall (w).  Likewise, the subscript t refers to the tissue (12, 161, 180, 259).  
For this set of simulations in order to set the consumption of NO at the vascular wall equivalent during 
the oxygen dependent NO metabolism to that observed when nitric oxide metabolism is modeled as 
being a first order function of nitric oxide the reaction rate is set to (1/47) torr-1s-1.  
Model development for Oxygen-Dependent Nitric Oxide Metabolism in Tissue 
To test the potential influence of incorporating oxygen dependence of NO metabolism in the vascular 
wall and tissue we turn to a mathematical model that has previously been applied to investigate the effect 
of the presence of red blood cells in the plasma layer near the arteriole wall on NO and O2 transport 
completed by Chen et al(179).  The applied model incorporates multiple layers.  The layers considered in 
the model are an RBC-rich core, an RBC-poor plasma layer, endothelial surface layer (ESL) or 
glycocalyx, endothelium, vascular wall, and surrounding tissue. A breakdown of the multiple layers of 
the model is provided in Figure 29. It should be mentioned that at times the terms RBC and Hct shall be 
used interchangeably, as Hct is a fractional representation of RBCs in a vessel.   
NOtw
NO C
dt
dC
,λ=
−
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Figure 29: Schematic Diagram of Vessel Model as made use of in this study.  The layers viewed as looking 
axially along the vessel are the RBC-rich layer, the RBC poor plasma layer, the ESL, the Endothelium, the 
Smooth Muscle Layer, and the Tissue layer.  The radii r1 and r2 describe the radius of the RBC-rich and 
RBC poor layers respectively.  Additional geometric features of the model can be found in Table 19. 
 
Parameter Value Units 
Vessel length (L) 250 µm 
Radius of RBC rich core 12.5 µm 
Thickness of Plasma 
Layer 
2 µm 
Thickness of Glycocalyx 1.5 µm 
Thickness of Endothelium 1 µm 
Thickness of Vascular 
Wall 
3 µm 
Table 19: Descriptive geometric values of arteriole section considered in this study with thickness of various 
model layers as well as the length of the vessel itself. 
 
 Governing Equations 
We begin the descriptions of the governing equations with the RBC-rich core and the RBC-poor layer.  
Within this layer oxygen transport is modeled using the previously applied equation describing oxygen 
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transport in the vascular lumen.  The cylindrical coordinate system is used to describe all equations.  
Nitric oxide transport within the RBC rich and RBC poor layers are described by a similar equation,  
 Equation 84. 
  .......................... Equation 84 
 
The hematocrit (H(r)) is modeled as being a linear step function within the vascular lumen that is 
dependent upon the radial position (r). The term HC is the core hematocrit, which is assumed within the 
core region of the vascular lumen. 
  .............................................................................. Equation 85 
 
This is an important equation as the consumption of nitric oxide (λ(r)) within the lumen as well as the 
carrying capacity of oxygen (C(r)) are both dependent upon the concentration of red blood cells within 
the lumen. 
  ........................................................................................... Equation 86 
 
  .......................................................................................... Equation 87 
 
HD is the discharge hematocrit and is assumed to equal the systemic blood hematocrit (45%). The nitric 
oxide scavenging rate in blood (λb) is assumed to be that for hemoglobin at a hematocrit of 45% and set 
to 382.5 s-1. Cb is the maximum O2-carrying capacity of blood at the same systemic hematocrit, 8,000 
µM.  Within the vascular lumen parabolic velocity profile is assumed for the blood flow. 
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  ............................................................................................... Equation 88 
The RBC-rich core is from the center of the lumen to r1, which is radius at which the RBC-rich core 
concludes and the plasma layer begins.  The RBC-poor layer begins at r1 and concludes at r2, Figure 29.   
The endothelial surface layer/ glycocalyx layer is assumed to be free of blood flow and borders the RBC 
free layer.  Because there is no fluid motion or assigned reaction occurring within the glycocalyx the 
transport of both oxygen and nitric oxide can be modeled with the steady-state diffusion equation below. 
 ..............................................................................................................................................  Equation 89 
 
Where C is either CNO or CPO2, depending what chemical species is modeled.  The diffusion coefficient is 
either DNO or αO2DO2 contingent upon which chemical species is modeled. 
Endothelial Layer 
Connected to the glycocalyx is the endothelial layer.  An equation similar to that applied in   
Equation 89 can be applied to define the transport of both oxygen and nitric oxide within the endothelial 
layer.  An additional term must be included to account for reactions pertaining to each of the chemical 
species.   
 .................................................................................................................................. 
 Equation 90 
 
The production of nitric oxide is modeled as being a function of oxygen alone.  Two oxygen molecules 
are consumed per the production of each NO molecule and the consumption of oxygen within the 
endothelium is modeled to represent this relationship. 
Vascular Wall and Tissue Layer 
As previously discussed, there exists a variety of manners that nitric oxide consumption in the vascular 
wall and the tissue can be modeled.  Previous simulations have made use of a first order equation in 
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which the constants λw and λt are 1 and 10 s-1(12, 161, 179, 180, 259).  We desire to explore the 
influence of incorporating the influence of competitive binding of NO and O2 in the tissue on the 
subsequent transport of NO. This shall be accomplished by comparing a modified equation describing 
the NO consumption as a function of oxygen and NO to the previous models considered in earlier 
computational studies. The new model will consider the consumption or inactivation of NO in the tissue 
to be a function of oxygen and nitric oxide 
  ............................................................................................ Equation 91 
The constant kNOw is set to 1/47 torr-1s-1, to allow for adequate comparison between the two models. This 
parameter is determined so that the metabolic demand for NO at the vascular wall is the same when its 
dependence on local O2 is considered as well as when NO metabolism in the vascular wall and tissue is 
modeled as a linear function of CNO. 
Computational Methods 
The coupled partial differential equations constituting this model were solved by a finite element method 
using commercial software (FlexPDE 4, PDESolutions, Antioch, CA).  The element type chosen for the 
study was cubic.  Mesh densities were adaptively refined by the program to ensure a relative accuracy of 
0.0001 for the numerical solutions. 
 Results: The incorporation of O2-dependent NO metabolism in tissue leads to greater CNO near 
arteriole wall in response to changes in O2 metabolism 
 
Three models of NO metabolism within tissue were considered. The first is that in which there is no NO 
metabolism, RC is 0 µM/s in both the vascular wall and surrounding tissue of our model, a very non-
physiological case but one which proves useful for comparison purposes. The second is our baseline 
model, in which NO metabolism in tissue is considered to be a linear function of CNO. The final case 
considered is that in which NO metabolism in the vascular wall and tissue is assumed to be a function of 
NOONOw
NO CCk
dt
dC
2=
−
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both CO2 and CNO, as modeled previously by Thomas et al. (185). As previously mentioned the constant 
kNOw was selected so that the rate of NO consumption in the vascular wall is the same for case 2 and case 
3 considered in this series of simulations. Consideration of oxygen dependent NO metabolism in tissue 
results in greater CNO measured along a centerline traveling radially from the center of our vessel when 
compared to the baseline simulations, but not when no NO metabolism is considered within the tissue 
and vascular wall, Figure 30. As previously reported (161), this increase in CNO results in greater PO2 
calculated along the same radial line, Figure 31. In a manner the decrease of NO metabolism in the tissue 
acts like an additional source of NO within the computational domain. 
 
Figure 30: Examination of the influence of different models of NO consumption on CNO inside the vessel and 
surrounding tissue.  Three different consumption rates within the tissue and the vascular wall are considered in 
reference to the metabolism of NO. This includes one without any NO metabolism within the tissue (dotted line, ‘0’), the 
second where NO metabolism is a linear function of NO (light grey, ‘R x NO’) and the third where nitric oxide 
consumption is dependent on both CNO and CPO2 (dark grey, R x NO x PO2).  
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Figure 31: Examination of the influence of different models of NO consumption on PO2 inside the vessel and 
surrounding tissue.  Three different consumption rates within the tissue and the vascular wall are 
considered in reference to the metabolism of NO. This includes one without any NO metabolism within the tissue 
(dotted line, ‘0’), the second where NO metabolism is a linear function of NO (light grey, ‘R x NO’) and the third where 
nitric oxide consumption is dependent on both CNO and CPO2 (dark grey, R x NO x PO2).  
As it is clear that modeling the consumption of NO in the tissue O2-dependent will alter the CNO 
distribution within the model, we seek to determine the influence of oxygen demand on CNO.  Over a 
range of 5 characteristic metabolic demands for oxygen, we observe a significant increase in CNO along 
the centerline extending radially from the center of our arteriole. The centerline occurs at the midpoint 
along our z-axis, which runs parallel to the blood flow. CNO increases within the tissue, as well as in the 
vascular wall, indicating a favorable link between this mechanism and NO-mediated dilation in response 
to changes in O2 demand within tissue, Figure 32. As expected, PO2 is predicted to decrease with 
increasing metabolic demand, Figure 33. 
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Figure 32: Comparison of the influence of oxygen metabolism on nitric oxide concentration within the tissue 
surrounding the arteriole. The five different maximal metabolic rates of oxygen considered are 1 (dash-dot 
line), 10 (dashed line), 20 (solid grey line), 50 (dotted line), and 100 µM/s (thick black line).   
 
Figure 33: Comparison of the influence of oxygen metabolism on oxygen partial pressure within the tissue 
surrounding the arteriole.  The different maximal metabolic rates of oxygen considered are 1 (dash-dot line), 
10 (dashed line), 20 (solid grey line), 50 (dotted line), and 100 µM/s (thick black line).   
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4.2.3 Heterogeneity of RBC distribution leads to increased heterogeneity of CNO distribution  
Reasoning behind Inclusion of Flow Heterogeneity 
As discussed by Fry(83, 281) at any given time  not all micro vessels shall contain red blood cells.  The 
distribution of red blood cells has been demonstrated to be a function of vessel architecture and 
geometry (1, 50, 176). The fact that vascular network architecture and hemodynamics exhibit a high 
degree of heterogeneity cannot be overlooked and partially responsible for the dynamic behavior of red 
blood cell distribution. This heterogeneity cannot be treated as a random biological phenomenon, but 
must be examined as having a functional role in normal and pathological operations of microvascular 
networks. 
Studies of the hamster cremaster muscle have demonstrated that a key location from which the 
distribution of red blood cell flux has been found to be regulated from is the parent vessel, the terminal 
arteriole feed vessel (TAF), from which a terminal arteriole originates(282).  The distribution of blood 
flow into the capillaries was found to spatially vary in a manner that was related to the position of 
terminal arterioles along the resistance network (283, 284).  Studies conducted in conjuncture of the 
blood flow distribution studies indicate that the outcome of this functional organization was to promote 
the uniform delivery of oxygen to skeletal muscle fibers(284)). Thus in a hierarchical manner the 
terminal arterioles are the control point for determining whether or not capillaries are perfused, whilst 
the distribution of blood flow among terminal arterioles is governed by the parent arterioles from which 
the terminal arterioles originate. 
Mathematical Considerations of Flow Heterogeneity 
As heterogeneity in blood flow and RBC distribution appears common, we desired to explore the impact 
that an unequal distribution of red blood cells will have in the three dimensional computational geometry 
considering the paired arterioles.  In particular, as we have observed that lower Hct in a vascular branch 
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results in greater local CNO when NO production is assumed to be a function of wall shear stress (WSS) 
alone, we wish to explore the influence of a large skewness in the red blood cell distribution between the 
two arterioles considered in the model. The model proposed considers oxygen dependent nitric oxide 
metabolism within the tissue and vascular wall, the mechanisms just discussed within the last section.  
Due to the pressure distribution and location of the two arterioles considered in this study it is assumed 
that one terminal arteriole does not receive any red blood cells. The other arteriole, the bifurcating 
arteriole in this particular instance still receives the same red blood cell flux as previously applied in both 
the shear stress dependent and oxygen/shear dependent NO models. The distribution of hematocrit is 
illustrated within Figure 34. Each terminal arteriole remains the same 10 µm diameter. The inlet 
hematocrit is set to equal 0.2 for A2 and 0 for A1.  Nitric oxide production is modeled as being a 
function of both oxygen and shear stress. 
Again, it is assumed that each arteriole feeds 20 capillaries. Therefore 1/40th of the total flow entering the 
terminal arteriole is assumed to enter each of the capillaries considered within the model, as to describe 
the capillary flow distribution for two terminal arterioles into 20 capillaries. The computational domain 
consists of nine capillaries, and it is assumed that each of the arterioles feeds three of the nine capillaries.   
Three of the capillaries that are connected to arteriole A1 receive zero flux of red blood cells and for this 
reason the inlet PO2 for these capillaries is set to a zero.  
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Figure 34:  Non-homogenous distribution of erythrocytes within the bifurcating arteriole tissue block model.  
Since the arteriole branches are assumed to feed the capillaries found within the surrounding tissue the 
approximated hematocrit in the arteriole branches will be greatly influenced by the changes in the 
hematocrit distribution to the two terminal arterioles.  
Results 
As demonstrated in Chapter 3, the arteriole or the branch with lower Hct will experience greater local 
CNO. In a similar manner, the arteriole receiving no red blood cells (A1) expresses greater concentrations 
of NO around the outlet branch wall (Figure 35). Consequently, due to the lower flux of red blood cells 
into this arteriole the partial pressures of oxygen observed here are much less than those observed in A2. 
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Figure 35: Comparison of oxygen saturation (PO2) and nitric oxide (NO) around the bifurcating arteriole 
model considering non-homogenous red blood cell distribution.  (A) Partial pressure of oxygen in the model 
indicating an increase around arteriole A2 in comparison to arteriole A1. (B) Surface plot of nitric oxide 
concentration in the model illustrating increases around arteriole A1 when compared to arteriole A2. (C) 
Average partial pressure of O2 and (D) concentration of NO at the larger outlets of A1 (blue bars) and A2 
(red bars) as a function of varying oxygen demand within the tissue. 
As the demand for O2 increases within the tissue the arteriole with a supply of red blood cells (A2) 
maintains a relatively constant average PO2, Figure 35 C, and also a constant CNO, Figure 35 D. The 
average PO2 and CNO for the arteriole not provided RBCs (A1) proves to be much more dependent upon 
the tissue demand for oxygen. It is clear that the arterioles subjected to zero red blood cell flux will also 
be the arterioles for which the average concentration of NO along the vascular wall will be greater. With 
this said the average CNO in these vessels is not observed to increase due to increases in tissue metabolic 
demand, indicating the need for other means of NO production due to metabolic demand to affirm a 
place for NO in the metabolic control of blood flow in the microcirculation. With this said these regions 
would initially be areas of higher CNO due to the lack of RBC-dependent scavenging.  
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4.3 CNO around the arteriole is responsive to O2 demand in tissue via an ATP-dependent pathway 
4.3.1 Motivation and Background: Additional Means of O2 mediated NO production 
An additional pathway by which a decrease in oxygen could promote an increase in CNO is via a release 
of ATP from red blood cells, which then locally trigger an increase in NO production from the 
endothelial cells located near the release. The role of this potential mechanism of oxygen dependent NO 
regulation can only be speculated as this is a computational model. With this stated, the impact of this 
additional regulatory role that RBCs may play in the control of NO transport needs to be considered and 
compared to earlier studies that only consider their role in scavenging NO. 
The NO response to changes in tissue O2 
There exists numerous potential flaws in the idea that NO plays an important role in hypoxic 
vasodilation (285).  The first is that NOS-derived nitric oxide requires molecular oxygen as a substrate. 
As the partial pressure of oxygen approaches hypoxic levels, eNOS production of NO decreases as a 
result of lower substrate concentration, Table 18.  This dependence of NO on oxygen makes it seem 
counterintuitive that a lack of oxygen could produce an increase in NO concentration in and around the 
endothelium or anywhere for that matter. This of course, shall be refuted. 
Secondly, increased arginase activity is a well-known and reported consequence of hypoxia (286, 287).  
This further reduces the amount of substrate available for NOS production of NO, as arginase competes 
with the substrates responsible for NO production (287-289). Finally NOS inhibition has been 
demonstrated to only partially modulate the change in vessel diameter due to an increase in metabolic 
demand leading to the belief that other mechanisms are involved with the local regulation of vessel 
diameter (290). 
While there exists many a case indicating that a mechanism involving endothelial NO production is not a 
means by which blood flow may be regulated in response to changes in tissue O2, there exists studies 
which present a more optimistic viewpoint. An increase in NO production from pulmonary ECs have 
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been found to result from exposure of cell suspension (291) and cells harvested from rats (292) to 
hypoxic conditions (arterial PO2 of approximately 5.3 kPa (40 torr)). 
Before we get into the mechanism through which changes in oxygen demand alter NO production from 
ECs, it is important to discuss the topic of O2 transport in greater detail.  There exists a variety of factors 
known to affect the extraction of O2 from capillary beds (293): 
1. Rate of O2 delivery to the capillary 
2. Oxygen-hemoglobin dissociation relation 
3. Size of the capillary to cellular PO2 gradient 
4. Rate of O2 consumption by the cells.  
 
Oftentimes the supply and demand for oxygen within the tissue does not adequately match up resulting 
in a fall in cellular oxygen. It is important to understand at what point a mismatch in oxygen supply and 
demand presents a problem for normal biological processes necessary for survival. The ability of tissue 
to function normally under decreased oxygen levels depends upon the tissue type under consideration. 
According to Leach and Treacher, tissue is considered to be hypoxic when the mitochondrial partial 
pressure of O2 falls within the range of 1-3torr (293).    
Hypoxic conditions can lead to failure of energy dependent membrane ion channels and subsequent 
changes in calcium homeostasis. For a brief period of time cells can survive with anaerobic energy 
production, yet this form of cellular respiration is highly inefficient.  For this reason it is an imperative 
function of the cardiovascular system to provide an adequate supply of oxygen and at the same time 
remove the waste products at an acceptable rate in order to maintain the homeostasis of cells and the 
entire organism as a whole.  Yet even after decades of research there appears to be little agreement with 
respect to the signaling mechanisms by which an organism can regulate its supply and demand on a local 
scale. Furthermore, many of the current proposed theories interested in the local regulation of blood flow 
fail to define a role for a very powerful and very interesting vasodilator, whose “molecular life” is highly 
dependent upon oxygen (117), NO.   
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Local regulation, as opposed to systemic regulation, is the alteration in the supply of red blood cells and 
other such oxygen and nutrient carriers through the capillaries and to the tissue in response to tissue 
metabolic needs.  The signals involved with local regulation occur at close proximity to the affected 
vasculature and therefore are believed to work their way up the cardiovascular system, from the smaller 
to larger vessels.  The question remains, how is NO related to local control of blood flow?  Further, what 
role does ATP play in this NO-mediated blood flow regulation pathway?   
Role of ATP in NO-dependent Metabolic Response 
ATP is a known vasodilator in humans (294), known to act through ECs (295), and play an important 
role in the vascular homeostasis with regards to O2 (61, 73). Previous computational studies of vascular 
networks have considered the role of an ATP-dependent signal in response to an increase in oxygen 
demand (72, 100).  While proving effective in some situations, the ATP-mediated dilatory response was 
found to fail in heterogeneous networks due to diverging bifurcations and the formation of vessels in 
which only plasma flows through (72, 100, 135). The ATP-dependent response was also found to oppose 
both the flow-mediated response, as well as the myogenic response (72).   
As NO production is found to depend upon shear stress and may also depend upon nucleotide 
concentration, there exists the potential for the ATP-dependent response and flow dependent response to 
act in concert and produce a dilatory response.  The role which NO plays in ATP-mediated dilation is in 
question (294).  In a similar fashion the role that ATP plays in NO production has also been questioned, 
in particular in the discussion of WSS-dependent NO production from ECs (112, 244).  As shear stress is 
known to release ATP from ECs (201, 240, 296), and ATP known to stimulate the production of 
endothelial nitric oxide (58, 194, 228, 230, 265) it is possible that nucleotide transport plays an integral 
role in the shear mediated production of NO.   
There exists a scant amount of experimental data describing the relationship between nucleotide 
concentration and nitric oxide production/release from ECs. Microfluidic studies of bovine artery 
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endothelial cells (bPAECs) have revealed that an increase in ATP release from RBCs within a flowing 
media separated from the bPAECs by a polycarbonate membrane results in an increase in NO release 
from the endothelial cells (245). Only two data points exist so it would be difficult to ascertain a 
mathematical relationship between the two signaling molecules. Yet the positive correlation is 
encouraging, as a 2.06 fold increase in ATP released from RBCs resulted in an approximate 1.34 fold 
increase in the concentration of NO when compared with responses in untreated RBCs. Several studies 
have found a positive correlation between nucleotide concentration and phosphorylation of eNOS (194, 
227, 230), which could be expected to produce an increase in NO production. Meanwhile, other studies 
have found that nucleotide concentration can be responsible for modulating the shear stress-dependent 
NO response from endothelial cells (32, 112).   
Incorporating ATP and ADP into the Vascular Network Models 
The current simulation set desires to examine the relationship between nitric oxide, oxygen, and the 
extracellular nucleotide transport within a bifurcating arteriole network. This model moves away from 
the earlier model concerning shear stress dependent nitric oxide release and also away from the later 
iteration of incorporating oxygen transport and role in the production of NO in the vascular endothelium. 
The novel aspect of this model is the inclusion of mechanistic behavior, which allows for nitric oxide 
production to be a function of the oxygen demand within the tissue. Other studies have incorporated 
oxygen dependent nitric oxide production, yet all of these studies have focused mainly on the fact that 
oxygen is a required substrate for the production of NO (161, 179, 180, 259, 297). Due to a constant 
supply of oxygen to the arterioles altering the tissue oxygen demand will not result in a great change in 
the nitric oxide production in the arterioles. In fact if any change were to occur, one would observe a 
decrease in nitric oxide production in response to a decreased supply of oxygen. 
The transport of NO and O2 can be further linked by incorporating the transport of nucleotides into our 
model. As discussed earlier, the influence of ATP released in an  O2 dependent manner had previously 
been considered by Arciero (2008). This mechanism was determined to be an adequate mode for ATP 
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signaling to participate in the metabolic response. As NO production is found to depend upon shear 
stress and may also depend upon nucleotide concentration, there exists the potential for the ATP-
dependent response and flow dependent response to act in concert and produce a dilatory response.  The 
role which NO plays in ATP-mediated dilation is in question (294).  In a similar fashion the role ATP 
plays in NO production has also been questioned, in particular in the discussion of WSS-dependent NO 
production from ECs (112, 244).  As shear stress is known to release ATP from ECs (201, 240, 296), and 
ATP known to stimulate the production of endothelial nitric oxide (58, 194, 228, 230, 265) it is possible 
that nucleotide transport plays an integral role in the shear mediated production of NO. We propose a 
pathway in which the ATP released from the circulating RBCs interacts with that released from ECs in 
response to shear stress and leads to an increase in EC NO production, Figure 36. 
 
	  
Figure 36: O2-ATP-NO pathway relating NO production from ECs to local PO2  
 
There exists a scant amount of experimental data describing the relationship between nucleotide 
concentration and nitric oxide production/release from ECs. Microfluidic studies of bovine artery 
endothelial cells (bPAECs) have revealed that an increase in ATP release from RBCs within a flowing 
media separated from the bPAECs by a polycarbonate membrane results in an increase in NO release 
from the endothelial cells (245). Only two data points exist so it would be difficult to ascertain a 
mathematical relationship between the two signaling molecules. Yet the positive correlation is 
encouraging, as a 2.06 fold increase in ATP resulted in an approximate 1.34 fold increase in the 
concentration of NO.  Other than this singular study, there does not appear to exist additional studies 
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linking nucleotide concentration with changes or absolute values of CNO. Several studies have found a 
positive correlation between nucleotide concentration and phosphorylation of eNOS (194, 227, 230), 
which could be expected to produce an increase in NO production. Meanwhile, other studies have found 
that nucleotide concentration can be responsible for modulating the shear stress-dependent NO response 
from endothelial cells (32, 112).   
As the Comerford model involves numerous approximations concerning the manner in which ATP 
promotes eNOS activation, we choose not to use the series of ordinary differential equations to represent 
the dependency of RNO on nucleotide concentration. This model considers two variations of equations 
representing nucleotide dependent NO production. Both of these models assume that the influence of 
nucleotide concentration on NO production takes the form of a Michalis type of equation (where ϕ is the 
summation of CATP and CADP): 
  ............................................................................................. Equation 92 
 
The influence of nucleotide concentration can then be applied to develop an equation that accounts for 
the influence of nucleotide, shear stress, and oxygen on NO production from ECs. It is modeled that the 
influence of shear stress-dependent and nucleotide dependent NO release is additive, or that NO 
production is a function of nucleotide concentration alone.  The discussion shall begin with the influence 
of shear stress and nucleotide being additive.  This assumption has previously been made by Comerford 
et al. (192) and also experimentally by Kanai et al. (244) who demonstrated a difference between the 
shear stress dependent and ATP-dependent NO production in vascular endothelial cells. The production 
of nitric oxide at the endothelial layer will be similar to that applied in Chapter 3 for the 3D vascular 
model with the addition of oxygen dependent terms (RNOO2) (which have been described in the modeling 
of oxygen dependent NO production), and the inclusion of the nucleotide dependent term (described 
above). 
)(_ ϕ
ϕϕ += CprodNO K
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 𝐹!" = 𝛿 !!!"# 𝑅!"!"#𝑓 𝑂! !!!!"# + 𝑓(𝜑)  ............................................................ Equation 93 
As hypothesized by Andrews (32) the proposed mechanism of shear stress dependent NO production 
involves shear stress causing the release of ATP and activation of the IP3 pathway. If it were assumed 
that the production of NO is only a function of nucleotide concentration, then the influence of shear 
dependent NO production would be included within the shear dependent production of ATP.      
 F!" = δ !!!"# R!"!"#f O! f(φ)  .................................................................................. Equation 94 
	  
 However, this approximation must be made with some caution as phosphorylation of eNOS has also 
been linked to pathways involving Akt, as it has been shown that Phosphoinositide 3-kinase (PI3K) 
inhibitors and mutations of Akt attenuate NO production (299, 300), which were demonstrated to be 
independent of extracellular calcium. It is also potentially incorrect to pursue a model in this manner 
since ADP and ATP are known to interact with different receptors and as previously described at 
different rates.     
The total nucleotide concentration corresponding to half the maximal rate of NO production is not 
known.  CATP within blood plasma has been reported to range from 0.5 to 2 µmol/L (261). Examining the 
data of Goncalves da Silva demonstrates an EC50 of 18 µM and ~0.8µM with respect to ATP and ADP-
mediated phosphorylation at the Ser1177 site respectively (230). Hess found that ADP promotes the 
phosphorylation of the endothelial isoform of eNOS at Ser1179 and Ser635, and dephosphorylates eNOS at 
the SER116site (194).   
Regardless we continue to explore physiological 
Model Parameters and Equations: 
The equations that govern the transport of oxygen, 
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Parameter Parameter Value Parameter Source 
Inlet Hct 0.2  
Capillary diameters (µm) 
c1-c13 3-6 (5, 12, 82) 
Venule Diameter (µm) 18 (5, 82, 160) 
Inlet Arteriole Diameter (µm) 
a1 and a2 10 (5, 82, 160) 
Pressure at Arteriole Inlet 26.7 mmHg (160) 
Pressure at Venule Outlet 17.4 mmHg (160) 
Figure 37: Dimensions and inputs for the connected 
 
4.3.2 Results: Inclusion of nucleotide dependent NO production fails to alter the general 
relationship between NO transport and Hct in bifurcating terminal arterioles  
 
The studies which considered nitric oxide to be a function of shear stress alone, demonstrated that local 
concentrations of nitric oxide appeared to be a function of input hematocrit and hematocrit distribution 
due in large part to the presence of a bifurcation in the arteriole (A2). The presence of this bifurcation 
leads to an unequal partitioning of the red blood cells traveling through the arteriole conduit.  Re-
evaluating the results highlighted by Chen et al. (12) as the input Hct decreases an increase in CNO is 
observed at each of the locations highlighted in Figure 38. A similar behavior is observed when the 
contribution of nucleotide concentration at the endothelial surface is considered in the production of NO, 
as modeled using  𝐹𝑁𝑂= 𝛿 !!!"# 𝑅!"!"#𝑓 𝑂! !!!!"# + 𝑓(𝜑)  Equation 93.  When considering the 
combined influence of shear stress dependent and nucleotide transport on NO production in the 
endothelium an increase between 10-40% in CNO is observed.  For which, as seen in Figure 39, the 
location in which the least change in CNO occurs is point 1.  With respect to geometric location the 
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degree of change in CNO in ascending order would be: Pt 1,5,4,2, and 3 respectively. This list differs 
from the model considering NO production as a function of local shear stress alone; which appears as Pt 
5,2, 1, 4, and 3.  Furthermore, in this case, the increase in CNO observed is between 10-25%. 
When the hematocrit is increased to 0.3 (30%), the 
 
 
Figure 38: Illustration of arteriole labeled as A2 by Chen 
 
Figure 39:  Plot of change in CNO in response to different inlet Hct at locations along the bifurcating 
arteriole. The 5 different markers in this figure correspond to the different locations along the arteriole A2 
as illustrated in Figure 38. Once more it is assumed that the baseline simulation corresponds to an input Hct 
135	  
	  
𝐹𝑁𝑂=𝛿𝑟𝑟𝑟𝑒𝑓𝑅𝑁𝑂𝑟𝑒𝑓𝑓𝑂2𝜏𝑤𝜏𝑟𝑒𝑓+𝑓(𝜑)  Equation 93 is used in modeling the combined influence of 
nucleotide concentration and shear stress in determination of the endothelial nitric oxide production. 
 
CNO is not sensitive to changes in O2 demand in the 
It was found that altering the tissue oxygen demand 
 
Table 20. Adding numerical backing to the above 
 
Table 20. As the simulations in which NO production is 
 
 
Table 20: CNO predicted at designated data points at 
 
 
Returning our examination to the simulations in which 
If RNO is a direct function of CNuc alone, the sensitivity of CNO to changes in local O2 demand is minimal 
for the bifurcating arteriole model 
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ATP is released from the endothelial surface in 
Figure 41.   
The summation of CATP and CADP is increased as the 
Figure 41.  This holds true even as nucleotide 
Figure 42.  
Figure 42 considers the release of ATP from both RBCs 
 
 
Figure 40: Partial pressure of oxygen profiles in tissue 
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Figure 41: The production of NO due to ADP and ATP is modeled to depend upon the sum of the two 
FNO=δrrrefRNOreffO2f(φ) Equation 94 is made use of to determine the production of NO with a Kc of 
0.1 µM.   A reference NO production rate of 150 µM/s is used. The legend considers concentrations of NO 
from the range of 0 to 400nM. 
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Figure 42: Intraluminal nucleotide concentration profiles 
 
 If RNO is a direct function of the summation of CNuc 
If we assume that the signal generated due to the 
 
Figure 43:  Average CNO at various locations of the 
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Figure 44: Average oxygen saturation in the capillaries (Ave_cap_sat, dotted outlined bar) and that within 
the arteriole (Ave_art_sat, solid black bar) is compared over a range of oxygen demands.  Nitric oxide 
production is modeled as being a function of nucleotide concentration and the magnitude of shear stress at 
   =𝛿𝑟𝑟𝑟𝑒𝑓𝑅𝑁𝑂𝑟𝑒𝑓𝑓𝑂2𝜏𝑤𝜏𝑟𝑒𝑓+𝑓(𝜑)  Equation 93.  
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Figure 45: Nitric oxide profiles within the bifurcating network over a range of metabolic demands 
characterized by the maximal metabolic demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 µM/s), D (10 
µM/s), E (20 µM/s), and F (50 µM/s)) The range of nitric oxide considered is from 0-500 nM.  Nitric oxide 
production is modeled as being a function of nucleotide concentration and the magnitude of shear stress at 
the local endothelial surface. 
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Figure 46:  Partial pressure oxygen profiles within the bifurcating network over a range of metabolic 
demands characterized by the maximal metabolic demand within the tissue (A (1 µM/s), B (5 µM/s), C (8 
µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) The range of oxygen partial pressures considered is from 
0-35 torr.  The simulation sets considered in this study consider nitric oxide production modeled as a 
function of nucleotide concentration and the magnitude of shear stress at the local endothelial surface.   
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Figure 47: Nucleotide concentration profiles illustrated within the capillaries and arterioles of the 
bifurcating network over a range of metabolic demands characterized by the maximal metabolic demand 
within the tissue (A  (1 µM/s), B (5 µM/s), C (8 µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) The range 
of nucleotide concentration predicted is from 0-2 mM. The simulation sets considered in this study consider 
nitric oxide production modeled as a function of nucleotide concentration and the magnitude of shear stress 
at the local endothelial surface. 
For each of the variations of the bifurcation geometry models the regions witnessing the greatest CNO are 
those near and around the arteriole,  
Figure 41 and Figure 45. When the demand for oxygen in the tissue increases the concentration of NO in 
this region is predicted to decrease a slight degree or remain constant depending upon the change in the 
tissue’s oxygen needs, Figure 43. While the concentration of NO near the arterioles is predicted to not 
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change to a great degree we can see that the nucleotide concentration in the capillaries increases 
significantly as a function of tissue oxygen need,  
Figure 42 and Figure 47.  As the saturation of oxygen in the arterioles is simulated to remain constant, 
Figure 44, the nucleotide concentration in the arterioles is also modeled to hold steady,  
Figure 42 and Figure 47.  In reference to the distribution of oxygen in the network, it is clear through 
inspection of Figure 46 that the greater oxygen concentrations are around A2 rather than A1. Comparing 
Figure 46 to Figure 40 it becomes clear that the transport of oxygen within the tissue is dependent upon 
the complementary transport of NO.  As the two models have different NO profiles the oxygen profiles 
and those describing the intraluminal transport of nucleotides will also differ.  
4.3.3 Expansion of vascular network increases the local CNO response to changes in oxygen demand. 
 
Figure 48:  Shear stress [dynes/cm2] distribution of the connected arteriole, capillary and venule model.  
This distribution of shear stress is determined for the calculated distribution of red blood cells. 
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To determine the influence of vascular architecture upon the combined influence of O2-CNuc-WSS on NO 
production two different models of NO production are considered. The first of which assumes that NO 
production is only a function of nucleotide concentration. As nucleotide concentration is a function of 
numerous fluid transport phenomena, including shear stress the production of NO will still be shear 
stress dependent.  The second model incorporates a separate term describing the shear stress dependent 
production of NO from ECs. As discussed in preceding sections the calculated hematocrit of the 
connected network proves to be highly heterogeneous. To explore the influence of this high degree of 
red blood cells further a more homogenous distribution of red blood cells is also considered. From this 
we gather a better understanding of the manner that a heavily heterogeneous distribution can have on NO 
transport and overall control of blood flow. Through the comparison of these modeling efforts it is 
desired to understand a potential mechanism by which NO production around arterioles can be altered in 
an O2-dependent manner.  It should remember that both of the models of red blood cell distributions 
consider heterogeneous distributions of RBCs. The more of the heterogeneous models makes use of the 
empirical formulae created by Pries and Secomb. The alternate distribution of red blood cells is 
dependent upon the size of the vessel, and the Hcts in each of the vessels is chosen so to conserve mass. 
As the alternative distribution is more chosen to have a lesser degree in variation in Hct per classification 
of vessel it is designated as being more homogenous than that governed purely by the empirical 
formulae.  
As CNO is a function of flow the distribution of shear stress remains an important determinant of local 
CNO, Figure 48.  The highest magnitude of shear stress occurs at the vascular wall of the terminal 
arteriole.  The shear stress in the different capillaries varies with the red blood cell distribution within 
these capillaries, as well as the overall blood distribution. As the diameter of the venule is much greater 
than all other vessels considered, the shear stress experienced at the venular vessel wall is much less than 
those experienced in the arteriole and the majority of the capillaries.   
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When the influence of shear stress is incorporated into the production of NO indirectly through the 
contribution that it makes to the release of endothelial ATP, an increase in CNO is observed in both the 
arteriole and venule walls, Error! Reference source not found.. Also illustrated in Error! Reference 
source not found. is the manner in which the oxygen tension at the vessel wall changes on average at 
the arteriole and venule for varying metabolic demand of oxygen.  The average arteriolar PO2 holds 
steady around 43torr, as it is close to the source of oxygen for the model and the venular PO2 is much 
more dependent upon an increase in metabolic demand.  Error! Reference source not found. illustrates 
similar behavior expressed in percent differences rather than absolute values. 
	  
Figure 49:Venule (top panel) and Arteriole (bottom panel) average calculated NO (left panel) and PO2 (right 
panel) in response to changes in tissue metabolic demand. 
 
Profiles of the distribution of NO around the arteriole specifically (Figure 50) and within the entire 
network (Figure 51) further illustrate the sensitivity of NO transport to changes in the metabolic demand 
for oxygen within the block model considering a connected vascular network.  Due to a decrease in 
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overall tissue block oxygen an increase in CNO is observed, which appears to increase along the vertical 
axis of the arteriole, Figure 50. With this said, the greatest concentrations of the signaling molecule are 
calculated to be in and around the capillaries found at the top of the computational domain. Over the 
simulated 10 fold increase in metabolic demand the oxygen profile illustrated in Figure 51 changes from 
a uniform concentration approximated to be around 40 torr to a more diverse distribution with the largest 
gradient in partial pressure occurring in the regions where the arterioles feed the capillaries. The NO 
profiles illustrated in the same figure undergo a similar loss of uniformity due to the increase in 
metabolic demand, with an overall behavior, which could be best explained as an increase in CNO. 
 
Figure 50: Concentration of NO along portion of arteriole wall for different maximal consumption rates of 
oxygen within the tissue. The maximal consumption rate of oxygen within the tissue is A) 1 B) 5 C) 10, and 
D) 20 uM/s. The above scale ranges from concentrations of 0 nM (dark blue) to 275 nM (dark red).The 
hematocrit and vessel viscosities are those of the set or alternative model. 
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Figure 51: Nitric Oxide (NO) concentration and partial pressure of oxygen (PO2) calculated throughout the 
microvascular unit structure considering a lower metabolic demand for oxygen in A) (1 uM/s) than B) 
(maximal oxygen consumption rate of 10 uM/s).The top plot of each subfigure illustrates the nitric oxide 
(range 0-500 nM) distribution and the bottom illustrates the distribution of the partial pressure of oxygen 
(range 0 to 50 torr) within our computational domain.  The hematocrit and vessel viscosities are those of the 
set model. 
 
When the production of endothelial NO is modeled in a manner in which the influence of shear stress is 
expected to go beyond the contribution of ATP to the model similar patterns of dependence are observed 
in comparison to the first version of the connected network model previously discussed. More 
specifically, as the tissue need for O2 increases CNO throughout the entirety of the computational domain 
also increases, Figure 52. The same figure illustrates a previous finding in that the greatest 
concentrations of NO are observed in and around the capillaries of the model, and the least in and around 
the arterioles.  As shown in Figure 54, the same argument cannot be made when discussing PO2 within 
the model.  In reference to PO2 the lowest partial pressures are observed in the venule, and the greatest 
are found in the terminal arteriole. As expected and as illustrated in Figure 56 and Figure 58 there exists 
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a strong relationship between oxygen saturation and nucleotide concentration. It is found that, as 
modeled, the location of the lowest oxygen saturation (the venule) is also the location of the greatest 
nucleotide concentration.  These same findings can be observed in the concentration profiles of Figure 
60, Figure 62, Figure 65, and Figure 67. Each of the just mentioned figures also illustrates that for the 
particular vessel geometry considered in this study the concentration of NO, nucleotides, and the partial 
pressure of oxygen are all sensitive to changes in the tissue requirements for oxygen.  
As observed in Figure 60 the region of the computational domain containing the capillaries corresponds 
to the maximal concentrations of NO observed within the computational domain. Also once more, when 
examining the distribution of nitric oxide along the surface of the arteriole the greater concentrations of 
NO are observed at the base of the branching arteriole away from the oxygen source, Figure 62. 
 
Figure 52: Average CNO at various locations of the connected network computational domain.  The average 
capillary (Cap_ave) nitric oxide concentration is graphed at 6 different characteristic metabolic demands for 
oxygen.  The average concentration of CNO in the arteriole (Ave_art_NO, checkered bar), tissue 
(Ave_tis_NO, dark black bar), and the venule (Ave_ven_NO, diagonal filled bar) are also illustrated over the 
range of oxygen consumptions considered. Nitric oxide production is modeled as being a function of 
nucleotide concentration (from both ECs and RBCs) and the magnitude of shear stress at the local 
endothelial surface.  The influence of shear stress on nitric oxide production is considered to be separate 
from the ATP-dependent contribution to the production of NO. The hematocrit and vessel viscosities are 
those of the set model. 
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Figure 53: Average CNO at various locations of the connected network computational domain.  The average 
capillary (Cap_ave) nitric oxide concentration is graphed at 6 different characteristic metabolic demands for 
oxygen.  The average concentration of CNO in the arteriole (Ave_art_NO, checkered bar), tissue 
(Ave_tis_NO, dark black bar), and the venule (Ave_ven_NO, diagonal filled bar) are also illustrated over the 
range of oxygen consumptions considered. Nitric oxide production is modeled as being a function of 
nucleotide concentration and the magnitude of shear stress at the local endothelial surface. The influence of 
shear stress on nitric oxide production is considered to be separate from the ATP-dependent contribution to 
the production of NO. The hematocrit and vessel viscosities are calculated based upon the geometry of the 
vascular and the driving inputs, which aid in the description of the flow. 
 
 
Figure 54: Average PO2 of the connected network computational domain.  The average tissue oxygen tension 
(Ave_tis_po, black bars)) is plotted at 6 different characteristic metabolic demands for oxygen.The average 
arteriole oxygen tension (Ave_art_po, checkered bar), capillary (Ave_cap_po, dotted outlined bar), and the 
venule (Ave_ven_po, diagonal filled bar) are also illustrated over the range of oxygen consumptions 
considered.  
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Figure 55: Average PO2 in the connected network computational domain. The average tissue oxygen tension 
(Ave_tis_po, black bars)) is plotted at 6 different characteristic metabolic demands for oxygen. The average 
arteriole oxygen tension (Ave_art_po, checkered bar), capillary (Ave_cap_po, dotted outlined bar), and the 
venule (Ave_ven_po, diagonal filled bar) are also illustrated over the range of oxygen consumptions 
considered.  
 
 
Figure 56: Average nucleotide concentration (CNUC) graphed within the computational network considered 
in this study. The average nucleotide concentration in the arteriole (Ave_art_nuc, checkered bars), capillary 
(Ave_cap_nuc, dotted-outlined bars), and venule (Ave_ven_nuc, diagonal bars) are plotted against the range 
in metabolic demand considered within this study. The hematocrit and vessel viscosities are those of the set 
model. 
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Figure 57: Nucleotide concentration (CNUC) graphed at the various domains within the computational 
network considered in this study.The average nucleotide concentration in the arteriole (Ave_art_nuc, 
checkered bars), capillary (Ave_cap_nuc, dotted-outlined bars), and venule (Ave_ven_nuc, diagonal bars) 
are plotted against the range in metabolic demand considered within this study. The influence of shear stress 
on nitric oxide production is considered to be separate from the ATP-dependent contribution to the 
production of NO.  The hematocrit and vessel viscosities are calculated based upon the geometry of the 
vascular and the driving inputs, which aid in the description of the flow. 
 
 
Figure 58: Average oxygen saturation within the arteriole (Ave_art, checkered bars), capillary (Ave_cap, 
dotted outlined bars), and the venule (Ave_ven, diagonal bars are plotted over a range of metabolic 
demands.  Nitric oxide production is modeled as being a function of nucleotide concentration and the 
magnitude of shear stress at the local endothelial surface. The hematocrit and vessel viscosities are for the 
more homogenous red blood cell distribution. 
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Figure 59: Average oxygen saturation within the arteriole (Ave_art, checkered bars), capillary (Ave_cap, 
dotted outlined bars), and the venule (Ave_ven, diagonal bars are plotted over a range of metabolic 
demands.  Nitric oxide production is modeled as being a function of nucleotide concentration and the 
magnitude of shear stress at the local endothelial surface. The hematocrit and vessel viscosities are 
calculated based upon the geometry of the vascular and the driving inputs which aid in the description of the 
flow. 
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Figure 60: Nitric oxide profiles within the connected network over a range of metabolic demands 
characterized by the maximal metabolic demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 µM/s), D (10 
µM/s), E (20 µM/s), and F (50 µM/s)) The range of nitric oxide simulated is from 0-1500 nM.  Nitric oxide 
production is modeled as being a function of nucleotide concentration and the magnitude of shear stress at 
the local endothelial surface.The influence of shear stress on nitric oxide production is considered to be 
separate from the ATP-dependent contribution to the production of NO. The hematocrit and vessel 
viscosities are those of the set model. 
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Figure 61: Nitric oxide profiles within the connected network over a range of metabolic demands 
characterized by the maximal metabolic demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 µM/s), D (10 
µM/s), E (20 µM/s), and F (50 µM/s)). The range of nitric oxide modeled is from 0-1500 nM.  Nitric oxide 
production is modeled as being a function of nucleotide concentration and the magnitude of shear stress at 
the local endothelial surface. The influence of shear stress on nitric oxide production is considered to be 
separate from the ATP-dependent contribution to the production of NO. The hematocrit and vessel 
viscosities are calculated using the empirical correlations from Pries and Secomb(1).   
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Figure 62: Nitric oxide profiles around the arteriole within the bifurcating network over a range of 
metabolic demands characterized by the maximal metabolic demand within the tissue (A (1 µM/s), B (5 
µM/s), C (8 µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) The range of nitric oxide predicted is from 0-
1200 nM.  Nitric oxide production is modeled as being a function of nucleotide concentration and the 
magnitude of shear stress at the local endothelial surface. The influence of shear stress on nitric oxide 
production is considered to be separate from the ATP-dependent contribution to the production of NO.  The 
hematocrit and vessel viscosities are those of the set model. 
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Figure 63: Nitric oxide profiles around the arteriole within the bifurcating network over a range of 
metabolic demands characterized by the maximal metabolic demand within the tissue (A  (1 µM/s), B (5 
µM/s), C (8 µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s))  The range of nitric oxide modeled is from 0-
1200 nM.  Nitric oxide production is modeled as being a function of nucleotide concentration and the 
magnitude of shear stress at the local endothelial surface. The hematocrit and vessel viscosities are 
calculated based upon the diameter and pressure distribution of the blood flow. 
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NO levels are also found to increase in and around the arteriole wall when decrease in NO inactivation at 
the cytochrome c oxidase site found in the mitochondria of the surrounding tissue is considered to be a 
function of local PO2 (124), Figure 32.  Five different characteristic oxygen consumption rates were 
considered in this study.  Ranging from a level of low metabolic demand, 1 µM/s, to a very high tissue 
demand for O2, 100µM/s a range of CNO at the arteriole wall is observed, Figure 64.  The observed 
pattern indicates that inclusion of this mechanism of NO and O2 interaction allows for an observed 
increase in CNO around the arteriole wall in response to an increase in O2 demand. 
 
Figure 64:  CNO predicted by model along centerline of single vessel model plotted as a function of oxygen 
demand.  NO inactivation is a function of local oxygen tension in the tissue. 
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Figure 65:  Partial pressure of oxygen profiles within the connected network over a range of metabolic 
demands characterized by the maximal metabolic demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 
µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) The range of oxygen tension predicted is from 0-50 torr.  
Nitric oxide production is modeled as being a function of nucleotide concentration and the magnitude of 
shear stress at the local endothelial surface. The hematocrit and vessel viscosities are those of the set model, 
alternative model. 
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Figure 66:  Partial pressure oxygen profiles within the connected network over a range of metabolic 
demands characterized by the maximal metabolic demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 
µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) The range of oxygen tension predicted is from 0-50 torr.  
Nitric oxide production is modeled as being a function of nucleotide concentration and the magnitude of 
shear stress at the local endothelial surface. The hematocrit and vessel viscosities are calculated based upon 
the diameter of the vascular components and the distribution of blood flow. 
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Figure 67: Nucleotide concentration profiles plotted with in the connected network model.  The nucleotide 
concentration is composed of the summation of both CATP and CADP.  The oxygen tension within the 
connected network is plotted over a range of metabolic demands characterized by the maximal metabolic 
demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) 
The range of CNUC simulated is from 0-0.4 µM.  Nitric oxide predicted is modeled as being a function of 
nucleotide concentration and the magnitude of shear stress at the local endothelial surface. The influence of 
shear stress on nitric oxide production is considered to be separate from the ATP-dependent contribution to 
the production of NO. The hematocrit and vessel viscosities are those of the set model, alternative model. 
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Figure 68: Nucleotide concentration profiles plotted with in the connected network model.  The nucleotide 
concentration is composed of the summation of both CATP and CADP.  The oxygen tension within the 
connected network is plotted over a range of metabolic demands characterized by the maximal metabolic 
demand within the tissue (A  (1 µM/s), B (5 µM/s), C (8 µM/s), D (10 µM/s), E (20 µM/s), and F (50 µM/s)) 
The range of CNUC considered is from 0-0.4 µM. Nitric oxide production is modeled as being a function of 
nucleotide concentration and the magnitude of shear stress at the local endothelial surface. Both the 
hematocrit and the vessel velocities are calculated based upon geometric properties and inputs of the 
network. 
 
The second network model considered here containing arterioles branching off into capillaries, which 
then drain into venules responds differently to the changes in metabolic demand than the bifurcating 
network previously considered.  Rather than a steady average concentration of NO around the arteriole 
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for changes in oxygen consumption, we observe an increase in both arteriole and venular wall CNO 
(Figure 63,Figure 62,Figure 61,Figure 60,Figure 53, and Figure 52). Simulations in which NO 
production is assumed to be triggered by both ATP release and a nucleotide independent-shear stress-
dependent mechanism are found to produce greater CNO than simulations in which the production of NO 
is based solely upon nucleotide concentration (resulting from the release of ATP from both ECs and 
RBCs), comparing Figure 60 to Figure 61 and Figure 62 to Figure 63. Further examination of Figure 62 
and Figure 63 one can notice that the lower portion of the arteriole correspond to regions of greater CNO 
in comparison to the remainder of the arteriole. This is an interesting observation and addressed further 
in the discussion section, as the lower region for all models is the region of higher Hct as previously 
discussed. 
Overall in each of the variations of the connected network models the minimal concentrations of nitric 
oxide are observed in and around the arteriole, Figure 52 and Figure 53.  The CNO in the arteriole wall is 
modeled to increase with an increase in metabolic demand for each of the red blood cell distribution 
models.  As seen in Figure 52, the average concentration of NO in the arteriole wall is the first of the 
calculated  outputs to reach a plateau as the metabolic demand continues to increase. The data for the 
more heterogeneous, calculated network hemodynamics, demonstrates a similar finding.  A difference 
exists in comparing Figure 52 and Figure 53 in that for the calculated network hemodynamics model CNO 
in the tissue, capillaries, and venules are all observed to decrease. 
Discussing nucleotide concentration, the greatest CNUC is observed to occur in the venule, followed by 
that in the capillaries.  In the study concerning the more homogenous distribution of red blood cells, the 
nucleotide concentration is predicted to increase to a slight degree in the capillaries, and then to a greater 
degree in the venules. Examination of Figure 56 serves as verification for the previous statement.  
Furthermore, the same statement can be applied in describing the distribution of nucleotides in the 
studies for which the network hemodynamics were calculated, Figure 57.   
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Extending our comparison of the simulations considering different red blood cell distributions, we find 
that the more heterogeneous red blood cell distribution results in lower average oxygen tensions in the 
monitored regions of the computational domain when compared to the more homogenous network, 
comparing Figure 65 and Figure 66.  As a result, greater nucleotide concentrations can be found in both 
the capillaries and venules of the heterogeneous network (Figure 67). The increase in adenine nucleotide 
concentration can be associated with a greater release of ATP from RBCs due to lower local PO2.  The 
more homogenous red blood cell distribution gives way to a more homogenous distribution of NO as 
metabolic demand is increased, Figure 60.  Meanwhile, the network models considering a more 
heterogeneous red blood cell distribution results in a more heterogeneous distribution of NO, Figure 61.  
In the heterogeneous model the capillaries closer in proximity to the oxygen source appear to produce a 
greater concentration of NO than the capillaries in the lower portion of the computational domain (upper 
and lower portion of the computational domain expressed along the vertical z-axis). 
4.4   Discussion 
Multiple simulation sets have been run whose purpose it was to delve deeper into the puzzle that is nitric 
oxide transport within the microcirculation.  The long held belief with regards to cardiovascular diseases 
is the regions of low wall shear stress (WSS) will experience lower [NO] due to a lesser degree of NO 
production (192, 219, 220). Yet as demonstrated in the simulations in these regions, we predict a 
decreased rate of scavenging of the known vasodilator as well. One of the goals of this work is to 
determine if the findings illustrated in the work conducted by Chen et al(12) still hold true as we include 
new mechanisms of NO production within the next generation of modeling. The later generations of 
transport models of this work focus upon the interplay between NO and O2. As earlier chapters have 
highlighted multiple integral roles for red blood cells in the transport of NO within the microcirculation, 
and red blood cells are well known transporters of O2, the inclusion of the interaction between NO and 
O2 appear to be a logical progression for the vascular network models. 
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Including O2 transport in the bifurcating arteriole network (examination of Figure 21, Figure 22, Figure 
23, and Figure 24) demonstrates a low degree of sensitivity of NO production to the local O2 
environment.  As previously demonstrated a decrease in tissue oxygen does have the tendency to reduce 
observed CNO(161), and as a decrease in NO production or activity has been linked to vasoconstriction or 
a decrease in the dilatory response of the vessel (120, 301-303) this loss of NO would prove 
counterproductive in terms of an O2-mediated NO production.  We shall return to this later. There are 
some potentially useful observations that are made with regards to these simulations.  The first of which, 
rather expected, is that as oxygen demand increases and tissue PO2 decreases the saturation of O2 
through the vessels also decreases, Table 18.  Also, the PO2 recorded along the length of different 
capillaries found in the computational domain appear relatively sensitive to changes in the tissue demand 
for oxygen, Figure 26 and Error! Reference source not found..  This sensitivity to oxygen demand is 
greater than that observed in the arteriole as metabolic demand is increased, Figure 25.  As the release of 
ATP from RBCs has been demonstrated to be depend upon the blood oxygen saturation(67, 73), the 
decrease of  SPO2 within the capillaries in particular indicate a potent source for ATP-mediated NO 
production.  This indicates a clear importance of other vascular components than the arterioles 
themselves in the control of blood flow and in particular the transport of NO. This importance shall be 
explored in Chapter 5. 
Results from a previous model concerning a simple geometry of a straight cylindrical representation of 
an arteriole and venule pair contained in a tissue block with an assumed capillary distribution has 
demonstrated that NO from venules can significantly alter the distribution of nitric oxide around local 
arterioles, depending upon the distance between the two vascular components (161).  Experimental 
studies conducted by Nase et al. (40) have demonstrated NO distributions in capillary perfused tissues. 
As demonstrated with the study, regions of tissue in areas of low capillary density are also regions in 
which one observes low levels of nitric oxide concentration.  Therefore one can conclude that for the 
sake of this modeling effort, capillaries should be considered as a potential source for NO within the 
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vascular model.  Also due to the presence of red blood cells in the model as well as in physiological 
tissue the capillaries could also act as a sink, and increase the scavenging of NO in certain regions of the 
tissue. 
There exists a bit of controversy with respect to the production/release of NO from the capillaries.  For 
the current modeling efforts the production of NO in the capillaries and the arterioles are scaled by the 
respective thickness of the endothelial layer surrounding each of the vessel types.  Capillaries are known 
to have a thin endothelial layer, the thickness of one endothelial cell and for this reason the production of 
NO is scaled down from that which we would observe in the arteriole, which is assumed to have a 
thicker layer of endothelial cells along the vessel lumen.  With this said there exists a history of studies 
that have examined the expression of eNOS in capillary endothelium. 
Kashiwagi et al. (137) found via immunohistochemical analysis that eNOS expression is greater in 
venules and capillaries than in arterioles.  Hence, it may prove useful, and perhaps more physiologically 
relevant to consider cases in which the production rate of NO in the capillaries is greater or less than that 
in the arterioles.  Previous studies, such as those conducted by Mitchell and Tyml (37) have 
demonstrated the important role that capillaries play as a go between the arteriole and venule. 
Examining the parameters that control the production of NO, as well as the other chemical species in the 
simulations, reveals that the capillaries are the vascular components in which the Hct is the lowest.  This 
is not surprising as explained by Ellis et al. as one descends along the arteriolar tree, the local hematocrit 
will decrease due to both the preferential distribution of RBCs at bifurcations as well as plasma 
skimming (304).  For this reason the efficiency of ATP signaling in response to changes in oxygen 
demand would be called into question within the capillary bed.   
As discussed, blood flow can be considered to be very heterogeneous.  What does this heterogeneity of 
blood flow mean when it comes to the transport of the chemical species of interest in this study?  A 
heterogeneous distribution of red blood cells in the bifurcating arteriole network considered results in a 
166	  
	  
heterogeneous distribution of O2, Figure 35.  The arteriole branches receiving a lesser flux of RBCs will 
subsequently also have a lower PO2. In a correlating manner the very same arteriole branch shall 
experience greater CNO in and around the arteriole wall.  Unless the partial pressure of O2 is very low, the 
production of NO from ECs is minimally influenced by the local O2 environment(270). Therefore, the 
existence of more inactivation of NO by RBCs found in the one arteriole leads to lower CNO, while the 
other branch with minimal RBC flux will experience a lower rate of NO scavenging.  This lower rate of 
scavenging leads to greater concentrations of NO observed around the arteriole branch, leading to the 
possibility for an increased relaxation of the vascular smooth muscle and an increase in vessel diameter.  
The considered mechanisms of this model allow for a coupling of a local increase in CNO correlating 
with a decrease in local PO2 independent of an oxygen-dependent increase in NO production from ECs.  
As this means of increased CNO does not involve active control of NO production, it can be categorized 
as a passive means by which PO2 and NO mediated dilation are coupled.  Therefore as one may expect, 
blood flow can have a significant impact on NO transport in the microvasculature. Yet this 
convection/reaction dominated means of NO regulation does not respond in the desired manner to 
changes in O2 demand.  In particular, as O2 demand increases CNO around the arteriole will decrease. The 
inability of the described passive control of local CNO to respond to increases in O2 demand in the desired 
manner indicates the need for a more active means of regulation of NO. 
When a nucleotide-dependent means of NO production is incorporated within the bifurcating arteriole 
network model, the chief role of the RBCs as deactivators of NO is not overcome.  Furthermore, the 
desired relationship between a decrease in local PO2 and a desired increase in CNO around the arteriole 
wall is not realized, Figure 43 exemplifies this behavior. In contrast to arterioles, the hematocrit in 
venules increases as blood flows along the venular tree.  This increased hematocrit increases the 
signaling efficiency of the red blood cells and furthermore low O2 saturations within the venule will 
further strengthen the erythrocyte derived signal, which can be conducted upstream.  As a result Arciero 
selected the venule as the primary site for regulating O2 supply (72). As a secondary result, the focus of 
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this project switched from the bifurcating arteriole computational domain to a connected arteriole venule 
computational domain.  
Within the network model based upon a vascular geometry previously applied to examine O2 transport in 
the microcirculation (5) we observe a very strong influence of NO generated within the capillaries and 
venules on the arteriole wall CNO.  Both the capillaries and the venules appear to be potentially 
significant sources of NO in response to changes in the tissue demand for O2, Figure 52 and Figure 53.  
These results are highly dependent upon the release of ATP from RBCs in the capillaries and the venules 
in response to a decrease in local SPO2.The greatest collective concentrations of ATP and ADP occur 
within the capillaries located furthest away from the arteriole inlet, immediately draining into the venule, 
Figure 67.  This will also correspond to the region of lowest measured PO2. 
The current mathematical model linking NO production to O2 demand relies heavily upon a release of 
ATP from RBCs. Recently, it has been demonstrated that ATP is only released via hemolysis when 
examining the release of ATP from suspensions of red blood cells due to hypotonic shock, mechanical 
stress, and hypoxia(305).  Yet numerous studies have reported inducible and hemolysis-independent 
ATP release from intact healthy human RBCs (67, 306-309).  With this said the idea that the only means 
by which cells may release ATP in response to different stimuli is via hemolysis, casts doubt upon the 
erythrocyte as a monitor for local oxygen levels. For this reason, as our results demonstrate a potential 
connection between O2 demand and an increase in endothelial NO production they should be viewed 
with caution. Much more research needs to be conducted on this topic before definitive conclusions can 
be made. 
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Chapter 5 Computational examination of the role of terminal arterioles in the control of NO-
dependent blood flow regulation 
	  
5.1 Motivation and Background 
Functional models of NO transport are required to fully understand the biological life of the signaling 
molecule (38). It is the goal of this project to create and analyze models that allow for us to study 
different aspects of a complete functional model that would predict how NO regulates blood flow and 
smooth muscle tone. Previous mathematical studies have attempted to produce a range of CNO that has 
been observed experimentally (12, 180, 181, 206, 211, 273, 328). These results reveal little about the 
truly dynamic nature of the role of NO in various physiological processes. If CNO is the final model 
output then nothing is revealed about how NO regulates vascular tone and diameter in the face of 
changes in local metabolic environment. To choose a target value of 400nM as a suitable physiological 
concentration of NO means nothing without a description of the tissue environment and a reference state 
(resting or basal concentration) of NO concentration. For this reason we have examined the pathway 
through which NO influences smooth muscle cell dynamics and vessel diameter. The goal of this model 
is to quantify the relationship of metabolically driven changes in local arteriole signaling molecule 
concentrations to changes in the smooth muscle tension and changes in diameter of that arteriole. As the 
terminal location of local blood flow control in the microcirculation has been determined to be the 
terminal arterioles, it is with a good deal of interest that we examine the influence of the change in 
diameter of these vessels on the transport of blood and its constituents.  
Established models of smooth muscle dynamics are applied to model the influence of NO on smooth 
muscle relaxation in two differently sized arterioles. Considering the changes in arteriole diameter found 
in the first part of the model a series of simulations are then run for the bifurcating arteriole geometry to 
explore the relationship between diameter change and NO/O2 transport. Further exploration of the 
influence between vessel diameter and the biotransport of NO and O2 is accomplished by exploring the 
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transport of red blood cells (RBCs) in a larger network model than that previously considered. RBCs 
play a pivotal role in the transport of oxygen (329). Blood plasma constitutes a greater percentage of the 
total composition of blood than erythrocytes, yet approximately 2% of oxygen traveling the arterial 
system is dissolved in the plasma and the remaining 98% is carried via the erythrocytes (and their 
concentrated solution of hemoglobin) (330). Thus, the distribution of RBCs will greatly influence the 
delivery of oxygen.   
 
When presented with the opportunity of entering two differently sized branches the RBCs will 
predominantly enter the larger of the two branches.  As was the case with our connected model this 
behavior leads to much greater hematocrits within the branch that constitutes a continuation of the 
arteriole in comparison to that in the ignored capillary branch, indicating the importance of upstream 
vessels on the control of RBC flux through a microvascular unit structure.  In particular we will examine 
how a change in the ratio of terminal arteriole diameter to feeding arteriole diameter influences the 
distribution of RBCs in a vascular network and related hemodynamic properties.  Due to the large role 
that RBCs play in NO transport the findings of this section can be applied to more interesting studies of 
the role NO may play in autoregulation of the microcirculation and overall behavior of the 
microcirculation.   
5.1.2 Theory of NO-dependent dilation of vessels 
In response to chemical agents such as bradykinin and acetylcholine or to a mechanical force such as 
shear stress, endothelial cells produce NO, which diffuses into vascular smooth muscle cells (SMCs) and 
produces a vasodilatory response (331-333).  Computational and experimental models have found that 
after being rapidly scavenged by deoxy- and oxy-hemoglobin, the remaining NO reaches SMCs in 
concentrations below the minimum reported ranges of molecular concentrations (80-250 nM) required to 
activate soluble guanylate cyclase (sGC) (334, 335) and elicit vasodilation.   
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The exact concentration of NO in and around the arterioles of the microvasculature has been discussed. 
Bohlen measured CNO of 353±28nM in the walls of arteries with a diameter of 128±80µm and 
401±48nM around veins of diameter 283±18 um in rat intestine (336). Meanwhile Vukosavljevic et al. 
reported concentrations of NO of 338±40nM and 313±48nM around arteriolar and venular walls 
respectively in the mesentery and intestine of rats (215).  Our own computational studies have focused 
on producing a concentration range between 200-500nM in and around the arteriole wall (12, 162, 180, 
181). It is important to expand upon these earlier simulations and speculate upon the role that NO 
concentrations play on vasodilation in the microcirculation.  
5.1.2 Activation of sGC by NO 
To study the influence which NO exudes upon the structure of resistive vessels, the relationship between 
the known vasodilator (NO) and its various targets within the smooth muscle of the surrounding vessel 
wall must be known. Jin Yang et al. (337) have created a mathematical model of this association. Nitric 
oxide is synthesized and diffuses rapidly into neighboring vascular smooth muscles in which NO 
activates sGC. NO binds to the basal form of the enzyme (E1) and transforms the enzyme to a six-
coordinate partially active nitrosyl intermediate (E2) (338). The reaction subsequently proceeds to the 
formation of the fully active five-coordinate enzyme (E3) through NO-dependent and –independent 
pathways. A two-step binding model has previously been proposed for the NO-sGC interaction, where 
NO is used as a ligand in the first step and a catalyst in the second step (339). The intermediate six-
coordinate sGC-NO complex was demonstrated to have substantial activity, and the deactivation of sGC 
was found to be generally slow and similar to that observed in vitro. Eventually NO dissociates from the 
heme domain of SGC and the enzyme is returned to its basal state. 
 
sGC is expressed in most cells of the cardiovascular system as well as in many other type of cells. The 
enzyme sGC is composed of two subunits α and β and functions as a heterodimer. The prosthetic heme 
group possessed by sGC operates as the receptor domain for NO (340) and CO (341). The NO-sGC-
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cGMP pathway is illustrated in Figure 69, which serves as the guide for the equations used to model the 
NO/cGMP- dependent dilation of an arteriole. 
 
 
Figure 69: Proposed in vivo mechanism(150) for the binding of free NO to sGC based on in vitro data (338).  
Solid lines represent experimentally observed phenomena and dashed lines represent proposed features 
based on analysis of in vitro data, as characterized by rate constant, kD.  The rate of cGMP formation 
depends upon the concentrations of the different forms of sGC, their respective turnover numbers, and upon 
NO concentration. KGCB, kGC6, and kGC5 are the turnover numbers (s-1) for the basal (E1), 6-coordinate 
nitrosyl (E2) and 5-coordinate nitrosyl (E3) forms of sGC respectively. 
     
5.1.3 cGMP Generation and Influence on Vessel Diameter 
Two enzymatic pathways exist by which cGMP is generated (342): 
1)  sGC is activated by either NO or carbon monoxide and converts guanosine triphosphate (GTP) 
to cGMP as discussed above (130). 
2) A family of particulate guanylate cyclases (pGC) that act as membrane receptors for the 
natriuretic peptide family have also been found to generate cGMP. 
cGMP-induced decrease in Ca2+ sensitivity is a possible manner by which one could achieve “active 
relaxation” of the smooth muscle. Smooth muscle relaxation by tradition is considered a default passive 
response, which occurs from a decrease of intracellular free calcium concentrations [Ca2+]i following a 
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decrease or loss in the contractile stimulus. The force within the smooth muscle is dependent upon the 
cross-bridge recruitment between myosin and actin filaments. Smooth muscle contraction and relaxation 
are dependent upon two competing processes. The first is the phosphorylation of the myosin light chains 
(MLC) by the myosin light chain kinases (MLCK) and the other is the dephosphorylation of the myosin 
light chains by myosin light chain phosphates (MLCP). MLCK is dependent upon the Ca2+-calmodulin 
complex (CaCM) and MCLP is activated directly by the cGMP/PKG pathway. The contractile state of 
the smooth muscle is dependent on the level of MLC phosphorylation, which is regulated by the balance 
of the MLCK and MLCP activity. Studies using isolated ilial (343) and arterial (344) SMCs from rabbits 
show that the cGMP-PKG pathway is capable of provoking  an increase in MLCP activity without 
influencing myosin light chain kinase. As explained by Carvajal, this shift in the MLCK/MLCP 
equilibrium results in a decrease in MLCP activity and hence a decrease in the sensitivity of the 
contractile system to the calcium ion and subsequently smooth muscle relaxation (342).    
5.2 Methods 
5.2.1 Model of smooth muscle mechanics 
To model the response of the vessel to variations in CNO we make use of the vessel wall mechanics 
model previously applied by Carlson and Beard (7) which is based upon the mechanical behavior of 
larger vessels (345). The model for the vessel mechanics is a collection of previously established models 
of vessel wall mechanics (130), vascular smooth muscle force generation (346), and vascular smooth 
muscle Ca2+ handling (131). NO is incorporated in the calcium handling model created by Kapela, yet 
the influence of a range of physiological concentrations of this vasodilatory agent were not considered in 
these earlier studies. 
 
The vessel wall (under tension due to the intraluminal pressure) is modeled as a contractile unit in 
parallel with a nonlinear spring. The passive resistance to vessel expansion under pressure illustrated 
within  
173	  
	  
Figure 70 is due to the fibrous connective tissue of the vascular wall. Meanwhile, the active component 
is a function of a variety of parameters including the calcium handling. 
 
 
Figure 70:  Spring-Dashpot representation of the total stress (σtotal) in the vascular wall. A passive 
component (σpass) is aligned in parallel with an active component (σactmax) due to the dynamics and signaling 
occurring within the vascular smooth muscle(VSM). 
 
The vascular wall is modeled as a parallel circuit in which the total stress in the vessel wall, σtotal, is the 
summation of the active and the passive components of the stress within the vascular wall: 
 ............................................................................................ Equation 95 
 
σpass is the nonlinear passive stress due to the material properties of the vessel wall and σmaxact is the 
maximally active stress. Likewise, if we assume that our vessel is under equilibrium conditions, the Law 
of Laplace gives the total circumferential stress in the vessel wall: 
 ............................................................................................................. Equation 96 
 
The intraluminal pressure, P, will change with respect to the diameter (D) of the vessel. The thickness of 
the vessel wall, δwall, will also change with respect to the diameter of the vessel to represent the influence 
max
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=
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of the stretching and compression of the wall as the diameter is altered. The nonlinear passive stress can 
then be expressed as a function of diameter: 
 ................................................................................... Equation 97 
 
Cpass is a reference passive tension that occurs at a reference circumference of the vessel, L0.  L0 is 
defined as πD0, where D0 is the passive vessel diameter at an intraluminal pressure of 100 mmHg.  C’pass 
describes the steepness of the exponential curve of the passive response.  These parameters, as well as 
those incorporated into the active response are altered to fit the respective empirical pressure diameter 
data of the particular vessel size for which they are compared. The parameters incorporated in the 
description of the active wall stress in the vessel wall are Cact, C’act, and C”act; which serve to describe the 
peak magnitude, relative peak location, and relative curve width of the active response respectively. 
 ............................................................................... 
Equation 98 
 
As previously stated, the thickness of the arteriole wall changes with respect to the diameter of the 
arteriole. This is possible as the cross-sectional vessel wall area is assumed to be conserved and 
calculated at a reference wall thickness, δwall,ref. 
 ......................................................................... Equation 99 
 
Rearranging  Equation 99 it becomes possible to calculate 
the vessel wall thickness for a particular vessel diameter. 
 .............................................................................. Equation 100 
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The parameters describing the pressure and diameter relationship for the vascular wall are fit based upon 
data from cannulated vessels with diameters much larger than the terminal arterioles considered in this 
study, 150µm (7). Table 1 of Carlson and Secomb demonstrates the strong dependence of the parameters 
on the vessel diameter (130). An initial examination of the influence of NO on the diameter of an 
arteriole considers these larger vessels, as this is the initial vessel size examined by Carlson and Secomb 
(130) and allows for smooth transition to application of the Carlson and Beard model (7). For the initial 
simulations considering the influence of CNO on the diameter of the vessel a larger earlier generation 
arteriole is considered for which the experimental data of resistance arteries from spontaneously 
hypertensive rats and Wistar-Kyoto normotensive rats under pressurized conditions in vitro (347) is 
applied to determine the active and passive parameters.  As the focus of this work has been on terminal 
arterioles and the arterioles that feed the terminal arterioles, we also consider data from cannulated 
vessels of smaller vessels (348, 349) and alter the parameters of the active and tension components of 
total wall stress appropriately. 
 
 
 
Table 21:  Vessel Wall Mechanics Parameters.  Parameters for the larger vessels are fit to data obtained by 
Bund(347) and are discussed by Carlson and Beard (7).  The parameters for the smaller arteriole are fit to 
data collected by Davis(350) and calculated by Carlson and Secomb (130). Descriptions of each of the 
parameters are described in the text above.  
 
5.2.2 Vascular Smooth Muscle (VSM) Activation  
Earlier models have expressed smooth muscle activation as a sigmoidal function dependent upon a 
variety of model parameters describing the tone in the vascular wall (130). The smooth muscle tone was 
considered to be a function of the summation of a variety of contributing sources such as: the myogenic 
response, conducted response, flow dependent response, and other signal sources known to influence 
Reference Species	  and	  Vessel	  Type Dp100(μm) Cpass	  (N/m) C'pass Cact	  (N/m) C'act C"act δwall,ref	  (μm)
Davis	  (1990) Hamster	  Cheek	  Pouch 43 0.316 11.247 0.392 0.903 0.618 1*
Bund	  (2001) Rat	  Mesenteric	  Arteriole 150 1.168 7.24 1.108 0.843 0.406 6.16**
*Approximation
**Direct	  Measurement	  by	  Carlson	  and	  Beard
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vessel diameter (72, 101). The contributions of these different sources of signal have been modeled in 
the form of an empirical formula. A study linking the concentration of a vasodilatory substance to 
alterations in smooth muscle properties has yet to be performed. Making use of the study describing 
calcium handling in the vascular smooth muscle, the calcium dynamics in the SMCs are linked to the 
changes of the vessel diameter and in the process allow for the older empirical formulae to be discarded 
(7). This allows for Carlson and Beard to eloquently fit the active stress in the vessel wall to a Hill 
Equation, which is a function of Ca2+, and allow for researchers such as myself to surmise the manner 
that vessel diameter will change at a particular pressure due to a variety of stimuli that alter the calcium 
dynamics. 
 
Before relating calcium dynamics to the changes in the vessel diameter, it is important to first describe 
the nature by which the active stress depends upon the activation of sarcomeric contraction in the VSM 
cells.  The force generated via sarcomeric contraction is dependent upon myosin binding and 
phosphorylation.  Based upon the four state model proposed by Hai and Murphy the myosin can either 
be free nonphosphorylated (M), free phosphorylated (Mp), attached phosphorylated (AMp), or attached 
dephosphorylated (AM) (346).  A set of ordinary differential equations similar to that applied by 
Koenigsberger (351) is made use of to determine the equilibrium active force generated in the vascular 
wall. 
 .................................................................... 
Equation 101 
 
 .................................................. 
Equation 102 
 
 ............................................ 
Equation 103 
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 .................................................................. 
Equation 104 
 
A schematic from which these kinetic equations are derived can be found within the cytosol of the 
smooth muscle cell (SMC) found in  
Figure 71. The rate constants K1 through K7 are the same as those applied by Carlson and Beard (7). As 
explained by Carlson and Koenigsberger (351) the rate constant for phosphorylation of myosin is 
dependent upon the cytosolic  Ca2+ within the SMC, with γCa describing the sensitivity of cross-bridge 
contraction to calcium.  
 ............................................................................................... Equation 105 
 
 
Table 22: Fixed Parameters applied for the VSM cross-bridge model.  Parameters are the same as those 
made use of by Koenigsberger (351). 
 
Relying upon the kinematic relationships described in 
 Equation 101-10 and operating with the understanding that attached myosin in both 
phosphorylated and dephosphorylated states are capable of generating force we can calculate the 
activation of the active response of the vessel wall (Act). 
 ............................................................................................ 
Equation 106 
  
The value (AMp + AM)max is the maximal concentration of myosin in the attached state. 
( )AMKmKmAMKm
dt
dAM
p 675 +−=
3
61 iCaCaKK γ==
Fixed	  Parameter Units Value
Km2 1/s 0.5
Km3 1/s 0.4
Km4 1/s 0.1
Km5 1/s 0.5
Km7 1/s 0.1
(AM+AMp)max -­‐ 0.8
γCa μm3/s 17
AMKmMKmMKm
dt
dM
p 721 ++−=
( )
max
AMAM
AMAM
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p
p
+
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Figure 71: Schematic of involved processes of endothelial derived signals modifying the contractive forces 
within the vascular wall. The cartoon consists of models previously applied and described in the works of 
Kapela et al.  (131, 352), Yang (337), and Lohman (56). The multiple endothelial cells are indicated with an 
EC and react to a nonspecific agonist to trigger the diffusion of NO and the transport of other signals to the 
VSMCs which turn these signals into new signals causing alterations in the constrictive forces of the cell.  
The changes in the active stress of the vascular wall are largely due to changes in intracellular calcium 
changes, which lead to modification of myosin binding and phosphorylation (sub diagram located within the 
cytoplasm of the smooth muscle cell). Further description of the processes involved in modulation of smooth 
muscle function can be found in the accompanying write-up and the referenced sources. 
 
 
 
5.2.3 VSM electrophysiology model 
The contraction of a resistive arteriole is triggered by the increase of the smooth muscle cytosolic 
calcium concentration (353). As previously stated Carlson and Beard were able to fit a Hill equation 
(functionally dependent upon the of cytosolic calcium concentration within the smooth muscle) to the 
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active response of the vessel wall. This active response had previously modeled with a set of ordinary 
differential equations describing myosin state (7). 
 ....................................................................................................................... 
Equation 107 
 
The parameters n and KM,Ca are determined by fitting the activation curve as a function of calcium to the 
activation curve obtained plotting the VSM cross-bridge,  Equation 106. 
The modeling of calcium handling in the smooth muscle as well as that of the muscle electrophysiology 
is based largely on the work of Kapela (131). The referenced model is composed of three compartments. 
These compartments are the plasma membrane, the cell cytosol, and the intracellular calcium store 
(which has been called the endoplasmic reticulum in previous models of calcium dynamics) (354).  Ion 
channels included in the model include the large conductance Ca2+-activated (BKCa) potassium channel, 
Ca2+-activated chloride channels, nonselective cation channels, store-operated cation channels, and 
voltage operated cation channels. The model also includes Na+-K+-ATPase (NaK) and plasma-
membrane Ca2+-ATPase (PMCA) pumps, the Na+-K+-Cl- cotransport (NaKCl) and the Na+-Ca2+ 
exchanger. Composed mainly of the sarcoplasmic reticulum, the intracellular calcium store contains 
mathematical descriptions for the sarcoplasmic reticulum Ca2+-ATPase pumps (SERCA), IP3 receptor 
Ca2+ channels (IP3R), ryodine receptor Ca2+ channels (RyR), a leak current, and calcium buffering. 
 
The Kapela model focuses on two opposing signaling pathways known to greatly influence calcium 
homeostasis.  The vasodilatory action of NO is modeled directly through an effect on BKCa channels and 
indirectly through the formation of cGMP.  The four targets of cGMP are ClCa channels, BKCa channels, 
the Na+/Ca2+ exchanger (NCX), and the cotransport.   
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5.2.4 Influence of NO on Ca2+ homeostasis and Membrane Electrophysiology 
A lumped Hodgkin-Huxley-type model is made use of to determine the rate of change of the membrane 
potential.  The transmembrane current through each component of the model is considered as influencing 
Vm except for the Na+-K+-Cl- cotransport system, which is electronuetral.  The voltage-operated calcium 
current (IVOCC) is modeled as a Goldman-Hodgkin-Katz current with a time and a voltage dependent 
open state probability. The potassium current through the large conductance Ca2+-activated K+ channels 
(IBKCA) has been demonstrated to fit well to the GHK equation (355). NO has been shown to activate the 
BKCa channels in SMCs from rat mesenteric arterioles directly and through the cGMP-dependent 
pathway without modifying channel conductance (272, 355, 356). The voltage-dependent K+ channel 
(KV) is considered when describing the voltage-dependent K+ channel current (IKV).  IKV activation and 
deactivation curves are described by Boltzmann equations (357).  Unspecified K+ leak currents (IKleak) 
are also considered within the model. The leak current is incorporated in the model as having a linear 
conductance, which is found to give a whole-cell current within the experimentally reported values for 
SMCs in intact rabbit mesenteric arteries (358). Assuming that DAG and IP3 concentrations are 
proportional to one another allows for the NSC channel activity to be expressed as a function of IP3 
concentration. The dependence of this current on IP3 is assumed to follow Michaelis-Menten kinetics. 
These NE activated channels were assumed to indirectly activate the agonist-induced calcium influx via 
membrane depolarization (359, 360) it was assumed that DAG activates sodium and potassium 
conductance’s, while there is only a small background, DAG-independent calcium current. 
 
To model the current through store-operated non-selective cation channels (ISOC), conductance for the 
Ca2+ and Na+ components were determined. The open probability of SOC (PSOC) channels is defined as 
a sigmoidal function of intracellular calcium concentration (361). Hill equations are applied to describe 
the Ca2+-activated chloride current (IClCa) activation by cGMP and calcium. The NSC flux of Na+ was 
identified by Carlson and Beard to allow for sufficient production of the observed steady-state diameter 
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changes with respect to pressure and also generate known trends with increasing pressure.  These 
findings indicate that the Na+ flux through the NSC may be responsible for the myogenic response (7). 
Considering this finding we incorporate the modifications made by Carlson and Beard when describing 
the behavior of this channel, in which the channel behavior is dependent upon the vessel wall stress as 
opposed to the strain.   
 
 The major pathway for calcium efflux and a key determinant of intracellular calcium concentration at 
rest and during stimulation is the plasma membrane Ca2+-ATPase current (IPMCA).  Michaelis-Menten 
kinetics was used to describe the IPMCA dependence on calcium.  Plasma membrane Na+-Ca2+ exchange 
current (INCX) was modeled using a formulation similar to that used by Lindblad et al. for rabbit atrial 
cells (362).  As previously explained, cGMP is modeled to stimulate NCX activity(363). Hill equations 
dependent upon the concentration of intracellular sodium and extracellular potassium are used to 
describe the sodium pump current (INaK).  Sodium-potassium-chloride transport is modeled as being a 
function of cGMP (364, 365). 
 
The influence of ryanodine and IP3 receptors are considered in the modeling of the sarcoplasmic 
reticulum (SR).  An uptake compartment with a SERCA pump, and a release compartment are all 
considered in this model of the SR. A four-state kinetic model of the ryanodine receptor also plays an 
important role in the model 279. A calcium leak from the internal stores, which is not mediated by 
ryanodine or IP3 receptors, is also incorporated. 
 
IP3 formation following activation of the α1-adrenoceptor is described by two coupled differential 
equations.  The G-protein is activated by unphosphorylated ligand bound receptor and to a smaller 
degree by an unbound receptor, and then activates phospholipase C. Activated phospholipase C then 
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leads to the formation of IP3 and DAG. The two products (IP3 and DAG) then activate the IP3 receptors 
in the SR and open non-selective cation channels in the plasma membrane respectively. 
5.2.5 Modifications of Modeling Smooth Muscle Dynamics 
As we desire to examine the possibility that the range of concentration in which NO exerts its greatest 
influence on the diameter of the vessel is in the 200-400 nM range rather than the  ~5-100 nM range 
previously focused on (131), we turn our focus to the NO/sGC/cGMP pathway. In an attempt to best 
model the influential players in the process of interest Yang et al. propose that there exists a local-
feedback loop, which senses the level of end-product cGMP, and this sensing in turn promotes sGC 
desensitization (337). The equation for the rate constant describing the decay of the activated sGC to the 
basal state (illustrated in Figure 69) is expressed as follows: 
 
 .................................................................................................... Equation 108 
 
 ....................................................................... 
Equation 109 
 
 .................................................... 
Equation 110 
 
 ........................................................................ 
Equation 111 
	  
        
Ex signifies the state of the sGC which have been previously described; the 1 subscript corresponds to 
the basal (B) state of the enzyme, while the subscript 2 is applied to describe the intermediate 6-
coordinate (6c) state the enzyme takes after initially binding with NO, and finally the subscript 3 
parallels the active five coordinate (5c) state of the enzyme.  Each specific state is measured as a fraction 
m
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of the total amount of sGC and for this reason Eb+E5c+E6c=1=E1+E2+E3.  In their analysis Yang et al. 
(337) rely upon a model for calculating [NO] modeling the consumption of NO due to binding with sGC 
with first order kinetics, coupled with a constant endogenous or exogenous NO influx. The simulations, 
which have been run incorporating this model and those to be run in the future, will not make the same 
approximation.  Instead, specific nitric oxide values will be acquired from the current NO model and 
then applied to the above set of ordinary differential equations.   
 
The active form of the enzyme soluble guanylate cyclase in turn catalyzes the conversion of GTP to 
cGMP. The synthesis of cGMP begins after E1 is formed (338). cGMP production from GTP depends 
primarily on the active form of sGC and is also dependent upon various isoforms of cyclic nucleotide 
phosphodieterases (PDEs).  PDEs hydrolyze the cylic nucleotide into cGMP.  The time rate of change of 
cGMP can be modeled with Michaelis-Menten kinetics. 
 
 ....................................................... 
Equation 112 
 
The first term of the equation accounts for the production of the cGMP due to sGC and the second 
corresponds to the degradation of cGMP due to hydrolysis. The Michaelis-Menten constant Km,pde is 
found through experimental studies (366, 367). Meanwhile, the basal level for PDE for cGMP hydrolysis 
is low, experimental evidence shows that this activity is greatly enhanced after cGMP binding at the 
NH2-terminal domain (368-370). For this reason the cGMP hydrolysis rate is defined by the following 
equation, which illustrates the reactions dependence upon cGMP:  
 
 ........................................................................................... Equation 113 
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Relying upon its second messenger capabilities, cGMP activates a family of serine/threonine protein 
kinases appropriately named cGMP-dependent protein kinases (PKGs). These PKGs reduce the cytosolic 
concentration of calcium and also cause calcium desensitization of the actin-myosin contractile system.  
This modeling of the NO/sGC/cGMP pathway is applied to examine the manner in which NO will 
influence the sGC and cGMP dynamics making use of data obtained from the shear stress dependent 
nitric oxide studies previously discussed (116). 
 
Condorelli and George modified the above two-step mechanism to include the influence of each of the 
forms of sGC complexes and a first-order dissociation constant (kd) of NO from E3 to account for the 
effect of NO scavangers such as Hb, Mb, and thiols on the half-life of the active enzyme(150). They also 
provide a description of the relative cGMP formation rate (VcGMP/VcGMP,max) at steady state as a function 
of nitric oxide.  The concentration of NO at which the half-maximum cGMP formation rate occurs 
KM,cGMP has yet to be clearly established.  In the study completed by Kapella et al. (131) the assumed 
kinetic mechanism is Km,cGMP =66 nM.  
 Equation 114 describes the rate of NO usage due to its reaction with sGC (NO is not consumed 
due to its role as a catalyst in the activation of sGC).  The model applied by Kapela and Carlson builds 
off of the earlier models (150). The usage of NO in the activation of the sGC residues takes the form of 
 Equation 114. 
 
 .................................................. 
Equation 114 
 
The first two terms  Equation 114 represent the 
forward and the reverse rates of NO consumption in the first binding phase of NO and sGC, and the last 
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term represents NO involved with the intermediate phase of sGC activation in the NO/sGC/cGMP 
pathway. The rate at which cGMP is produced can be represented with the following ordinary 
differential equation, considering the influence of each of the three different states of the sGC complex:	  
 ................................................................. 
Equation 115 
 
Likewise as performed for nitric oxide usage, the production of cGMP can be expressed as a ratio of the 
current production rate to the maximal cGMP production (θ). 
 
 .................. Equation 116 
 
 
Where BB=kD/k1,, B6=(kD+k-2)/k3, B5=k2/k3, γGCB =kGCB/kGC5, and γGC6=kGC6/kGC5 
 
 ........................................................................... 
Equation 117 
 
As previously discussed we also desired to alter the range of nitric oxide concentrations, which exerted 
the greatest influence on the arteriole diameter.  To do so, we examined the rate constants describing the 
state of sGC; in particular to alter the half maximal effective concentration for NO as it contributes to the 
production of cGMP. Altering this characteristic parameter will have the desired influence on the 
behavior of the vessel diameter with respect to nitric oxide concentration at a constant pressure.  This 
can occur in a variety of manners amongst which is a decrease in the rate constant which describes the 
manner in which NO binds to the heme of the sGC to form a 6-coordinate, non-activated, intermediate 
which then decays to a final 5-coordinate complex which triggers the formation of cGMP from GTP.  In 
the original simulation set considered in this study k1 is set to 2e3 (1/(ms *mM)).  At lower temperatures 
and as reported by Zhao et al. (338)  this rate constant has been measured as being 0.14e3 (1/(ms*mM)).  
If we were to decrease k1 to this experimentally observed value the resulting half maximal concentration 
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of NO would be 101nM, which appears to be closer to the range that previous mathematical and various 
in vivo experiments have described for the physiological values of NO.  In most cases it is desirable to 
increase this parameter even further to allow for the range of influential NO concentration to be more 
reflective of those in the cited experiments and mathematical models, a range ideally determined to be 
within the hundreds of nanomolar range in this study. Decreasing the rate at which the fully activated 
NO-sGC compound contributes to the production of cGMP will undoubtedly move us closer towards 
this goal. Once again decreasing the rate constant from the parameters made use of by Carlson and Beard 
to those determined in Zhao the rate constant k3 is decreased from 4.2 (1/(ms*mM)) to 0.24 
(1/(ms*mM)).  The result is half activation constant for NO around 409 nM, a value that is even more 
reflective of those cited and observed in a variety of situations.  A third parameter for which alternative 
experimental values has been found is the dissociation rate constant from the partially active form of the 
non-activated intermediate complex.  Increasing k-1 from 15e-3 to 50e-3 (1/ms), once again deferring to 
rates found in Zhao et al, we discover that EC50 would now be approximately 759nM.  Allowing for the 
maximal half activation rate constant to be at values this great indicates a possibility of nitric oxide 
having a greater influence over the diameter of the vessel in concentrations cited in various literature 
locations as well as previous studies conducted by this lab 
 
Input Units Median SD Zhao constants@ 
4°C 
Carlson and Beard 
Constants 
γGCB - 0.004 0.002   
γGC6 - 0.5 0.3   
kD s-1 0.01 0.01  400 
k1 nM-1s-1 2.0 2.0 0.14 2.0 
k2 s-1 0.1 0.1 0.0087 6.4 
k3 nM-1s-1 0.003 0.003 0.00024 4.2e-3 
k-1 s-1 600.0 600 50 15e3 
k-2 s-1 0.002 0.002  0.1 
Table 23: Input parameter values assumed for in vivo sensitivity analysis conducted by Condorelli and 
George (150). The input column consists of the different rate constants found within the NO/sGC/cGMP 
pathway.  The units, median, and standard deviation (SD) are all gathered from the study conducted by 
Condorelli and George.  Corresponding rate constants are also included from the study conducted by Zhao 
et al. at 4°C (338) as well as those made use by Carlson and Beard at physiological conditions (7). It should 
be noted that in the study completed by Condorelli and George more than one rate constant kD is examined 
for deactivation scenarios with kD=0,0.1, and 0.2 s-1. 
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5.2.6 Study of the dependence of NO and O2 transport on vessel diameter 
Two additional aspects of NO-mediated vasodilation are examined to gather a greater grasp upon the 
influence NO has on the regulation of blood flow in the microcirculation.  The first additional aspect is 
the relationship between vessel diameter and NO and O2 transport. Nitric oxide is known to be a very 
strong vasodilator.  For this reason we examine the influence of vessel diameter on the transport of NO 
and O2 in and around the vasculature. To do so the diameter of the arterioles incorporated within the 
bifurcating arteriole geometry is altered from the baseline diameter of 10µm over a range of other 
diameters such as 8,12,18,20, and 24µm. The studies involving changing the diameter of the vessel do 
not consider the theoretical pathways of ATP-mediated NO production from ECs as in the previous 
chapter.  
5.2.6.1 Study of the location in which blood flow is regulated in the microcirculation 
In this section we will discuss the potential alterations in transport of NO, O2, nucleotide, and overall 
blood transport in an extended microcirculatory network. This series of simulations will be a departure 
from the previous sets considered in multiple manners. First and foremost the network structure will 
extend further upstream and consider a feeding arteriole as well as multiple MVUs. Secondly, the 
influence of alterations in this network geometry on the distribution of red blood cells throughout the 
vascular domain is determined. The transport of chemical species such as NO, ATP, ADP, and O2 has 
not been simulated in this study.  However, with knowledge of the influence of red blood cells on the 
transport of each of these molecules one can ascertain how the findings described in this study will 
influence the behavior of these signaling molecules. 
Description of new vascular network 
The simulations considered in this work so far have focused on the terminal arterioles and capillaries. It 
was seen in Chapter 4 that altering the diameter of the terminal arteriole, even in a bifurcation, will not 
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influence the distribution of red blood cells in the capillary blood.  It is hypothesized that if the flow 
model is extended to incorporate the feeding arterioles, this will allow for a better approximation of 
changes in red blood cell distribution due to changes in terminal arteriole diameter.  In particular it is 
posited that increasing the diameter of the terminal arteriole, will result in an increase in red blood cell 
flux into said terminal arteriole and downstream capillaries.  
 
As shown in  
Figure 72, the newly expanded network now considers 29 paths for blood to flow. The 29 total vessels 
were created assuming that each vessel can only divide via a bifurcation and also each terminal arteriole 
branch will feed numerous capillaries. The new inlet boundary condition of the network is set to an inlet 
arteriole pressure of 30torr. The parameter value estimated for this inlet is assumed to be slightly greater 
than the 26.7torr measured at the inlet of terminal arterioles by Hutchins et al. (82) and Davis et al.(161). 
The outlet pressure (Pout) for which all flow is assumed to drain is the same as that used in the earlier 
connected network study.  The flow path originates with a feeding arteriole (FA1), which bifurcates into 
terminal arteriole 1 (TA1) and a continuation of the feeding arteriole (FA2). Influenced by the ratio of 
the diameter of the two vessels, the flux of blood and RBCs that continues along the feeding arteriole till 
it encounters another bifurcation. Once again at this bifurcation the bulk blood as well as the red blood 
cells are presented the opportunity to traverse down a second MVU beginning with a terminal arteriole 
(TA4) or continue further down the feeding arteriole (FA3). The path “chosen” by the blood and the red 
blood cells is once again a function of the ratio of the daughter vessel diameters and the downstream 
resistance.  The distribution of RBCs at a bifurcation is calculated using the empirical formulations 
previously described (1). The same set of equations is used to describe the distribution of red blood cells 
at each bifurcation, and the subsequent hematocrit dependent viscosities in each of the vascular 
components. 
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Figure 72: Lumped network circuit representation of expanded network composed of a feeding arteriole and 
two MVUs. Vascular resistances are labeled as boxes outlined in black with identifying labels centrally 
located in each box. The resistances whose label begins with FA are part of the feeding arteriole. When 
identified with a TA the network component is a terminal arteriole. The final alpha-identifier applied is C, 
capillaries.     
 
The influence of the diameter of the feeding arteriole (FA1, FA2, and FA3), the inlet hematocrit into the 
feeding arteriole (Hctin), and diameter of the terminal arterioles (TA1-6) is altered to determine the 
predicted influence of these actions on the RBC distribution and associated behaviors. Distributions of 
diameters for the different vascular components are illustrated below. 
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Figure 73: Initial diameters of vascular components of network circuit from  
Figure 72 
 
Description of simulation procedure examining the diameter change in MVU 
Changing the diameter of a vessel should influence the distribution of blood flow in a microvascular unit 
(MVU) structure.  Using the network diagram in  
Figure 72, a series of simulations were run to examine the influence of changing the diameter of different 
arterioles and the influence of these actions on the Hct in the upstream and downstream vascular 
components.  The vascular components of interest are the terminal arteriole 1 (pathway 2, TA1), 
terminal arteriole 2 (pathway 6, TA2), terminal arteriole 3 (pathway 7, TA3), and terminal arteriole 4 
(pathway 4, TA4).  Changes in the diameter of each of these vascular components will trigger changes in 
blood flow, causing passive changes in the Hct in each of the associated vascular components).  The 
simulation trials considered are labeled in the following form: (Da,Da1,Da2,Da3,Da4),  where Da is the 
arteriole diameter associated with TA5 and TA6, Da1 is the diameter of TA1, Da2 is the diameter of 
TA2, Da3 is the diameter of TA3, and Da4 is the diameter of TA4. The simulation set considers several 
different scenarios. 
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Scenario 1: 
 
The diameter of TA1 is increased; all other arterioles considered here are maintained at a constant 
diameter, all vessel diameters are described in the units of µm. 
1. (10,10,10,8,10) 
2. (10,12,10,8,10) 
3. (10,14,10,8,10) 
4. (10,16,10,8,10) 
 
Scenario 2 
 
The diameter of TA1 is altered from the original diameter of 10µm to 14µm and the diameter of TA2 is 
varied: 
1. (10,14,10,8,10) 
2. (10,14,12,8,10) 
3. (10,14,14,8,10) 
4. (10,14,16,8,10) 
 
Scenario 3 
 
The diameter of TA1 is altered from the original diameter of 10µm to 14µm and the diameter of TA3 is 
varied: 
1. (10,14,10,8,10) 
2. (10,14,10,10,10) 
3. (10,14,10,12,10) 
4. (10,14,10,14,10) 
 
Scenario 4 
 
The diameter of TA1 is altered from the original diameter of 10µm to 14µm and the diameter of TA2 
and TA3 are varied: 
1. (10,14,10,8,10) 
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2. (10,14,10,10,10) 
3. (10,14,12,10,10) 
4. (10,14,12,12,10) 
5. (10,14,10,14,10) 
 
Scenario 5 
 
The diameter of TA4 is altered: 
1. (10,10,10,8,10) 
2. (10,10,10,8,12) 
3. (10,10,10,8,14) 
4. (10,10,10,8,16) 
6. (10,14,10,810) 
 
Scenario 6 
 
The diameter of TA4,TA5, and TA6  is altered: 
1. (8,14,10,8,14) 
2. (10,14,10,10,14) 
3. (12,14,10,12,14) 
4. (14,14,10,14,14) 
 
For each of the above scenarios the respective distribution of RBCs throughout the network is 
determined using the associated fluid circuit and empirical formulae derived by Pries and Secomb (1).   
 
5.3 Results 
5.3.1 Continuing the Study of NO dependent vessel dilation 
Increases in CNO results in a decrease in the myogenic response of larger upstream arterioles.    
Neither Yang et al.(337), Kapella et al(131)., nor Carlson and Beard(7)  provide an in-depth examination 
of the influence of NO on the diameter of arterioles. We begin our analysis with the change in diameter 
of the rat mesenteric arteriole with a characteristic diameter of 150µm.   
Figure 74 considers two different models of diameter change with respect to pressure and nitric oxide. 
The sodium influx through the nonselective cation (NSC) channel was demonstrated by Carlson and 
Beard as the most likely channel responsible for the stress dependent diameter change, an assumption 
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continued within our modeling effort. As explained in the methods section of this chapter we decide to 
compare two variations of the NO/sGC/cGMP pathway.   
Figure 74(A) incorporates the influence of each of the different states of sGC activation on cGMP 
activity.   
Figure 74(B) makes use of a modification to the sGC/cGMP model in which the contribution of the basal 
and partially activated heterodimer is neglected.  The rate constants and other terms describing the 
calcium handling and other incorporated mechanisms remain constant from model to model and all other 
means by which NO alters the smooth muscle electrophysiology remain unaltered in the two variations 
of the NO/sGC/cGMP pathway. 
 
 
Figure 74: Comparison of the influence of NO on the diameter of a mesenteric rat arteriole making use of 
the conclusions deduced by Carlson and Beard (7).   
Figure 74(A) incorporates the influence of each of the three considered sGC complexes on cGMP activation 
as modeled in Condorelli and George (150).    
Figure 74 (B) makes use of the same mathematical model as applied by Carlson and Beard while altering the 
NO concentration to which the smooth muscles surrounding the resistive vessel are exposed.   Nitric Oxide 
concentrations considered are 10 x 10-6mM ( 10nM/ solid black line), 20nM (dashed black line), 25nM 
(dotted black line), 50nM (solid red line), 200nM (dash-dot black line), and 400nM (blue star).  The black 
dot represent data and corresponding error bars recorded in an experimental study on rat mesenteric 
arterioles (347).  Additional focus is placed on the range between 20 and 50nM since this is the range of NO 
values chosen by Carlson and Beard to be that in which NO most greatly influences the diameter of the 
vessel of interest.  In each simulation set the NO-large conductance pathway is not altered from the Carlson 
and Beard model. 
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As modeled in  
Figure 74 there are regions in which a change in nitric oxide concentration at the vascular wall can trigger 
a significant change in the diameter of the arteriole. The greatest changes in diameter due to NO are 
observed between the intraluminal pressures of 50 and 200torr.  It appears as if the greatest jump in 
diameter for a constant pressure occurs between 10nM to 50nM, or 50nM to 200nM depending upon 
which of the NO/sGC/cGMP model is applied. Furthermore, it is clear from comparing  
Figure 74 (A) and (B) that manipulation of the equation relating NO to cGMP activation will result in a 
difference dependence of vessel diameter on NO concentration. Lower concentrations of nitric oxide 
result in larger vessel diameters when comparing the influence of all sGC complexes ( 
Figure 74(A)) than when only the fully activated form of the sGC complex is considered to influence the 
activation of cGMP ( 
Figure 74(B)).  This results in a lower range of vessel diameters per respective pressure value over the 
range of NO considered.   
 
 Returning to our simulations of changes in nitric oxide concentration in response to alterations in the 
metabolic demand we can observe that basal concentrations of NO are much greater than 1nM.   As 
stated earlier there exists disparity in the literature when defining physiological concentrations of NO, 
the same statement can be made with regards to the change in concentration, which leads to a change in 
vessel structure to allow for it to dilate. At their resting state the majority of the arterioles considered 
throughout this work are reported to have average NO concentrations in the vascular wall within the 
range of 300-600nM, concentrations much greater than the range of concentrations shown to most 
greatly influence the 150µm diameter resistive vessel.  For this reason we decided to alter the range of 
CNO that the vessel response is most sensitive/responsive to. 
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The initial set of parameters used by Carlson and Beard dictates a half maximal effective concentration 
(EC50) of 66nM.  The contribution of the neglected mechanisms appears to have a large influence on the 
vessel response as demonstrated in  
Figure 74. The model described by Condorelli and George (150) leads to a half maximal effective nitric 
oxide concentration of 26nM. The remainder of the appropriate model modifications shall be completed 
under the assumption that multiple phases of the sGC complex influence the activation of cGMP through 
the conversion of GTP. Other studies have found a half-activation concentration of NO with respect to 
cGMP activation around 250nM (146). 
 
 
 
Figure 75: Diameter (µm) vs. Pressure (mmHg) concerning a range (~0-400nM) of stimulation brought upon 
by changes in CNO to which the smooth muscle is exposed. The vessels of interest are rat mesenteric vessels 
with a diameter of 150um when cannulated at a pressure of 100mmHg.  A large pressure range is covered in 
order to explore the multiple phases of a vessels response to changes in pressure. The NO-sGC-cGMP 
pathway is modeled making use of the simplified set of equations suggested by Carlson and Beard(7). For 
which the maximal half activation of cGMP is set to 101nM of nitric oxide. Nitric Oxide concentrations 
considered are 10 x 10-6mM (10nM/ solid black line), 20nM (dashed black line), 25nM (dotted black line), 
50nM (solid red line), 200nM (dash-dot black line), and 400nM (blue star). The black dots represent data 
and corresponding error bars recorded in an experimental study on rat mesenteric arterioles (347). 
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Figure 76: Diameter (µm) vs. Pressure (mmHg) concerning a range (~0-400nM) of stimulation brought upon 
by changes in CNO to which the smooth muscle is exposed. The vessels of interest are rat mesenteric vessels 
with a diameter of 150 um when cannulated at a pressure of 100 mmHg. A large pressure range is covered in 
order to explore the multiple phases of a vessels response to changes in pressure. The NO/sGC/cGMP 
pathway is modeled making use of the simplified set of equations suggested by Carlson and Beard (7). For 
which the maximal half activation of cGMP is set to 759nM of nitric oxide. Nitric Oxide concentrations 
considered are 10 x 10-6 mM (10nM/ solid black line), 20nM (dashed black line), 25nM (dotted black line), 
50nM (solid red line), 200nM (dash-dot black line), and 400nM (blue star).  The black dots represent data 
and corresponding error bars recorded in an experimental study on rat mesenteric arterioles (347). 
 
Altering the EC50 of NO in reference to the activation of cGMP by altering the rate constants involved 
within the pathways it is clear (by comparing  
Figure 74(A),  
Figure 75, and  
Figure 76) that altering the EC50 will alter the response of the vessel to NO. As the EC50 is increased the 
lower concentrations of NO are found to illicit a lesser degree of NO mediated dilation.  Furthermore, 
the sensitivity of the vessel to higher concentrations of NO is enhanced leading to a greater change in the 
vessel diameter when comparing the plots in the region in which the myogenic response is known to take 
effect.  
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Figure 74,  
Figure 75, and  
Figure 76 all illustrate a typical myogenic response to a change in intravascular pressure.  Initially, at 
lower pressures the diameter of the vessel is observed to increase.  In this region the influence of NO 
appears to be very minimal.  At a certain point the second phase of the myogenic response initiates as the 
mechanisms responsible for the smooth muscle force begin to overcome the increase in pressure and the 
diameter of the vessel decreases. It is in this region that the greatest influence of NO is observed. 
Towards the higher range of CNO, it appears that these greater concentrations of NO are capable of 
attenuating the myogenic response. This holds true in all of the referenced figures when CNO is 400nM. 
As pressure continues to increase the myogenic response is overcome and the vessel will continue to 
increase in diameter.  
 
 
 
 
 
Figure 77:  Data plot of Diameter (µm) vs. Pressure (mmHg) concerning a range (~0-300nM) of stimulation 
brought upon by changes in nitric oxide to which the smooth muscle is exposed.  Diameters are examined at 
specific pressures for certain concentrations of NO in order to gain a better perspective of how NO 
influences the diameter of a resistive vessel.  The vessels of interest are rat mesenteric vessels with a diameter 
of 150µm when cannulated at a pressure of 100 mmHg. The NO-sGC-cGMP pathway is modeled making use 
of the simplified set of equations suggested by Carlson and Beard (7).  For which the maximal half activation 
8888888	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of cGMP is set to 66nM of nitric oxide. Nitric Oxide concentrations considered are 10 x 10-15 mM (solid 
black circle), 35nM (black cross), 70nM (black square), 100nM (black diamond), 200nM (red triangle 
opening to left), and 300nM (red triangle opening to right).   
 
 
Figure 78: Data plot of Diameter (µm) vs. Pressure (mmHg) concerning a range (~0-400nM) of stimulation 
brought upon by changes in nitric oxide to which the smooth muscle is exposed.  Diameters are examined at 
specific pressures for certain concentrations of NO in order to gain a better perspective of how NO 
influences the diameter of a resistive vessel.  The vessels of interest are rat mesenteric vessels with a diameter 
of 150 um when cannulated at a pressure of 100 mmHg. The NO-sGC-cGMP pathway is modeled making 
use of the simplified set of equations suggested by Carlson and Beard (7). The maximal half activation of 
cGMP is set to 66nM of nitric oxide. Nitric Oxide concentrations considered are 10 x 10-15mM (solid black 
circle), 10nM (black cross), 20nM (black square), 50nM (black diamond), 200nM (red triangle opening to 
left), and 400nM (red triangle opening to right). 
Increases in CNO around the terminal arteriole results in a reduction of the myogenic response, vessel 
dilation to a lesser degree then the upstream larger arterioles.  
In this project we were interested in simulating the control of blood flow and subsequent oxygen 
delivery in the microcirculation in response to changes in the metabolic environment.  These alterations 
in vessel diameter result from changes in CNO, which themselves occur due to changes in the 
microcirculatory metabolic demand. As we are interested in what is believed to be the smallest control 
point of blood flow, the MVU as defined by Segal, it is the terminal arteriole that is considered to be the 
focal point of blood flow regulation and therefore oxygen and nutrient delivery to the surrounding 
tissue(76).  Examination of  
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Figure 77 allows an understanding of the relationship between nitric oxide and the first order rat 
mesenteric arteriole diameter. At lower pressures before the myogenic response initiates the influence of 
NO appears to be minimal, a substantial change in CNO in the range of 100s of nM leads to an 
approximate 5% maximum change in diameter of the resistive vessel.  Meanwhile, at pressures at which 
the myogenic response clearly plays a dominant role in the forces controlling the diameter of the 
resistive arteriole, the changes in NO concentration results in greater changes in the vessel diameter.   At 
intraluminal pressures of 100 and 150 mmHg the result of increasing the CNO from 0nM to 300nM 
results in a 20% and 28.5% maximum change in the arteriole diameter respectfully.  
 
Figure 79 and Figure 80 illustrate similar patterns for varying nitric oxide conditions, rate constants 
involved in the NO/sGC/cGMP pathway, and vessel diameters. The most evident manner in which the 
two figures illustrate similar patterns is that as NO increases the diameter of the vessel will increase for a 
constant pressure. This occurs regardless of the range for CNO that the dilatory response has been chosen 
to be most sensitive for. Furthermore, the maximum and minimum diameters at each respective pressure 
are similar no matter the sensitivity of the constrictive mechanisms to NO. The parameters describing the 
passive and active response of the vessel to differing pressures are fit to experimental results (348). 
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Figure 79:  Higher generation of resistive vessel data plot of Diameter (µm) vs. Pressure (mmHg) concerning 
a range(~0-400nM) of stimulation brought upon by changes in nitric oxide to which the smooth muscle is 
exposed.  Diameters are examined at specific pressures for certain concentrations of NO in order to gain a 
better perspective of how NO influences the diameter of a resistive vessel.  The NO-sGC-cGMP pathway is 
modeled making use of the simplified set of equations suggested by Carlson and Beard (7).  The maximal 
half activation of cGMP is set to 66nM of nitric oxide. Nitric Oxide concentrations considered are 10 x 10-
15mM (solid black circle), 10nM (black cross), 20nM (black square), 50nM (black diamond), 200nM (red 
triangle opening to left), and 400nM (red triangle opening to right).  Experimental data corresponding to the 
mechanical response of the vessel are taken from a study conducted by Sun et al.(348). 
 
 
Figure 80: Higher generation of resistive vessel data plot of Diameter(µm) vs. Pressure (mmHg) concerning 
a range (~0-400nM) of stimulation brought upon by changes in nitric oxide to which the smooth muscle is 
exposed. Diameters are examined at specific pressures for certain concentrations of NO in order to gain a 
better perspective of how NO influences the diameter of a resistive vessel.  The NO-sGC-cGMP pathway is 
modeled making use of the simplified set of equations suggested by Carlson and Beard (7). The maximal half 
activation of cGMP is set to 759nM of nitric oxide. Nitric Oxide concentrations considered are 10 x 10-15mM 
(solid black circle), 10nM (black cross), 20nM (black square), 50nM (black diamond), 200nM (red triangle 
opening to left), and 400nM (red triangle opening to right).  Experimental data corresponding to the 
mechanical response of the vessel are taken from a study conducted by Sun et al. (348). 
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The diameter of the vessel is observed to increase about 8 um at an approximate 400nM increase in [NO] 
at pressures around 5mmHg.  Yet, according to physiological measurements a typical arteriole pressure 
is around 27torr (161). Depending on the range of sensitivity for which NO is set to influence the cGMP 
dependent dilation of the resistive vessel it appears that increasing the CNO 400nM results in diameter 
changes of 4um at an arteriole pressure of 20torr and 5µm at 40torr or 2.5µm and 3µm for EC50 of 66 and 
759nM respectfully. 
 
 
 
Figure 81: Higher generation of resistive vessel data plot of Diameter (µm) vs. Pressure (mmHg) concerning 
a range (~0-400nM).  The vessels of interest are isolated from the hamster cheek pouch of golden hamsters 
with a mean diameter of 43 um when cannulated at a pressure of 100 mmHg(350).   The NO-sGC-cGMP 
pathway is modeled making use of the complete equation set as proposed by Condorelli and George (150).  
For which the maximal half activation of cGMP is set to 66nM of nitric oxide.  Nitric Oxide concentrations 
considered are 10 x 10-15mM (solid black circle), 10nM (black cross), 20nM (black square), 50nM (black 
diamond), 200nM (red triangle opening to left), and 400nM (red triangle opening to right).   
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Figure 82: Higher generation of resistive vessel data plot of Diameter (µm) vs. Pressure (mmHg) concerning 
a range (~0-400nM). The vessels of interest are isolated from the hamster cheek pouch of golden hamsters 
with a mean diameter of 43µm when cannulated at a pressure of 100mmHg (350). The NO-sGC-cGMP 
pathway is modeled making use of the complete equation set as proposed by Condorelli  and George (150).  
The maximal half activation of cGMP is set to 759nM of nitric oxide.  Nitric Oxide concentrations 
considered are 10 x 10-15mM (solid black circle), 10nM (black cross), 20nM (black square), 50nM (black 
diamond), 200nM (red triangle opening to left), and 400nM (red triangle opening to right).   
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When comparing the response of the very same vessel (hamster cheek arterioles with an average 
diameter of 43µm) with two different sets of rate constants concerning the NO/sGC/cGMP pathway, it 
becomes clear that alterations of the rate constants will not influence the maximum diameter of the 
vessel at a particular pressure.  As shown in  
Figure 81 and Figure 82 it is believed that in order to achieve a significant change in vessel diameter it is 
necessary to expose the smooth muscle cell to saturating levels of NO. 
 
It is interesting to note that the change in vessel diameter observed over the range of CNO considered in 
this study is independent of the rate constants describing the NO/sGC/cGMP pathway.  This observation 
can be verified with a comparison of  
Figure 81 with Figure 82.  Examining the maximal diameters, which occur at the same pressure, we 
observe that changing the CNO, results in an approximate 3um increase in vessel diameter for a constant 
pressure.  As expected, the variation of the rate constants alters the vessels response to nitric oxide 
concentrations between 0 and 400nM.  Yet in both of the scenarios considered within this study the 
manner by which NO is known to alter the concentrations of signaling molecules in the SMCs 
surrounding the arteriole is saturated at 400nM, therefore indicating that it is at this concentration (as 
well as the concentrations around this particular concentration and of course all concentrations greater) 
this is the maximal achievable vessel diameter for this model. 
An increase in vessel diameter correlates with an increase in PO2 and a decrease in NO 
The preceding section demonstrated that altering CNO results in a change in the diameter of the vessel. 
Examination of our connected network model, described in Chapter 4 reveals interesting behaviors with 
regards to the nature that blood flow is controlled. The model focuses on the terminal arterioles as the 
location at which the control of the blood flow is primarily controlled. More specifically, as the diameter 
of the terminal arteriole increases the blood flow and potentially the flow of oxygen carrying 
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erythrocytes will increase in the capillaries branching off from the terminal arteriole. An increase in 
blood flow/erythrocyte flow only occurs if the inlet boundary condition of the terminal arteriole is a 
function of the diameter of the terminal arteriole. If we define the inlet boundary partial pressure of the 
network vascular structure as a constant we observe a very small change in the oxygen tension around 
the arterioles and therefore throughout the remainder of the computational geometry, Table 24. 
 
Diameter(µm) Average PO2 (torr) around 
Arteriole Branches 
8 33.3 
10 33.4 
12 32.9 
Table 24:  Relationship between diameter of arteriole branches (µm) and average PO2 (torr) measured 
around the surface of the arteriole branches. A constant inlet oxygen tension of 35 torr is assumed for each 
of the simulation sets. 
 
As can be observed in Table 24 over a range of 4µm of arteriole diameter the average partial pressure of 
oxygen does not waiver greatly from 33torr.  A different boundary condition can be applied in which the 
inlet concentration of O2 can be assumed to be a function of the inlet velocity (an empirical formula that 
has been calculated by Intaglietta (2)).  Figure 83 illustrates the manner in which average oxygen tension 
around the terminal arterioles will change with respect to their diameter when the inlet oxygen tension is 
expressed as a function of the fluid velocity.  At lower metabolic requirements for oxygen the average 
PO2 around the arteriole wall does not change significantly with respect to the diameter of the arteriole. 
As the metabolic demand is increased the change in average PO2 around the arteriole wall increases from 
the original change of 4torr observed at low metabolic demands to 6, to 11, and finally to 12torr as the 
vessel diameter is increased from 8µm to 24µm. 
 
We expand upon our analysis of the influence of diameter on the transport of NO and O2 in a model in 
which NO transport is coupled with local PO2 and WSS. The general behavior of CNO as the diameter of 
the terminal arteriole increases is shown in Figure 84, with a decrease in CNO as the vessel diameter 
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increases. This occurs even as the fluid inlet velocity increases as a function of vessel diameter in our 
bifurcating arteriole model. The equations relating the blood flow to the vessel diameter as well as the 
inlet blood PO2 to fluid velocity have been discussed in previous sections. 
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Figure 83:  Change in average oxygen tension (torr) around the arterioles of the bifurcating arteriole model 
plotted versus diameter of the inlet arteriole (µm).  Each of the plots considers the same model in which the 
influence of myoglobin is considered.  The inlet boundary condition describing the inlet PO2 is assumed to 
depend on the fluid velocity. Each of the different levels of oxygen demand are characterized by the 
parameter describing the maximal oxygen consumption rate per simulation set (A) 1 µM/s, (B) 5 µM/s, (C) 
10 µM/s, and (D) 15µM/s 
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Figure 84:  Average arteriole CNO plotted as a function of the tissue metabolic demand for oxygen for a 
variety of arteriole vessel diameters. The solid bars refer to data for an inlet arteriole radius of 4µm.  The 
dotted bar presents data for an inlet arteriole radii of 5µm, in many cases this is considered our baseline 
radius as the original simulations considered by Chen et al. (12). A lighter grey fill represents the data for 
simulations in which the parent arteriole has a radius of 6µm.  The bars filled with both horizontal and 
vertical lines illustrate the data for which the parent arteriole’s diameter is 9µm.  Data describing the 
behavior of the model in which the inlet arteriole is 10µm is represented by the bars filled with arrows and 
that for an inlet diameter of 12µm are represented with horizontal lines. 
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Figure 85: Average arteriole PO2 plotted as a function of the tissue metabolic demand for oxygen for a 
variety of arteriole vessel diameters. The solid bars refer to data for an inlet arteriole radius of 4µm.  The 
dotted bar presents data for an inlet arteriole radii of 5µm, in many cases this is considered our baseline 
radius as the original simulations considered by Chen et al. (12). A lighter grey fill represents the data for 
simulations in which the parent arteriole has a radius of 6µm.  The bars filled with both horizontal and 
vertical lines illustrate the data for which the parent arteriole’s diameter is 9µm.  Data describing the 
behavior of the model in which the inlet arteriole is the bars filled with arrows represent 10µm and that for 
an inlet diameter of 12µm are represented with horizontal lines. 
209	  
	  
 
Figure 86: Average tissue PO2 plotted as a function of the tissue metabolic demand for oxygen for a variety 
of arteriole vessel diameters.  The solid bars refer to data for an inlet arteriole radius of 4µm.  The dotted 
bar presents data for an inlet arteriole radii of 5µm, in many cases this is considered our baseline radius as 
the original simulations considered by Chen et al. (12).  A lighter grey fill represents the data for simulations 
in which the parent arteriole has a radius of 6µm.  The bars filled with both horizontal and vertical lines 
illustrate the data for which the parent arteriole’s diameter is 9µm.  Data describing the behavior of the 
model in which the inlet arteriole is the bars filled with arrows represent 10µm and that for an inlet 
diameter of 12µm are represented with horizontal lines. 
 
As the diameter of the vessel increases we observe an increase in both the average arteriole PO2 and the 
average tissue PO2, Figure 85 and Figure 86.  This result is in no way unexpected, as the inlet boundary 
condition describing the PO2 will increase with increasing vessel diameter.  It is firmly believed that a 
more mechanistic dependent examination is required to fully understand the actual physiological 
relationship between vessel diameter, NO, and PO2. 
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Increasing the diameter of terminal arteriole does not greatly increase the flux of red blood cells to the 
capillary. 
 
To examine in a more intricate fashion the impact of altering the vessel diameter on the transport of NO 
and O2 in the microvasculature we extend our network to that illustrated in  
Figure 72. As previously shown, the transport of both NO and O2 is greatly influenced by RBCs and for 
this reason we can make useful approximation of NO and O2 transport based upon the changes in RBC 
distribution within a microvascular network structure.   Initially we assume that the diameter of the 
feeding arteriole is 15µm and that each of the terminal arterioles are of the diameter of 10µm.  The order 
by which the diameters of the different vascular components are altered has previously been described in 
methods section of this chapter. 
 
As illustrated in the preceding section for the smaller of the resistive vessels (arterioles) we can expect a 
change in diameter of approximately 1-2µm depending upon the internal pressure of the vessel, Figure 
80-Figure 82, if we assume that physiological concentrations of NO lies within the range of 100s of nMs. 
Using this knowledge the diameter of TA1 is increased from the baseline diameter of 10µm to 
16µm,Figure 87. Increasing the diameter of TA1 alone does not result in an increase in Hct either in the 
arteriole whose diameter had been increased or in the downstream vasculature. 
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Figure 87:  Influence of changing the terminal arteriole branching off of the feeding arteriole (TA1) a range 
of 6µm from 10-16 µm on Hct distribution throughout the vascular network structure.  The legend describes 
the diameters of the terminal arterioles extending from terminal arteriole 4, the diameter of terminal 
arteriole 1, the diameter of terminal arteriole 2, the diameter of terminal arteriole 3, and the diameter of 
terminal arteriole 4 (Da, Da1,Da2,Da3,Da4). Please note that some markers are behind other markers. 
 
If the diameter of TA1 is increased beyond the baseline diameter of 10µm, to 14µm, and the diameter of 
TA2 is also increased an increase in red blood cell flux to the downstream vasculature is observed in the 
computational studies plotted in Figure 88.  The change in Hct is slight in magnitude, as the Hct in the 
branching capillaries is small.  When considering the percent difference when increasing the diameter of 
TA2 a maximal change in Hct is observed in capillary C7 in reference to % change (48% in comparison 
with the first set of diameters considered in the simulation set Scenario 2). 
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Figure 88: Influence of increasing the diameter of TA1 and also changing the terminal arteriole branching 
off TA1 (TA2) a range of 6µm from 10-16 µm on Hct distribution throughout the vascular network 
structure.  The legend describes the diameters of the terminal arterioles extending from terminal arteriole 4, 
the diameter of terminal arteriole 1, the diameter of terminal arteriole 2, the diameter of terminal arteriole 
3, and the diameter of terminal arteriole 4 (Da, Da1,Da2,Da3,Da4). Please note that some markers are behind 
other markers. 
 
 
 
Figure 89: Influence of increasing the diameter of TA1 and also changing the terminal arteriole branching 
off TA1 (TA3) a range of 6µm from 10-16 µm on Hct distribution throughout the vascular network 
structure.  The legend describes the diameters of the terminal arterioles extending from terminal arteriole 4, 
the diameter of terminal arteriole 1, the diameter of terminal arteriole 2, the diameter of terminal arteriole 
3, and the diameter of terminal arteriole 4 (Da, Da1,Da2,Da3,Da4). Please note that some markers are behind 
other markers. 
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Increasing the diameter of TA1 and then increasing the diameter of TA3 does not result in an increase in 
Hct in downstream vasculature over the range of diameters considered for TA3, Figure 89.  When 
considering the possibility that all TA1, TA2, and TA3 are dilated at the same time a clear descriptive 
behavior cannot be observed.  Yet, when the diameter of TA3 is greater than that of TA2 the Hcts 
observed in the different vascular components are lower than if TA2 and TA3 are of the same diameter 
or if that of TA2 is greater than the diameter of TA3. 
 
 
 
Figure 90: Influence of increasing the diameter of TA1 and also changing the two terminal arteriole 
branching off TA1 (TA2 and TA3) a range of 2µm and 6µm, respectively on Hct distribution throughout the 
vascular network structure.  The legend describes the diameters of the terminal arterioles extending from 
terminal arteriole 4, the diameter of terminal arteriole 1, the diameter of terminal arteriole 2, the diameter 
of terminal arteriole 3, and the diameter of terminal arteriole 4 (Da, Da1,Da2,Da3,Da4). Please note that some 
markers are behind other markers. 
 
As the diameter of TA4 is increased we observe an increase in the Hct within some of the earlier 
upstream capillaries, C13 (vascular component 20) and C14 (vascular component 22).  Increasing the 
diameter of TA4 along with the diameter of the continuing arteriole, results in an increase in the same 
capillaries as observed in Figure 91.   
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Figure 91: Influence of increasing the diameter of TA4 a range of 6µm, respectively on Hct distribution 
throughout the vascular network structure.  The legend describes the diameters of the terminal arterioles 
extending from terminal arteriole 4, the diameter of terminal arteriole 1, the diameter of terminal arteriole 
2, the diameter of terminal arteriole 3, and the diameter of terminal arteriole 4 (Da, Da1,Da2,Da3,Da4). Please 
note that some markers are behind other markers. 
 
 
 
Figure 92: Influence of increasing the diameter of TA4 and altering the downstream arteriole diameter a 
range of 6µm, respectively on Hct distribution throughout the vascular network structure.  The legend 
describes the diameters of the terminal arterioles extending from terminal arteriole 4, the diameter of 
terminal arteriole 1, the diameter of terminal arteriole 2, the diameter of terminal arteriole 3, and the 
diameter of terminal arteriole 4 (Da, Da1,Da2,Da3,Da4). Please note that some markers are behind other 
markers. 
 
The majority of the red blood cells flow along the path of the feeding arterioles.  For this reason even if 
the Hct is increased within a capillary branch the absolute change in Hct is small. If we consider the 
particular case in which TA4 is increased in diameter we observe that capillary C20 experiences an 
increase in Hct.  The absolute change in Hct as the diameter of TA4 is increased from 10 to 16µm is 
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from 0.036 to 0.044.  The Hct in TA4 is lower when the diameter increases as the overall blood flow 
increases disproportionally to the increase in red blood cell flux. 
 
 
 
Figure 93:  Red blood cell flux continuation in feeding arteriole as the diameter of terminal arteriole A1 
(TA1) is increased. 
	  
	  
Figure 94: Increase in RBC flux in response to increase in diameter of terminal arteriole 1. 
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When considering the instance in which the terminal arteriole A1 is increased in diameter we simulate a 
decrease in the RBC flux (fRBC) remaining within the feeding arteriole,  
Figure 93.  The hematocrit in the feeding arteriole 2 (FA2) and feeding arteriole 3 (FA3) is also observed 
to slightly decrease as the diameter of TA1 is increased. This is affirming in that an increase in Hct and 
RBC flux will promote oxygen delivery to needy tissue. Yet the question that remains, is this enough of 
a predicted change in Hct to account for the driving changes in metabolic demand? 
 
Would a 1-3µm change in vessel diameter over a 100nM change in CNO around the arteriole wall leading 
to a 22% increase in capillary Hct be able to provide enough oxygen to surrounding tissue with a 
changing metabolic demand? There is no easy answer to this question.  Also, as is the case with flow 
control of the capillaries the importance of upstream resistive vessels and conducted signals cannot be 
overstated.  It is also imperative that the distribution of red blood cells in a dynamic flow environment be 
adequately modeled. 
 
5.4 Discussion 
5.4.1The influence of NO on vessel diameter is dependent upon arteriole size 
As illustrated in  
Figure 74 the diameter of the resistive arteriole could increase from 10 to 30µm, over the range of CNO 
considered within this study. The smaller arteriole is proposed to increase 3µm over the same range of 
CNO considered for the larger arteriole ( 
Figure 77,  
Figure 78,  
Figure 79, Figure 80,  
Figure 81, and Figure 82). As this is a computational study we will not be able to determine the 
physiological range for which the different vessels are most sensitive to CNO relying solely upon the data 
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generated in the accompanying simulations. It has been demonstrated within this dissertation that 
altering various parameters dealing with the NO-sGC pathway it is possible to alter the range of vascular 
smooth muscle sensitivity to NO.  Large arterioles in the rat intestine have been shown to be more 
responsive to changes in local CNO than smaller, higher generation, arterioles (371). Introduction of the 
NO synthase inhibitor L-NAME was not found to inhibit the dilatory signal due to bradykinin (371). 
This indicates, the importance of NO-independent signaling in the diameter control of this particular 
tissue type. The limited influence of NO in attenuating the myogenic response in smaller arterioles (36-
65µm) when compared to the significance of NO control of the myogenic response in larger arterioles 
(65-127µm) has been observed in hamster cremaster muscles (372). 
 
Bohlen et al. theorize that it is the larger of the arterioles whose control of diameter is more greatly 
dependent upon flow-mediated signaling when compared to the smaller arterioles (371). As it is well 
known that NO production from ECs is highly dependent upon flow-dependent mechanisms, it is not a 
far stretch to assume that this high dependency on flow-mediated responses equates to a greater 
importance in NO-dependent mechanisms in the control of larger diameter arterioles. Similarly NO was 
found to play a more significant role in the control of small coronary arteries rather than smaller 
arterioles in a study of open-chested dogs (373). These findings are compatible with the theory that 
endothelium (NO)-dependent dilation of large micro vessels occurs as a consequence of the 
metabolically induced increases in flow, caused by the smaller downstream vessels. At the same time, 
reports of this nature bring into question the motivation to study the influence of NO-mediated control 
on terminal arterioles in a computational manner, such as this one. With this said, it still would be 
relevant to determine the manner that CNO is regulated in and around the terminal arterioles and the 
microvascular unit structures, as NO has been demonstrated to diffuse from one source to another and 
also play an important role in the conducted dilatory response to changes in local hemodynamic and 
metabolic conditions(371, 374-376).  
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Depending upon the initial diameter of the arteriole, as well as the different modalities of NO transport 
considered within the model, an increase in vessel diameter can lead to either an increase or decrease in 
CNO.  As illustrated in Figure 84, the CNO in and around the arterioles of the bifurcating arteriole model 
will increase as the diameter of the terminal arteriole is increased from 4 to 6µm. After the diameter of 
the arteriole reaches 6µm a further increase in vessel diameter leads to a decrease in local CNO with 
respect to the previous diameter applied in the simulation.  The simulations considered here do not 
consider the influence of nucleotide transport on CNO transport.  For this reason we can only speculate on 
the potential ramifications altering the vessel diameter will have on nucleotide transport and the 
subsequent changes encountered with regards to NO transport.As there currently exists no known 
relationship between nucleotide concentration and NO production from ECs, any mechanisms included 
would be speculation.  So to fully consider the influence of nucleotide transport on that of NO and O2 it 
is necessary to adequately address the issue of modeling the transport of RBCs throughout the 
microvascular network. The modeling considered in this dissertation considers the influence of diameter 
change on the distribution of red blood cells in a microvascular unit structure, and shall be discussed in 
greater detail in later sections. 
 
Typical experimental studies such as those conducted by Bohlen (371, 377) measure the change in vessel 
diameter as a consequence to change in CNO(378). The goal of this study is to examine the influence of 
changing local CNO on the diameter of the terminal arteriole.  
It is important to remember that this is a dynamic process and for this reason altering the diameter of the 
vessel will result in changes in the transport of blood and nutrients throughout the system. Subsequently 
the local CNO will be changed and a very dynamic series of events will occur. To better understand the 
dynamics of the terminal arteriole to changes in CNO, studies that stimulate the release of NO without the 
introduction of additional NO and record the change in vessel diameter as well as the local change in 
CNO are necessary. Studies of this nature are very rare in literature and could consider the change in 
219	  
	  
vessel diameter and nitric oxide concentration due to such stimuli as changes in local oxygen tension, as 
well as local nucleotide concentration. Studies such as those conducted in 2011 by Bohlen would prove 
useful in understanding the functional behavior of nitric oxide in the microcirculation. 
5.4.2 Local CNO is influenced by local changes in Hct 
The simulations concerned with diameter dependence as well as the majority of the simulations 
considered in earlier sections of this dissertation make use of an empirical formula to relate inlet PO2 of 
the respective terminal arteriole and the fluid velocity.  As discussed earlier, the increase in PO2 incurred 
due to an increase in fluid velocity can largely be attributed to an increase in RBC flux through a 
particular vessel.  For this reason we sought out to explore how changes in vessel diameter will alter the 
Hct distribution within an extended vascular network,  
Figure 72.  Increasing the diameter of the terminal arteriole would result in a slight increase in Hct within 
downstream vasculature, yet the majority of the red blood cells would remain within the feeding 
arteriole.  Required questions dealing with this set of simulations include those that examine the 
influence of the small changes in Hct on CNO near and around the vessel of interest, and also if the 
distribution of Hct is appropriately modeled for feeding arterioles branching into terminal arterioles and 
terminal arterioles leading to capillaries.  
 
Small changes of Hct in terminal arterioles has been mathematically demonstrated to result in a slight 
increase in peak CNO at the vascular wall when shear dependent NO production is considered (379).  
Simulations not incorporating shear stress dependent NO release showed that for an increase in Hct, the 
peak CNO occurring at the vascular wall will decrease.  Concentrations of NO where found to range from 
0.3 to 0.35nM when wall shear stress dependent NO production is not considered, and then 0.36 to 
0.42nM when wall shear stress dependent NO production is incorporated. In both simulation sets PO2 is 
observed to increase as Hct increases (379). The simulations examining the influence of changing the 
Hct in Chapter 4 of this dissertation illustrate that for larger increases in Hct we would expect a decrease 
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in local CNO. Of course all simulations concerning the dependence of NO transport on Hct rely greatly 
upon the mechanisms by which the two components are modeled to interact.   
 
5.4.3 Changes in terminal arteriole diameter results in changes in Hct distribution 
As NO transport is influenced by Hct distribution, the importance of adequately modeling the 
distribution of RBCs within a microcirculatory network becomes evident.  Previous computational 
models have demonstrated that assuming a homogenous distribution for blood will not result in 
significant changes when compared to a model considering discrete red blood cells at a specific juncture 
of time (211). A question that remains is if the assumption of blood as a homogenous phase correctly 
models the distribution of RBCs? In particular it would be of interest to determine if the empirical 
formulae deduced by Pries and Secomb (1) apply to the RBC distribution as capillaries bifurcate off of 
arterioles. The distribution of RBCs, represented by the Hct in the network structure considered in this 
study, proves highly heterogeneous with much lower Hcts observed within the capillaries (Figure 87-
Figure 92).  As the capillaries are known to be a location of major exchange between O2 and the 
surrounding tissue, it is important to properly consider the dynamics of the distribution of RBCs in 
response to changes in the metabolic needs of the tissue. 
 
As the capillaries cannot actively change their diameter in response to metabolic changes; downstream 
vessels must communicate metabolic needs to upstream arterioles, which must control blood flow and 
red blood cell distribution.  Unequal red blood cell distribution at diverging bifurcations contributes to 
capillary recruitment and enhances tissue oxygenation.  Capillary recruitment has been suggested to aid 
in the close matching of oxygen and nutrient supply and demand between vasculature and surrounding 
tissue(380, 381).   
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Fry defined a perfused capillary as one in which the RBC flux is greater than 12.5 cell/s (299).   If we 
assume a capillary diameter of 6µm, with a mean corpuscular volume of 69.3µm3, and a blood velocity 
of either 51 or 93.6µm/s as done in previous studies (12); we end up calculating a minimal Hct in the 
capillaries of 0.32 or 0.6. The equation used to determine Hctmicro has been described previously in 
Chapter 3. Examining this equation, one will quickly ascertain that the slower the RBC velocity the 
greater the calculated Hct. This indicates that a perfused capillary as defined by Fry, must have a 
relatively high Hct. Furthermore, as the aforementioned study does not focus on diameter change, and 
instead upon changes in perfusion it becomes more difficult to compare their results with those found in 
this study. As the mathematical studies conducted by Fry do not report the change in diameter in 
response to changes in metabolic demand it becomes further complicated to compare the two studies. 
Without consideration of a particular vasodilator Fry observes an increase in capillary recruitment with 
an increase in metabolic demand (299).   
 
The exact means by which the demand for oxygen is matched with the supply is not known(380, 382).  
Experimental results from the rabbit tenuissimus muscle in response to changes in oxygen availability 
have demonstrated a sequential opening of individual capillaries is possible(383).  As there appears to be 
very little evidence linking the control of capillary flow to the individual capillary level it appears as if 
the flow in individual and groups of capillaries is controlled by the terminal arterioles(80, 300, 383-385). 
Comparison of control state to pharmacologically-induced maximally dilated states of the hamster 
cremaster muscle reveled a 26% increase in the total number of flowing vessels between the control and 
dilated states(380). Computational studies have postulated that number of flowing arterioles and 
capillaries increases progressively with increasing oxygen demand. The number of flowing arterioles and 
capillaries increases by about 16% (from 98 to 114) as demand is increased 8 fold(83). 
 
222	  
	  
We propose that the dilatory signal experienced in the terminal arterioles is NO-dependent.  To explore 
this theory we first examined the range of diameter change one could expect if CNO were to change in a 
manner dependent upon the metabolic demand in the surrounding tissue. Examination of  
Figure 79- Figure 82 allows for us to estimate a change in vessel diameter around 3µm, due to the 
expected changes in CNO. Depending upon the basal level of NO production, this change in vessel 
diameter could even potentially be less. For example, if the baseline concentration of NO is 
approximately 200 nM and we experience a 200nM change in NO in response to some sort of agonist 
then only a 1µm change in vessel diameter could be expected.  The simulations concerned with 
incorporating a feeding arteriole and multiple terminal arterioles (Figure 87-Figure 92), fail to 
demonstrate a significant increase in capillary recruitment when terminal arterioles are dilated in pairs or 
alone by the change in diameter predicted in our models. This observation is indicative of one of three 
things: 
 
1. The terminal arterioles are not the location of control of red blood cell flow 
2. The modeling of red blood cells distribution requires further modification, and attention 
3. The vessels must dilate more, and perhaps in a NO-independent manner to properly account for 
changes in metabolic demand. 
 
As described in earlier sections the distribution of Hct within the network is assumed to be a function of 
vessel diameter, flow rate, and inlet Hct. Therefore, we can use these calculated parameters of our 
network as well as the equation applied to determine the microcirculatory Hct (described in Chapter 3) to 
determine the red blood cell flux throughout each network configuration considered. What we observe is 
a decrease in RBC flux in the continuation of the feeding arteriole, which is indicative of an increase in 
the RBC flux into the terminal arterioles and the branching capillaries.  
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The division of RBCs at a bifurcation is modeled making use of empirical formulae derived by Pries and 
Secomb (98).  These bifurcation rules were derived from experimental data where the feeding vessel was 
mainly 10µm or larger, with smaller daughter branches.  Another model for two phase blood flow relied 
upon pressure gradient as the driving force for RBC distribution, yet this model considers RBCs at an 
individual level and usage of such would require a drastic change in the governing equations paramount 
to this study (386). This change would be required as the current transport of nucleotides, NO, and O2 
are all functions of Hct, assuming a continuum of red blood cell flow. For this reason there exists no 
better manner to approximate the distribution of RBCs at a bifurcation.  While the study conducted by 
Obrist et al (386) may be one of the few considering the distribution of RBCs at bifurcating smaller 
vessels, there exists numerous modeling efforts concerned with the analysis of blood flow stepping away 
from the consideration of modeling blood as a continuum. Several of these studies have been 
summarized by Yamaguchi (387) and Fedosov(388). Continuation of the mathematical analysis of blood 
flow in the microcirculation and its control at a local level should take into consideration the modeling of 
RBCs and other constituents of blood and the impact of various modeling alterations on the transport of 
NO and O2. 
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Chapter 6: Overall Discussions and Conclusions 
6.1 Final Discussion 
What is it that we can expect with a potential change in vascular diameter of 1µm?  If we compare the 
change in diameter due to the infusion of nitric oxide for our small and large diameter vessels we predict 
a maximal change of approximately 5% for the small diameter vessel and a 6% to 13% change in 
diameter of the larger resistive arteriole, when considering a change in nitric oxide considered to occur 
within the range of physiological significance.  Our primary interest is with the smaller of the vessels as 
this vessel is more on the size scale of the terminal arteriole.  For a 200 nM change in local CNO we can 
expect a 5% in vessel diameter as illustrated in Figure 82.  If the sensitivity of the sGC-cGMP pathway 
to NO is set for a lower range of CNO then we can expect to observe no change in the diameter of the 
vessel, as the NO signal will be saturated before a CNO of 200 nM is obtained.   For the smaller of the 
vessels considered it appears within a physiological range (defined to be between 20 and 40 mmHg) of 
intraluminal pressure the greatest response to NO occurs around an internal pressure of 20 mmHg. The 
larger vessels appear to express a much greater sensitivity to changes in NO at greater intraluminal 
pressures between 75 and 150 mmHg.  As we recall, explained by Carlson and Secomb(130), at low 
pressures arterioles dilate passively with increasing pressure, between 20 to 120 mmHg the myogenic 
response is activated.  The vessel is dilated at very high pressures of 140 mmHg despite near maximal 
tone due to the myogenic response. 
Observation of  
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Figure 75 and  
Figure 76 illustrates a considerable influence of NO in attenuating the myogenic response.  Depending 
upon the range of concentration for which the NO-mediated response is designated to be most sensitive, 
the largest response of the vessel diameter will occur either just before or during the early stages of the 
myogenic response, “early” in terms of occurring at lower pressures. 
The remaining question is what do these changes in diameter lead to in reference to the control of blood 
flow?  As observed in Figure 84, depending upon the initial diameter of the vessel, as the diameter of the 
vessel the average CNO around the terminal arteriole may increase or decrease. As modeled in Figure 85 
and Figure 86 the average PO2 in the arteriole and surrounding tissue shall increase with increasing 
vessel diameter.  This increase in intravascular PO2 and subsequent increase in tissue PO2 is due to the 
inlet boundary condition made use of to describe the inlet partial pressure of oxygen at the inlet of the 
arteriole, which is based upon experimental observations completed by Intaglietta et al. (2).  The 
increase in tissue PO2 may also occur due to a decrease in the region of the computational domain in 
which oxygen is consumed due to the geometric increase in the arteriole vessel diameter. 
A mechanism responsible for the increase in PO2 due to increased blood flow is increased RBC flux.  As  
explained by Popel, 98% of the 0.2 ml of O2 carried by each millimeter of blood is reversibly bound to 
hemoglobin, which of course is contained within RBCs(389).  For obvious reasons it is clear that the 
flow of red blood cells will greatly influence the local distribution of oxygen within tissue. 
As it is likely the case that the increase in local levels of oxygen in the computational domain are due to 
an increase in the flux of red blood cells to the terminal arteriole, we would also expect to predict a 
subsequent decrease in CNO due to the scavenging of NO within the arteriole being a function of local 
Hct.  There currently exists some controversy with regards to the exact role that red blood cells may play 
in the transport of NO, but they remain a traditional NO scavenger.  It appears that the scavenging of NO 
by RBCs may depend upon oxygenation of the erythrocytes(390), yet they remain scavengers regardless. 
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As has been modeled throughout this work, the vasculature in which the flux of RBCs is relatively great 
will correspond to regions of lower CNO when compared to regions of lower Hct, Figure 35.  As our 
studies involving the increase in vascular diameter do not consider a corresponding increase Hct, Figure 
34 and Figure 35, we are not considering a potential major sink for NO. This influence is of course 
controlled by the manner that red blood cell flow is altered as the diameter of particular vascular 
components is changed. 
To gather a greater understanding of the manner that Hct may change in a terminal arteriole due to an 
increase in vessel diameter we choose to take a step back from the MVU structure defined by Delshaw 
and Duling (79), Emerson and Segal (81), and Lo et al. (168).  Rather than originating our computational 
domain at the terminal arteriole we move a little bit upstream to the feeding arteriole.  Taking this action 
allows for us to examine the manner which red blood cells may distribute in response to changes in 
vascular diameter and other input parameters (discharge Hct and diameter of feeding arteriole). 
As predicted by the simulations illustrated in Figure 87-Figure 92, as the diameter of the terminal 
arteriole is increased we predict a subsequent increase in Hct in that arteriole as well as all downstream 
branches..  This result would have interesting consequences with regards to the transport of NO and 
predictably lead to a decrease in the dilatory signal.  Before we can make this conclusion it could prove 
useful to take a greater look at things. 
In reference to shear stress and nitric oxide production, as shear stress is increased we observe a general 
behavior of an increase in CNO around the endothelial cells.  With respect to the parallel plate flow 
chamber simulations and experimental studies the lone step change in shear that did not result in an 
increase in CNO occurred as the shear stress was increased from 0.1 to 1 dynes/cm2.  It is believed that 
within this range of shear stresses convective transport will dominate over the increased NO production. 
This finding leads one to consider once more what the shear stress is that occurs within the capillaries of 
our three dimensional mathematical models.  Furthermore, are the shear stresses occurring within the 
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capillaries above this observed threshold from in vitro experiments?  If the shear stress calculated within 
the capillaries were near this threshold, would it be advantageous in the hopes of generating greater CNO 
to have lower blood flow rates within the capillaries? 
Making use of  
Table 6 we are able to deduce that the approximated shear stress with in the capillaries of the bifurcating 
arteriole network is greater than the 1 dyne/cm2 threshold set in the in vitro parallel plate flow chamber 
studies.  While there exists a good understanding that in vitro experimental results do not correlate 
perfectly with in vivo behavior, it at least provides guidelines which we may make use of in attempt to 
understand a variety of biological phenomena.  Therefore, it is highly likely that the threshold describing 
the set point in which the increase in shear dependent NO release overcomes the increased convective 
washout is very likely different from the 0.1-1 dyn/cm2 range observed(116).   
If we maintain our focus on the bifurcating arteriole geometry considered in this study we can observe 
once more that increasing the Hct in a particular terminal arteriole results in a decrease in CNO in and 
around said arteriole, Figure 39.  Additionally, studies considering a highly heterogenous red blood cell 
distribution with in the microcirculation drive home the inverse correlation between increased red blood 
cell flux through a section of vasculature and CNO in and around that vascular component, Figure 35.  As 
can be observed in Figure 39 we do not foresee a change in this behavior as the release of ATP from the 
RBCs is incorporated into the model, as is the influence of nucleotide dependent NO release.  Even as 
the oxygen metabolism in tissue is increased we fail to observe a significant increase in CNO in the 
vicinity of the terminal arterioles.  All of the studies considering nucleotide dependent release of NO 
from ECs illustrate a decrease in overall CNO as oxygen metabolism is increased with the tissue when 
considering the bifurcating arteriole network,  
Figure 41,Figure 43, and Figure 45.   
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If we move our attention away from the bifurcating arteriole to the connected arteriole/venule model, I 
wish to make a few comments on the shear stress distribution illustrated in Figure 48.  The greatest 
stresses occur within the arteriole and capillary c1.  The high shear stress observed in capillary c1 is due 
in large part to the closeness in capillary diameter to that of the arteriole from which it branches.  Due to 
the closeness in dimensions a relatively high level of blood shall flow into this capillary.  The majority of 
the shear stresses observed within the connected arteriole/venule model is greater than our previously 
discussed in vitro threshold.  The shear stress in the larger diameter venule shall be less than that which 
we could consider the aforementioned critical range. 
When scrutinizing the CNO profiles of the connected network model we observe that the average CNO 
around the capillaries is the greatest in comparison to all other regions considered with in our 
computational domain; Figure,Figure 53,Figure 60, and Figure 61.  To refresh, the different regions 
considered in our computational domain are the tissue, the arteriole, the capillary, and the venule.  As 
opposed to the bifurcating arteriole geometry the capillaries of the connected arteriole/venule model are 
spaced further away from the oxygen feeding terminal arterioles.  Therefore, these capillaries are less 
influenced by the oxygen transport of the arterioles and are better suited to respond to the tissue 
environment and it’s oxygen demand. 
The CNO near capillary c1 is relatively large even at low levels of metabolic demand, as in this capillary 
we observe a larger blood flow, which results in greater Hct and viscosity.  As has been modeled by 
Pries et al(1, 51) the viscosity of blood will depend upon the local Hct.  
 If we restrict our analysis to the capillaries, the capillaries with the greatest Hcts are c5, c10, c11, and 
c12.  If we focus particularly on capillary c12 and compare the shear stress in this capillary with that in 
c2 we’d observe a decrease in shear stress.  The ratio of shear stresses (c12/c2) would be 0.13.  In this 
particular case the Hct is relatively high as the majority of the red blood cells have continued along the 
arteriole path, rather than entering the various capillary branches available upstream.  This behavior has 
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previously been discussed and is due to the non-equal distribution of red blood cells described by Pries 
and Secomb (98).  For numerous reasons the red blood cells refuse to distribute in a manner proportional 
to the overall distribution of blood flow in a bifurcation.  In order to add to this discussion further it is 
desired to compare the shear stress incurred by c5 to that in c2.  Comparing the shear stress in each of 
the capillaries, once more we observe a decrease in relative shear rate of 0.72.  This decrease in shear 
stress is once more accompanied with an increase in viscosity.  The decrease in shear stress coupled with 
the increase in Hct can account for the lower CNO observed around the capillaries positioned furthest 
from the arteriole inlet.  A better comparison between the strength of the increase in shear stress 
dependent NO production due to an increase in Hct and the increased consumption of NO by the RBCs 
can be made by once more returning our discussion to our bifurcating arteriole network. 
6.2 Conclusions and Remarks 
Various factors have been found to modulate the production of NO from endothelial cells.  Two factors 
known to influence the production of NO from endothelial cells are shear stress and oxygen.  The 
relationship between nitric oxide productions is very direct, in that shear stress stimulates the production 
and release of the signaling molecule from endothelial cells lining the vascular lumen.  With this said 
due to changes in other avenues of NO transport beyond endothelial production and questions with 
regards to the pathways by which the aforementioned endothelial cells produce NO in response to WSS 
the exact relationship between WSS and NO production has yet to be completely identified.  The 
relationship between oxygen and nitric oxide within a microvascular structure is even more complex 
than that between NO and WSS.  This complexity occurs due to numerous interactions between the two 
molecules in terms of one another’s metabolism, transport, and even production in terms of oxygen’s 
influence on NO. 
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6.3 Model Limitation/Recommendations for future work 
Simplified relationships are used to relate NO production to τw, PO2, and nucleotide concentrations. 
Studies, such as those conducted by Koo et al.(117) consider more so the mechanisms involved in eNOS 
activation leading to an increase in NO production. This in itself is simply a step, as an exact correlation 
between eNOS activation and endothelial NO production does not exist.  
Beyond more specific modeling of the mechanisms involved in the production of NO, other factors 
contributing to NO bioavailability should also be examined. This model considers the role of the known 
NO scavenger hemoglobin, yet the role and influence of myoglobin is largely ignored. Computational 
studies have modeled myoglobin as an effective scavenger of perivascular NO(391). This perivascular 
scavenging of NO would greatly reduce its concentrations within tissue, and potentially limit the 
effectiveness of diffusion dependent signaling in the MVU and beyond. 
Other sources of NO during increased O2 demand should also be considered, such as oxygen dependent 
reduction of nitrite as well as the role of rbcs as potential sources of NO.  As demonstrated in this 
dissertation, the network geometry will influence the mass transport and signaling within a network 
structure. For this reason different microvascular network structures should be modeled. Also the tissue 
models could be modified so to represent different tissue types and then be applied to model potential 
heterogeneities in the role of NO as a signaling molecule in different tissue types. 
The original intention of this project was to model a dynamic model, which calculated the NO-dependent 
response of terminal arterioles to changes in local tissue O2-demand. As there existed a great many 
questions with regards to the mechanisms by which these dynamic responses occurred, the aims of this 
thesis were modified. These modification lead to the formation of a foundation that a dynamic network 
model can be created. Due to changes in tissue oxygen a change in local NO concentration occurs 
leading to changes in blood flow and oxygen delivery. These changes in blood and mass transport will 
lead to changes in the bioavailability of NO and trigger further changes of the vessel. Eventually a steady 
231	  
	  
state will be reached in which the supply of O2 and nutrients meets the demand. When this steady state is 
reached and the numerous control points necessary are not known. Further simulations examining the 
sensitivity of the concentrations of the different signaling molecules to inputs such as fluid velocity, red 
blood cell flux, molecular scavenging/metabolism, etc. should be conducted so to better characterize the 
response.  
The roles of venules, capillaries, and tissue should be further studied in reference to NO and O2 
transport. There exists numerous more questions with regards to the role of NO in metabolic control of 
blood flow in the microcirculation. As modeled in the general microcirculatory networks considered in 
this study there exists a variety of manners that NO can contribute to a vascular responses in immediate 
response to changes in the local tissue O2 environment. While NO more than likely does not work alone 
in the control of blood in the microcirculation, the bioavailability of NO appears to be a valid therapeutic 
target in the management of diseases affecting the microcirculation. 
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Appendix A: List of Nomenclature 
 
Nomenclature ...................................................... Definition 
CNO ...................................................................... NO concentration 
CO2 ...................................................................... O2 concentration 
PO2 ....................................................................... Partial pressure of Oxygen or Oxygen tension 
k ............................................................................ General reaction rate constant 
sGC ....................................................................... Soluble guanylate cyclase 
Km ........................................................................ Michaelis-Menten constant 
Ci .......................................................................... Concentration of chemical species (NO, O2, etc.) 
V,u ........................................................................ Fluid velocity 
Ri .......................................................................... General chemical reaction (could be a source or a sink) 
Di .......................................................................... Diffusivity of chemical species 
µ ............................................................................ Viscocity of fluid 
cGMP .................................................................... cyclic guanosine monophosphate 
ΔP ......................................................................... Pressure gradient 
Q ........................................................................... Volumetric flowrate 
R ........................................................................... Lumped network resistance 
D ........................................................................... Vessel diameter 
Hct ........................................................................ Hematocrit 
RBC ...................................................................... Red blood cell 
HD ........................................................................ Discharge hematocrit 
ρ ............................................................................ Fluid density 
F ............................................................................ Body forces 
τ ............................................................................ Shear stress 
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αO2 ....................................................................... Solubility of O2 in blood 
S(PO2) .................................................................. Saturation of PO2 
M .......................................................................... Consumption of chemical species 
S ............................................................................ Production of chemical species 
δ ............................................................................ Thickness 
σ ............................................................................ Stress 
CSAref ................................................................... Reference cross sectional area 
Ref ........................................................................ Reference parameter 
M .......................................................................... Free nonphosphorylated myosin 
Mp ........................................................................ Phosphorylated myosin 
AMp ...................................................................... Attached phosphorylated myosin 
AM ........................................................................ Attached dephosphorylated myosin 
Ca .......................................................................... Calcium 
VSM ..................................................................... Vascular smooth muscle 
Ei .......................................................................... State of sGC 
TA ......................................................................... Terminal arteriole 
MVU ..................................................................... Microvascular unit 
[C] ......................................................................... Concentration of chemical species 
H(r) ....................................................................... Spatially dependent Hct 
λ(r) ........................................................................ Spatially dependent consumption 
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Appendix B: Other sources of NO in the vasculature: 
	  
Originally considered inert NO2- has come to be known as a stable reservoir for bioactive NO and other 
reactive nitrogen species during hypoxia(137). Amongst the nitrogen oxides nitrite is unique in its redox 
position between oxidative and reductive signaling and its relative stability in blood and tissues (137). 
B1: Sources of Nitrite and Physiological concentrations of the anion 
It was originally believed that the majority of nitrite within a physiological body comes from dietary 
sources, yet it is now recognized that only approximately 30% of nitrite is derived by dietary sources(12, 
143). Nitrite can be found in micromolar concentrations (1-20 uM) within the tissue and nanomolar 
concentrations (100-200 nM) within the blood (138, 139). Compared to the two electron oxidation of NO 
to nitrate by heme proteins in the blood and tissue, the auto-oxidation of NO to nitrite is a relatively slow 
process. This process can be catalyzed by the multicopper oxidase ceruloplasmin in the plasma or 
cytochrome c oxidase inside of tissues(140-142).  
Nitrate is reduced in the body by commensal bacteria in the oral cavity and the gastrointestinal tract and 
also by mammalian xanthine oxidoreductase (XOR) in the liver(144).  Nitrite itself can be reduced to 
NO in a variety of manners. 
B2: Nitrite reduction: 
Nitrite can be reduced to bioactive NO via acidification or through a reaction with a number of proteins 
possessing nitrite reductase activity. Heme-globins(145-147), molybdenum-containing enzymes(148, 
149), NOS(150) and components of the mitochondrial electron transport chain (ETC)(151-153) are all 
examples of proteins that have been linked to the reduction of nitrite to NO.  Nitrite reductase activity by 
all mammalian reductases is optimized in conditions of acidosis and hypoxia. 
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NO2- reductases from the heme-globins is one of the most well-characterized mammalian reactions for 
reduction of nitrite to NO: 
( ) ( ) −+− ++→++ OHNOFeHNOFedeoxy IIIII .2   
 
The hemoglobin reduction of nitrite to bioactive NO is thought to be a possible mechanism by which 
blood flow is controlled when NOS mediated dilation is in jeopardy, such as conditions in which oxygen 
concentration is decreased.  Multiple recent studies have cast a shadow on the possibility that 
hemoglobin can act as signaling generating source in reference to NO-mediated dilation. This doubt 
revolves around apparent insignificant quantitates of NO generated through this mechanism(155-157). 
As discussed in the mathematical modeling effort conducted by Buerk et al. none of the NO generated 
within the blood, which was assumed to be reducing nitrite to NO at its optimum rate, made it in the 
perivascular tissue(155).  Instead it appears that the NO formed from reductase activity within the tissue 
can play a greater role in NO release and associated activities. With in tissues the monomeric heme 
globins, myoglobin (Mb) and neuroglobin (Ngb), catalyze NO2- reduction by the same mechanism has 
hemoglobin but do so at lower oxygen tensions (p50 for Mb=2.4 mmHg; p50 for Ngb). 
B3: Incorporation of Nitrite Reduction to NO 
We seek to create a simple model to further explore the interaction between NO and O2 within a vascular 
network. To do so we make use of the bifurcating network geometry along with all of the partial 
differential equations and different reactions presented to this point describing nitric oxide and oxygen 
transport within the bifurcating arteriole networks. An additional reaction has been added to account for 
oxygen dependent reduction of the assumed constant concentration of nitrite within the tissue to NO.  
This same manner of incorporating nitrite reduction to NO has previously been applied by Buerk et 
al.(208) for a single arteriole tissue geometry and not incorporating the influence of oxygen dependent 
nitric oxide metabolism within the tissue.  As it was found to be insignificant in the aformetnioned Buerk 
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model NO2- reduction by hemoglobin (RbNRA) was assumed to be negligible.  NO production from the 
reduction of NO2- in tissue (RtNRA) was assumed to be an inverse function of tissue pO2 given by: 
⎟
⎠
⎞
⎜
⎝
⎛
⎥⎦
⎤
⎢⎣
⎡+
=
t
tNRA
tNRA
k
pO
R
R
2
max
1
  ........................................................................................................................................ Equation 118 
 
 The parameters found in  Equation 118 originate from studies of heart and liver homogenates 
from male Sprague-Dawley rats(210).  The oxygen sensitivity parameter, kt=12 torr, was estimated from 
O2-dependent nitrite reductase activity data reported from these tissue homogenate studies as was the 
maximal reduction rate parameter, RtNRAmax.  The maximal reduction rate in the tissue homogenates was 
found to be greater than 0.5 nM x s-1(210) and the previous mathematical study conducted by Buerk et 
al. considered maximal reduction rates of 1 and 1.5 nM x s-1 as well(208).  Due to our desire to fully 
explore this phenomena and its role on the interaction between NO and O2 within an in vivo 
microcirculatory environment further amplifications of this maximal rate were also explored over a 
range of tissue oxygen consumptions.  For each of the simulation sets completed certain descriptive 
values of the steady state NO and O2 transport were recorded and described below. 
B4: Considering the Influence of Myoglobin 
At high partial pressures of oxygen the influence of myoglobin-dependent transport of O2 has been found 
to be minimal(24) (340).  In a more sparse oxygen environment, the presence of myoglobin can prove 
useful in extending the region of perfusion from a particular vessel.  Furthermore, computational studies 
have found the myoglobin is an effective scavenger of perivascular NO(352) 
Myoglobin (Mb) is known to passively store O2 and facilitate the transport of the molecule through 
tissue.  Mb can also act as an effective NO scavenger beyond the vascular wall in skeletal and cardiac 
tissues(340, 352). The consumption of nitric oxide by Mb is modeled as a first order equation, which is a 
function of CNO,CMb, and a rate constant. The concentration of myoglobin is assumed to be equal to 0.38 
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mM, as has been measured from hamster retractor muscle cells(353).  The rate constant made use of 
describing the rate of NO scavenging by Mb (kMb) is 4.3 x 10-7 1/(Ms), and was obtained from 
experimental studies obtained through stopped-flow spectroscopy(354).  The transport of oxygen via Mb 
is modeled as a function of CMb, the diffusion of myoglobin, and the partial pressure of oxygen within a 
particular region of study(355),  Equation 119. 
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The saturation of Mb with oxygen can be described with the oxy-myoglobin saturation equation,  
 Equation 120.  P50Mb is the partial pressure of oxygen required for 50% myoglobin saturation. 
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NOMbMbNOMb CkCR =  .........................................................................................  Equation 121 
	  
	  
Parameter	   Value	   Units	  
Diffusivity	  of	  Mb	  (DMb)	   2.41	  x	  10-­‐5	   cm2s-­‐1	  
P50Mb	   5.3	   torr	  
CMb	   0.38	   mM	  
 
Table 25: Descriptive parameters of Mb mediated O2 transport 
 
02 =−−∇ NOMbNOtNONO RCCD λ   .................................................................. Equation 122 
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2
22 OMbOO RMPOD −=∇α   .......................................................................... Equation 123 
	  
B4: Results 
When simulations consider a maximum rate of Nitrite reduction to NO, mirroring that applied in the 
study conducted by Buerk (208) an increase in tissue O2 demand is modeled to trigger a decrease in CNO 
throughout all of the computational domains considered. As the O2 metabolism is increased from resting 
to more active levels the average CNO in the capillaries (CapNO), large diametered daughter branch 
(BNOout), and tissue (AvetisNO) all decrease. The average partial pressure of oxygen (AvetisO2) and 
the lowest partial pressure of oxygen (Low O2) also decrease with increasing metabolic need for O2, 
Table 26.  
It is simulated that increasing the maximal rate of nitrite reduction could lead to an increase in NO 
throughout the computational domain, Table 27. The maximal reduction rate of nitrite to NO must be 
increased three-fold the rate previously applied. 
	  
	  
Table 26: Examination of the influence of increasing the oxygen consumption rate on NO and PO2 within the 
bifurcating arteriole vascular network.   
	  
Table 27: Examination of the influence of increasing the oxygen consumption rate on NO and PO2 within the 
bifurcating arteriole vascular network. The maximal reduction rate of nitrite is chosen as an amplification of 
the maximal parameter value considered within Buerk’s study(208) so to determine how greatly the 
Max	  NO	  Nitrite	  
(mol/m^3*s)
Max	  Rate	  of	  O2	  
Cons	  (mM/s)
CapNO	  (nM) BNOout(nM) AvetisO2(torr) Low	  O2	  (torr) AvetisNO(nM) %diffave
0.001 82.27 379.37 31.98 27.24 115.04 100.00%
0.008 81.45 378.31 26.94 19.94 113.99 99.75%
0.05 74.54 372.91 11.16 0.14 105.37 98.51%
0.0000015	  
(1.5nM/s)
Max	  NO	  Nitrite	  
(mol/m^3*s)
Max	  Rate	  of	  O2	  
Cons	  (mM/s)
CapNO	  (nM) BNOout(nM) AvetisO2(torr) Low	  O2	  (torr) AvetisNO(nM) %diffave
0.001 166.17 432.33 32.08 27.20 239.69 100.00%
0.008 175.45 434.60 27.89 22.10 254.18 100.43%
0.05 227.23 450.42 15.12 4.90 335.19 103.31%
0.0015	  	  	  	  
(1500nM/s)
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contribution of nitric oxide provided via the reduction of NO2- would theoretically have to be to greatly 
influence CNO in and around the vascular within the network considered. 
Incorporating myoglobin metabolism of NO greatly decreases the concentration of NO in the capillaries 
(Figure 95), different portions of the bifurcating arteriole (Figure 96, Figure 97 and Figure 98), and within 
the tissue (Figure 100). A series of simulations are conducted, which examine the influence of 
incorporating different mechanisms on the concentrations of NO and O2 in the network. Simulations in 
which myoglobin metabolism of NO is incorportated along with nitrite reduction and O2 dependent 
metabolism of NO in the tissue (green bars) illustrate that the inclusion of the myoglobin dependent 
metabolism greatly attenuates the average NO around each of the vessel types when only nitrite 
reduction and O2 – dependent metabolism are considered alone (orange bars). Overall the inclusion of 
myoglobin simulates lower NO concentrations no matter what other mechanisms are incorporated into 
the model. Myoglobin dependent transport of O2 does not appear to result in increases of NO in 
measured regions of the simulation, Figure 99.  Figure 100 
	  
Figure 95:  Average CNO around the 9 capillaries considered within the bifurcating arteriole network model 
in response to changes in tissue and vascular wall metabolism.  The response of CNO to changes in O2 
metabolism is examined for various models incorporating nitrite and myoglobin dependent transport of NO 
and O2. 
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Figure 96: Average CNO around the larger of the two outlet daughter arteriole branches of the bifurcating 
arteriole A2. The response of CNO to changes in O2 metabolism is examined for various models incorporating 
nitrite and myoglobin dependent transport of NO and O2. 
	  
	  
Figure 97: Average CNO around the smaller of the two outlet daughter arteriole branches of the bifurcating 
arteriole A2. The response of CNO to changes in O2 metabolism is examined for various models incorporating 
nitrite and myoglobin dependent transport of NO and O2. 
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Figure 98: Average CNO around the parent branch of the bifurcating arteriole A2. The response of CNO to 
changes in O2 metabolism is examined for various models incorporating nitrite and myoglobin dependent 
transport of NO and O2.  
	  
Figure 99: Average tissue PO2 within the tissue of the bifurcating arteriole network. The response of PO2 to 
changes in O2 metabolism is examined for various models incorporating nitrite and myoglobin dependent 
transport of NO and O2.   
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  Figure 100: Average tissue CNO within the tissue of the bifurcating arteriole network. The response of CNO 
to changes in O2 metabolism is examined for various models incorporating nitrite and myoglobin dependent 
transport of NO and O2. 
  
B5 :Discussion 
The inclusion of Nitrite Reduction due to oxygen concentration does not allow for a significant increase 
in CNO around the arteriole wall in response to an increase in tissue metabolic needs. An increase in 
arteriole NO is observed only after the maximal reduction rate of nitrite to NO is increased 1000 fold 
values reported experimentally(209). The additional scavenging due to myoglobin results in large 
decreases in CNO observed throughout the model. Inclusion of the reduction of nitrite does not lead to an 
increase in CNO in the arteriole wall of the different sections of the arteriole in response to changes in 
metabolic demand. 
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Appendix C: Matlab Codes of Use 
	  
Code for calculating red blood cell distribution at a bifurcation 
function	  out=bifartterm(D1)	  
	  
%D1=12;	  
Vi=1.5*10^3*((D1/2)/5)^3;%1.5*10^3*(7.65/4)^3;%um/s	  
Hct1=0.2;%Hematocrit	  
visc1=eta(D1,Hct1);%Units????cPoise	  
	  
	  
%Need	  to	  use	  Pouseille	  flow	  to	  determine	  the	  pressure	  at	  the	  outlet	  
	  
%pressure	  at	  the	  inlet	  of	  the	  vessel	  
	  
%(31	  is	  in	  torr	  and	  I	  am	  converting	  it	  to	  Pascal)	  
	  
	  
Li=78.5398;%	  um	  length	  of	  the	  tube	  
Lc=500;%{	  um	  length	  of	  the	  capillary	  
	  
Di=D1;%Diameter	  of	  the	  parent	  vessel	  (um)	  
Dc=D1;%*(3/4);	  %Diameter	  of	  the	  branching	  capillaries	  (um)	  
Dc2=D1;	  
r=Di/2;	  
rc=Dc/2;	  
rc2=Dc2/2;	  
	  
%Pb=3740;%Pbiff(	  Vi,Pi,visc1*10^-­‐3,Li,r);	  
	  
Qp=Vi*r^2*pi;%Volumetric	  flowrate	  inlet	  
	  
%Need	  to	  define	  the	  vessel	  resistances	  to	  calculate	  the	  vessel	  flowrates	  
	  
%initial	  guesses	  for	  viscocity	  and	  Hct	  these	  will	  be	  iteratively	  changed	  
	  
%	  Da=(4/5)*Di;	  
%	  	  
%	  Db=Di;	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Dp=Di;Bc=Bee(Hct1,	  Dp);xo=Xo	  (Hct1,Dp);	  
	  
L2=Lc;	  
	  
L3=Lc;%*2;	  
	  
r1=r;r2=rc;r3=rc;	  
	  
	  
visc2=eta(Dc,Hct1);	  
	  
visc3=eta(Dc2,Hct1);	  
	  
R1=(8*visc1*10^-­‐4*Li*10^-­‐6)/(pi*(r*10^-­‐6)^4);	  
	  
R2=(8*visc2*10^-­‐4*Lc*10^-­‐6)/(pi*(r2*10^-­‐6)^4);	  
	  
R3=(8*visc3*10^-­‐4*Lc*10^-­‐6)/(pi*(r3*10^-­‐6)^4);	  
	  
	  
%delp=(8*Qp*visc1*Li)/(pi*r^4);%Pressure	  change	  along	  the	  vessel	  
	  
%Need	  to	  calculate	  the	  other	  defining	  parameters	  in	  the	  two	  other	  
	  
%bifurcating	  segments	  of	  the	  vessel	  
	  
%Bifurcation	  segment	  1	  
	  
P1o=17.4*133.33;%outlet	  pressure	  at	  each	  outlet	  of	  the	  bifurcation	  
dp=Qp*((R1+(R2*R3/(R2+R3))));	  
dpb=Qp*(((R2*R3/(R2+R3))));	  
	  
%P2o=30.5*133.33;%Outlet	  pressure	  at	  second	  outlet	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
	  
	  
Flow=VFRtwo2(Qp,R2,dpb);	  
	  
Qa=Flow(2);Qp=Flow(1);Qb=Flow(3);	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Fqbalpha=Qa/Qp;Fqbbeta=Qb/Qp;	  
	  
lfebeta=fraclogit(A(Dc,Dc2,Dp,Hct1),Bee	  (Hct1,	  Dp),Fqbbeta,Xo	  (Hct1,Dp)	  );	  
	  
lfealpha=fraclogit(A(Dc,Dc2,Dp,Hct1),Bee	  (Hct1,	  Dp),Fqbalpha,Xo	  (Hct1,Dp)	  );	  
	  
%Now	  I	  must	  solve	  these	  fractions	  to	  determine	  the	  Hcts	  in	  the	  branches	  
	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
	  
Fea=exp(lfealpha)/(1+exp(lfealpha));	  
	  
Feb=exp(lfebeta)/(1+exp(lfebeta));	  
Hcta=(Fea/Fqbalpha)*Hct1;Hctb=(Feb/Fqbbeta)*Hct1;	  
Error=700;	  
	  
while	  Error==700;	  
	  
%Now	  to	  calc	  the	  Hcts	  
%Applying	  these	  we	  can	  calculate	  new	  viscocities	  
	  
visc2n=eta(Dc,Hcta);	  
visc3n=eta(Dc2,Hctb);	  
R1n=(8*visc1*10^-­‐4*Li*10^-­‐6)/(pi*(r*10^-­‐6)^4);	  
R2n=(8*visc2n*10^-­‐4*Lc*10^-­‐6)/(pi*(r2*10^-­‐6)^4);	  
R3n=(8*visc3n*10^-­‐4*Lc*10^-­‐6)/(pi*(r3*10^-­‐6)^4);	  
P1on=17.4*133.33;%outlet	  pressure	  at	  each	  outlet	  of	  the	  bifurcation	  
dpn=Qp*((R1n+(R2n*R3n/(R2n+R3n))));	  
dpbn=Qp*(((R2n*R3n/(R2n+R3n))));	  
	  
	  
%Using	  the	  new	  visc	  to	  get	  new	  flowrates	  
	  
Flown=VFRtwo2(Qp,R2n,dpbn);	  
Qan=Flown(2);Qp=Flown(1);Qbn=Flown(3);	  
	  
	  
%We	  can	  then	  now	  calculate	  new	  Hcts!!!	  
	  
Fqbalphan=Qan/Qp;Fqbbetan=Qbn/Qp;	  
lfebetan=fraclogit(A(Dc,Dc2,Dp,Hct1),Bee	  (Hct1,	  Dp),Fqbbetan,Xo	  (Hct1,Dp)	  );	  
lfealphan=fraclogit(A(Dc,Dc2,Dp,Hct1),Bee	  (Hct1,	  Dp),Fqbalphan,Xo	  (Hct1,Dp)	  );	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%Now	  I	  must	  solve	  these	  fractions	  to	  determine	  the	  Hcts	  in	  the	  branches	  
	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
	  
Fean=exp(lfealphan)/(1+exp(lfealphan));	  
Febn=exp(lfebetan)/(1+exp(lfebetan));	  
%Now	  to	  calc	  the	  Hcts	  
Hctan=Fean*(1./Fqbalphan)*Hct1;	  
Hctbn=Febn*(1./Fqbbetan)*Hct1;	  
	  
	  
E=abs(Hctan-­‐Hcta)+abs(Hctbn-­‐Hctb);	  
if	  E<0.0001	  
	  	  	  	  Error=0;	  
end	  
	  
Hcta=Hctan;	  Hctb=Hctbn;	  
end	  
Comp=abs(Flown(1)*Hct1-­‐(Flown(2)*Hcta+Flown(3)*Hctb))/(Flown(1)*Hct1);	  
out=[Hcta	  Hctb	  Comp]';	  
end	  
	  
Embeded	  Codes	  
	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
function	  Ap	  =	  A(Da,Db,Dp,Hd)	  
%UNTITLED3	  Summary	  of	  this	  function	  goes	  here	  
%	  	  	  Detailed	  explanation	  goes	  here	  
Ap=-­‐13.29*(((Da^2)/(Db^2)-­‐1)/((Da^2)/(Db^2)+1))*(1-­‐Hd)/Dp;	  
	  
end	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
function	  Be	  =	  Bee	  (Hd,	  Dp)	  
%UNTITLED4	  Summary	  of	  this	  function	  goes	  here	  
%	  	  	  Detailed	  explanation	  goes	  here	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Be=1+6.98*(1-­‐Hd)/Dp;	  
End	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
function	  Volflow	  =	  VFRtwo2(	  Qpar,FR2,delp)	  
%VFRtwo(Inlet	  flow	  rate,	  Resistiance	  1,	  Resistance	  2)	  I'm	  assuming	  both	  Poiseaille	  flow	  as	  
%well	  as	  ohms	  law	  now	  to	  calculate	  how	  the	  flowrates	  change	  as	  we	  travel	  
%through	  the	  bifurcations	  
%	  Using	  Poiseaille	  Flow	  
%R1=8*n2*L2/(pi*r2^4);R2=8*n3*L3/(pi*r3^4);	  
Volflow(1)=Qpar;	  
Volflow(2)=Qpar-­‐delp/FR2;	  
Volflow(3)=delp/FR2;	  
Volflow=Volflow(:);	  
end	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%Larger	   Network	  
Sims%%%%%%%%%%%%%%%%%	  
function	  hout=newnetcalcs(D1)	  
%Attempting	  to	  create	  a	  model	  for	  a	  slightly	  different	  network,	  with	  extra	  
%capillaries	  and	  no	  longer	  a	  nozzle	  effect	  in	  the	  one	  capillary	  
%Setting	  up	  an	  external	  matlab	  loop	  to	  calculate	  the	  desired	  outputs	  
%(viscosity	  and	  Hematocrit)	  in	  the	  different	  branches	  of	  the	  vasculature	  
Hct1=0.2;%Hematocrit	  going	  into	  the	  terminal	  arterioles	  
%It	  will	  be	  assumed	  that	  for	  this	  simulation	  that	  all	  of	  the	  capillaries	  
%have	  the	  same	  diameter	  
%Also	  we	  are	  neglecting	  the	  change	  in	  resistance	  and	  therefore	  pressure	  as	  
%we	  travel	  through	  the	  venule	  and	  encounter	  different	  capillary	  outlets	  
visc1=eta(D1,Hct1);%Units????cPoise	  viscosity	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%{in	  arterioles	  and	  potentially	  venules	  
%Need	  to	  use	  Pouseille	  flow	  to	  determine	  the	  pressure	  at	  the	  outlet	  
Pi=(27.6)*133.2;%Pa,...	  
%pressure	  at	  the	  inlet	  of	  the	  vessel	  
Po=2347;%Pa	  
%pressure	  at	  the	  outlet	  of	  the	  vessel	  
%(31	  is	  in	  torr	  and	  I	  am	  converting	  it	  to	  Pascal)	  
%{Lc=400;%	  um	  length	  of	  the	  capillary	  tubes	  
Di=D1;%Diameter	  of	  the	  parent	  vessel	  (um)	  
rc=3;%{um},	  radius	  of	  capillaries	  
Dc=2*rc;%(94),	  diameters	  of	  capillaries	  
rven=9;%{um},radius	  of	  venule	  
Dv=2*rven;	  
lc=200;%um,	  length	  of	  the	  capillaries	  
lc2=600;%	  	  
la=200;%length	  of	  arteriole	  branch	  
lv=100;%length	  of	  the	  venule	  branch1	  
ra=D1/2;%{	  radii	  of	  different	  arteriole	  branches	  
rca=[rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc	  rc];	  %radii	  of	  diff	  caps	  
lac=[lc	  lc	  lc	  lc2	  lc2	  lc	  lc	  lc	  lc	  lc	  lc	  lc	  lc	  lc];	  
%initializing	  the	  viscosities	  
viscc=eta(Dc,Hct1);%viscosity	  of	  capillaries,	  at	  least	  initially	  
viscv=eta(Dv,Hct1);%{approximate	  viscosity	  of	  venule	  
visart=visc1;	  
	  
	  
vc=[viscc	  viscc	  viscc	  viscc	  viscc	  viscc	  viscc	  viscc	  viscc	  viscc	  viscc...	  
	  	  	  	  viscc	  viscc	  viscc	  ];	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Rc=((8).*lac./(pi.*rca.^4)).*vc;	  
Rv=((8)*lv/(pi*rven^4)).*viscv;	  
Ra=((8)/(pi*ra^4))*visart*la;	  
%I	  suppose	  now	  is	  time	  to	  create	  and	  breakdown	  the	  vascular	  network	  as	  to	  
%determine	  the	  flow	  rates	  in	  the	  respective	  branches	  
R1=	  Rc(8)*Rc(7)/(Rc(8)+Rc(7));%Equivalent	  circuit	  1	  
R2=Rc(11)*Rc(12)/(Rc(11)+Rc(12));%Cir2	  
R3=Rc(3)+R1+Rc(9);%{Rc(9)*R2*Rc(10)/(Rc(9)*R2+Rc(9)*Rc(10)+R2*Rc(10));	  
R4=Rc(6)+R2+Rc(13);	  
R5=R3*Rc(4)/(R3+Rc(4));	  
R6=Rc(5)*R4/(Rc(5)+R4);	  
R7=Rc(1)+R5+Rc(10);%R6*Rc(6)/(R6+Rc(6));	  
R8=Rc(2)+R6+Rc(14);	  
R9=R7*R8/(R8+R7);	  
R10=Ra(1)+R9+Rv;	  
	  
%{Rtot=R11+R10+Rv;%the	  total	  resistance	  of	  our	  network	  
%{Ltot=la1+la1+la3+lc+lv;	  
	  
%Also	  need	  to	  provide	  equations	  to	  equivalate	  the	  fluid	  flow	  through	  the	  
%model	  
	  
%First	  I	  think	  that	  we	  are	  capable	  of	  solving	  for	  the	  fluid	  flow	  through	  
%the	  entire	  network	  
	  
	  %The	  total	  vascular	  resistance	  
%Uisng	  this	  total	  resistance	  we	  can	  then	  calculate	  out	  approximate	  inflow	  
delp=Pi-­‐Po;%Pressure	  drop	  over	  the	  branch,	  definately	  an	  approx.	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Qp=(delp/(R10));%Volumetric	  flowrate	  inlet	  
%now	  to	  break	  down	  we	  need	  to	  come	  up	  with	  a	  system	  of	  equations	  for	  our	  
%respective	  flow	  rates	  
mat=[1	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  1	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  1	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  1	  1	  0	  0	  -­‐1	  0	  0	  0	  0	  ;	  ...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  1	  -­‐1	  ;...	  
	  	  	  	  0	  0	  0	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  1	  0	  -­‐1	  0	  0	  0	  ;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  1	  0	  -­‐1	  0;...	  
	  	  	  	  1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  0	  1	  0	  -­‐1	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  -­‐Rc(8)	  Rc(7)	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐Rc(11)	  Rc(12)	  0	  0	  0	  0	  0	  ;...	  
	  	  	  	  0	  0	  0	  -­‐Rc(3)	  Rc(4)	  0	  0	  0	  -­‐Rc(7)	  0	  0	  -­‐Rc(9)	  0	  0	  0	  0	  ;...	  
	  	  	  	  0	  0	  0	  0	  0	  -­‐Rc(6)	  Rc(5)	  0	  0	  0	  -­‐Rc(12)	  0	  -­‐Rc(13)	  0	  0	  0;...	  
	  	  	  	  0	  -­‐Rc(1)	  Rc(2)	  0	  -­‐Rc(4)	  Rc(6)	  0	  0	  0	  Rc(11)	  0	  0	  Rc(13)	  -­‐Rc(10)	  Rc(14)	  0];	  
ex=[0	  0	  0	  0	  0	  0	  0	  0	  0	  Qp	  0	  0	  0	  0	  0	  0];	  
inmat=inv(mat);	  
Aumont=inmat*ex';	  	  
%Aumont=[A1	  C1	  C2	  C3	  C4	  C6	  C5	  C8	  C7	  C11	  C12	  C9	  C13	  C10	  C14	  V]	  
%{Qp=Aumont(1)+Aumont(2);	  
	  
%So	  this	  appears	  to	  work	  and	  solve	  for	  the	  desired	  flowrates,	  I	  was	  
%previously	  making	  use	  of	  the	  wrong	  matlab	  command...be	  more	  careful	  in	  the	  
%future.	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%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
	  
%Calculating	  the	  fractions	  of	  the	  flow	  we	  get	  as	  follows:	  
%Flow	  diverging	  from	  inlet	  1	  (the	  only	  inlet	  of	  our	  redesigned	  network)	  
Xoc1=Xo	  (Hct1,Di);F1C1=Aumont(2)/Aumont(1);	  
if	  F1C1<=Xoc1	  
	  	  	  	  Hctc1=0;	  
else	  
lfealpha=fraclogit(A(Di,Dc,Dc,Hct1),Bee	  (Hct1,	  Di),F1C1,Xo	  (Hct1,Di)	  );	  
Feb=exp(lfealpha)/(1+exp(lfealpha));	  
Hctc1=(Feb)*(1/F1C1)*Hct1;	  
end	  
	  
	  
F1C2=Aumont(3)/Aumont(1);Xoc2=Xo	  (Hct1,Di);	  
if	  F1C2<=Xoc2	  
	  	  	  	  Hctc2=0;	  
else	  
lfealphc2=fraclogit(A(Di,Dc,Dc,Hct1),Bee	  (Hct1,	  Di),F1C2,Xo	  (Hct1,Di)	  );	  
Fec2=exp(lfealphc2)/(1+exp(lfealphc2));	  
Hctc2=(Fec2)*(1/F1C2)*Hct1;	  
end	  
	  
	  
%We	  no	  longer	  have	  any	  trifurcations	  or	  anything	  of	  that	  nature	  so	  what	  
%will	  follow	  is	  a	  calculation	  of	  the	  respecitve	  hematocrits	  along	  each	  of	  
%the	  vascular	  pathways	  originating	  from	  capillaries	  1	  and	  2.	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%Begining	  as	  one	  would	  more	  than	  likely	  expect	  with	  capillary	  branch	  1	  we	  
%go	  C1	  branches	  into	  C3	  and	  C4.	  C3	  branches	  into	  C8	  and	  C7,	  which	  then	  come	  
%together	  into	  branch	  C9.	  	  C9	  and	  C4	  merge	  to	  get	  C10	  
	  
F1C3=Aumont(4)/Aumont(2);Xoc3=Xo	  (Hctc1,Dc);	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula	  
	  
if	  F1C3<=Xoc3	  
	  	  	  	  Hctc3=0;	  
else	  
lfealphc3=fraclogit(A2c(Dc,Dc,Dc,Dc,Hctc1),Bee	  (Hctc1,	  Dc),F1C3,Xo	  (Hctc1,Dc)	  );	  
Fec3=exp(lfealphc3)/(1+exp(lfealphc3));	  
Hctc3=(Fec3)*(1/F1C3)*Hctc1;	  
end	  
	  
	  
F1C4=Aumont(5)/Aumont(2);Xoc4=Xo	  (Hctc1,Dc);	  
if	  F1C4<=Xoc4	  
	  	  	  	  Hctc4=0;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula	  
lfealphc4=fraclogit(A2c(Dc,Dc,Dc,Dc,Hctc1),Bee	  (Hctc1,	  Dc),F1C4,Xo	  (Hctc1,Dc)	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec4=exp(lfealphc4)/(1+exp(lfealphc4));	  
%Now	  to	  calc	  the	  Hcts	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Hctc4=(Fec4)*(1/F1C4)*Hctc1;	  
end	  
	  
%So	  here	  on	  forwards	  things	  are	  going	  to	  be	  a	  little	  bit	  tricky,	  but	  what	  I	  
%will	  be	  doing	  is	  assuming	  bifurcations	  where	  trifurcations	  occur,	  and	  
%slight	  changes	  in	  Hct	  and	  so	  forth	  
%C8	  and	  C9	  and	  Art	  7	  
F1C8=Aumont(8)/Aumont(4);Xoc8=Xo	  (Hctc3,Dc);	  
if	  F1C8<=Xoc8	  
	  	  	  	  Hctc8=0;	  
else	  
lfealphc8=fraclogit(A2c(Dc,Dc,Dc,Di,Hctc3),Bee	  (Hctc3,	  Dc),F1C8,Xo	  (Hctc3,Dc)	  );	  
Fec8=exp(lfealphc8)/(1+exp(lfealphc8));	  
	  
Hctc8=(Fec8)*(1/F1C8)*Hctc3;	  
end	  
	  
	  
F1C7=Aumont(9)/Aumont(2);Xoc7=Xo	  (Hctc3,Dc);	  
if	  F1C7<=Xoc7	  
	  	  	  	  Hctc7=0;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc7=fraclogit(A2c(Dc,Dc,Dc,Dc,Hctc3),Bee	  (Hctc3,	  Dc),F1C7,Xo	  (Hctc3,Dc)	  );	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec7=exp(lfealphc7)/(1+exp(lfealphc7));	  
%Now	  to	  calc	  the	  Hcts	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Hctc7=(Fec7)*(1/F1C7)*Hctc3;	  
end	  
	  
Hctc9=(Aumont(9)*Hctc7+Aumont(8)*Hctc8)/Aumont(12);	  
	  
Hctc10=(Hctc9*Aumont(12)+Hctc4*Aumont(5))/(Aumont(14));	  
	  
%Now	  progressing	  down	  the	  other	  capillary	  branching	  pathway	  from	  capillary	  
%2.	  	  C2	  branches	  into	  C5	  and	  C6.	  C6	  branches	  into	  C11	  and	  C12,	  which	  come	  
%together	  to	  make	  C13.	  	  C13	  gets	  together	  with	  C5	  to	  make	  C14.	  	  Finally	  
%C14	  and	  C10	  branch	  together	  into	  our	  venule.	  
	  
	  
F1C6=Aumont(6)/Aumont(3);Xoc6=Xo	  (Hctc3,Dc);	  
if	  F1C6<=Xoc6	  
	  	  	  	  Hctc6=0;	  
elseif	  F1C6>=0.94;	  
	  	  	  	  Fec6=1;	  
	  	  	  	  Hctc6=(Fec6)*(1/F1C6)*Hctc3;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula	  
lfebetc6=fraclogit(A(Dc,Dc,Dc,Hctc3),Bee	  (Hctc3,	  Dc),F1C6,Xo	  (Hctc3,Dc)	  );	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec6=exp(lfebetc6)/(1+exp(lfebetc6));	  
%Now	  to	  calc	  the	  Hcts9	  
Hctc6=(Fec6)*(1/F1C6)*Hctc3;	  
end	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F1C5=Aumont(7)/Aumont(3);Xoc5=Xo	  (Hctc3,Dc);	  
if	  F1C5<=Xoc5	  
	  	  	  	  Hctc5=0;	  
elseif	  F1C5>=0.94	  
	  	  	  	  Fec5=1;	  
	  	  	  	  Hctc5=(Fec5)*(1/F1C5)*Hctc3;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc5=fraclogit(A(Dc,Dc,Dc,Hctc3),Bee	  (Hctc3,	  Dc),F1C5,Xo	  (Hctc3,Dc)	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec5=exp(lfealphc5)/(1+exp(lfealphc5));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc5=(Fec5)*(1/F1C5)*Hctc3;	  
end	  
	  
	  
%{%{%{%{	  
	  
	  
	  
F1C11=Aumont(10)/Aumont(6);Xoc11=Xo	  (Hctc6,Dc);	  
if	  F1C11<=Xoc11	  
	  	  	  	  Hctc11=0;	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elseif	  F1C11>=0.94	  
	  	  	  	  Fec11=1;	  
	  	  	  	  Hctc11=(Fec11)*(1/F1C11)*Hctc6;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc11=fraclogit(A(Dc,Dc,Dc,Hctc6),Bee	  (Hctc6,	  Dc),F1C11,Xoc11	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec11=exp(lfealphc11)/(1+exp(lfealphc11));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc11=(Fec11/F1C11)*Hctc6;	  
end	  
	  
	  
F1C12=Aumont(11)/Aumont(6);Xoc12=Xo	  (Hctc6,Dc);	  
if	  F1C12<=Xoc12	  
	  	  	  	  Hctc12=0;	  
elseif	  F1C12>=0.94	  
	  	  	  	  Fec12=1;	  
	  	  	  	  Hctc12=(Fec12)*(1/F1C12)*Hctc6;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc12=fraclogit(A(Dc,Dc,Dc,Hctc6),Bee	  (Hctc6,	  Dc),F1C12,Xoc12	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec12=exp(lfealphc12)/(1+exp(lfealphc12));	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%Now	  to	  calc	  the	  Hcts	  
Hctc12=(Fec12)*(1/F1C2)*Hctc6;	  
end	  
	  
Hctc13=(Aumont(11)*Hctc12+Aumont(10)*Hctc11)/Aumont(13);	  
	  
Hctc14=(Hctc5*Aumont(7)+Hctc13*Aumont(13))/(Aumont(15));	  
	  
%	  And	  now	  determining	  the	  hematocrit	  inside	  of	  the	  venule	  
Hctv=(Hctc14*Aumont(15)+Hctc10*Aumont(14))/Aumont(16);	  
	  
%Now	  all	  of	  the	  Hematocrits	  should	  be	  calculated	  and	  we	  can	  iterate	  to	  
%determine	  what	  the	  viscosities	  and	  hcts	  should	  be	  in	  each	  of	  the	  branches	  
E6=0;	  
i=0;%initializing	  our	  stepping	  function	  
%Initializing	  the	  error	  parameters	  
while	  E6==0	  
i=i+1;	  
%Using	  these	  new	  viscocities	  we	  can	  then	  calculate	  new	  flow	  rates	  
%Applying	  these	  we	  can	  calculate	  new	  viscocities	  
visart=eta(Di,Hct1);	  
viscv=eta(Dv,Hct1);%{approximate	  viscosity	  of	  venule	  
	  	  	  	  	  
%Defining	  resistances	  multiplied	  by	  length	  
vc=[eta(Dc,Hctc1)	  eta(Dc,Hctc2)	  eta(Dc,Hctc3)	  eta(Dc,Hctc4)	  ...	  
	  	  	  	  eta(Dc,Hctc5)	  eta(Dc,Hctc6)	  eta(Dc,Hctc7)	  eta(Dc,Hctc8)	  ...	  
	  	  	  	  eta(Dc,Hctc9)	  eta(Dc,Hctc10)	  eta(Dc,Hctc11)	  eta(Dc,Hctc12)...	  
	  	  	  	  eta(Dc,Hctc13)	  eta(Dc,Hctc14)	  ];	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%initializing	  the	  viscosities	  
Rc=((8.*lac)./(pi.*rca.^4)).*vc;	  
%{Rv=((8*lv)./(pi*rven^4)).*viscv;	  
Ra=((8)./(pi.*ra.^4)).*visart.*la;	  
Rv=((8)*lv/(pi*rven^4)).*viscv;	  
%I	  suppose	  now	  is	  time	  to	  create	  and	  breakdown	  the	  vascular	  network	  as	  to	  
%determine	  the	  flow	  rates	  in	  the	  respective	  branches	  
R1=	  Rc(8)*Rc(7)/(Rc(8)+Rc(7));%Equivalent	  circuit	  1	  
R2=Rc(11)*Rc(12)/(Rc(11)+Rc(12));%Cir2	  
R3=Rc(3)+R1+Rc(9);%{Rc(9)*R2*Rc(10)/(Rc(9)*R2+Rc(9)*Rc(10)+R2*Rc(10));	  
R4=Rc(6)+R2+Rc(13);	  
R5=R3*Rc(4)/(R3+Rc(4));	  
R6=Rc(5)*R4/(Rc(5)+R4);	  
R7=Rc(1)+R5+Rc(10);%R6*Rc(6)/(R6+Rc(6));	  
R8=Rc(2)+R6+Rc(14);	  
R9=R7*R8/(R8+R7);	  
R10=Ra(1)+R9+Rv;	  
	  
%{Rtot=R11+R10+Rv;%the	  total	  resistance	  of	  our	  network	  
%{Ltot=la1+la1+la3+lc+lv;	  
	  
%Also	  need	  to	  provide	  equations	  to	  equivalate	  the	  fluid	  flow	  through	  the	  
%model	  
	  
%First	  I	  think	  that	  we	  are	  capable	  of	  solving	  for	  the	  fluid	  flow	  through	  
%the	  entire	  network	  
	  
	  %The	  total	  vascular	  resistance	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%Uisng	  this	  total	  resistance	  we	  can	  then	  calculate	  out	  approximate	  inflow	  
delp=Pi-­‐Po;%Pressure	  drop	  over	  the	  branch,	  definately	  an	  approx.	  
Qp=(delp/(R10));%Volumetric	  flowrate	  inlet	  
%now	  to	  break	  down	  we	  need	  to	  come	  up	  with	  a	  system	  of	  equations	  for	  our	  
%respective	  flow	  rates	  
mat=[1	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  1	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  1	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  1	  1	  0	  0	  -­‐1	  0	  0	  0	  0	  ;	  ...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  1	  -­‐1	  ;...	  
	  	  	  	  0	  0	  0	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  1	  0	  -­‐1	  0	  0	  0	  ;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  1	  0	  -­‐1	  0;...	  
	  	  	  	  1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  0	  1	  0	  -­‐1	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  -­‐Rc(8)	  Rc(7)	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐Rc(11)	  Rc(12)	  0	  0	  0	  0	  0	  ;...	  
	  	  	  	  0	  0	  0	  -­‐Rc(3)	  Rc(4)	  0	  0	  0	  -­‐Rc(7)	  0	  0	  -­‐Rc(9)	  0	  0	  0	  0	  ;...	  
	  	  	  	  0	  0	  0	  0	  0	  -­‐Rc(6)	  Rc(5)	  0	  0	  0	  -­‐Rc(12)	  0	  -­‐Rc(13)	  0	  0	  0;...	  
	  	  	  	  0	  -­‐Rc(1)	  Rc(2)	  0	  -­‐Rc(4)	  Rc(6)	  0	  0	  0	  Rc(11)	  0	  0	  Rc(13)	  -­‐Rc(10)	  Rc(14)	  0];	  
ex=[0	  0	  0	  0	  0	  0	  0	  0	  0	  Qp	  0	  0	  0	  0	  0	  0];	  
inmat=inv(mat);	  
Aumont=inmat*ex';	  	  
%Aumont=[A1	  C1	  C2	  C3	  C4	  C6	  C5	  C8	  C7	  C11	  C12	  C9	  C13	  C10	  C14	  V]	  
%{Qp=Aumont(1)+Aumont(2);	  
	  
%So	  this	  appears	  to	  work	  and	  solve	  for	  the	  desired	  flowrates,	  I	  was	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%previously	  making	  use	  of	  the	  wrong	  matlab	  command...be	  more	  careful	  in	  the	  
%future.	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
	  
%Calculating	  the	  fractions	  of	  the	  flow	  we	  get	  as	  follows:	  
%Flow	  diverging	  from	  inlet	  1	  (the	  only	  inlet	  of	  our	  redesigned	  network)	  
Xoc1=Xo	  (Hct1,Di);F1C1=Aumont(2)/Aumont(1);	  
if	  F1C1<=Xoc1	  
	  	  	  	  Hctc1n=0;	  
else	  
lfealpha=fraclogit(A(Di,Dc,Dc,Hct1),Bee	  (Hct1,	  Di),F1C1,Xo	  (Hct1,Di)	  );	  
Feb=exp(lfealpha)/(1+exp(lfealpha));	  
Hctc1n=(Feb)*(1/F1C1)*Hct1;	  
end	  
	  
	  
F1C2=Aumont(3)/Aumont(1);Xoc2=Xo	  (Hct1,Di);	  
if	  F1C2<=Xoc2	  
	  	  	  	  Hctc2n=0;	  
else	  
lfealphc2=fraclogit(A(Di,Dc,Dc,Hct1),Bee	  (Hct1,	  Di),F1C2,Xo	  (Hct1,Di)	  );	  
Fec2=exp(lfealphc2)/(1+exp(lfealphc2));	  
Hctc2n=(Fec2)*(1/F1C2)*Hct1;	  
end	  
	  
	  
%We	  no	  longer	  have	  any	  trifurcations	  or	  anything	  of	  that	  nature	  so	  what	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%will	  follow	  is	  a	  calculation	  of	  the	  respecitve	  hematocrits	  along	  each	  of	  
%the	  vascular	  pathways	  originating	  from	  capillaries	  1	  and	  2.	  
	  
%Begining	  as	  one	  would	  more	  than	  likely	  expect	  with	  capillary	  branch	  1	  we	  
%go	  C1	  branches	  into	  C3	  and	  C4.	  C3	  branches	  into	  C8	  and	  C7,	  which	  then	  come	  
%together	  into	  branch	  C9.	  	  C9	  and	  C4	  merge	  to	  get	  C10	  
	  
F1C3=Aumont(4)/Aumont(2);Xoc3=Xo	  (Hctc1n,Dc);	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula	  
	  
if	  F1C3<=Xoc3	  
	  	  	  	  Hctc3n=0;	  
else	  
lfealphc3=fraclogit(A2c(Dc,Dc,Dc,Dc,Hctc1n),Bee	  (Hctc1n,	  Dc),F1C3,Xo	  (Hctc1n,Dc)	  );	  
Fec3=exp(lfealphc3)/(1+exp(lfealphc3));	  
Hctc3n=(Fec3)*(1/F1C3)*Hctc1;	  
end	  
	  
	  
F1C4=Aumont(5)/Aumont(2);Xoc4=Xo	  (Hctc1n,Dc);	  
if	  F1C4<=Xoc4	  
	  	  	  	  Hctc4n=0;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula	  
lfealphc4=fraclogit(A2c(Dc,Dc,Dc,Dc,Hctc1n),Bee	  (Hctc1n,	  Dc),F1C4,Xo	  (Hctc1n,Dc)	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	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Fec4=exp(lfealphc4)/(1+exp(lfealphc4));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc4n=(Fec4)*(1/F1C4)*Hctc1n;	  
end	  
	  
%So	  here	  on	  forwards	  things	  are	  going	  to	  be	  a	  little	  bit	  tricky,	  but	  what	  I	  
%will	  be	  doing	  is	  assuming	  bifurcations	  where	  trifurcations	  occur,	  and	  
%slight	  changes	  in	  Hct	  and	  so	  forth	  
%C8	  and	  C9	  and	  Art	  7	  
F1C8=Aumont(8)/Aumont(4);Xoc8=Xo	  (Hctc3n,Dc);	  
if	  F1C8<=Xoc8	  
	  	  	  	  Hctc8n=0;	  
else	  
lfealphc8=fraclogit(A2c(Dc,Dc,Dc,Di,Hctc3n),Bee	  (Hctc3n,	  Dc),F1C8,Xo	  (Hctc3n,Dc)	  );	  
Fec8=exp(lfealphc8)/(1+exp(lfealphc8));	  
	  
Hctc8n=(Fec8)*(1/F1C8)*Hctc3n;	  
end	  
	  
	  
F1C7=Aumont(9)/Aumont(2);Xoc7=Xo	  (Hctc3n,Dc);	  
if	  F1C7<=Xoc7	  
	  	  	  	  Hctc7n=0;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc7=fraclogit(A2c(Dc,Dc,Dc,Dc,Hctc3n),Bee	  (Hctc3n,	  Dc),F1C7,Xo	  (Hctc3n,Dc)	  );	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	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Fec7=exp(lfealphc7)/(1+exp(lfealphc7));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc7n=(Fec7)*(1/F1C7)*Hctc3n;	  
end	  
	  
Hctc9n=(Aumont(9)*Hctc7n+Aumont(8)*Hctc8n)/Aumont(12);	  
	  
Hctc10n=(Hctc9n*Aumont(12)+Hctc4n*Aumont(5))/(Aumont(14));	  
	  
%Now	  progressing	  down	  the	  other	  capillary	  branching	  pathway	  from	  capillary	  
%2.	  	  C2	  branches	  into	  C5	  and	  C6.	  C6	  branches	  into	  C11	  and	  C12,	  which	  come	  
%together	  to	  make	  C13.	  	  C13	  gets	  together	  with	  C5	  to	  make	  C14.	  	  Finally	  
%C14	  and	  C10	  branch	  together	  into	  our	  venule.	  
	  
	  
F1C6=Aumont(6)/Aumont(3);Xoc6=Xo	  (Hctc2n,Dc);	  
if	  F1C6<=Xoc6	  
	  	  	  	  Hctc6n=0;	  
elseif	  F1C6>=0.94;	  
	  	  	  	  Fec6=1;	  
	  	  	  	  Hctc6n=(Fec6)*(1/F1C6)*Hctc2n;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula	  
lfebetc6=fraclogit(A(Dc,Dc,Dc,Hctc2n),Bee	  (Hctc2n,	  Dc),F1C6,Xo	  (Hctc2n,Dc)	  );	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec6=exp(lfebetc6)/(1+exp(lfebetc6));	  
%Now	  to	  calc	  the	  Hcts9	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Hctc6n=(Fec6)*(1/F1C6)*Hctc2n;	  
end	  
	  
	  
	  
F1C5=Aumont(7)/Aumont(3);Xoc5=Xo	  (Hctc2n,Dc);	  
if	  F1C5<=Xoc5	  
	  	  	  	  Hctc5n=0;	  
elseif	  F1C5>=0.94	  
	  	  	  	  Fec5=1;	  
	  	  	  	  Hctc5n=(Fec5)*(1/F1C5)*Hctc2n;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc5=fraclogit(A(Dc,Dc,Dc,Hctc2n),Bee	  (Hctc2n,	  Dc),F1C5,Xo	  (Hctc2n,Dc)	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec5=exp(lfealphc5)/(1+exp(lfealphc5));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc5n=(Fec5)*(1/F1C5)*Hctc2n;	  
end	  
	  
	  
%{%{%{%{	  
	  
	  
	  
F1C11=Aumont(10)/Aumont(6);Xoc11=Xo	  (Hctc6n,Dc);	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if	  F1C11<=Xoc11	  
	  	  	  	  Hctc11n=0;	  
elseif	  F1C11>=0.94	  
	  	  	  	  Fec11=1;	  
	  	  	  	  Hctc11n=(Fec11)*(1/F1C11)*Hctc6n;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc11=fraclogit(A(Dc,Dc,Dc,Hctc6n),Bee	  (Hctc6n,	  Dc),F1C11,Xoc11	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	  
%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec11=exp(lfealphc11)/(1+exp(lfealphc11));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc11n=(Fec11/F1C11)*Hctc6n;	  
end	  
	  
	  
F1C12=Aumont(11)/Aumont(6);Xoc12=Xo	  (Hctc6n,Dc);	  
if	  F1C12<=Xoc12	  
	  	  	  	  Hctc12n=0;	  
elseif	  F1C12>=0.94	  
	  	  	  	  Fec12=1;	  
	  	  	  	  Hctc12n=(Fec12)*(1/F1C2)*Hctc6n;	  
else	  
%Solving	  now	  for	  aspects	  of	  the	  empirical	  formula1	  
lfealphc12=fraclogit(A(Dc,Dc,Dc,Hctc6n),Bee	  (Hctc6n,	  Dc),F1C12,Xoc12	  );	  
	  
%Now	  these	  fractions	  are	  used	  to	  determine	  the	  Hcts	  in	  each	  of	  the	  branches	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%	  The	  fractions	  of	  rbcs	  in	  the	  branches	  
Fec12=exp(lfealphc12)/(1+exp(lfealphc12));	  
%Now	  to	  calc	  the	  Hcts	  
Hctc12n=(Fec12)*(1/F1C12)*Hctc6n;	  
end	  
	  
Hctc13n=(Aumont(11)*Hctc12n+Aumont(10)*Hctc11n)/Aumont(13);	  
	  
Hctc14n=(Hctc5*Aumont(7)+Hctc13n*Aumont(13))/(Aumont(15));	  
	  
%	  And	  now	  determining	  the	  hematocrit	  inside	  of	  the	  venule	  
Hctvn=(Hctc14*Aumont(15)+Hctc10n*Aumont(14))/Aumont(16);	  
	  
	  
	  
Error=(abs(Hctc1n-­‐Hctc1)+abs(Hctc2n-­‐Hctc2)+abs(Hctc3n-­‐Hctc3)+...	  
	  	  	  	  abs(Hctc4n-­‐Hctc4)+abs(Hctc5n-­‐Hctc5)...	  
	  	  	  	  +abs(Hctc6n-­‐Hctc6)+abs(Hctc7n-­‐Hctc7)+abs(Hctc8n-­‐Hctc8)+...	  
	  	  	  	  abs(Hctc9n-­‐Hctc9)+abs(Hctc10n-­‐Hctc10)+abs(Hctc11n-­‐Hctc11)+...	  
	  	  	  	  abs(Hctc12n-­‐Hctc12)+abs(Hctc13n-­‐Hctc13)+abs(Hctc14n-­‐Hctc14)+...	  
	  	  	  	  abs(Hctvn-­‐Hctv));	  
	  if	  Error	  <	  0.0001	  
	  	  	  	  	  E6=1;	  
	  end	  
	  
%Redefining	  the	  Hematocrits	  for	  the	  next	  iteration	  
Hctc1=Hctc1n;Hctc2=Hctc2n;	  
Hctc3=Hctc3n;Hctc4=Hctc4n;Hctc5=Hctc5n;Hctc6=Hctc6n;Hctc7=Hctc7n;	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Hctc8=Hctc8n;Hctc9=Hctc9n;Hctc10=Hctc10n;Hctc11=Hctc11n;	  Hctc12=Hctc12n;	  
Hctc13=Hctc13n;	  Hctc14=Hctc14n;	  Hctv=Hctvn;	  
	  
hout=[Hctc1n	  Hctc2n	  Hctc3n	  Hctc4n	  Hctc5n	  Hctc6n	  Hctc7n	  Hctc8n...	  
	  	  	  	  Hctc9n	  Hctc10n	  Hctc11n	  Hctc12n	  Hctc13n	  Hctc14n	  Hct1	  Hctv...	  
	  	  	  	  vc(1)	  vc(2)	  vc(3)	  vc(4)	  vc(5)	  vc(6)	  vc(7)	  vc(8)...	  
	  	  	  	  vc(9)	  vc(10)	  vc(11)	  vc(12)	  vc(13)	  vc(14)	  visart	  viscv]';	  
	  
	  
	  
end	  
	  
end	  
	  
	  	  	  	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
	  
function	  logitfrac	  =	  fraclogit(	  Al,Bill,frac,oxo	  )	  
%function	  Hemato	  is	  supposed	  to	  calculate	  the	  Hct	  in	  the	  daughter	  branches	  
%given	  the	  input	  parameters	  from	  the	  parent	  and	  such	  
%	  	  	  Detailed	  explanation	  goes	  here	  
logitfrac=Al+Bill*logit((frac-­‐oxo)/(1-­‐oxo));	  
end	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
function	  nv	  =	  visc(	  n,Hd,D,C	  )	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%UNTITLED3	  Summary	  of	  this	  function	  goes	  here	  
%	  	  	  Detailed	  explanation	  goes	  here	  
nv=(1+(n-­‐1)*((1-­‐Hd)^C-­‐1)/((1-­‐0.45)^C-­‐1)*(D/(D-­‐1.1))^2)*(D/(D-­‐1.1))^2;	  
	  
end	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
function	  nff	  =	  visco45(	  D	  )	  
%UNTITLED2	  Summary	  of	  this	  function	  goes	  here	  
%	  	  	  Detailed	  explanation	  goes	  here	  
	  
nff=6*exp(-­‐0.085*D)+3.2-­‐2.44*exp(-­‐0.06*D^0.645);	  
end	  
function	  Xoarg	  =	  Xo	  (Hd,Dp)	  
%UNTITLED5	  Summary	  of	  this	  function	  goes	  here	  
%	  	  	  Detailed	  explanation	  goes	  here	  
Xoarg=0.964*(1-­‐Hd)/Dp;	  
	  
	  
End	  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%	  
function	  flow_out=fee_art_sepwcaps(D1,Da1,Da2,Da3,Da4)	  
	  
%Modeling	  the	  flow	  seperation	  from	  the	  terminal	  feeding	  arteriole	  to	  the	  
%two	  arterioles...one	  of	  which	  being	  the	  bifurcating	  arteriole.	  
%Defining	  the	  properties	  of	  the	  terminal	  feeding	  arteriole	  
%For	  the	  feeding	  arteriole	  much	  information	  is	  taken	  from	  House	  and	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%Lipowsky	  Microvascular	  Rheology	  and	  Hemodynamics	  (2005)	  
Hct1=0.2;%Hematocrit	  
Dfee=15;%[um]	  diameter	  of	  terminal	  feeding	  arteriole,	  shall	  be	  kept	  at	  15	  
Df2=Dfee*(7/8);	  
rf2=Df2/2;	  
rfee=Dfee/2;%of	  
Pfee=30*133.33;%	  Pa,	  pressure	  at	  inlet	  of	  terminal	  feeding	  arteriole	  section	  
Vfee=7000;%um/s,	  assumed	  velocity	  in	  the	  terminal	  feeding	  art	  
Q1=(Vfee*(Dfee/2)^2*pi)*(10^-­‐6)^3;%Volumeteric	  Flowrate	  through	  feed	  art	  
Fd1=50;%[um]	  length	  	  beginning	  portion	  of	  feed	  arteriole	  
Fd3=2500;%um	  the	  distance	  seperating	  the	  end	  of	  the	  vascular	  component	  
%	  considered	  and	  the	  desired	  pressure,	  approximation	  
Fd2=100;%Distance	  seperating	  the	  two	  arterioles	  
visc1=eta(Dfee,Hct1);%viscosity	  at	  the	  inlet	  of	  the	  feeding	  arteriole.	  
R1=(8*visc1*10^-­‐4*Fd1*10^-­‐6)/(pi*(rfee*10^-­‐6)^4);	  
Pi1=Pfee-­‐Q1*R1;%Pressure	  at	  inlet	  of	  bifurcation	  arteriole	  
%Now	  need	  to	  calculate	  the	  Pressure	  of	  the	  other	  arteriole	  
visc3=eta(Df2,Hct1);%viscosity	  at	  the	  inlet	  of	  the	  feeding	  arteriole.	  
visc5=eta(Df2,Hct1);	  
R3=(8*visc3*10^-­‐4*Fd2*10^-­‐6)/(pi*(rf2*10^-­‐6)^4);	  
R5=(8*visc5*10^-­‐4*Fd3*10^-­‐6)/(pi*(rf2*10^-­‐6)^4);	  
%The	  same	  hematocrit	  shall	  be	  applied	  here	  as	  at	  the	  inlet	  of	  the	  two	  
%arteriole	  branches	  previously	  
%D1=12;	  
%Vi=1.5*10^3*((D1/2)/4)^3;%1.5*10^3*(7.65/4)^3;%um/s	  
La2a=35;%[um]	  first	  part	  of	  arteriole	  branch	  
La2b=40;%[um]second	  part	  of	  arteriole	  
Lcap1=275;%[um],Length	  of	  cap	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Lcap2=225;%[um],	  Length	  of	  other	  cap	  
	  
rcap=3;%[um]	  radius	  of	  capillaries	  
Dcap=2*rcap;	  
visccap=eta(Dcap,Hct1);%Initializing	  the	  caps	  
visc3=eta(Dfee,Hct1);	  
%viscosity	  at	  the	  inlet	  of	  the	  feeding	  arteriole.	  
%This	  is	  the	  same	  as	  the	  inlet	  viscosity	  inside	  the	  first	  arteriole	  branch	  
	  
visca=eta(D1,Hct1);%Units????cPoise	  %*//////////////////////////	  
%Need	  to	  use	  Pouseille	  flow	  to	  determine	  the	  pressure	  at	  the	  outlet	  
%Pin=26.7*133.33;%Pa,...	  
%pressure	  at	  the	  inlet	  of	  the	  vessel	  
%(31	  is	  in	  torr	  and	  I	  am	  converting	  it	  to	  Pascal)	  
Li=75;%	  um	  length	  of	  the	  tube	  
Di=D1;%Diameter	  of	  the	  parent	  vessel	  (um),diameter	  of	  terminol	  arteriole	  
	  
r=Di/2;	  
	  
Dc=3;%[um],	  diameter	  of	  capillaries	  
%Pb=3740;%Pbiff(	  Vi,Pi,visc1*10^-­‐3,Li,r);	  
%Qp=Vi*r^2*pi;%Volumetric	  flowrate	  inlet	  
%Trying	  to	  calculate	  the	  flowrate	  through	  the	  different	  arteriole	  branches	  
%These	  will	  also	  serve	  as	  initial	  guesses	  as	  we	  iteratively	  solve	  for	  flow	  
%rates,	  viscosities,	  and	  hcts	  
Lc=400;%[um],assumed	  length	  of	  capillaries	  
%Pout1=29*133.3;%Outlet	  of	  the	  bifurcating	  arterioles	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%Need	  to	  define	  the	  vessel	  resistances	  to	  calculate	  the	  vessel	  flowrates	  
%initial	  guesses	  for	  viscocity	  and	  Hct	  these	  will	  be	  iteratively	  changed	  
Da=Di;%*//////////////////////////	  
Db=Da3;%;{6;%(4/5)*Di;%um	  
Dp=Di;Bc=Bee(Hct1,	  Dp);xo=Xo	  (Hct1,Dp);	  
L2=75;%{Length	  of	  the	  arteriole	  branch	  plus	  the	  capillary	  
L3=75;%{note	  that	  this	  is	  only	  an	  approximation	  
r1=r;r2=Da/2;r3=Db/2;	  
visc6=eta(Da2,Hct1);	  
visc7=eta(Da3,Hct1);	  
visc8=eta(Dc,Hct1);	  
visc9=eta(Dc,Hct1);	  
visc10=eta(Dc,Hct1);	  
visc11=eta(Dc,Hct1);	  
visc12=eta(Dc,Hct1);	  
visc13=eta(Dc,Hct1);	  
visc14=eta(Dc,Hct1);	  
visc15=eta(Dc,Hct1);	  
visc16=eta(Dc,Hct1);	  
visc17=eta(Dc,Hct1);	  
visc18=eta(Dc,Hct1);	  
visc19=eta(Dc,Hct1);	  
R2=(8*visca*10^-­‐4*Li*10^-­‐6)/(pi*(r*10^-­‐6)^4);%*//////////////////////////	  
R6=(8*visc6*10^-­‐4*L2*10^-­‐6)/(pi*((Da2/2)*10^-­‐6)^4);	  
R7=(8*visc7*10^-­‐4*L3*10^-­‐6)/(pi*((Da3/2)*10^-­‐6)^4);	  
rc=3;	  
%For	  the	  moment	  we	  will	  assume	  that	  all	  of	  the	  capillaries	  are	  of	  the	  same	  
%length.	  	  Now	  this	  may	  change	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R8=(8*visc8*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R9=(8*visc9*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R10=(8*visc10*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R11=(8*visc11*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R12=(8*visc12*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R13=(8*visc13*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R14=(8*visc14*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R15=(8*visc15*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R16=(8*visc16*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R17=(8*visc17*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R18=(8*visc18*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R19=(8*visc19*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
%Large	  BIfurcation	  equivalent	  circuit	  
Rb1=R19*R18/(R19+R18);	  
Rb2=Rb1+R11;	  
Rb3=R17*R16/(R17+R16);	  
Rb4=Rb3+R10;	  
Rb5=Rb2*Rb4/(Rb2+Rb4);	  
Rb6=R7+Rb5;	  
Rb7=R14*R15/(R14+R15);	  
Rb8=Rb7+R9;	  
Rb9=R12*R13/(R12+R13);	  
Rb10=R8+Rb9;	  
Rb11=Rb10*Rb8/(Rb10+Rb8);	  
Rb12=Rb11+R6;	  
Rb13=Rb12*Rb6/(Rb12+Rb6);	  
Rb14=R2+Rb13;	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%Other	  arteriole	  equivalent	  circuit	  for	  the	  other	  arteriole	  
%Before	  I	  can	  calculate	  the	  equivalent	  circuit	  for	  the	  other	  arteriole,	  it	  
%is	  neccesary	  to	  calculate	  the	  resitances	  in	  each	  of	  the	  equivalent	  
%components!	  
%Larts=25;%[um]length	  of	  small	  part	  of	  the	  arteriole	  parts	  in	  the...	  
%second	  arteriole	  
visc4=eta(Da4,Hct1);%*//////////////////////////	  
visc20=eta(Dc,Hct1);	  
visc21=eta(Da,Hct1);%*//////////////////////////	  
visc22=eta(Dc,Hct1);	  
visc23=eta(Da,Hct1);%*//////////////////////////	  
visc24=eta(Dc,Hct1);	  
visc25=eta(Dc,Hct1);	  
visc26=eta(Dc,Hct1);	  
visc27=eta(Dc,Hct1);	  
visc28=eta(Dc,Hct1);	  
visc29=eta(Dc,Hct1);	  
R4=(8*visc4*10^-­‐4*La2a*10^-­‐6)/(pi*((Da4/2)*10^-­‐6)^4);	  
R20=(8*visc20*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R21=(8*visc21*10^-­‐4*La2b*10^-­‐6)/(pi*((Da/2)*10^-­‐6)^4);	  
R22=(8*visc22*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R23=(8*visc23*10^-­‐4*Li*10^-­‐6)/(pi*((Da/2)*10^-­‐6)^4);	  
R24=(8*visc24*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R25=(8*visc25*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R26=(8*visc26*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R27=(8*visc27*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R28=(8*visc28*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R29=(8*visc29*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	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%Now	  for	  the	  eq	  circuit	  
	  
	  
Rb21=R29*R28/(R29+R28);	  
Rb22=R24+Rb21;	  
Rb23=R26*R27/(R26+R27);	  
Rb24=R25+Rb23;	  
Rb25=Rb24*Rb22/(Rb24+Rb22);	  
Rb26=Rb25+R23;	  
Rb27=Rb26*R22/(Rb26+R22);	  
Rb28=R21+Rb27;	  
Rb29=R20*Rb28/(R20+Rb28);	  
Rb30=R4+Rb29;	  
	  
%Total	  equivalent	  circuit	  for	  the	  feeding	  arteiole	  and	  the	  two	  terminal	  
%arterioles:This	  is	  an	  approximation	  to	  determine	  the	  external	  pressure	  
	  
Rb31=Rb30*R5/(Rb30+R5);	  
Rb32=Rb31+R3;	  
Rb33=Rb32*Rb14/(Rb32+Rb14);	  
Retot=Rb33+R1;%our	  total	  equivalent	  circuit	  
	  
Pout=Pfee-­‐Q1*Retot;%Outlet	  pressure	  	  
	  
Q2=(Pi1-­‐Pout)/Rb14;%Flow	  through	  the	  first	  arteriole	  branch	  
Q3=Q1-­‐Q2;%Flow	  continuing	  from	  the	  first	  arteriole	  along	  	  
%the	  terminal	  arteriole	  towards	  the	  additional	  arteriole.	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%To	  calculate	  the	  Pressure	  before	  entering	  the	  second	  arteriole	  
Part2=Pi1-­‐Q3*R3;%Pressure	  into	  the	  inlet	  of	  second	  arteriole.	  
	  
%We	  can	  now	  assume	  the	  flow	  through	  the	  second	  arteriole	  branch	  
Q4=(Part2-­‐Pout)/Rb30;	  
Q5=Q3-­‐Q4;	  
	  
	  
%Going	  to	  try	  and	  calculate	  the	  flow	  through	  the	  different	  vascular	  
%components	  
mat=[0	  0	  0	  0	  0	  0	  -­‐R12	  R13	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  -­‐R8	  R9	  0	  0	  0	  -­‐R13	  R14	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R14	  R15	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  -­‐R6	  R7	  0	  -­‐R9	  R10	  0	  0	  0	  0	  -­‐R15	  R16	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  ;...24	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R16	  R17	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R18	  R19	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R26	  R27	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  R24	  -­‐R25	  0	  -­‐R27	  R28	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  	  -­‐R28	  R29;...checked	  
	  	  	  	  	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  1	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  	  
	  	  	  	  	  0	  1	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  1	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0;...	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  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  -­‐1	  -­‐1	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  -­‐1	  -­‐1	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  R20	  -­‐R21	  -­‐R22	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  -­‐R10	  R11	  0	  0	  0	  0	  0	  -­‐R17	  R18	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  R22	  -­‐R23	  -­‐R24	  0	  0	  0	  0	  -­‐R29];	  
	  	  	  	  	  	  
	  	  
	  ex=[0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐Q2	  0	  0	  0	  0	  0	  0	  -­‐Q4	  0	  0	  0	  0	  0	  0	  0];	  
	  	  
	  inmat=inv(mat);	  
	  Flows=inmat*ex';	  	  
	  Q6=Flows(1);	  Q7=Flows(2);	  Q8=Flows(3);Q9=Flows(4);Q10=Flows(5);	  
	  Q11=Flows(6);	  Q12=Flows(7);	  Q13=Flows(8);Q14=Flows(9);Q15=Flows(10);	  
	  Q16=Flows(11);	  Q17=Flows(12);	  Q18=Flows(13);Q19=Flows(14);Q20=Flows(15);	  
	  Q21=Flows(16);	  Q22=Flows(17);	  Q23=Flows(18);Q24=Flows(19);Q25=Flows(20);	  
	  Q26=Flows(21);	  Q27=Flows(22);	  Q28=Flows(23);Q29=Flows(24);	  
	  %Flowcalc=Q1-­‐Q12-­‐Q13-­‐Q14-­‐Q15-­‐Q16-­‐Q17-­‐Q18-­‐Q19-­‐Q26-­‐Q27-­‐Q28-­‐Q29-­‐Q20-­‐Q22-­‐Q5;	  
	  %flow_out=(Flowcalc/Q1)*100;	  
	  %flow_out=[Q1	  Q2	  Q3	  Q4	  Q5	  Q6	  Q7	  Q8	  Q9	  Q10	  Q11	  Q12	  Q13	  Q14	  Q15	  Q16	  ...	  
	  	  	  	  %	  Q17	  Q18	  Q19	  Q20	  Q21	  Q22	  Q23	  Q24	  Q25	  Q26	  Q27	  Q28	  Q29];	  	  	  	  	  
	  
%Now	  the	  flowrates	  and	  hcts	  in	  the	  respective	  other	  branches	  must	  be	  
%calculated	  
	  
%In	  actuality	  the	  first	  division	  of	  blood	  shall	  occur	  when	  the	  blood	  
%decides	  to	  enter	  the	  first	  bifurcating	  arteriole	  or	  not.	  	  Therefore:	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%Where	  BFc	  is	  the	  continuation	  of	  the	  blood	  flow	  pass	  the	  first	  bifurcation	  
	  
%Looking	  at	  the	  fractions	  of	  blood	  flow	  we	  get	  
	  
Fb2=Q2/Q1;	  Fb3=Q3/Q1;	  Xob1=Xo	  (Hct1,Dfee);	  
	  
if	  Fb2<=Xob1	  
	  	  	  	  Hct2=0;	  %*//////////////////////////	  
else	  
	  	  	  	  	  
Sbeta1=fraclogit(A(Da1,Df2,Dfee,Hct1),Bee	  (Hct1,	  Dfee),Fb2,Xo	  (Hct1,Dfee)	  );	  
Fr2=exp(Sbeta1)/(1+exp(Sbeta1));	  
	  
Hct2=(Fr2)*(1/Fb2)*Hct1;%Hct	  entering	  the	  first	  arteriole	  %*//////////////////////////	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb3>=0.94	  
	  	  	  	  Fr3=1;	  
else	  
Salpha1=fraclogit(A(Da1,Df2,Dfee,Hct1),Bee	  (Hct1,	  Dfee),Fb3,Xo	  (Hct1,Dfee)	  );	  
	  
Fr3=exp(Salpha1)/(1+exp(Salpha1));	  
end	  
Hct3=(Fr3)*(1/Fb3)*Hct1;	  %Hct	  bypassing	  the	  first	  arteriole	  
	  
%Now	  to	  work	  our	  way	  down	  the	  bifurcations	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%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb6=Q6/Q2;Fb7=Q7/Q2;Xob2=Xo	  (Hct2,Da1);	  
	  
if	  Fb6<=Xob2	  
	  	  	  	  Hct6=0;	  
else	  
lfebeta=fraclogit(A(Da3,Da2,Da1,Hct2),Bee	  (Hct2,	  Da1),...	  
	  	  	  	  Fb6,Xo	  (Hct2,(Da1/2))	  );	  
Feb6=exp(lfebeta)/(1+exp(lfebeta));	  
Hct6=(Feb6)*Hct2*(1/Fb6);	  
end	  
	  
if	  Fb7>=0.94	  
	  	  	  	  Fea7=1;	  
else	  
	  
lfealpha7=fraclogit(A(Da3,Da2,Da1,Hct2),Bee	  (Hct2,	  Da1),...	  
	  	  	  	  Fb7,Xo	  (Hct2,Da1)	  );	  
Fea7=exp(lfealpha7)/(1+exp(lfealpha7));	  
end	  
	  
Hct7=(Fea7)*Hct2*(1/Fb7);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  capillaries	  
Fb8=Q8/Q6;	  Fb9=Q9/Q6;	  Xob3=Xo	  (Hct6,Da2);	  
	  
if	  Fb8<=Xob3	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  Hct8=0;	  
else	  
	  	  	  	  	  
Sbeta8=fraclogit(A(Dc,Dc,Da2,Hct6),Bee	  (Hct6,	  Da2),Fb8,Xo	  (Hct6,Da2)	  );	  
Fr8=exp(Sbeta8)/(1+exp(Sbeta8));	  
	  
Hct8=(Fr8)*(1/Fb8)*Hct6;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb9>=0.94	  
	  	  	  	  Fr9=1;	  
else	  
Salpha9=fraclogit(A(Dc,Dc,Da2,Hct6),Bee	  (Hct6,	  Da2),Fb9,Xo	  (Hct6,Da2)	  );	  
	  
Fr9=exp(Salpha9)/(1+exp(Salpha9));	  
end	  
Hct9=(Fr9)*(1/Fb9)*Hct6;	  	  
	  
%Continuing	  down	  the	  same	  capillary	  path....	  
	  
Fb12=Q12/Q8;Fb13=Q13/Q8;Xob4=Xo	  (Hct8,Dc);	  
	  
if	  Fb12<=Xob4	  
	  	  	  	  Hct12=0;	  
else	  
lfebeta12=fraclogit(A(Dc,Dc,Dc,Hct8),Bee	  (Hct8,	  Dc),Fb12,Xo	  (Hct8,Dc)	  );	  
Feb12=exp(lfebeta12)/(1+exp(lfebeta12));	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Hct12=(Feb12)*Hct8*(1/Fb12);	  
end	  
	  
if	  Fb13>=0.94	  
	  	  	  	  Fea13=1;	  
else	  
	  
lfealpha13=fraclogit(A(Dc,Dc,Dc,Hct8),Bee	  (Hct8,	  Dc),Fb13,Xo	  (Hct8,Dc)	  );	  
Fea13=exp(lfealpha13)/(1+exp(lfealpha13));	  
end	  
	  
Hct13=(Fea13)*Hct8*(1/Fb13);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  more	  capillaries	  
Fb14=Q14/Q9;	  Fb15=Q15/Q9;	  Xob5=Xo	  (Hct9,Dc);	  
	  
if	  Fb14<=Xob5	  
	  	  	  	  Hct14=0;	  
else	  
	  	  	  	  	  
Sbeta14=fraclogit(A(Dc,Dc,Dc,Hct9),Bee	  (Hct9,	  Dc),Fb14,Xo	  (Hct9,Dc)	  );	  
Fr14=exp(Sbeta14)/(1+exp(Sbeta14));	  
	  
Hct14=(Fr14)*(1/Fb14)*Hct9;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb15>=0.94	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  Fr15=1;	  
else	  
Salpha15=fraclogit(A(Dc,Dc,Dc,Hct9),Bee	  (Hct9,	  Dc),Fb15,Xo	  (Hct9,Dc)	  );	  
	  
Fr15=exp(Salpha15)/(1+exp(Salpha15));	  
end	  
Hct15=(Fr15)*(1/Fb15)*Hct9;	  	  
	  
%Now	  to	  work	  our	  way	  down	  the	  bifurcations	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb10=Q10/Q7;Fb11=Q11/Q7;Xob6=Xo	  (Hct7,Da3);	  
	  
if	  Fb10<=Xob6	  
	  	  	  	  Hct10=0;	  
else	  
lfebeta10=fraclogit(A(Dc,Dc,Da3,Hct7),Bee	  (Hct7,	  Da3),Fb10,Xo	  (Hct7,Da3)	  );	  
Feb10=exp(lfebeta10)/(1+exp(lfebeta10));	  
Hct10=(Feb10)*Hct7*(1/Fb10);	  
end	  
	  
if	  Fb11>=0.94	  
	  	  	  	  Fea11=1;	  
else	  
	  
lfealpha11=fraclogit(A(Dc,Dc,Da3,Hct7),Bee	  (Hct7,	  Da3),Fb11,Xo	  (Hct7,Da3)	  );	  
Fea11=exp(lfealpha11)/(1+exp(lfealpha11));	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end	  
	  
Hct11=(Fea11)*Hct7*(1/Fb11);	  
	  
%Continuing	  down	  
Fb16=Q16/Q10;Fb17=Q17/Q10;Xob7=Xo	  (Hct10,Dc);	  
	  
if	  Fb16<=Xob7	  
	  	  	  	  Hct16=0;	  
else	  
lfebeta16=fraclogit(A(Dc,Dc,Dc,Hct10),Bee	  (Hct10,	  Dc),Fb16,Xo	  (Hct10,Dc)	  );	  
Feb16=exp(lfebeta16)/(1+exp(lfebeta16));	  
Hct16=(Feb16)*Hct10*(1/Fb16);	  
end	  
	  
if	  Fb17>=0.94	  
	  	  	  	  Fea17=1;	  
else	  
	  
lfealpha17=fraclogit(A(Dc,Dc,Dc,Hct10),Bee	  (Hct10,	  Dc),Fb17,Xo	  (Hct10,Dc)	  );	  
Fea17=exp(lfealpha17)/(1+exp(lfealpha17));	  
end	  
	  
Hct17=(Fea17)*Hct10*(1/Fb17);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  more	  capillaries	  
Fb18=Q18/Q11;	  Fb19=Q19/Q11;	  Xob8=Xo	  (Hct11,Dc);	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if	  Fb18<=Xob8	  
	  	  	  	  Hct18=0;	  
else	  
	  	  	  	  	  
Sbeta18=fraclogit(A(Dc,Dc,Dc,Hct11),Bee	  (Hct11,	  Dc),Fb18,Xo	  (Hct11,Dc)	  );	  
Fr18=exp(Sbeta18)/(1+exp(Sbeta18));	  
	  
Hct18=(Fr18)*(1/Fb18)*Hct11;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb19>=0.94	  
	  	  	  	  Fr19=1;	  
else	  
Salpha19=fraclogit(A(Dc,Dc,Dc,Hct11),Bee	  (Hct11,	  Dc),Fb19,Xo	  (Hct11,Dc)	  );	  
	  
Fr19=exp(Salpha19)/(1+exp(Salpha19));	  
end	  
Hct19=(Fr19)*(1/Fb19)*Hct11;	  	  
	  
%Finishing	  the	  first	  of	  the	  arterioles.....moving	  along	  to	  the	  other	  
%arterioles	  
	  
Fb4=Q4/Q3;	  Fb5=Q5/Q3;	  Xob9=Xo	  (Hct3,Dfee);	  
	  
if	  Fb4<=Xob9	  
	  	  	  	  Hct4=0;	  
else	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Sbeta4=fraclogit(A(Da4,Df2,Df2,Hct3),Bee	  (Hct3,	  Df2),Fb4,Xo	  (Hct3,Df2)	  );	  
Fr4=exp(Sbeta4)/(1+exp(Sbeta4));	  
	  
Hct4=(Fr4)*(1/Fb4)*Hct3;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb5>=0.94	  
	  	  	  	  Fr5=1;	  
else	  
Salpha5=fraclogit(A(Da4,Df2,Df2,Hct3),Bee	  (Hct3,	  Df2),Fb5,Xo	  (Hct3,Df2)	  );	  
	  
Fr5=exp(Salpha5)/(1+exp(Salpha5));	  
end	  
Hct5=(Fr5)*(1/Fb5)*Hct3;	  %Hct	  bypassing	  the	  first	  arteriole	  
	  
%Now	  to	  work	  our	  way	  down	  the	  additional	  arteriole	  	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb20=Q20/Q4;Fb21=Q21/Q4;Xob10=Xo	  (Hct4,Da4);	  
	  
if	  Fb20<=Xob10	  
	  	  	  	  Hct20=0;	  
else	  
lfebeta20=fraclogit(A(Da,Dc,Da4,Hct4),Bee	  (Hct4,	  Da4),Fb20,Xo	  (Hct4,Da4)	  );	  
Feb20=exp(lfebeta20)/(1+exp(lfebeta20));	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Hct20=(Feb20)*Hct4*(1/Fb20);	  
end	  
	  
if	  Fb21>=0.94	  
	  	  	  	  Fea21=1;	  
else	  
	  
lfealpha21=fraclogit(A(Da,Dc,Da4,Hct4),Bee	  (Hct4,	  Da4),Fb21,Xo	  (Hct4,Da4)	  );	  
Fea21=exp(lfealpha21)/(1+exp(lfealpha21));	  
end	  
	  
Hct21=(Fea21)*Hct4*(1/Fb21);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  more	  capillaries	  
Fb22=Q22/Q21;	  Fb23=Q23/Q21;	  Xob11=Xo	  (Hct21,Da4);	  
	  
if	  Fb22<=Xob11	  
	  	  	  	  Hct22=0;	  
else	  
	  	  	  	  	  
Sbeta22=fraclogit(A(Da,Dc,Da,Hct21),Bee	  (Hct21,	  Da),Fb22,Xo	  (Hct21,Da)	  );	  
Fr22=exp(Sbeta22)/(1+exp(Sbeta22));	  
	  
Hct22=(Fr22)*(1/Fb22)*Hct21;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb23>=0.94	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  Fr23=1;	  
else	  
Salpha23=fraclogit(A(Da,Dc,Da,Hct21),Bee	  (Hct21,	  Da),Fb23,Xo	  (Hct21,Da)	  );	  
	  
Fr23=exp(Salpha23)/(1+exp(Salpha23));	  
end	  
Hct23=(Fr23)*(1/Fb23)*Hct21;	  	  
	  
%Continuing	  down	  the	  same	  capillary	  path....	  
	  
Fb25=Q25/Q23;Fb24=Q24/Q23;Xob12=Xo	  (Hct23,Da);	  
	  
if	  Fb25<=Xob12	  
	  	  	  	  Hct25=0;	  
else	  
lfebeta25=fraclogit(A(Dc,Dc,Da,Hct23),Bee	  (Hct23,	  Da),Fb23,Xo	  (Hct23,Da)	  );	  
Feb25=exp(lfebeta25)/(1+exp(lfebeta25));	  
Hct25=(Feb25)*Hct23*(1/Fb25);	  
end	  
	  
if	  Fb24>=0.94	  
	  	  	  	  Fea24=1;	  
else	  
	  
lfealpha24=fraclogit(A(Dc,Dc,Da,Hct23),Bee	  (Hct23,	  Da),Fb24,Xo	  (Hct23,Da)	  );	  
Fea24=exp(lfealpha24)/(1+exp(lfealpha24));	  
end	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Hct24=(Fea24)*Hct23*(1/Fb24);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  final	  capillaries	  
Fb28=Q28/Q24;	  Fb29=Q29/Q24;	  Xob13=Xo	  (Hct24,Dc);	  
	  
if	  Fb28<=Xob13	  
	  	  	  	  Hct28=0;	  
else	  
	  	  	  	  	  
Sbeta28=fraclogit(A(Dc,Dc,Dc,Hct24),Bee	  (Hct24,	  Dc),Fb28,Xo	  (Hct24,Dc)	  );	  
Fr28=exp(Sbeta28)/(1+exp(Sbeta28));	  
	  
Hct28=(Fr28)*(1/Fb28)*Hct24;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb29>=0.94	  
	  	  	  	  Fr29=1;	  
else	  
Salpha29=fraclogit(A(Dc,Dc,Dc,Hct24),Bee	  (Hct24,	  Dc),Fb29,Xo	  (Hct24,Dc)	  );	  
	  
Fr29=exp(Salpha29)/(1+exp(Salpha29));	  
end	  
Hct29=(Fr29)*(1/Fb29)*Hct24;	  	  
	  
%Final	  Capillary	  bifurcation	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	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%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb26=Q26/Q25;Fb27=Q27/Q25;Xob14=Xo	  (Hct25,Dc);	  
	  
if	  Fb26<=Xob14	  
	  	  	  	  Hct26=0;	  
else	  
lfebeta26=fraclogit(A(Dc,Dc,Dc,Hct25),Bee	  (Hct25,	  Dc),Fb26,Xo	  (Hct25,Dc)	  );	  
Feb26=exp(lfebeta26)/(1+exp(lfebeta26));	  
Hct26=(Feb26)*Hct25*(1/Fb26);	  
end	  
	  
if	  Fb27>=0.94	  
	  	  	  	  Fea27=1;	  
else	  
	  
lfealpha27=fraclogit(A(Dc,Dc,Dc,Hct25),Bee	  (Hct25,	  Dc),Fb27,Xo	  (Hct25,Dc)	  );	  
Fea27=exp(lfealpha27)/(1+exp(lfealpha27));	  
end	  
	  
Hct27=(Fea27)*Hct25*(1/Fb27);	  
	  
%This	  should	  be	  it	  for	  the	  arterioles	  
	  
	  
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{	  
%	  %So	  that	  should	  be	  it	  for	  the	  first	  arteriole	  
%	  	  
%	  %Moving	  down	  to	  solve	  for	  the	  hct	  distribution	  in	  the	  second	  arteriole	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%Blood	  Flows	  
%Calculating	  and	  resetting	  the	  viscosities	  
visc6n=eta(Da2,Hct6);	  
visc7n=eta(Da3,Hct7);	  
visc8n=eta(Dc,Hct8);	  
visc9n=eta(Dc,Hct9);	  
visc10n=eta(Dc,Hct10);	  
visc11n=eta(Dc,Hct11);	  
visc12n=eta(Dc,Hct12);	  
visc13n=eta(Dc,Hct13);	  
visc14n=eta(Dc,Hct14);	  
visc15n=eta(Dc,Hct15);	  
visc16n=eta(Dc,Hct16);	  
visc17n=eta(Dc,Hct17);	  
visc18n=eta(Dc,Hct18);	  
visc19n=eta(Dc,Hct19);	  
	  
visc4n=eta(Da4,Hct4);	  
visc20n=eta(Dc,Hct20);	  
visc21n=eta(Da,Hct21);	  
visc22n=eta(Dc,Hct22);	  
visc23n=eta(Da,Hct23);	  
visc24n=eta(Dc,Hct24);	  
visc25n=eta(Dc,Hct25);	  
visc26n=eta(Dc,Hct26);	  
visc27n=eta(Dc,Hct27);	  
visc28n=eta(Dc,Hct28);	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visc29n=eta(Dc,Hct29);	  
viscan=eta(Da1,Hct2);	  
	  
	  
	  
%Initializing	  the	  error	  parameters	  
Error=1;	  maxi=100;	  
while	  Error>=0.001	  
	  
	  
R2n=(8*viscan*10^-­‐4*Li*10^-­‐6)/(pi*(r*10^-­‐6)^4);	  
R6n=(8*visc6n*10^-­‐4*L2*10^-­‐6)/(pi*((Da2/2)*10^-­‐6)^4);	  
R7n=(8*visc7n*10^-­‐4*L3*10^-­‐6)/(pi*((Da3/2)*10^-­‐6)^4);	  
%For	  the	  moment	  we	  will	  assume	  that	  all	  of	  the	  capillaries	  are	  of	  the	  same	  
%length.	  	  Now	  this	  may	  change	  
R8n=(8*visc8n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R9n=(8*visc9n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R10n=(8*visc10n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R11n=(8*visc11n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R12n=(8*visc12n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R13n=(8*visc13n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R14n=(8*visc14n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R15n=(8*visc15n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R16n=(8*visc16n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R17n=(8*visc17n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R18n=(8*visc18n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R19n=(8*visc19n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
%Large	  BIfurcation	  equivalent	  circuit	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Rb1n=R19n*R18n/(R19n+R18n);	  
Rb2n=Rb1n+R11n;	  
Rb3n=R17n*R16n/(R17n+R16n);	  
Rb4n=Rb3n+R10n;	  
Rb5n=Rb2n*Rb4n/(Rb2n+Rb4n);	  
Rb6n=R7n+Rb5n;	  
Rb7n=R14n*R15n/(R14n+R15n);	  
Rb8n=Rb7n+R9n;	  
Rb9n=R12n*R13n/(R12n+R13n);	  
Rb10n=R8n+Rb9n;	  
Rb11n=Rb10n*Rb8n/(Rb10n+Rb8n);	  
Rb12n=Rb11n+R6n;	  
Rb13n=Rb12n*Rb6n/(Rb12n+Rb6n);	  
Rb14n=R2n+Rb13n;	  
	  
%Other	  arteriole	  equivalent	  circuit	  for	  the	  other	  arteriole	  
%Before	  I	  can	  calculate	  the	  equivalent	  circuit	  for	  the	  other	  arteriole,	  it	  
%is	  neccesary	  to	  calculate	  the	  resitances	  in	  each	  of	  the	  equivalent	  
%components!	  
%Larts=25;%[um]length	  of	  small	  part	  of	  the	  arteriole	  parts	  in	  the...	  
%second	  arteriole	  
	  
R4n=(8*visc4n*10^-­‐4*La2a*10^-­‐6)/(pi*((Da4/2)*10^-­‐6)^4);	  
R20n=(8*visc20n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R21n=(8*visc21n*10^-­‐4*La2b*10^-­‐6)/(pi*((Da/2)*10^-­‐6)^4);	  
R22n=(8*visc22n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R23n=(8*visc23n*10^-­‐4*Li*10^-­‐6)/(pi*((Da/2)*10^-­‐6)^4);	  
R24n=(8*visc24n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	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R25n=(8*visc25n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R26n=(8*visc26n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R27n=(8*visc27n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R28n=(8*visc28n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
R29n=(8*visc29n*10^-­‐4*Lc*10^-­‐6)/(pi*(rc*10^-­‐6)^4);	  
	  
%Now	  for	  the	  eq	  circuit	  
	  
	  
Rb21n=R29n*R28n/(R29n+R28n);	  
Rb22n=R24n+Rb21n;	  
Rb23n=R26n*R27n/(R26n+R27n);	  
Rb24n=R25n+Rb23n;	  
Rb25n=Rb24n*Rb22n/(Rb24n+Rb22n);	  
Rb26n=Rb25n+R23n;	  
Rb27n=Rb26n*R22n/(Rb26n+R22n);	  
Rb28n=R21n+Rb27n;	  
Rb29n=R20n*Rb28n/(R20n+Rb28n);	  
Rb30n=R4n+Rb29n;	  
	  
%Total	  equivalent	  circuit	  for	  the	  feeding	  arteiole	  and	  the	  two	  terminal	  
%arterioles:This	  is	  an	  approximation	  to	  determine	  the	  external	  pressure	  
	  
Rb31n=Rb30n*R5/(Rb30n+R5);	  
Rb32n=Rb31n+R3;	  
Rb33n=Rb32n*Rb14n/(Rb32n+Rb14n);	  
Retotn=Rb33n+R1;%our	  total	  equivalent	  circuit	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Poutn=Pfee-­‐Q1*Retotn;%Outlet	  pressure	  	  
	  
Q2n=(Pi1-­‐Poutn)/Rb14n;%Flow	  through	  the	  first	  arteriole	  branch	  
Q3n=Q1-­‐Q2n;%Flow	  continuing	  from	  the	  first	  arteriole	  along	  	  
%the	  terminal	  arteriole	  towards	  the	  additional	  arteriole.	  
%To	  calculate	  the	  Pressure	  before	  entering	  the	  second	  arteriole	  
Part2n=Pi1-­‐Q3n*R3;%Pressure	  into	  the	  inlet	  of	  second	  arteriole.	  
	  
%We	  can	  now	  assume	  the	  flow	  through	  the	  second	  arteriole	  branch	  
Q4n=(Part2n-­‐Pout)/Rb30n;	  
Q5n=Q3n-­‐Q4n;	  
	  
	  
%Going	  to	  try	  and	  calculate	  the	  flow	  through	  the	  different	  vascular	  
%components	  
matn=[0	  0	  0	  0	  0	  0	  -­‐R12n	  R13n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  -­‐R8n	  R9n	  0	  0	  0	  -­‐R13n	  R14n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R14n	  R15n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  -­‐R6n	  R7n	  0	  -­‐R9n	  R10n	  0	  0	  0	  0	  -­‐R15n	  R16n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  ;...24	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R16n	  R17n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R18n	  R19n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐R26n	  R27n	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  R24n	  -­‐R25n	  0	  -­‐R27n	  R28n	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  	  -­‐R28n	  R29n;...checked	  
	  	  	  	  	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  1	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  	  
	  	  	  	  	  0	  1	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
323	  
	  
	  	  	  	  	  0	  0	  0	  1	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  1	  0	  0	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  -­‐1	  -­‐1	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  -­‐1	  -­‐1	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  -­‐1	  -­‐1	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  1	  0	  0	  0	  -­‐1	  -­‐1;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  R20n	  -­‐R21n	  -­‐R22n	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  -­‐R10n	  R11n	  0	  0	  0	  0	  0	  -­‐R17n	  R18n	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0;...	  
	  	  	  	  	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  0	  R22n	  -­‐R23n	  -­‐R24n	  0	  0	  0	  0	  -­‐R29n];	  
	  	  	  	  	  	  
	  	  
	  exn=[0	  0	  0	  0	  0	  0	  0	  0	  0	  -­‐Q2n	  0	  0	  0	  0	  0	  0	  -­‐Q4n	  0	  0	  0	  0	  0	  0	  0];	  
	  	  
	  inmatn=inv(matn);	  
	  Flowsn=inmatn*exn';	  	  
	  Q6n=Flowsn(1);	  Q7n=Flowsn(2);	  Q8n=Flowsn(3);Q9n=Flowsn(4);Q10n=Flowsn(5);	  
	  Q11n=Flowsn(6);	  Q12n=Flowsn(7);	  Q13n=Flowsn(8);Q14n=Flowsn(9);Q15n=Flowsn(10);	  
	  Q16n=Flowsn(11);	  Q17n=Flowsn(12);	  Q18n=Flowsn(13);Q19n=Flowsn(14);Q20n=Flowsn(15);	  
	  Q21n=Flowsn(16);	  Q22n=Flowsn(17);	  Q23n=Flowsn(18);Q24n=Flowsn(19);Q25n=Flowsn(20);	  
	  Q26n=Flowsn(21);	  Q27n=Flowsn(22);	  Q28n=Flowsn(23);Q29n=Flowsn(24);	  
	  %Flowcalc=Q1-­‐Q12-­‐Q13-­‐Q14-­‐Q15-­‐Q16-­‐Q17-­‐Q18-­‐Q19-­‐Q26-­‐Q27-­‐Q28-­‐Q29-­‐Q20-­‐Q22-­‐Q5;	  
	  %flow_out=(Flowcalc/Q1)*100;	  
	  %flow_out=[Q1	  Q2	  Q3	  Q4	  Q5	  Q6	  Q7	  Q8	  Q9	  Q10	  Q11	  Q12	  Q13	  Q14	  Q15	  Q16	  ...	  
	  	  	  	  %	  Q17	  Q18	  Q19	  Q20	  Q21	  Q22	  Q23	  Q24	  Q25	  Q26	  Q27	  Q28	  Q29];	  	  	  	  	  
	  
%Now	  the	  flowrates	  and	  hcts	  in	  the	  respective	  other	  branches	  must	  be	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%calculated	  
	  
%In	  actuality	  the	  first	  division	  of	  blood	  shall	  occur	  when	  the	  blood	  
%decides	  to	  enter	  the	  first	  bifurcating	  arteriole	  or	  not.	  	  Therefore:	  
	  
%Where	  BFc	  is	  the	  continuation	  of	  the	  blood	  flow	  pass	  the	  first	  bifurcation	  
	  
%Looking	  at	  the	  fractions	  of	  blood	  flow	  we	  get	  
	  
Fb2n=Q2n/Q1;	  Fb3n=Q3n/Q1;	  Xob1n=Xo	  (Hct1,Dfee);	  
	  
if	  Fb2n<=Xob1n	  
	  	  	  	  Hct2n=0;	  
else	  
	  	  	  	  	  
Sbeta1n=fraclogit(A(Da1,Dfee,Dfee,Hct1),Bee	  (Hct1,	  Dfee),Fb2n,Xo	  (Hct1,Dfee)	  );	  
Fr2n=exp(Sbeta1n)/(1+exp(Sbeta1n));	  
	  
Hct2n=(Fr2n)*(1/Fb2n)*Hct1;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb3n>=0.94	  
	  	  	  	  Fr3n=1;	  
else	  
Salpha1n=fraclogit(A(Da1,Df2,Dfee,Hct1),Bee	  (Hct1,	  Dfee),Fb3n,Xo	  (Hct1,Dfee)	  );	  
	  
Fr3n=exp(Salpha1n)/(1+exp(Salpha1n));	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end	  
Hct3n=(Fr3n)*(1/Fb3n)*Hct1;	  %Hct	  bypassing	  the	  first	  arteriole	  
	  
%Now	  to	  work	  our	  way	  down	  the	  bifurcations	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb6n=Q6n/Q2n;Fb7n=Q7n/Q2n;Xob2n=Xo	  (Hct2n,Da1);	  
	  
if	  Fb6n<=Xob2n	  
	  	  	  	  Hct6n=0;	  
else	  
lfebetan=fraclogit(A(Da3,Da2,Da1,Hct2n),Bee	  (Hct2n,	  Da1),Fb6n,Xo	  (Hct2n,Da1)	  );	  
Feb6n=exp(lfebetan)/(1+exp(lfebetan));	  
Hct6n=(Feb6n)*Hct2n*(1/Fb6n);	  
end	  
	  
if	  Fb7n>=0.94	  
	  	  	  	  Fea7n=1;	  
else	  
	  
lfealpha7n=fraclogit(A(Da3,Da2,Da1,Hct2n),Bee	  (Hct2n,	  Da1),Fb7n,Xo	  (Hct2n,Da1)	  );	  
Fea7n=exp(lfealpha7n)/(1+exp(lfealpha7n));	  
end	  
	  
Hct7n=(Fea7n)*Hct2n*(1/Fb7n);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  capillaries	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Fb8n=Q8n/Q6n;	  Fb9n=Q9n/Q6n;	  Xob3n=Xo	  (Hct6n,Da2);	  
	  
if	  Fb8n<=Xob3n	  
	  	  	  	  Hct8n=0;	  
else	  
	  	  	  	  	  
Sbeta8n=fraclogit(A(Dc,Dc,Da2,Hct6n),Bee	  (Hct6n,	  Da2),Fb8n,Xo	  (Hct6n,Da2)	  );	  
Fr8n=exp(Sbeta8n)/(1+exp(Sbeta8n));	  
	  
Hct8n=(Fr8n)*(1/Fb8n)*Hct6n;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb9n>=0.94	  
	  	  	  	  Fr9n=1;	  
else	  
Salpha9n=fraclogit(A(Dc,Dc,Da2,Hct6n),Bee	  (Hct6n,	  Da2),Fb9n,Xo	  (Hct6n,Da2)	  );	  
	  
Fr9n=exp(Salpha9n)/(1+exp(Salpha9n));	  
end	  
Hct9n=(Fr9n)*(1/Fb9n)*Hct6n;	  	  
	  
%Continuing	  down	  the	  same	  capillary	  path....	  
	  
Fb12n=Q12n/Q8n;Fb13n=Q13n/Q8n;Xob4n=Xo	  (Hct8n,Dc);	  
	  
if	  Fb12n<=Xob4n	  
	  	  	  	  Hct12n=0;	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else	  
lfebeta12n=fraclogit(A(Dc,Dc,Dc,Hct8n),Bee	  (Hct8n,	  Dc),Fb12n,Xo	  (Hct8n,Dc)	  );	  
Feb12n=exp(lfebeta12n)/(1+exp(lfebeta12n));	  
Hct12n=(Feb12n)*Hct8n*(1/Fb12n);	  
end	  
	  
if	  Fb13n>=0.94	  
	  	  	  	  Fea13n=1;	  
else	  
	  
lfealpha13n=fraclogit(A(Dc,Dc,Dc,Hct8n),Bee	  (Hct8n,	  Dc),Fb13n,Xo	  (Hct8n,Dc)	  );	  
Fea13n=exp(lfealpha13n)/(1+exp(lfealpha13n));	  
end	  
	  
Hct13n=(Fea13n)*Hct8n*(1/Fb13n);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  more	  capillaries	  
Fb14n=Q14n/Q9n;	  Fb15n=Q15n/Q9;	  Xob5n=Xo	  (Hct9n,Dc);	  
	  
if	  Fb14n<=Xob5n	  
	  	  	  	  Hct14n=0;	  
else	  
	  	  	  	  	  
Sbeta14n=fraclogit(A(Dc,Dc,Dc,Hct9n),Bee	  (Hct9n,	  Dc),Fb14n,Xo	  (Hct9n,Dc)	  );	  
Fr14n=exp(Sbeta14n)/(1+exp(Sbeta14n));	  
	  
Hct14n=(Fr14n)*(1/Fb14n)*Hct9n;%Hct	  entering	  the	  first	  arteriole	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end	  
	  
if	  Fb15n>=0.94	  
	  	  	  	  Fr15n=1;	  
else	  
Salpha15n=fraclogit(A(Dc,Dc,Dc,Hct9n),Bee	  (Hct9n,	  Dc),Fb15n,Xo	  (Hct9n,Dc)	  );	  
	  
Fr15n=exp(Salpha15n)/(1+exp(Salpha15n));	  
end	  
Hct15n=(Fr15n)*(1/Fb15n)*Hct9n;	  	  
	  
%Now	  to	  work	  our	  way	  down	  the	  bifurcations	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb10n=Q10n/Q7n;Fb11n=Q11n/Q7n;Xob6n=Xo	  (Hct7n,Da3);	  
	  
if	  Fb10<=Xob6	  
	  	  	  	  Hct10n=0;	  
else	  
lfebeta10n=fraclogit(A(Dc,Dc,Da3,Hct7n),Bee	  (Hct7n,	  Dp),Fb10n,Xo	  (Hct7n,Da3)	  );	  
Feb10n=exp(lfebeta10n)/(1+exp(lfebeta10n));	  
Hct10n=(Feb10n)*Hct7n*(1/Fb10n);	  
end	  
	  
if	  Fb11n>=0.94	  
	  	  	  	  Fea11n=1;	  
else	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lfealpha11n=fraclogit(A(Dc,Dc,Da3,Hct7n),Bee	  (Hct7n,	  Da3),Fb11n,Xo	  (Hct7n,Da3)	  );	  
Fea11n=exp(lfealpha11n)/(1+exp(lfealpha11n));	  
end	  
	  
Hct11n=(Fea11n)*Hct7n*(1/Fb11n);	  
	  
%Continuing	  down	  
Fb16n=Q16n/Q10n;Fb17n=Q17n/Q10n;Xob7n=Xo	  (Hct10n,Dc);	  
	  
if	  Fb16n<=Xob7n	  
	  	  	  	  Hct16n=0;	  
else	  
lfebeta16n=fraclogit(A(Dc,Dc,Dc,Hct10n),Bee	  (Hct10n,	  Dc),Fb16n,Xo	  (Hct10n,Dc)	  );	  
Feb16n=exp(lfebeta16n)/(1+exp(lfebeta16n));	  
Hct16n=(Feb16n)*Hct10n*(1/Fb16n);	  
end	  
	  
if	  Fb17n>=0.94	  
	  	  	  	  Fea17n=1;	  
else	  
	  
lfealpha17n=fraclogit(A(Dc,Dc,Dc,Hct10n),Bee	  (Hct10n,	  Dc),Fb17n,Xo	  (Hct10n,Dc)	  );	  
Fea17n=exp(lfealpha17n)/(1+exp(lfealpha17n));	  
end	  
	  
Hct17n=(Fea17n)*Hct10n*(1/Fb17n);	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%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  more	  capillaries	  
Fb18n=Q18n/Q11n;	  Fb19n=Q19n/Q11n;	  Xob8n=Xo	  (Hct11n,Dc);	  
	  
if	  Fb18n<=Xob8n	  
	  	  	  	  Hct18n=0;	  
else	  
	  	  	  	  	  
Sbeta18n=fraclogit(A(Dc,Dc,Dc,Hct11n),Bee	  (Hct11n,	  Dc),Fb18n,Xo	  (Hct11n,Dc)	  );	  
Fr18n=exp(Sbeta18n)/(1+exp(Sbeta18n));	  
	  
Hct18n=(Fr18n)*(1/Fb18n)*Hct11n;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb19n>=0.94	  
	  	  	  	  Fr19n=1;	  
else	  
Salpha19n=fraclogit(A(Dc,Dc,Dc,Hct11n),Bee	  (Hct11n,	  Dc),Fb19n,Xo	  (Hct11n,Dc)	  );	  
	  
Fr19n=exp(Salpha19n)/(1+exp(Salpha19n));	  
end	  
Hct19n=(Fr19n)*(1/Fb19n)*Hct11n;	  	  
	  
%Finishing	  the	  first	  of	  the	  arterioles.....moving	  along	  to	  the	  other	  
%arterioles	  
	  
Fb4n=Q4n/Q3n;	  Fb5n=Q5n/Q3n;	  Xob9n=Xo	  (Hct3n,Dfee);	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if	  Fb4n<=Xob9n	  
	  	  	  	  Hct4n=0;	  
else	  
	  	  	  	  	  
Sbeta4n=fraclogit(A(Da4,Df2,Df2,Hct3n),Bee	  (Hct3n,	  Df2),Fb4n,Xo	  (Hct3n,Df2)	  );	  
Fr4n=exp(Sbeta4n)/(1+exp(Sbeta4n));	  
	  
Hct4n=(Fr4n)*(1/Fb4n)*Hct3n;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb5n>=0.94	  
	  	  	  	  Fr5n=1;	  
else	  
Salpha5n=fraclogit(A(Da4,Df2,Df2,Hct3n),Bee	  (Hct3n,	  Df2),Fb5n,Xo	  (Hct3n,Df2)	  );	  
	  
Fr5n=exp(Salpha5n)/(1+exp(Salpha5n));	  
end	  
Hct5n=(Fr5n)*(1/Fb5n)*Hct3n;	  %Hct	  bypassing	  the	  first	  arteriole	  
	  
%Now	  to	  work	  our	  way	  down	  the	  additional	  arteriole	  	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb20n=Q20n/Q4n;Fb21n=Q21n/Q4n;Xob10n=Xo	  (Hct4n,Da4);	  
	  
if	  Fb20n<=Xob10n	  
	  	  	  	  Hct20n=0;	  
332	  
	  
else	  
lfebeta20n=fraclogit(A(Da,Dc,Da4,Hct4n),Bee	  (Hct4n,	  Da4),Fb20n,Xo	  (Hct4n,Da4)	  );	  
Feb20n=exp(lfebeta20n)/(1+exp(lfebeta20n));	  
Hct20n=(Feb20n)*Hct4n*(1/Fb20n);	  
end	  
	  
if	  Fb21n>=0.94	  
	  	  	  	  Fea21n=1;	  
else	  
	  
lfealpha21n=fraclogit(A(Da,Dc,Da4,Hct4n),Bee	  (Hct4n,	  Da4),Fb21n,Xo	  (Hct4n,Da4)	  );	  
Fea21n=exp(lfealpha21n)/(1+exp(lfealpha21n));	  
end	  
	  
Hct21n=(Fea21n)*Hct4n*(1/Fb21n);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  more	  capillaries	  
Fb22n=Q22n/Q21n;	  Fb23n=Q23n/Q21n;	  Xob11n=Xo	  (Hct21n,Da4);	  
	  
if	  Fb22n<=Xob11n	  
	  	  	  	  Hct22n=0;	  
else	  
	  	  	  	  	  
Sbeta22n=fraclogit(A(Da,Dc,Da4,Hct21n),Bee	  (Hct21n,	  Da4),Fb22n,Xo	  (Hct21n,Da4)	  );	  
Fr22n=exp(Sbeta22n)/(1+exp(Sbeta22n));	  
	  
Hct22n=(Fr22n)*(1/Fb22n)*Hct21n;%Hct	  entering	  the	  first	  arteriole	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end	  
	  
if	  Fb23n>=0.94	  
	  	  	  	  Fr23n=1;	  
else	  
Salpha23n=fraclogit(A(Da,Dc,Da,Hct21n),Bee	  (Hct21n,	  Da),Fb23n,Xo	  (Hct21n,Da)	  );	  
	  
Fr23n=exp(Salpha23n)/(1+exp(Salpha23n));	  
end	  
Hct23n=(Fr23n)*(1/Fb23n)*Hct21n;	  	  
	  
%Continuing	  down	  the	  same	  capillary	  path....	  
	  
Fb25n=Q25n/Q23n;Fb24n=Q24n/Q23n;Xob12n=Xo	  (Hct23n,Da);	  
	  
if	  Fb25n<=Xob12n	  
	  	  	  	  Hct25n=0;	  
else	  
lfebeta25n=fraclogit(A(Dc,Dc,Da,Hct23n),Bee	  (Hct23n,	  Da),Fb23n,Xo	  (Hct23n,Da)	  );	  
Feb25n=exp(lfebeta25n)/(1+exp(lfebeta25n));	  
Hct25n=(Feb25)*Hct23n*(1/Fb25n);	  
end	  
	  
if	  Fb24n>=0.94	  
	  	  	  	  Fea24n=1;	  
else	  
	  
lfealpha24n=fraclogit(A(Dc,Dc,Da,Hct23n),Bee	  (Hct23n,	  Da),Fb24n,Xo	  (Hct23n,Da)	  );	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Fea24n=exp(lfealpha24n)/(1+exp(lfealpha24n));	  
end	  
	  
Hct24n=(Fea24n)*Hct23n*(1/Fb24n);	  
	  
%Moving	  along	  the	  arteriole	  we	  get	  to	  some	  final	  capillaries	  
Fb28n=Q28n/Q24n;	  Fb29n=Q29n/Q24n;	  Xob13n=Xo	  (Hct24n,Dc);	  
	  
if	  Fb28n<=Xob13n	  
	  	  	  	  Hct28n=0;	  
else	  
	  	  	  	  	  
Sbeta28n=fraclogit(A(Dc,Dc,Dc,Hct24n),Bee	  (Hct24n,	  Dc),Fb28n,Xo	  (Hct24n,Dc)	  );	  
Fr28n=exp(Sbeta28n)/(1+exp(Sbeta28n));	  
	  
Hct28n=(Fr28n)*(1/Fb28n)*Hct24n;%Hct	  entering	  the	  first	  arteriole	  
	  	  	  	  	  	  	  	  
end	  
	  
if	  Fb29n>=0.94	  
	  	  	  	  Fr29n=1;	  
else	  
Salpha29n=fraclogit(A(Dc,Dc,Dc,Hct24n),Bee	  (Hct24n,	  Dc),Fb29n,Xo	  (Hct24n,Dc)	  );	  
	  
Fr29n=exp(Salpha29n)/(1+exp(Salpha29n));	  
end	  
Hct29n=(Fr29n)*(1/Fb29n)*Hct24n;	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%Final	  Capillary	  bifurcation	  
	  
%Using	  these	  things	  we	  should	  be	  able	  to	  gather	  the	  flowrates	  
%Checking	  out	  the	  bifurcation	  into	  the	  first	  arteriole	  
Fb26n=Q26n/Q25n;Fb27n=Q27n/Q25n;Xob14n=Xo	  (Hct25n,Dc);	  
	  
if	  Fb26n<=Xob14n	  
	  	  	  	  Hct26n=0;	  
else	  
lfebeta26n=fraclogit(A(Dc,Dc,Dc,Hct25n),Bee	  (Hct25n,	  Dc),Fb26n,Xo	  (Hct25n,Dc)	  );	  
Feb26n=exp(lfebeta26n)/(1+exp(lfebeta26n));	  
Hct26n=(Feb26n)*Hct25n*(1/Fb26n);	  
end	  
	  
if	  Fb27n>=0.94	  
	  	  	  	  Fea27n=1;	  
else	  
	  
lfealpha27n=fraclogit(A(Dc,Dc,Dc,Hct25n),Bee	  (Hct25n,	  Dc),Fb27n,Xo	  (Hct25n,Dc)	  );	  
Fea27n=exp(lfealpha27n)/(1+exp(lfealpha27n));	  
end	  
	  
Hct27n=(Fea27n)*Hct25n*(1/Fb27n);	  
	  
%Recalulating	  the	  viscosities	  
viscan=eta(Da,Hct2n);	  
visc6n=eta(Da2,Hct6n);	  
visc7n=eta(Da3,Hct7n);	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visc8n=eta(Dc,Hct8n);	  
visc9n=eta(Dc,Hct9n);	  
visc10n=eta(Dc,Hct10n);	  
visc11n=eta(Dc,Hct11n);	  
visc12n=eta(Dc,Hct12n);	  
visc13n=eta(Dc,Hct13n);	  
visc14n=eta(Dc,Hct14n);	  
visc15n=eta(Dc,Hct15n);	  
visc16n=eta(Dc,Hct16n);	  
visc17n=eta(Dc,Hct17n);	  
visc18n=eta(Dc,Hct18n);	  
visc19n=eta(Dc,Hct19n);	  
	  
visc4n=eta(Da4,Hct4n);	  
visc20n=eta(Dc,Hct20n);	  
visc21n=eta(Da,Hct21n);	  
visc22n=eta(Dc,Hct22n);	  
visc23n=eta(Da,Hct23n);	  
visc24n=eta(Dc,Hct24n);	  
visc25n=eta(Dc,Hct25n);	  
visc26n=eta(Dc,Hct26n);	  
visc27n=eta(Dc,Hct27n);	  
visc28n=eta(Dc,Hct28n);	  
visc29n=eta(Dc,Hct29n);	  
Error=(abs(Hct2-­‐Hct2n)+abs(Hct3-­‐Hct3n)+abs(Hct14-­‐Hct14n)+...	  
	  	  	  	  abs(Hct11-­‐Hct11n)+abs(Hct5-­‐Hct5n)+abs(Hct22-­‐	  Hct22n))/6;	  
%Redefining	  our	  Hcts	  
Hct1=	  Hct1;	  Hct2=Hct2n;	  Hct3=	  Hct3n;	  Hct4=Hct4n;	  Hct5=Hct5n;	  Hct6=Hct6n;	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Hct7=	  Hct7n;	  Hct8=Hct8n;	  Hct9=	  Hct9n;	  Hct10=Hct10n;	  Hct11=Hct11n;	  
Hct12=Hct12n;Hct13=Hct13n;Hct14=Hct14n;Hct15=Hct15n;Hct16=Hct16n;	  
Hct17=Hct17n;Hct18=Hct18n;Hct19=Hct19n;Hct20=Hct20n;Hct21=Hct21n;	  
Hct22=Hct22n;Hct23=Hct23n;Hct24=Hct24n;Hct25=Hct25n;Hct26=Hct26n;	  
Hct27=Hct27n;Hct28=Hct28n;Hct29=Hct29n;	  
end	  
%flow_out=[Hctan(101),Hctbn(101),visc2n(101),visc3n(101),Qan(101),Qbn(101),	  Qpn(101)]';	  
outhct=[Hct1,Hct2,Hct3,Hct4,Hct5,Hct6,Hct7,...	  
	  	  	  	  Hct8,Hct9,Hct10,Hct11,	  Hct12,	  Hct13,	  Hct14,	  Hct15,	  Hct16,...	  
	  	  	  	  Hct17,	  Hct18,	  Hct19,	  Hct20,	  Hct21,Hct22,	  Hct23,Hct24,Hct25,...	  
	  	  	  	  Hct26,Hct27,	  Hct28,	  Hct29]';	  	  
flow_out=outhct	  
	  
 
Appendix D: FlexPDE Codes 
D.1: Example parallel plate flow chamber coding: 
 
ATP/ADP Transport 
TITLE 'Correct velocity ATP/ADP in Chamber Due to shear stress step changes ' 
 SELECT 
 !cubic 
 errlim=1e-2 
 gridlimit=600000 
 !stages=3 
  
  
  
VARIABLES     { system variables } 
             Ct (5e-4) {ATP Conc} 
             Cd(5e-4){ADP Conc} 
 
 !p1(5e-4){Shear stress dependent release state variable} 
 !p2(5e-4){Second State Variable} 
  
DEFINITIONS   { parameter definitions } 
338	  
	  
! mina=1e-26 
 C0 = 1{nM} 
 D = 3300 {um2/s} 
 k = 2e-6 {nM-1/s} 
 h = 254   {um height} 
 L = 24000 {um length of Transwell membrane} 
 WSS1=0.1{Initial Wall Shear Stress} 
 WSS2=9.9{Increased wall shear stress} 
 Tau =0.1+WSS2*ustep(t-60)! {dynes/cm^2} 
 TauRef = 2 {dynes/cm2} 
 mu = 0.00696{dynes*s/cm2} 
 U = h*Tau/(4*mu) 
 VEL =4*(y)*(1-y)!dimensionless velocity 
 a=1 
pc=0.5!1/s positive feedback constant 
!Nucleotide parameters 
 Datp=236!{um^2/s$} 
 Dadp=257!{um^2/s$} 
 Kat=475e-3{(micorM)}!the new units are nM.....mol/m^3 
 Kad=155e-3{(micorM)}!the new units are nM....mol/m^3 
  
 Vmaxat=8e-7!0.8e6{mols-1m-2} 
 Vmaxad=1e-7!0.1e6!same units as above; 
  
 Co=0.1e-3!0.1e3!uM_the new units are nM_now back to uM....mol/m^3 
  
 !vb=0.1 
  !w=2*3.14159265 
  
 !Sax=1e-9!nM/s!1e-9/1e6 {molm-2s-1} 
! Satp=Sax*(1-exp(-Tau/4))^3!Shear stress is measured in units of dynes/cm^2 as is the reference shear 
stress 
 Ratp=0 
 Radp=0 
  
  
  
! tref=0.00001 {half life of NO in blood_may need to change this to make it approriate for the chamber 
model} 
  timeref=10{A time constant I approximate from the experimental data} 
  
!Model parameters for the ATP dynamics within the model as suggested by Qin 
 a1d=0.65e-13!molm-2s-2 
 a2d=2.79e-10!molm-2s-2 
 a3d=6.96*10!Pa {altered to dyne/cm^2$} 
 T1d=17.4!s 
 T2d=218.9!s 
!Dynamic model w/o receptor desensitization 
 a1d2=0.65e-13!molm-2s-2 
 a2d2=2.79e-10!molm-2s-2 
 a3d2=6.96!Pa 
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 T1d2=10.1!s 
!Alternate linear static model 
 Smax2=3e-10!molm-2s-1 
!Time constants 
Tim1=60!sTurn on the first increase in shear*10 
  
  
fss=a1d+a2d*Tau/(a3d+Tau)! 
fss1=a1d+a2d*WSS1/(a3d+WSS1)! 
fss2=a1d+a2d*WSS2/(a3d+WSS2)! 
  
  
!pones! Time dependent dynamic ATP release...complex due to many step changes in shear 
pon1=T1d*fss1*(1-exp(-t/T1d)) 
pon2=T1d*exp(-t/T1d)*(fss1*(exp(Tim1/T1d)-1)+fss2*(exp(t/T1d)-exp(Tim1/T1d))) 
  
!defininig our state variables 
p1=pon1+ustep(t-Tim1)*(pon2-pon1)!+ustep(t-Tim2)*(pon3-pon2)+ustep(t-Tim3)*(pon4-
pon3)+ustep(t-Tim4)*(pon5-pon4)+ustep(t-Tim5)*(pon6-pon5)+ustep(t-Tim6)*(pon7-pon6)+ustep(t-
Tim7)*(pon8-pon7)+ustep(t-Tim8)*(pon9-pon8) 
p2=exp(-t/T2d) 
  
!Simply initializing one of our variables describing the shear stress dependence of ATP release from 
endos 
Satpss=0 
  
  
INITIAL VALUES 
 Ct=0 
 Cd=0 
 !p1=0 
 !p2=1 
  
EQUATIONS     { PDE's, one for each variable } 
  
Ct: dy(dy(Ct/C0)) + ((h/L)^2)*dx(dx(Ct/C0))  - 
1*(h^2*U*VEL/(Datp*L))*dx(Ct/C0)+Ratp*(h^2)/(Datp*C0) = dt(Ct/C0) 
  
Cd: dy(dy(Cd/C0)) + (h/L)^2*dx(dx(Cd/C0))  - 
1*(h^2*U*VEL/(Dadp*L))*dx(Cd/C0)+Radp*(h^2)/(Datp*C0) = dt(Cd/C0) 
  
  
  
  
CONSTRAINTS 
BOUNDARIES 
  REGION 1 'Flow Chamber' 
  
 START(0,0) 
 natural(Ct)=0 
 natural(Cd)=0 
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 line to (1,0) 
 natural(Ct)=0 
 natural(Cd)=0 
  line to(1,1) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to (0,1) 
  
 value(Ct)=0 
 value(Cd)=0 
 line to finish 
  
  REGION 2 {Endothelial Layer} 
 h=5 
 L=24000 
 U=0 
 Satpss=p1*p2 
 Ratp=(-(Vmaxat*Ct/(Kat+Ct))+Satpss+pc*Ct)/(h*1e-6) 
 Radp=(-(Vmaxad*Cd/(Kad+Cd))+(Vmaxat*Ct/(Kat+Ct)))/(h*1e-6) 
 START(0,-1) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to (1,-1) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to (1,0) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to (0,0) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to finish 
  
REGION 3 {Membrane} 
  
 h=10 
 L=24000 
 U=0 
 D=3300*.005 
 START(0,-2) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to(1,-2) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to(1,-1) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to(0,-1) 
 natural(Ct)=0 
 natural(Cd)=0 
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 line to finish 
  
  
  
  
REGION 4 {air layer} 
  
 h=10 
 L=24000 
 U=0 
  
 START(0,-3) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to(1,-3) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to(1,-2) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to(0,-2) 
 natural(Ct)=0 
 natural(Cd)=0 
 line to finish 
  
  
  
TIME 0 TO 360 
  
MONITORS 
  
 FOR T=0.01 BY 1 TO endtime 
 elevation(VEL) from (0.5,0) to (0.5,1) 
 elevation(Ct) from (0.5,0) to (0.5,1) 
 elevation(Cd) from (0.5,0) to (0.5,1) 
  
 contour(Ct) zoom (0,0,1,1) 
 contour(Cd) zoom (0,0,1,1) 
  
elevation(Ratp) from (0.5,-1) to (0.5,0) 
elevation(Radp) from (0.5,-1) to (0.5,0) 
  
PLOTS 
  
 FOR T=0.01 BY 1 TO endtime 
  
  
 elevation(Ct) from (0,0) to (1,0)  {export format "#y#b#1" file="pct1qin@ecs.txt"} 
 elevation(Cd) from (0,0) to (1,0)  {export format "#y#b#1" file="pcd1qin@ecs.txt"} 
  
 contour(Ct) zoom (0,0,1,0)  painted 
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 contour(Cd) zoom (0,0,1,0)  painted 
  
  
  
HISTORIES     { time dependent or staged } 
  
  
  
  
  
history(Ct) at (0.5,0) export format "#t#b#1" file="pfATP10qin@ecs.txt"   {@Inside} 
history(Cd) at (0.5,0) export format "#t#b#1" file="pfADP10qin@ecs.txt"   {@Inside} 
history(Ct) at (0.5,-1) export format "#t#b#1" file="pfATP10qin@elecs.txt"   {@Inside} 
history(Cd) at (0.5,-1) export format "#t#b#1" file="pfADP10qin@elecs.txt"   {@Inside} 
history(Ratp) at (0.5,-0.5) export format  "#t#b#1" file="pfRatp10.txt"   {@Inside} 
  
  
  
  
  
END 
 
 
TITLE 'New_Chamber_redos ' 
!I'm going to assume that the concentration of Ap in the chamber does not change as a function of flow 
{Interaction between ATP and apyrase outside of the membrane is determined using "Biolumnometric 
Method for Real-time Detection of ATPase Activity (2001)} 
  
 SELECT 
 !cubic 
 errlim=5e-4 
 gridlimit=600000 
 !stages=3 
  
  
  
VARIABLES     { system variables } 
 NO(5e-4) 
  
  
DEFINITIONS   { parameter definitions } 
 mina=1e-26 
 C0 = 1{nM} 
 D = 3300 {um2/s} 
 k = 2e-6 {nM-1/s} 
 h = 254   {um height} 
 L = 121920 {um length} 
 WSS1=0.1{Initial Wall Shear Stress} 
 WSS2=9.9{Increased wall shear stress} 
 Tau =0.1+WSS2*ustep(t-200)! 
 TauRef = 2 {dynes/cm2} 
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 mu =0.00696! 0.01{dynes*s/cm2} 
 U = h*Tau/(4*mu) 
 VEL =4*U*y*(1-y) 
 a=1 
 Rno=0 
 RnoBasal=2.13!16.7!2.13!7!2.13{nM/s} 
 B=457.5!394.8!457.5!320!457.5!400!457.5{nM/s} 
 Tcheck=35!22.12!35!15!25!120!100 !35{dyns/cm^2} 
  
 tref=0.00001 {half life of NO in blood_may need to change this to make it approriate for the 
chamber model} 
  timeref=10{A time constant I approximate from the experimental data} 
  
INITIAL VALUES 
 NO = 0 
  
  
EQUATIONS     { PDE's, one for each variable } 
 NO:  (D)*((1/h^2)*dy(dy(NO*C0)) +a*(1/L^2)*dx(dx(NO*C0))) - k*Abs(NO)*Abs(NO)*C0 - 
1*VEL/L*dx(NO*C0) {+VEL/L*dx(NO*C0)*ustep(t-150) }+ Rno = dt(NO*C0)/10 
  
  
  
CONSTRAINTS 
BOUNDARIES 
  
!Altering the geometry so to allow for the correct flow profile....moving everything up by 0.5 
  REGION 1 'Flow Chamber' 
  
 START(0,0) 
  natural(NO)=0 
  
 line to (1,0) 
 natural(NO)=0 
  
  line to(1,1) 
 natural(NO)=0.0 
  
 line to (0,1) 
 value(NO)=0 
  
 line to finish 
  
  REGION 2 {Endothelial Layer} 
 h=5 
 L=24000 
 U=0 
 !Rno=3.43+ustep(t-200)*uramp(t-200,t-206)*62.5 
 Rno=(Rnobasal)+B*WSS1/(WSS1+Tcheck)+ustep(t-200)*(-
(B*WSS1/(WSS1+Tcheck))+uramp(t-200,t-204)*(B*((WSS2+WSS1)/((WSS2+WSS1)+Tcheck)))) 
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 !Rno=(Rnobasal)+B*WSS1/(WSS1+Tcheck)+ustep(t-50)*(uramp(t-40,t-
42)*(B*(Tau/(Tau+Tcheck)))) 
 START(0,-1) 
 natural(NO)=0 
  
 line to (1,-1) 
  
 natural(NO)=0 
 line to (1,0) 
  
 natural(NO)=0 
 line to (0,0) 
 natural(NO)=0 
  
 line to finish 
  
REGION 3 {Membrane} 
   
 !h=10 
 !L=2400 
 !U=0 
 D=3300*.005 
 START(0,-2) 
 natural(NO)=0 
  
 line to(1,-2) 
 natural(NO)=0 
  
 line to(1,-1) 
 natural(NO)=0 
  
 line to(0,-1) 
 natural(NO)=0 
  
 line to finish 
  
  
  
  
REGION 4 {air layer} 
  
 h=10 
 L=24000 
 U=0 
  
 START(0,-3) 
 natural(NO)=0 
  
 line to(1,-3) 
 natural(NO)=0 
  
345	  
	  
 line to(1,-2) 
 natural(NO)=0 
  
 line to(0,-2) 
 natural(NO)=0 
  
 line to finish 
  
  
  
TIME 0 TO 300 
  
MONITORS 
  
 FOR T=0.01 BY 4 TO endtime 
  
 elevation(NO) from (0.5,0) to (0.5,1) 
  
  
  
PLOTS 
  
 FOR T=0.01 BY 4 TO endtime 
  
 elevation(NO) from (0,5,0) to (0.5,1)  export format "#y#b#1" file="corNO_geo10.txt" 
  
 elevation (VEL) from  (0.5,0) to (0.5,1)  export format "#y#b#1" file="cor_geovvelsse10.txt" 
  
 !contour(NO) zoom (0,0,1,1)  painted 
  
  
  
  
HISTORIES     { time dependent or staged } 
  
  
  
 history(NO) at (0.5,-1) export format "#t#b#1" file="cor_geoelectrodessdyne10.txt"   {@Inside} 
  
 history(NO) at (0.5,0) export format "#t#b#1" file="cor_geogvredoNO@ecsdyn10.txt"   
{@Inside$} 
  
 history(VEL) at (0.5,0) export format "#t#b#|1" file="cor_geogvveltd10.txt" {Velocity Profile} 
  
  
  
  
  
  
  
END 
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D2: NO and O2 transport in single vessel. FlexPDE model used to compare the different models of 
NO metabolism in tissue 
 
TITLE 'Chapter 3 Simulation for RBCs in the plasma layer' 
COORDINATES xcylinder 
SELECT CUBIC SELECT UPFACTOR=50 
ERRLIM = 1e-04 
VARIABLES 
 .............................................................................. NO 
 .............................................................................. PO2 
 DEFINITIONS 
Pmax = 50.0 !specify input PO2} 
Rin = 15.000 
! Rp = 13.000 
Rp = 12.500 !increase the thickness of the plasma layer to 2.5 microns} 
Rg = 14.500 
Re = 16.000 
Rw = 19.000 
Rout = 120.000 
long = 250.000 
 KS 
! KS1 = 397.81 !Carsen & Comroe, 45% Hct blood scavenging rate} 
KS_core=391.4304397 
KS1 =if (r<Rp) then KS_core !Carsen & Comroe, 45% Hct blood scavenging rate} 
else 
if (r>=Rp) and (r<=Rg) then KS_core*(r-Rg)/(Rp-Rg) else 0 
KS2 = 0 
KS3 = 1*max(PO2,1e-9) 
KS4 = 1*max(PO2,1e-9) 
kmo21=1*(1+(max(NO,1e-9) / .027)) 
A1 
!zero rate in endothelium} !scavenging rate in wall} 
!tissue scavenging rate} 
A1A=1.34 
A1B =1.34 !uM/Torr} 
Cmax_core = 8186.780439 
Cmax = if (r<Rp) then Cmax_core 
else 
if (r>=Rp) and (r<=Rg) then Cmax_core*(r-Rg)/(Rp-Rg) else 0 
Ps = 2.756*7.5 
K = 0.544/7.5 
M = .9601 
Sz = M/(1.0-EXP(EXP(K*Ps))) W = K * (Ps - max(PO2,1e-9)) 
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Sat = (M-Sz)*exp(-exp(W))+Sz Slope = K*(Sat-Sz) * EXP(W) 
B1 B1A=Cmax*Slope 
B1B=0 
D1 = 3300 !NO diffusivity} 
D2 = 2800 !O2 diffusivity} 
!O2-Dependent NO Production Parameters} 
V 
V1 = 0 
V2 = 150.0 
KMNO1 = 4.7 
RNO 
RNO1 = 0 
RNO2 = (V2*max(PO2,1e-9)/(KMNO1+max(PO2,1e-9))) 
!O2 dependent NO Production} 
!eNOS rate - should be low for capillaries} 
Q 
Q1 = 0 !no consumption in blood} 
Q2 = -2*RNO2 !equal to -RNO2 - endothelial O2 consumption = NO production} 
Mmax1 = 0 
Mmax2 = Q2 !endothelium} 
Mmax3 = -1.00 !wall} 
Q3 = (Mmax3*max(PO2,1e-9)) / (max(PO2,1e-9)+kmo21) 
Mmax4 = -145.00 !tissue} 
Q4 = (Mmax4*max(PO2,1e-9)) / (max(PO2,1e-9)+kmo21) 
!Velocity profile} 
Vmax = 1500 
VEL 
VEL1= 1*Vmax* (1-(r/Rg )^2) !Poisseuille Flow} 
VEL2 = 0 
!!just for O2 delivery: Sat=normal value when r<Rp; 0 when r>=Rp} 
Sat_temp = if (r<Rg) then sat 
else 0 
delivery = 2*3.14159*r*(Vel*SAT_temp*Cmax+Vel*A1*PO2) 
INITIAL VALUE 
PO2 = Pmax 
NO = 0.006 
EQUATIONS 
NO: div(D1*grad(NO)) - KS*NO - 1 * VEL * dz(NO) + RNO = 0 
PO2: A1*div(D2*grad(PO2)) + Q - 1 * VEL * (A1+B1)*dz(PO2) = 0 
BOUNDARIES 
Region 1 !Blood} 
KS = KS1 
A1 = A1A 
B1 = B1A 
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Q = Q1 
RNO = RNO1 
V = V1 
VEL = VEL1 
START(0.0,0.0) NATURAL(PO2) = 0 
!zero flux at centerline} 
NATURAL(NO) = 0 LINE TO(long,0.0) 
NATURAL(PO2) = 0 
NATURAL(NO)=0 LINE TO(long,Rp) 
NATURAL(PO2) = 0 
NATURAL(NO)=0 LINE TO(0,Rp) 
VALUE(PO2) = Pmax-11.1167*(r/Rp)^2 
VALUE(NO)=(0.4290051784e-2)+(0.1423422849e-2)*exp((.3269878737)*r) !for inlet NO } 
LINE TO FINISH 
Region 2 !plasma layer} 
KS = KS1 
A1 = A1B 
B1 = B1A 
Q = Q1 
RNO = RNO1 V = V1 
VEL = VEL1 
START(0, Rp) 
NATURAL(PO2)=0 
NATURAL(NO)=0 LINE TO(long,Rp) 
NATURAL(PO2)=0 
NATURAL(NO)=0 LINE TO(long,Rg) 
NATURAL(PO2)=0 
NATURAL(NO)=0 LINE TO(0,Rg) 
NATURAL(PO2)=0 
NATURAL(NO)=0 LINE TO FINISH 
Region 3 !glycocalyx} 
A1 =A1B 
B1 = B1B 
KS = KS2 
Q = Q1 RNO=RNO1 V=V1 
VEL = VEL2 
START(0.0, Rg) 
NATURAL(PO2)=0 
NATURAL(NO)=0 LINE TO(long,Rg) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 LINE TO(long,Re) 
NATURAL(PO2)=0 
NATURAL(NO)=0 LINE TO(0,Re) 
NATURAL(PO2) = 0 
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NATURAL(NO) = 0 LINE TO FINISH 
Region 4 !Endothelium} 
A1 =A1B 
B1 = B1B 
KS = KS2 
Q = Q2 
RNO=RNO2 
V=V2 
VEL = VEL2 
START(0.0, Rin) 
NATURAL(PO2)=0 
NATURAL(NO)=0 
LINE TO(long,Rin) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO(long,Re) 
NATURAL(PO2)=0 
NATURAL(NO)=0 
LINE TO(0,Re) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO FINISH 
Region 5 !wall} 
A1 =A1B 
B1 = B1B 
KS = KS3 
Q = Q3 
RNO=RNO1 
V=V1 
VEL = VEL2 
START(0,Re) 
NATURAL(PO2)=0 
NATURAL(NO)=0 
LINE TO(long, Re) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO(long, Rw) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO(0,Rw) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO FINISH 
Region 6 !Tissue} 
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A1 =A1B 
B1 = B1B 
KS = KS4 
Q = Q4 
RNO=RNO1 
V=V1 
VEL = VEL2 
START(0,Rw) 
NATURAL(PO2)=0 
NATURAL(NO)=0 
LINE TO(long, Rw) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO(long, Rout) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO(0,Rout) 
NATURAL(PO2) = 0 
NATURAL(NO) = 0 
LINE TO FINISH 
  
MONITORS 
CONTOUR(PO2) PAINTED FIXED RANGE (51,0) NOMINMAX 
CONTOUR(1000*NO) PAINTED FIXED RANGE (10,0) NOMINMAX 
  
PLOTS 
!ELEVATION(NO*1000) FROM (0,Re) TO (long,Re) POINTS = 1001 export format 
"#x#b#1"file="NORe.txt" 
ELEVATION(NO * 1000) FROM (long/2,0) TO (long/2,Rout) POINTS = 1001 export format 
"#y#b#1"file="NOmid145newalt.txt" 
!ELEVATION(NO * 1000) FROM (0.05*long,0) TO (0.05*long,Rout) POINTS = 1001 export 
format"#y#b#1" file="NO_in.txt" 
!ELEVATION(NO * 1000) FROM (0.95*long,0) TO (0.95*long,Rout) POINTS = 1001 export 
format"#y#b#1" file="NO_out.txt" 
CONTOUR(1000*NO) PAINTED FIXED RANGE (450,0) NOMINMAX 
!ELEVATION(PO2) FROM (0.05*long,0) TO (0.05*long,Rout) POINTS = 1001 export format 
"#y#b#1"file="PO2_in.txt" 
ELEVATION(PO2) FROM (long/2,0) TO (long/2,Rout) POINTS = 1001 export format 
"#y#b#1"file="PO2mid145newalt.txt" 
!ELEVATION(PO2) FROM (0.95*long,0) TO (0.95*long,Rout) POINTS = 1001 export format 
"#y#b#1"file="PO2_out.txt" 
CONTOUR(PO2) PAINTED FIXED RANGE (51,0) NOMINMAX 
!ELEVATION(SAT) FROM (0.5*long,0) TO (0.5*long,Rout) POINTS = 1001 export format "#y#b#1" 
file="SAT.txt" 
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!ELEVATION(SAT) FROM (0.05*long,0) TO (0.05*long,Rout) POINTS = 1001 export format 
"#y#b#1" file="SAT_in.txt" 
!ELEVATION(SAT) FROM (0.95*long,0) TO (0.95*long,Rout) POINTS = 1001 export format 
"#y#b#1" file="SAT_out.txt" 
!ELEVATION(Vel) FROM (0.05*long,0) TO (0.05*long,Rout) POINTS = 1001 
!ELEVATION(delivery) FROM (0.05*long,0) TO (0.05*long,Rout) POINTS = 1001 export format 
"#y#b#1" file="O2delivery_in.txt" 
!ELEVATION(delivery) FROM (0.95*long,0) TO (0.95*long,Rout) POINTS = 1001 export format 
"#y#b#1" file="O2delivery_out.txt" 
!elevation(Cmax) from (1/2*long,0) to (1/2*long,Rin) points = 600 elevation (KS) from (1/2*long,0) to 
(1/2*long,Rin) points = 600 
HISTORIES 
END 
 
E: Additional Matlab Files for Smooth Muscle Cell Dynamics 
	  
Matlab files used for solving the smooth muscle dynamics. Many of which have been modified from the 
source codes made available and Developed by: 
              Brian Carlson 
                      Computational Bioengineering Group 
                      Biotechnology and Bioengineering Center 
                      Medical College of Wisconsin 
 
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{	  
%%   SingVess_MyogResp - Simulation of VSM ephys, contraction and vessel response 
% 
*********************************************************************************** 
%   V A S C U L A R   S M O O T H   M U S C L E   E L E C T R O P H Y S I O L O G Y 
%       A N D   V E S S E L   W A L L   M E C H A N I C S   O F   S I N G L E 
%              A R T E R I O L A R   M Y O G E N I C   R E S P O N S E 
%                           INFLUENCE OF NITRIC OXIDE 
% 
*********************************************************************************** 
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% 
%   This script defines the underlying vascular smooth muscle (VSM) function in  
%   terms of channel currents, cytosolic calcium handling and force generation  
%   that is necessary to generate the myogenic response in pressureized single  
%   cannulated isolated arteriolar vessels.  There are three sections in 
%   the code 
%   involved in the simulation of the vessel diameter in the myogenic response: 
% 
%   1) Experimental data containing the passive and the myogenically active steady  
%      state vessel response to pressure is entererd along with the previously  
%      determined adjustable parameter values (Carlson and Secomb Microcirculation  
%      12:327-338, 2005) for the vessel wall mechanics portion of the integrated  
%      model (Model 1), the fixed parameters for the VSM crossbridge kinetics, and  
%      the fixed parameters defining the VSM electrophysiology and Ca2+ handling. 
%       
%   2) Next the four-state Hai and Murphy model of crossbridge force generation in  
%      VSM cells (AJP 254:C99-C106, 1988) is run to steady state to define the VSM  
%      activation as a function of cytosolic Ca.  The fixed parameters used in the  
%      model are as presented by Koenigsberger et al. (Biophys J 91:1663-1674,  
%      2006).  A simple Hill function is fit to these simulation "data" points.   
%      This optimized fit of VSM crossbridge activation is used to connect 
%      the cytosolic Ca concenteration generated in the VSM electrophysiology  
%      model of step 3) to the mogenic response data in step 1). 
% 
%   3) The final portion of this script loads the previously determined adjustable  
%      parameter values for the stress-controlled channel variants, simulates the  
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%      VsM ephys, Ca2+ levels, force generation and steady-state diameter response 
%      to changes in pressure and then plots out some figures from the paper.  The  
%      VSM epectrophysiology model is based on the model developed by Kapela et al.  
%      (J Theor Biol 253:238-260, 2008) with the addition of vessel wall stress- 
%      controlled NSC, Ca2+, Na+, L-type Ca2+ or BKCa as described in the paper.   
%      Each of the nine vessel stress-controlled channel variants is inserted in  
%      the model in turn and the myogenic response is simulated.  The figures that 
%      are replicated are Figure 4, 5 and 6 from the paper. 
%   
% 
%   4) Additional changes were made to the program in attempt to analyze 
%       the influence of nitric oxide on the myogenic response.  In particular 
%       it was desired to see how changes in nitric oxide concentration leads 
%       to changes in vessel diameter at a set pressure. 
% 
%   5) It was also discovered that this mathematical model makes use of the 
%       assumption that it is only the fully activated form of sGC which 
%       controls the transition from GTP to cGMP.  Yet in the study conducted 
%       by Condorelli and George it was found that each of the different forms  
%       of the sGC complex contributes in its own way to the reaction from 
%       GTP to cGMP.  For this reason appropriate changes have been made to 
%       the m-file SingVess_SFSim.m. 
%    
%   Model originally created on      28 May  2010 
%   Model last modfied on             2 June 2011 
%   Model modified by Patrick Kirby   1 August 2013 
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% 
%   Developed by        Brian Carlson 
%                       Computational Bioengineering Group 
%                       Biotechnology and Bioengineering Center 
%                       Medical College of Wisconsin 
% 
%   COPYRIGHT AND REQUEST FOR ACKNOWLEDGMENT OF USE:    
%   Copyright (C) 2011 Medical College of Wisconsin.  This software was developed 
%   by the Computational Bioengineering Group, Director D.A. Beard, Director,  
%   Department of Physiology and Biotechnology and Bioengineering Center, Medical  
%   College of Wisconsin, Milwaukee, WI. 53226. Software may be copied for use by  
%   academic institutions so long as these copyright rights are acknowledged.   
%   Commercial use requires a license. 
% 
%   This software was developed with support from NSF grant EFRI 0735903.  
%   Please cite this grant in any publication for which this software is used  
%   and send an email with the citation and, if possible, a PDF file of the paper  
%   to: becarlson@mcw.edu. 
% 
% 
*********************************************************************************** 
 
%% 
********************************************************************************** 
%   Start of Script         S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
%   Fixed Paramters for     S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
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% 
*********************************************************************************** 
    function output=Autoreg_resp(Drefin,Prefin,NO) 
 
    tic 
    MesFem_Flag=1; 
     
     
%     SINGLE VESSEL EXPERIMENTAL DATA 
%     ------------------------------- 
    % Determine whether we are fitting mesenteric or femoral data 
    % Get experimental data 
%     if (MesFem_Flag ==1) 
%         [Header Data] =  ...                        % Loading all data in 
%             Irreg_HD_Load('Davis_myogenic_resp_data.txt'); 
%{Irreg_HD_Load('SVData_SunFig1Mes.txt');Irreg_HD_Load('SVData_BundFig1Mes.txt' 
%     else 
%         [Header Data] = ... 
%             Irreg_HD_Load('SVData_BundFig1Fem.txt'); 
%     end 
    % Break dataset out into individual matrices 
%     Pass_Data = [Data(:,1) Data(:,2)];          %  Assign passive data %These values may require 
changes to be made 
%     Myo_Data = [Data(:,3) Data(:,4)];           %  Assign myogenic data 
    Wallt_Ref =1;%hoping the units are um Data(1,5);                      %  Assign reference wall t 
    LumD_Ref = 10;%Once again hoping for um units I'll check back laterData(2,5);                       %  
Assign reference lumen D 
    % Conversion factors 
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    Conv1 = 0.13332239;                             % Conv from mmHg to kPa 
    Conv2 = 7500.615613;                            % Conv from N/m to mmHg*um 
    Conv3 = 1.00e3;                                 % Conv from N/(m*um) to kPa 
    Conv4 = 0.00013332239;                          % Conv from mmHg*um to N/m 
    % Set options for fzero 
    fz_OptsVMech = optimset('fzero'); 
    fz_OptsVMech.TolX = 1e-6; 
    % Fixed parameter structure 
    VMech_FPValues = {MesFem_Flag Wallt_Ref LumD_Ref Conv1 Conv2 ... 
                       Conv3 Conv4 fz_OptsVMech}; 
    VMech_FPFields = {'MesFem_Flag' 'Wallt_Ref' 'LumD_Ref' 'Conv1' 'Conv2' ... 
                       'Conv3' 'Conv4' 'fz_OptsVMech'}; 
    VMech_FPStruct = cell2struct(VMech_FPValues,VMech_FPFields,2); 
%     % Loading in the previously determined vessel wall mechanics opt params 
%     pass_par=fun_passfit; 
%     act_par=fun_tot_fit; 
 
% I beleive that the above lines were inserted by myself when I was 
% attempting to fit data to various experimental curves,  I switched from 
% that to simply using fits obtained by Carlson and fellow reasearchers in 
% reference to smaller diameter vessels 
     
%     if (MesFem_Flag == 1) 
        % Optim param values for rat mesen artls from Carlson and Secomb, 2005 
        Cpass_Opt =0.316;             % Passive tension at 100 mmHg  (N/m) 
        D100_Opt =43.0;         % Diameter at 100 mmHg         (um) 
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        Cprpass_Opt =11.247;           % Steepness of passive tension (uls) 
        Cact_Opt =0.392;%    % Max active tension           (N/m) 
        Cpract_Opt =0.903;%    % Position of act ten curve    (uls) 
        Cdpract_Opt =0.618;%   % Width of act ten curve       (uls) 
%     else 
%         
%         % Optim param values for rat fem artls from Carlson and Secomb, 2005 
%         Cpass_Opt = 1.416;                 % Passive tension at 100 mmHg  (N/m) 
%         D100_Opt = 172.8;                  % Diameter at 100 mmHg         (um) 
%         Cprpass_Opt = 7.901;               % Steepness of passive tension (uls) 
%         Cact_Opt = 1.499;                  % Max active tension           (N/m) 
%         Cpract_Opt = 0.742;                % Position of act ten curve    (uls) 
%         Cdpract_Opt = 0.353;               % Width of act ten curve       (uls) 
%     end 
    % Optimized vessel mechanics parameter structure used to pass to functions 
    VMech_OPValues = {D100_Opt Cpass_Opt Cprpass_Opt ... 
                       Cact_Opt Cpract_Opt Cdpract_Opt}; 
    VMech_OPFields = {'D100_Opt' 'Cpass_Opt' 'Cprpass_Opt' ... 
                       'Cact_Opt' 'Cpract_Opt' 'Cdpract_Opt'}; 
    VMech_OPStruct = cell2struct(VMech_OPValues,VMech_OPFields,2); 
 
     
%     XBRIDGE MODEL PARAMETERS 
%     ------------------------ 
    % Rate constants for state variables 
    K_2 = 0.5;                      % Rate of dephosphorylation of Mp     (1/s) 
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    K_3 = 0.4;                      % Rate of reattachment of A and Mp    (1/s) 
    K_4 = 0.1;                      % Rate of detachment of AMp           (1/s) 
    K_5 = 0.5;                      % Rate of dephosphylation of AMp      (1/s) 
    K_7 = 0.1;                      % Rate of detachment of AM            (1/s) 
    % Remaining fixed parameters 
    AMpAM_Max = 0.8;                % Max frac of attached xbidges        (unitless) 
    gamma = 17;                     % AM/M phosph rate sensitivity to Ca  (uM^3/s) 
    % ODE solver parameters 
    ode15s_OptsXB = odeset( ...     % Setting ode15s options for XB steady state 
       'RelTol',1.0e-4, ...         %  Set relative tolerance 
       'AbsTol',1.0e-8);            %  Set absolute tolerance 
    % Initial conditions 
    x0_XB(1) = 0.25;                % IC free unphosph xbridges      (unitless) 
    x0_XB(2) = 0.25;                % IC free phosph xbridges        (unitless) 
    x0_XB(3) = 0.25;                % IC attached phosph xbridges    (unitless) 
    x0_XB(4) = 0.25;                % IC attached dephosph xbridges  (unitless) 
    % Optimization parameters 
    fmc_OptsXB = ....               % Grab default settings 
           optimset('fmincon');  
    fmc_OptsXB.Algorithm = ...      % Set algorithm type 
                 'active-set'; 
    fmc_OptsXB.Display = 'iter';    % Set display content 
    fmc_OptsXB.TolFun = 1e-10;      % Set tolerance on function 
    fmc_OptaXB.MaxFunEvals = 600;   % Set maximum number of functional evals 
    fmc_OptsXB.MaxIter = 200;       % Set maximum number of iterations 
    % Fixed parameter structure 
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    XB_FPValues = {K_2 K_3 K_4 K_5 K_7 gamma}; 
    XB_FPFields = {'K_2' 'K_3' 'K_4' 'K_5' 'K_7' 'gamma'}; 
    XB_FPStruct = cell2struct(XB_FPValues,XB_FPFields,2); 
     
%     VSM ELECTROPHYSIOLOGY MODEL PARAMETERS 
%     -------------------------------------- 
    % Universal constants 
    F = 96485.3399;                % Faraday constant           (C/mole) 
    R = 8314.472;                  % Gas constant               ((C*mV)/(K*mole)) 
    T = 293;                       % Temperature                (K) 
    RT = R*T;                      % RT term                    ((C*mV)/mole) 
    FRT = F/RT;                    % F/RT term                  (1/mV) 
    N_Avo = 6.022e23;              % Avogadro's number          (1/mole) 
    % Membrane properties    
    C_m = 25;                      % Total membrane capacitance (pF) 
    A_m = C_m/1e6;                 % Area scaled by capacitance (cm^2) 
    % Ionic valences     
    z_K = 1;                       % Potassium valence          (unitless) 
    z_Na = 1;                      % Sodium valence             (unitless) 
    z_Ca = 2;                      % Calcium valence            (unitless) 
    z_Cl = -1;                     % Chloride valence           (unitless) 
    % External ionic concentrations     
    Ca_e = 2.0;                    % External Ca concentration  (mM) 
    Na_e = 140;                    % External Na concentration  (mM) 
    K_e = 5;                       % External K concentration   (mM) 
    Cl_e = 129;                    % External Cl concentration  (mM) 
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    % Compartmental volumes 
    Vol_i = 1;                     % Cytsolic volume            (pL) 
    Vol_Ca = 0.7;                  % Cyto volume avail to Ca    (pL) 
    Vol_SRu = 0.07;                % SR uptake volume           (pL) 
    Vol_SRr = 0.007;               % SR release volume          (pL) 
    % L-type voltage operated Ca channel     
    P_VOCC = 1.88e-5;              % L-type Ca permeability     (cm/s) 
    % Large conductance Ca-activated K channel     
    N_BKCa = 6.6e6;                % Ca-act K channel density   (1/cm^2) 
    tau_pf = 0.84;                 % Ca-act K fast time const   (ms) 
    tau_ps = 35.9;                 % Ca-act K slow time const   (ms) 
    dV_50KCaNO = 46.3;             % Max NO-ind V50KCa shift    (mV) 
    dV_50KCacGMP = 76;             % Max cGMP-ind V50KCa shift  (mV) 
    P_BKCa = 3.9e-13;              % Ca-act K permeability      (cm/s) 
    % Voltage dependent K channel     
    g_Kv = 1.35;                   % Max whole cell Kv conduct  (nS) 
    tau_q1 = 371;                  % V-depend K fast inact tau  (ms) 
    tau_q2 = 2884;                 % V-depend K slow inact tau  (ms) 
    % Unspecified K leak channels 
    g_Kleak = 0.067;               % Max whole cell Kleak cond  (nS) 
    % Non-selective cation channels  
    K_NSC = 3e-3;                  % Half-max act DAG concen    (mM) 
    d_NSCmin = 0.0244;             % Min constiuent activation  (unitless) 
    PNa_NSC = 5.11e-7;             % Whole cell Na NSC perm     (cm/s) 
    PK_NSC = 1.06*PNa_NSC;         % Whole cell K NSC perm      (cm/s) 
    PCa_NSC = 4.54*PNa_NSC;        % Whole cell Ca NSC perm     (cm/s) 
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    % Store-operated non-selective cation channel     
    gCa_SOC = 0.0083;              % Max whole cell Ca conduct  (nS) 
    gNa_SOC = 0.0575;              % Max whole cell Na conduct  (nS) 
    K_SOC = 1e-4;                  % Half-max act Ca concen     (mM) 
    tau_SOC = 100;                 % SOC act gate tau           (ms) 
    % Calcium-activated chloride channel 
    g_ClCa = 0.23;                 % Max conduct Ca-act Cl      (nS/pF) 
    R_ClcGMPmin = 0.0132;          % cGMP-indep component       (unitless) 
    n_ClCa = 2;                    % Ca-act Cl Ca Hill coeff    (unitless) 
    K_ClCa = 3.65e-4;              % EC50 Ca-act Cl Ca concen   (mM) 
    n_ClcGMP = 3.3;                % Ca-act Cl cGMP Hill coeff  (unitless) 
    K_ClcGMP = 6.4e-3;             % EC50 Ca-act Cl cGMP concen (mM) 
    % Plasma membrane Ca pump 
    Ibar_PMCA = 5.37;              % Max PM Ca-ATPase current   (pA) 
    K_mPMCA = 1.70e-4;             % PM Ca-ATPase Michaelis K   (mM) 
    % Plasma membrane Na-Ca exchanger (Lindblad et al. 1996)   
    g_NCX = 0.000487;              % NCX maximal current        (pA) 
    d_NCX = 0.0003;                % NCX scaling factor         (unitless) 
    gamma_NCX = 0.45;              % NCX non-sym V-Dep part prm (unitless) 
    % Na-K pump 
    Ibar_NaK = 2.3083;             % Max NaK pump current       (pA/pF) 
    n_HKe = 1.1;                   % Ext K Hill coerricient     (unitless) 
    K_dKe = 1.6;                   % Ext K binding constant     (mM) 
    n_HNai = 1.7;                  % Cyto Na Hill coefficient   (unitless) 
    Na_dNai = 22;                  % Cyto Na binding constant   (mM) 
    Q_10 = 1.87;                   % Temp correction to NCX     (unitless) 
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    % Na-K_Cl cotransporter (Strieter et al. 1990) 
    L_NaKCl = 1.79e-8;             % Na-K-Cl cotrans coeff      (n(mole^2)/J*s*cm^2) 
    % Sarcoplasmic reticulum IP3 receptor 
    Ibar_IP3 = 2880e-6;            % Max rate Ca release IP3    (1/ms) 
    K_IP3 = 1.20e-4;               % Disoc cnst IP3-IP3 recpt   (mM) 
    K_actIP3 = 1.70e-4;            % Disoc cnst Ca activation   (mM) 
    k_onIP3 = 1.4;                 % Rate Ca bnd to inhib site  (1/(ms*mM)) 
    K_inhIP3 = 1.00e-4;            % Disoc cnst Ca inhibition   (mM) 
    % Sarcoplasmic reticulum SERCA, uptake, release and internal diffusion 
    Ibar_SERCA = 6.68;             % Max SERCA current control  (pA) 
    % Ibar_SERCA = 20;               % Max SERCA current adjust   (pA) 
    K_mup = 1e-3;                  % SERCA Michaelis constant   (mM) 
    tau_tr = 1000;                 % SR int diff time constant  (ms) 
    R_leak = 1.07e-5;              % SR leak parameter control  (unitless) 
    tau_rel = 0.0333;              % SR Ca release time const   (ms) 
    CSQNbar = 15;                  % Ave calsequestrin conc SR  (mM) 
    K_CSQN = 0.8;                  % Bind aff calsequestrin     (mM) 
    % Sarcoplasmic reticulum ryanodine receptor four state model 
    K_r1 = 2500;                   % Rate Ca bnd to act site    (1/(ms*mM^2)) 
    K_r2 = 1.05;                   % Rate Ca bnd to inact site  (1/(ms*mM)) 
    K_mr1 = 0.0076;                % Rate Ca unbnd from act     (1/ms) 
    K_mr2 = 0.084;                 % Rate Ca unbnd from inact   (1/ms) 
    % Alpha1-adrenoceptor activation and IP3 formation (Bennett et al. 2005) 
    k_rG = 1.75e-7;                % Receptor recycling rate    (1/ms) 
    xi_G = 0.85;                   % Frac of mobile receptors   (unitless) 
    R_TG = 2e4;                    % Total number of recptors   (# recpetprs) 
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    k_pG = 0;                      % Recept phos rate NE desens (1/ms) 
    K_1G = 0.01;                   % Unphos recept dissoc const (mM) 
    k_eG = 6e-6;                   % Receptor endocytosis rate  (1/ms) 
    K_2G = 0.2;                    % Phos recept dissoc const   (mM) 
    k_aG = 0.17e-3;                % G-protein activation rate  (1/ms) 
    G_TG = 1e5;                    % Tot # G-protein molecules  (# molecules) 
    k_dG = 1.5e-3;                 % G-protein deactiv rate     (1/ms) 
    alpha_G = 2.781e-8;            % Eff signal gain param      (1/ms) 
    K_cG = 0.4e-3;                 % Ca-PLC dissoc constant     (mM) 
    gamma_G = 1e-15*N_Avo*Vol_i;   % Conv of # PIP2 to concen   (mM) 
    k_degG = 1.25e-3;              % IP3 degradation rate       (1/ms) 
    r_rG = 0.015e-3;               % PIP2 replenishment rate    (1/ms) 
    PIP2_T = 5e7;                  % Total # PIP2 molecules     (# molecules) 
    % sGC activation and cGMP formation (Condorelli 2001, Tsoukias 2004, Yang 2005) 
    V_cGMPmax = 1.26e-7;           % Max cGMP formation rate    (mM/ms) 
    k_2sGC = 0.64e-5;              % sGC full act E3 NOind form (1/ms) 
    k_3sGC =4.2;%{0.24;%{                  % sGC full act E3 NOdep form (1/(ms*mM)) 
    k_m1sGC =15e-3;%{50e-3;               % sGC part act E2 dissoc     (1/ms) 
    k_DsGC = 0.4e-3;               % sGC full act E3 NOdep diss (1/ms) 
    k_m2sGC = 0.1e-6;              % sGC full act E3 NOind diss (1/ms) 
    k_1sGC = 2e3; %{0.14e3                % sGC part act E2 form       (1/(ms*mM)) 
    k_DrsGC = 0.1e-3;              % cGMP inv max tau form rate (1/ms) 
    k_pdecGMP = 0.0695e-3;         % cGMP PDE cat hydrol rate   (1/ms) 
    K_mpde = 1e-3;                 % cGMP PDE cat Micaelis cnst (mM) 
    % Ionic balances 
    Sbar_CM = 0.1;                 % Calmodulin concen          (mM) 
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    K_dCM = 2.60e-4;               % Calmodulin-Ca dissoc const (mM) 
    Bbar_F = 0.1;                  % Other Ca buffers concen    (mM) 
    K_dB = 5.298e-4;               % Other buff-Ca dissoc const (mM) 
    % ODE solver parameters 
    ode15s_OptsVSME = odeset(...   % Setting ode15s ptions for VSME steady state 
       'RelTol',1.0e-4, ...        %  Set relative tolerance 
       'AbsTol',1.0e-8);           %  Set absolute tolerance 
    % Calculation of ICs from minimal set of specified ICs 
    V_m0 = -59.4;                                  % Intial Vm                  (mV) 
    d_L0 = 1 / (1 + exp(-V_m0/8.3));               % Calc L-type Ca d gate      (uls) 
    f_L0 = 1 / (1 + exp((V_m0+42)/9.1));           % Calc L-type Ca f gate      (uls) 
    Ca_i0 = 68.0e-6;                               % Initial cyto Ca concen     (mM) 
    NO_0 = 1e-12;                                  % Initial NO concen          (mM) 
    cGMP_i0 = 0;                                   % Initial cGMP concen        (mM)%{%{%{%{%{was 0.2e-3 
    R_NO0 = NO_0 / (NO_0 + 0.2e-3);                % Calc BKCa NO reg factor    (uls)also tried 0.5e-3 
switching from 0.2e-3 to 0.025e-3%{%{%{%{%{%{%{%{%{ 
    R_cGMP0 = (cGMP_i0^2) / ...                    % Calc BKCa cGMP reg factor  (uls) 
               ((cGMP_i0^2) + ((0.55e-3)^2)); 
    V_50KCa0 = (-41.7 * log10(Ca_i0)) - ...        % Calc BKCa half activation  
                 128.2 - (dV_50KCaNO*R_NO0) - ...  %  membrane voltage          (mV) 
                 (dV_50KCacGMP*R_cGMP0); 
    p_f0 = 1 / (1 + exp(-(V_m0-V_50KCa0)/18.25));  % Calc BKCa fast p gate      (uls) 
    p_s0 = 1 / (1 + exp(-(V_m0-V_50KCa0)/18.25));  % Calc BKCa slow p gate      (uls) 
    p_K0 = 1 / (1 + exp(-(V_m0+11)/15));           % Calc V-dep K var p gate    (uls) 
    q_10 = 1 / (1 + exp((V_m0+40)/14));            % Calc V-dep K fix q1 gate   (uls) 
    q_20 = 1 / (1 + exp((V_m0+40)/14));            % Calc V-dep K fix q2 gate   (uls) 
    h_IP30 = K_inhIP3 / (Ca_i0+K_inhIP3);          % Calc IP3 recept h gate     (uls) 
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    R_supSG0 = R_TG * xi_G;                        % Calc unphos NE recept #    (uls) 
    IP3_0 = 0;                                     % Initial cyto IP2 concen    (mM) 
    PIP2_0 = PIP2_T - ((1 + (k_degG/r_rG)) ...     % Calc cyto PIP2 # moleec    (uls) 
              * gamma_G * IP3_0); 
    r_hG0 = (k_degG * gamma_G * IP3_0) / PIP2_0;   % Calc Hydrol rate PIP2     (1/ms) 
    G_0 = (r_hG0*(K_cG+Ca_i0)) / (alpha_G*Ca_i0);  % Calc act G protein in PM  (uls) 
    deltaG_0 = (k_dG * G_0) / ...                  % Calc ratio act lig unbnd  (uls) 
                 (k_aG * (G_TG - G_0));            %  to lig bnd receptors 
    % Assigning all ICs into vector to use to start solution of ODEs 
    x0_VSME(1) = d_L0;             % Init L-type Ca act prob, d_L       (unitless) 
    x0_VSME(2) = f_L0;             % Init L-type Ca inact prob, f_L     (unitless) 
    x0_VSME(3) = p_f0;             % Init Ca-act K fast gate prob, p_f  (unitless) 
    x0_VSME(4) = p_s0;             % Init Ca-act K slow gate prob, p_s  (unitless) 
    x0_VSME(5) = p_K0;             % Init K_V p activ gate prob, p_K    (unitless) 
    x0_VSME(6) = q_10;             % Init K_V q fast activ prob, q_1    (unitless) 
    x0_VSME(7) = q_20;             % Init K_V q slow activ prob, q_2    (unitless) 
    x0_VSME(8) = 0;                % Init SOC act gate prob, P_SOC      (unitless) 
    x0_VSME(9) = h_IP30;           % Init IP3 act gate prob, h_IP3      (unitless) 
    x0_VSME(10)  = 0.66;           % Init SR uptake Ca concen, Ca_u     (mM) 
    x0_VSME(11)  = 0.57;           % Init SR release Ca concen, Ca_r    (mM) 
    x0_VSME(12) = 0.0033;          % Init RyR w/ act Ca bnd, R_10       (unitless) 
    x0_VSME(13) = 4e-6;            % Init RyR w/ act-inact Ca bnd, R_11 (unitless) 
    x0_VSME(14) = 0.9955;          % Init RyR w/ inact Ca bnd, R_01     (unitless) 
    x0_VSME(15) = R_supSG0;        % Init # unphos surf recept, R_supSG (#) 
    x0_VSME(16) = 0;               % Init # phos surf recept, R_supSPG  (#) 
    x0_VSME(17) = G_0;             % Init # sctive G protein, G         (#) 
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    x0_VSME(18)  = 0;              % Init cyto IP3 concen, IP3          (mM) 
    x0_VSME(19) = PIP2_0;          % Init # cyto PIP2 molecules, PIP2   (#) 
    x0_VSME(20) = 0;               % Init rate of cGMP form, V_cGMP     (mM/ms) 
    x0_VSME(21) = 0;               % Init cyto cGMP concen, cGMP_i      (mM) 
    x0_VSME(22)  = Ca_i0;          % Init cyto Ca concen, Ca_i          (mM) 
    x0_VSME(23)  = 8.4;            % Init cyto Na concen, Na_i          (mM) 
    x0_VSME(24)  = 140.0;          % Init cyto K concen, K_i            (mM) 
    x0_VSME(25)  = 59.4;           % Init cyto Cl concen, Cl_i          (mM) 
    x0_VSME(26)  = V_m0;           % Init membrane potential, V_m       (mV) 
    % Optimization parameters 
    fmc_OptsVSME = ....                 % Grab default settings 
           optimset('fmincon');  
    fmc_OptsVSME.Algorithm = ...        % Set algorithm type 
                 'active-set'; 
    fmc_OptsVSME.Display = 'iter';      % Set display content 
    fmc_OptsVSME.TolFun = 1e-6;        % Set tolerance on function 
    fmc_OptsVSME.TolCon = 1e-6;        % Set tolerance on bound constraints 
    fmc_OptaVSME.MaxFunEvals = 600;     % Set maximum number of functional evals 
    fmc_OptsVSME.MaxIter = 200;         % Set maximum number of iterations 
    % Fixed parameter structure 
    VSME_FPValues = {F R T RT FRT N_Avo C_m A_m z_K z_Na z_Ca z_Cl ... 
            Ca_e Na_e K_e Cl_e Vol_i Vol_Ca Vol_SRu Vol_SRr P_VOCC ... 
            N_BKCa tau_pf tau_ps dV_50KCaNO dV_50KCacGMP P_BKCa ... 
            g_Kv tau_q1 tau_q2 g_Kleak K_NSC d_NSCmin PNa_NSC PK_NSC ... 
            PCa_NSC gCa_SOC gNa_SOC K_SOC tau_SOC g_ClCa R_ClcGMPmin ... 
            n_ClCa K_ClCa n_ClcGMP K_ClcGMP Ibar_PMCA K_mPMCA g_NCX ... 
368	  
	  
            d_NCX gamma_NCX Ibar_NaK n_HKe K_dKe n_HNai Na_dNai Q_10 ... 
            L_NaKCl Ibar_IP3 K_IP3 K_actIP3 k_onIP3 K_inhIP3 ... 
            Ibar_SERCA K_mup tau_tr R_leak tau_rel CSQNbar K_CSQN ... 
            K_r1 K_r2 K_mr1 K_mr2 k_rG xi_G R_TG k_pG K_1G k_eG ... 
            K_2G k_aG G_TG k_dG alpha_G K_cG gamma_G k_degG r_rG ... 
            PIP2_T V_cGMPmax k_2sGC k_3sGC k_m1sGC k_DsGC k_m2sGC ... 
            k_1sGC k_DrsGC k_pdecGMP K_mpde Sbar_CM K_dCM Bbar_F ... 
            K_dB ode15s_OptsVSME deltaG_0}; 
    VSME_FPFields = {'F' 'R' 'T' 'RT' 'FRT' 'N_Avo' 'C_m' 'A_m' 'z_K' 'z_Na' ... 
            'z_Ca' 'z_Cl' 'Ca_e' 'Na_e' 'K_e' 'Cl_e' 'Vol_i' 'Vol_Ca' ... 
            'Vol_SRu' 'Vol_SRr' 'P_VOCC' 'N_BKCa' 'tau_pf' 'tau_ps' ... 
            'dV_50KCaNO' 'dV_50KCacGMP' 'P_BKCa' 'g_Kv' 'tau_q1' 'tau_q2' ... 
            'g_Kleak' 'K_NSC' 'd_NSCmin' 'PNa_NSC' 'PK_NSC' 'PCa_NSC' ... 
            'gCa_SOC' 'gNa_SOC' 'K_SOC' 'tau_SOC' 'g_ClCa' 'R_ClcGMPmin' ... 
            'n_ClCa' 'K_ClCa' 'n_ClcGMP' 'K_ClcGMP' 'Ibar_PMCA' 'K_mPMCA' ... 
            'g_NCX' 'd_NCX' 'gamma_NCX' 'Ibar_NaK' 'n_HKe' 'K_dKe' 'n_HNai' ... 
            'Na_dNai' 'Q_10' 'L_NaKCl' 'Ibar_IP3' 'K_IP3' 'K_actIP3' ... 
            'k_onIP3' 'K_inhIP3' 'Ibar_SERCA' 'K_mup' 'tau_tr' 'R_leak' ... 
            'tau_rel' 'CSQNbar' 'K_CSQN' 'K_r1' 'K_r2' 'K_mr1' 'K_mr2' ... 
            'k_rG' 'xi_G' 'R_TG' 'k_pG' 'K_1G' 'k_eG' 'K_2G' 'k_aG' 'G_TG' ... 
            'k_dG' 'alpha_G' 'K_cG' 'gamma_G' 'k_degG' 'r_rG' 'PIP2_T' ... 
            'V_cGMPmax' 'k_2sGC' 'k_3sGC' 'k_m1sGC' 'k_DsGC' 'k_m2sGC' ... 
            'k_1sGC' 'k_DrsGC' 'k_pdecGMP' 'K_mpde' 'Sbar_CM' 'K_dCM' ... 
            'Bbar_F' 'K_dB' 'ode15s_OptsVSME' 'deltaG_0'}; 
    VSME_FPStruct = cell2struct(VSME_FPValues,VSME_FPFields,2); 
    % Load all fixed parameters in one cell array of structures 
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    FixPStruct_Cell = cell(3,1); 
    FixPStruct_Cell{1} = VMech_FPStruct; 
    FixPStruct_Cell{2} = XB_FPStruct; 
    FixPStruct_Cell{3} = VSME_FPStruct; 
     
 
%% 
********************************************************************************** 
%   Act/Ca Xbridge Fit for  S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
 
%     Using system of ODEs solving for VSM crossbridge dynamics in the steady 
%     state so the steady state VSM cytosolic Ca2+ levels can be determined 
%     as a function of VSM activation 
%     t_Start = 0;                                    % Starting time of SS calc  (s) 
%     t_End = 60;                                     % Ending time of SS calc    (s) 
%  
%     Cai_Min = 0.010;                                % Min cyto Ca concen        (uM) 
%     Cai_Max = 1.500;                                % Max cyto Ca concen        (uM) 
%     Cai_Grid = 100;                                 % Grid of cyto Ca range  
%     Cai_Disc = logspace(log10(Cai_Min), ...         % Discretized Cai domain    (uM) 
%                   log10(Cai_Max),Cai_Grid); 
%      
%     t_Out = cell(Cai_Grid,1);                       % Preallocating cell arrays 
%     x_Out = cell(Cai_Grid,1);                       %  and activation matrix 
%     Act_Sim = zeros(Cai_Grid,1); 
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%      
%     for i = 1:Cai_Grid                              % Calculate SS act at each Ca_i 
%         Ca_i = Cai_Disc(i); 
%         XBdXdt_Hndl = @(t,x) dXdT_VSMXB ...         % Setting crossbridge function 
%             (t,x,Ca_i,XB_FPStruct);                 %  handle of system of ODEs 
%         [t_Out{i},x_Out{i}] = ode15s( ...           % ODE solution over time domain 
%             XBdXdt_Hndl,[t_Start t_End], ... 
%             x0_XB,ode15s_OptsXB); 
%         Act_Sim(i) =(x_Out{i}(end,3) + ...         % Calculate activation 
%             x_Out{i}(end,4)) / AMpAM_Max; 
%     end 
%  
%     XBDyn_tSim = t_Out;                             % Store XB time vector 
%     XBDyn_SVSim = x_Out;                            % Store XB state variables 
%     CaiAct_Sim = [Cai_Disc' Act_Sim];               % Store SS Cai and VSM Act 
%      
%     % Optimized crossbridge parameter structure 
%     XB_SimValues = {XBDyn_tSim XBDyn_SVSim CaiAct_Sim}; 
%     XB_SimFields = {'XBDyn_tSim' 'XBDyn_SVSim' 'CaiAct_Sim'}; 
%     XB_SimStruct = cell2struct(XB_SimValues,XB_SimFields,2); 
%      
%     % Calling fmincon to optimize the fit to the steady state  
%     % activation with Hill function equation 
%     K_AInit = 1;                                    % Setting the initial 
%     n_Init = 0.1;                                   %  free parameter values 
%     p_XB(1) = K_AInit; 
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%     p_XB(2) = n_Init;     
%  
%     pHill_LowB(1) = 0;                              % Setting the lower and 
%     pHill_LowB(2) = 0;                              %  upper bounds for the 
%     pHill_UpB(1) = 1.6;                             %  impulse function fit 
%     pHill_UpB(2) = 20; 
%      
%     XBOF_Hndl = @(p_XB) VSMXB_ObjFun ...            % Setting crossbridge objective 
%         (p_XB,CaiAct_Sim);                          %  function handle 
%     p_XB = fmincon(XBOF_Hndl,p_XB,[], ...           % Optimization call for 
%         [],[],[],pHill_LowB,pHill_UpB, ...          %  the Hill function fit 
%         [],fmc_OptsXB);  
%             
%     K_AOpt = p_XB(1);                               % Optimized free parameter 
%     n_Opt = p_XB(2);                                %  values  
%      
     
    K_AOpt = 1.6;                               % Optimized free parameter 
    n_Opt = 20;                                %  values from previous simulations 
                                                    %  These calculations 
                                                    %  have been removed to 
                                                    %  save time  
     
     
    % Optimized crossbridge parameter structure 
    XB_OPValues = {K_AOpt n_Opt}; 
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    XB_OPFields = {'K_AOpt' 'n_Opt'}; 
    XB_OPStruct = cell2struct(XB_OPValues,XB_OPFields,2); 
     
     
%% 
********************************************************************************** 
%   Save Prev OptP for      S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
 
%     Building the cell array conatining the previously optimized parameters 
%     which will be used in the final optimization 
    OptPStruct_Cell = cell(2,1); 
    OptPStruct_Cell{1} = VMech_OPStruct; 
    OptPStruct_Cell{2} = XB_OPStruct; 
     
     
%% 
********************************************************************************** 
%   Opt VSME params for     S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
***********************************************************************************     
 
    Num_Models =1;%{2; %{9;                                             % # models to try 
     
%     if (MesFem_Flag == 1) 
          pVSME_Opt = [6.997 82.245 4.161]; 
%         pVSME_Opt{1} = [5.628 82.690 3.475]; 
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%         pVSME_Opt{2} = [6.997 82.245 4.161]; 
%         pVSME_Opt{3} = [403.429 91.222 2.299]; 
%         pVSME_Opt{4} = [2.365 1881.08 1.647]; 
%         pVSME_Opt{5} = [4.272 300.937 2.707]; 
%         pVSME_Opt{6} = [32.490 74.463 2,875];         %These channel 
%         pVSME_Opt{7} = [7.134 76.946 3.194];          %varients are assumed irrelavant as was found by 
Carlson and Beard 
%         pVSME_Opt{8} = [20.00 54.598 2.000]; 
%         pVSME_Opt{9} = [0.000 49.620 2.027]; 
%     else 
%         pVSME_Opt{1} = [14.610 76.746 1.790]; 
%         pVSME_Opt{2} = [7.931 34.107 2.742]; 
%         pVSME_Opt{3} = [665.142 82.789 1.136]; 
%         pVSME_Opt{4} = [3.926 764.942 1.755]; 
%         pVSME_Opt{5} = [5.139 211.178 1.948]; 
%         pVSME_Opt{6} = [71.636 68.855 1.346]; 
%         pVSME_Opt{7} = [20.000 84.928 1.535]; 
%         pVSME_Opt{8} = [19.866 1010.50 2.504]; 
%         pVSME_Opt{9} = [0.000 1.648 1.711]; 
%      end 
 
 
%% 
********************************************************************************** 
%   Figures for             S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
      Model_Flag=1; 
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%     Simulated myogenic response of each model variant in turn 
%     disp(' ') 
%     for i = 1:Num_Models 
%         Model_Flag = i; 
%         DispStrg = ['Simulating channel variant ' num2str(i)]; 
%         disp(DispStrg) 
        x0_In = x0_VSME;                                        % Load ICs 
%         if (Model_Flag == 4 || Model_Flag == 5)                 % Ohmic channels 
%             x0_In(27) = 0.50;                                   % Add extra IC 
%         end 
        output=SingVess_SFSim3(Drefin,Prefin,NO,pVSME_Opt,Model_Flag,x0_In, ...  
                         FixPStruct_Cell,OptPStruct_Cell); 
     
 toc 
   end 
     
                
 
%% 
********************************************************************************** 
%  End of Script            S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
%  References for           S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
% 
%   Bund SJ 
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%   Spontaneously hypertensive rat resistance artery structure related to myogenic 
%   and mechanical properties. 
%   Clinical Science 101:385-393, 2001. 
%    
%   Carlson BE and Secomb TW. 
%   A theoretical model for the myogenic response based on the length-tension  
%   characteristics of vascular smooth muscle. 
%   Microcirculation 12:327-338, 2005. 
% 
%   Hai CM and Murphy RA. 
%   Cross-bridge phosphorylation and regulation of latch state in smooth muscle. 
%   American Journal of Physiology, Cell Physiology 254:C99-106, 1988.     
% 
%   Koenigsberger M, Sauser R, Beny J-L and Meister J-J. 
%   Effects of arterial wall stress on vasomotion. 
%   Biophysical Journal 91:1663-1674, 2006. 
% 
%   Kapela A, Bewerianos A and Twoukias NM. 
%   A mathematical model of Ca2+ dynamics in rat mesenteric smooth muscle cell: 
%   agonist and NO simulation. 
%   Journal of Theoretical Biology 253:238-260, 2008 
% 
%   Condorelli P, George SC. 
%   In Vivo control of soluble guanylate cyclase activation by nitric 
%   oxide: a kinetic analysis. 
%   Biophysical Journal 80: 2110-2119, 2001 
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% 
% 
*********************************************************************************** 
%  Modification Log of      S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
%   18 May     2010 --> Developed code integrating the passive/myogenic fits to  
%                        experimental data, Hai and Murphy crossbridge model and  
%                        the Kapela et al. vascular smooth muscle ephys model 
%   10 June    2010 --> 3 parameter fits for stress activated Ca and Na channels  
%                        integrated into code and sucessfully fit 
%    1 October 2010 --> Edited the XB simulation and fit code in Step 2 and  
%                        broke out the XB simulation and fit plot as a separate 
%                        function.  Finished fully commenting code. 
%   18 January 2011 --> Added the nine different channel configurations and enabled 
%                        the input of initial guesses, log scaled optimization, 
%                        and lower and upper parameter bounds through a single  
%                        matrix.  Added the Vm plot at the end of the figure section 
%    5 April   2011 --> Trimmed out all the optimization code except that for the  
%                        determination of the Hill fit to VSM crossbridge activation 
%                        and left in the functions to plot out Figure 4 or 5 and 6 
%                        in the paper 
%    2 June    2011 --> Final edits and comments 
%    2 October 2013 --> Final additions and comments by Patrick Kirby 
%    (modification of original code) 
% 
*********************************************************************************** 
377	  
	  
Press_Dia_plots  - Generates Diameter/Pressure Plots for each of the different channel varients in the 
Carlson Model% 
%************************************************************************** 
%   PLOTTING CODE FOR THE DIFFERENT CHANNEL VARIENTS AND THE DIFFERENT 
%                           NITRIC OXIDE INPUTS 
%**************************************************************************** 
%Its the purpose of this file to plot the variation of the diameter with 
%respect to intraluminal pressure at different concentrations of NO which 
%the smooth muscle is exposed. 
%diameter curves 
function Press_Dia_plotsNE(Num_Models,FixPStruct_Cell) 
%%***************************************************************** 
% Loading Params from Single Vessel Press Diam Solution Again 
%%****************************************************************** 
% Unpacking the vessel wall mechanics data and fixed parameters for 
% plotting purposes 
VMech_FPStruct = FixPStruct_Cell{1}; 
    MesFem_Flag = VMech_FPStruct.MesFem_Flag; 
    Myo_Data = VMech_FPStruct.Myo_Data; 
 
   Title_String = {'NSC \sigma C Na^+ cond'};  
%                     'NSC \sigma C gate V' ... 
%                     'Supp Ca^{2+} \sigma C cond' ... 
%                     'Supp Na^+ \sigma C cond' ... 
%                     'L-type Ca^{2+} \sigma C gate V' ... 
%                     'L-type Ca^{2+} \sigma C cond' ... 
%                     'BK_{Ca} \sigma C gate V' ... 
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%                     'BK_{Ca} \sigma C cond'}; 
 
%  NOit=[10e-6 20e-6 25e-6 50e-6 200e-6 400e-6];        
 
Model_Strgs = { 'Davis Data'... 
                '[NE]=10 x 10^-^9mM'... 
                '[NE]=1 x 10^-^6 mM' ... 
               ' [NE]=10 x 10^-^6 mM'  ... 
               ' [NE]=20 x 10^-^6 mM' ... 
               ' [NE]=40 x 10^-^6 mM' ... 
               ' [NE]=80 x 10^-^6 mM'... 
               ' [NE]=100 x 10^-^6' ... 
               ' [NE]=200 x 10^-^6'}; 
          
                                      
% Model_Strgs = {' [NO]=1 x 10^-^1^2mM'  ... 
%                ' [NO]=1 x 10^-^9mM' ... 
%                ' [NO]=1 x 10^-^6mM' ... 
%                ' [NO]=100 x 10^-^6mM'... 
%                ' [NO]=200 x 10^-^6mM'}; 
%     Load error bars 
        Noitsm=9;% the number of Changes in NO concentration 
 
 
    if (MesFem_Flag == 1) 
        [Header EB_Data] = Irreg_HD_Load ...            % Load in symmetric 
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              ('ErrorBars_Davis_Myogenic.txt');     %  error bars 
('ErrorBars_Sungrac.txt');('ErrorBars_BundFem.txt'); 
    else 
        [Header EB_Data] = Irreg_HD_Load ...            % Load in symmetric 
              ('ErrorBars_BundFem.txt');                %  error bars 
    end  
    Legend_Strgs = cell(9,1);                  %Preallocating the legend space 
for i=1:Num_Models 
    if i==1 
        open('SingVess_Model1.mat') 
    end 
     
    if i==2 
        open('SingVess_Model2.mat') 
     
%         elseif i==2 
%         open('SingVess_Model2.mat') 
%         elseif i==3 
%         open('SingVess_Model3.mat') 
%         elseif i==4 
%         open('SingVess_Model4.mat') 
%         elseif i==5 
%         open('SingVess_Model5.mat') 
%         elseif i==6 
%         open('SingVess_Model6.mat') 
%         elseif i==7 
%         open('SingVess_Model7.mat') 
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%         elseif i==8 
%         open('SingVess_Model8.mat') 
%         else 
%         open('SingVess_Model9.mat') 
    end 
    figure(i+7) 
         ModelFit_MatFile{1} = ['SingVess_Model' ... 
            num2str(i) '.mat']; 
        load(ModelFit_MatFile{1}) 
       plot(Myo_Data(:,1),Myo_Data(:,2),'ok','MarkerSize',8) 
       errorbar(Myo_Data(:,1),Myo_Data(:,2),... 
           EB_Data, 'ok','MarkerSize',8,... 
           'LineWidth',1,'MarkerFaceColor','k') 
        hold on 
         plot(PSim_SS(:,1),DSim_SS(:,1),'-k',PSim_SS(:,2),DSim_SS(:,2),... 
             '--k',PSim_SS(:,3),DSim_SS(:,3),'ko',PSim_SS(:,4),... 
             DSim_SS(:,4),'kx', PSim_SS(:,5),DSim_SS(:,5),'k*',PSim_SS(:,6),DSim_SS(:,6),'-.k',... 
             PSim_SS(:,7),DSim_SS(:,7),'-g',PSim_SS(:,8),DSim_SS(:,8),'r-','LineWidth',1)      % Plot 
simulation curve 
        set(gca,'FontSize',18,'Box','off') 
        for j=1:Noitsm 
        Legend_Strgs{j} = Model_Strgs{j};   
        end 
        XLim_Min = 0 * min(Myo_Data(:,1)); 
        XLim_Max = 1.25 * max(Myo_Data(:,1)); 
        xlim([XLim_Min XLim_Max]) 
        if (MesFem_Flag == 1) 
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            YLim_Min = 0; 
            YLim_Max = 180; 
        else 
            YLim_Min = 50; 
            YLim_Max = 200; 
        end 
        ylim([YLim_Min YLim_Max]) 
       legend(Legend_Strgs,0,'Fontsize',10) 
       legend('boxoff') 
        ylabel('Diameter (\muM)','FontSize',18)     % Y labels on left figures 
        xlabel('Pressure (mmHg)','FontSize',18)     % X labels on bottom figures 
        
        title(Title_String{i}) 
         
end 
     
drawnow 
 
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{% 
 
%%   SingVess_MyogResp - Simulation of VSM ephys, contraction and vessel response 
% 
*********************************************************************************** 
%   V A S C U L A R   S M O O T H   M U S C L E   E L E C T R O P H Y S I O L O G Y 
%       A N D   V E S S E L   W A L L   M E C H A N I C S   O F   S I N G L E 
%              A R T E R I O L A R   M Y O G E N I C   R E S P O N S E 
%                           INFLUENCE OF NITRIC OXIDE 
382	  
	  
% 
*********************************************************************************** 
% 
%   This script defines the underlying vascular smooth muscle (VSM) function in  
%   terms of channel currents, cytosolic calcium handling and force generation  
%   that is necessary to generate the myogenic response in pressureized single  
%   cannulated isolated arteriolar vessels.  There are three sections in 
%   the code 
%   involved in the simulation of the vessel diameter in the myogenic response: 
% 
%   1) Experimental data containing the passive and the myogenically active steady  
%      state vessel response to pressure is entererd along with the previously  
%      determined adjustable parameter values (Carlson and Secomb Microcirculation  
%      12:327-338, 2005) for the vessel wall mechanics portion of the integrated  
%      model (Model 1), the fixed parameters for the VSM crossbridge kinetics, and  
%      the fixed parameters defining the VSM electrophysiology and Ca2+ handling. 
%       
%   2) Next the four-state Hai and Murphy model of crossbridge force generation in  
%      VSM cells (AJP 254:C99-C106, 1988) is run to steady state to define the VSM  
%      activation as a function of cytosolic Ca.  The fixed parameters used in the  
%      model are as presented by Koenigsberger et al. (Biophys J 91:1663-1674,  
%      2006).  A simple Hill function is fit to these simulation "data" points.   
%      This optimized fit of VSM crossbridge activation is used to connect 
%      the cytosolic Ca concenteration generated in the VSM electrophysiology  
%      model of step 3) to the mogenic response data in step 1). 
% 
%   3) The final portion of this script loads the previously determined adjustable  
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%      parameter values for the stress-controlled channel variants, simulates the  
%      VsM ephys, Ca2+ levels, force generation and steady-state diameter response 
%      to changes in pressure and then plots out some figures from the paper.  The  
%      VSM epectrophysiology model is based on the model developed by Kapela et al.  
%      (J Theor Biol 253:238-260, 2008) with the addition of vessel wall stress- 
%      controlled NSC, Ca2+, Na+, L-type Ca2+ or BKCa as described in the paper.   
%      Each of the nine vessel stress-controlled channel variants is inserted in  
%      the model in turn and the myogenic response is simulated.  The figures that 
%      are replicated are Figure 4, 5 and 6 from the paper. 
%   
% 
%   4) Additional changes were made to the program in attempt to analyze 
%       the influence of nitric oxide on the myogenic response.  In particular 
%       it was desired to see how changes in nitric oxide concentration leads 
%       to changes in vessel diameter at a set pressure. 
% 
%   5) It was also discovered that this mathematical model makes use of the 
%       assumption that it is only the fully activated form of sGC which 
%       controls the transition from GTP to cGMP.  Yet in the study conducted 
%       by Condorelli and George it was found that each of the different forms  
%       of the sGC complex contributes in its own way to the reaction from 
%       GTP to cGMP.  For this reason appropriate changes have been made to 
%       the m-file SingVess_SFSim.m. 
%    
%   Model originally created on      28 May  2010 
%   Model last modfied on             2 June 2011 
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%   Model modified by Patrick Kirby   1 August 2013 
% 
%   Developed by        Brian Carlson 
%                       Computational Bioengineering Group 
%                       Biotechnology and Bioengineering Center 
%                       Medical College of Wisconsin 
% 
%   COPYRIGHT AND REQUEST FOR ACKNOWLEDGMENT OF USE:    
%   Copyright (C) 2011 Medical College of Wisconsin.  This software was developed 
%   by the Computational Bioengineering Group, Director D.A. Beard, Director,  
%   Department of Physiology and Biotechnology and Bioengineering Center, Medical  
%   College of Wisconsin, Milwaukee, WI. 53226. Software may be copied for use by  
%   academic institutions so long as these copyright rights are acknowledged.   
%   Commercial use requires a license. 
% 
%   This software was developed with support from NSF grant EFRI 0735903.  
%   Please cite this grant in any publication for which this software is used  
%   and send an email with the citation and, if possible, a PDF file of the paper  
%   to: becarlson@mcw.edu. 
% 
% 
*********************************************************************************** 
 
%% 
********************************************************************************** 
%   Start of Script         S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
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%   Fixed Paramters for     S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
function SingVess_MyoRespIIit(NOs,Press,Diams,it_num) 
    
    tic 
    MesFem_Flag=1; 
     
     
%     SINGLE VESSEL EXPERIMENTAL DATA 
%     ------------------------------- 
    % Determine whether we are fitting mesenteric or femoral data 
    % Get experimental data 
    if (MesFem_Flag ==1) 
        [Header Data] =  ...                        % Loading all data in 
            Irreg_HD_Load('Davis_myogenic_resp_data.txt'); 
%{Irreg_HD_Load('SVData_SunFig1Mes.txt');Irreg_HD_Load('SVData_BundFig1Mes.txt' 
    else 
        [Header Data] = ... 
            Irreg_HD_Load('SVData_BundFig1Fem.txt'); 
    end 
    % Break dataset out into individual matrices 
    Pass_Data = [Data(:,1) Data(:,2)];          %  Assign passive data %These values may require changes to 
be made 
    Myo_Data = [Press Diams];           %  Assign myogenic data 
    Wallt_Ref = Data(1,5);                      %  Assign reference wall t 
    LumD_Ref = Data(2,5);                       %  Assign reference lumen D 
    % Conversion factors 
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    Conv1 = 0.13332239;                             % Conv from mmHg to kPa 
    Conv2 = 7500.615613;                            % Conv from N/m to mmHg*um 
    Conv3 = 1.00e3;                                 % Conv from N/(m*um) to kPa 
    Conv4 = 0.00013332239;                          % Conv from mmHg*um to N/m 
    % Set options for fzero 
    fz_OptsVMech = optimset('fzero'); 
    fz_OptsVMech.TolX = 1e-6; 
    % Fixed parameter structure 
    VMech_FPValues = {MesFem_Flag Press Diams NOs ... 
                       Wallt_Ref LumD_Ref Conv1 Conv2 ... 
                       Conv3 Conv4 fz_OptsVMech}; 
    VMech_FPFields = {'MesFem_Flag' 'Pressure' 'Diameter' 'NOconc' ... 
                       'Wallt_Ref' 'LumD_Ref' 'Conv1' 'Conv2' ... 
                       'Conv3' 'Conv4' 'fz_OptsVMech'}; 
    VMech_FPStruct = cell2struct(VMech_FPValues,VMech_FPFields,2); 
%     % Loading in the previously determined vessel wall mechanics opt params 
%     pass_par=fun_passfit; 
%     act_par=fun_tot_fit; 
 
% I beleive that the above lines were inserted by myself when I was 
% attempting to fit data to various experimental curves,  I switched from 
% that to simply using fits obtained by Carlson and fellow reasearchers in 
% reference to smaller diameter vessels 
     
%     if (MesFem_Flag == 1) 
        % Optim param values for rat mesen artls from Carlson and Secomb, 2005 
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        Cpass_Opt =0.316;             % Passive tension at 100 mmHg  (N/m) 
        D100_Opt =43.0;         % Diameter at 100 mmHg         (um) 
        Cprpass_Opt =11.247;           % Steepness of passive tension (uls) 
        Cact_Opt =0.392;%    % Max active tension           (N/m) 
        Cpract_Opt =0.903;%    % Position of act ten curve    (uls) 
        Cdpract_Opt =0.618;%   % Width of act ten curve       (uls) 
%     else 
%         
%         % Optim param values for rat fem artls from Carlson and Secomb, 2005 
%         Cpass_Opt = 1.416;                 % Passive tension at 100 mmHg  (N/m) 
%         D100_Opt = 172.8;                  % Diameter at 100 mmHg         (um) 
%         Cprpass_Opt = 7.901;               % Steepness of passive tension (uls) 
%         Cact_Opt = 1.499;                  % Max active tension           (N/m) 
%         Cpract_Opt = 0.742;                % Position of act ten curve    (uls) 
%         Cdpract_Opt = 0.353;               % Width of act ten curve       (uls) 
%     end 
    % Optimized vessel mechanics parameter structure used to pass to functions 
    VMech_OPValues = {D100_Opt Cpass_Opt Cprpass_Opt ... 
                       Cact_Opt Cpract_Opt Cdpract_Opt}; 
    VMech_OPFields = {'D100_Opt' 'Cpass_Opt' 'Cprpass_Opt' ... 
                       'Cact_Opt' 'Cpract_Opt' 'Cdpract_Opt'}; 
    VMech_OPStruct = cell2struct(VMech_OPValues,VMech_OPFields,2); 
 
     
%     XBRIDGE MODEL PARAMETERS 
%     ------------------------ 
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    % Rate constants for state variables 
    K_2 = 0.5;                      % Rate of dephosphorylation of Mp     (1/s) 
    K_3 = 0.4;                      % Rate of reattachment of A and Mp    (1/s) 
    K_4 = 0.1;                      % Rate of detachment of AMp           (1/s) 
    K_5 = 0.5;                      % Rate of dephosphylation of AMp      (1/s) 
    K_7 = 0.1;                      % Rate of detachment of AM            (1/s) 
    % Remaining fixed parameters 
    AMpAM_Max = 0.8;                % Max frac of attached xbidges        (unitless) 
    gamma = 17;                     % AM/M phosph rate sensitivity to Ca  (uM^3/s) 
    % ODE solver parameters 
    ode15s_OptsXB = odeset( ...     % Setting ode15s options for XB steady state 
       'RelTol',1.0e-4, ...         %  Set relative tolerance 
       'AbsTol',1.0e-8);            %  Set absolute tolerance 
    % Initial conditions 
    x0_XB(1) = 0.25;                % IC free unphosph xbridges      (unitless) 
    x0_XB(2) = 0.25;                % IC free phosph xbridges        (unitless) 
    x0_XB(3) = 0.25;                % IC attached phosph xbridges    (unitless) 
    x0_XB(4) = 0.25;                % IC attached dephosph xbridges  (unitless) 
    % Optimization parameters 
    fmc_OptsXB = ....               % Grab default settings 
           optimset('fmincon');  
    fmc_OptsXB.Algorithm = ...      % Set algorithm type 
                 'active-set'; 
    fmc_OptsXB.Display = 'iter';    % Set display content 
    fmc_OptsXB.TolFun = 1e-10;      % Set tolerance on function 
    fmc_OptaXB.MaxFunEvals = 600;   % Set maximum number of functional evals 
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    fmc_OptsXB.MaxIter = 200;       % Set maximum number of iterations 
    % Fixed parameter structure 
    XB_FPValues = {K_2 K_3 K_4 K_5 K_7 gamma}; 
    XB_FPFields = {'K_2' 'K_3' 'K_4' 'K_5' 'K_7' 'gamma'}; 
    XB_FPStruct = cell2struct(XB_FPValues,XB_FPFields,2); 
     
%     VSM ELECTROPHYSIOLOGY MODEL PARAMETERS 
%     -------------------------------------- 
    % Universal constants 
    F = 96485.3399;                % Faraday constant           (C/mole) 
    R = 8314.472;                  % Gas constant               ((C*mV)/(K*mole)) 
    T = 293;                       % Temperature                (K) 
    RT = R*T;                      % RT term                    ((C*mV)/mole) 
    FRT = F/RT;                    % F/RT term                  (1/mV) 
    N_Avo = 6.022e23;              % Avogadro's number          (1/mole) 
    % Membrane properties    
    C_m = 25;                      % Total membrane capacitance (pF) 
    A_m = C_m/1e6;                 % Area scaled by capacitance (cm^2) 
    % Ionic valences     
    z_K = 1;                       % Potassium valence          (unitless) 
    z_Na = 1;                      % Sodium valence             (unitless) 
    z_Ca = 2;                      % Calcium valence            (unitless) 
    z_Cl = -1;                     % Chloride valence           (unitless) 
    % External ionic concentrations     
    Ca_e = 2.0;                    % External Ca concentration  (mM) 
    Na_e = 140;                    % External Na concentration  (mM) 
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    K_e = 5;                       % External K concentration   (mM) 
    Cl_e = 129;                    % External Cl concentration  (mM) 
    % Compartmental volumes 
    Vol_i = 1;                     % Cytsolic volume            (pL) 
    Vol_Ca = 0.7;                  % Cyto volume avail to Ca    (pL) 
    Vol_SRu = 0.07;                % SR uptake volume           (pL) 
    Vol_SRr = 0.007;               % SR release volume          (pL) 
    % L-type voltage operated Ca channel     
    P_VOCC = 1.88e-5;              % L-type Ca permeability     (cm/s) 
    % Large conductance Ca-activated K channel     
    N_BKCa = 6.6e6;                % Ca-act K channel density   (1/cm^2) 
    tau_pf = 0.84;                 % Ca-act K fast time const   (ms) 
    tau_ps = 35.9;                 % Ca-act K slow time const   (ms) 
    dV_50KCaNO = 46.3;             % Max NO-ind V50KCa shift    (mV) 
    dV_50KCacGMP = 76;             % Max cGMP-ind V50KCa shift  (mV) 
    P_BKCa = 3.9e-13;              % Ca-act K permeability      (cm/s) 
    % Voltage dependent K channel     
    g_Kv = 1.35;                   % Max whole cell Kv conduct  (nS) 
    tau_q1 = 371;                  % V-depend K fast inact tau  (ms) 
    tau_q2 = 2884;                 % V-depend K slow inact tau  (ms) 
    % Unspecified K leak channels 
    g_Kleak = 0.067;               % Max whole cell Kleak cond  (nS) 
    % Non-selective cation channels  
    K_NSC = 3e-3;                  % Half-max act DAG concen    (mM) 
    d_NSCmin = 0.0244;             % Min constiuent activation  (unitless) 
    PNa_NSC = 5.11e-7;             % Whole cell Na NSC perm     (cm/s) 
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    PK_NSC = 1.06*PNa_NSC;         % Whole cell K NSC perm      (cm/s) 
    PCa_NSC = 4.54*PNa_NSC;        % Whole cell Ca NSC perm     (cm/s) 
    % Store-operated non-selective cation channel     
    gCa_SOC = 0.0083;              % Max whole cell Ca conduct  (nS) 
    gNa_SOC = 0.0575;              % Max whole cell Na conduct  (nS) 
    K_SOC = 1e-4;                  % Half-max act Ca concen     (mM) 
    tau_SOC = 100;                 % SOC act gate tau           (ms) 
    % Calcium-activated chloride channel 
    g_ClCa = 0.23;                 % Max conduct Ca-act Cl      (nS/pF) 
    R_ClcGMPmin = 0.0132;          % cGMP-indep component       (unitless) 
    n_ClCa = 2;                    % Ca-act Cl Ca Hill coeff    (unitless) 
    K_ClCa = 3.65e-4;              % EC50 Ca-act Cl Ca concen   (mM) 
    n_ClcGMP = 3.3;                % Ca-act Cl cGMP Hill coeff  (unitless) 
    K_ClcGMP = 6.4e-3;             % EC50 Ca-act Cl cGMP concen (mM) 
    % Plasma membrane Ca pump 
    Ibar_PMCA = 5.37;              % Max PM Ca-ATPase current   (pA) 
    K_mPMCA = 1.70e-4;             % PM Ca-ATPase Michaelis K   (mM) 
    % Plasma membrane Na-Ca exchanger (Lindblad et al. 1996)   
    g_NCX = 0.000487;              % NCX maximal current        (pA) 
    d_NCX = 0.0003;                % NCX scaling factor         (unitless) 
    gamma_NCX = 0.45;              % NCX non-sym V-Dep part prm (unitless) 
    % Na-K pump 
    Ibar_NaK = 2.3083;             % Max NaK pump current       (pA/pF) 
    n_HKe = 1.1;                   % Ext K Hill coerricient     (unitless) 
    K_dKe = 1.6;                   % Ext K binding constant     (mM) 
    n_HNai = 1.7;                  % Cyto Na Hill coefficient   (unitless) 
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    Na_dNai = 22;                  % Cyto Na binding constant   (mM) 
    Q_10 = 1.87;                   % Temp correction to NCX     (unitless) 
    % Na-K_Cl cotransporter (Strieter et al. 1990) 
    L_NaKCl = 1.79e-8;             % Na-K-Cl cotrans coeff      (n(mole^2)/J*s*cm^2) 
    % Sarcoplasmic reticulum IP3 receptor 
    Ibar_IP3 = 2880e-6;            % Max rate Ca release IP3    (1/ms) 
    K_IP3 = 1.20e-4;               % Disoc cnst IP3-IP3 recpt   (mM) 
    K_actIP3 = 1.70e-4;            % Disoc cnst Ca activation   (mM) 
    k_onIP3 = 1.4;                 % Rate Ca bnd to inhib site  (1/(ms*mM)) 
    K_inhIP3 = 1.00e-4;            % Disoc cnst Ca inhibition   (mM) 
    % Sarcoplasmic reticulum SERCA, uptake, release and internal diffusion 
    Ibar_SERCA = 6.68;             % Max SERCA current control  (pA) 
    % Ibar_SERCA = 20;               % Max SERCA current adjust   (pA) 
    K_mup = 1e-3;                  % SERCA Michaelis constant   (mM) 
    tau_tr = 1000;                 % SR int diff time constant  (ms) 
    R_leak = 1.07e-5;              % SR leak parameter control  (unitless) 
    tau_rel = 0.0333;              % SR Ca release time const   (ms) 
    CSQNbar = 15;                  % Ave calsequestrin conc SR  (mM) 
    K_CSQN = 0.8;                  % Bind aff calsequestrin     (mM) 
    % Sarcoplasmic reticulum ryanodine receptor four state model 
    K_r1 = 2500;                   % Rate Ca bnd to act site    (1/(ms*mM^2)) 
    K_r2 = 1.05;                   % Rate Ca bnd to inact site  (1/(ms*mM)) 
    K_mr1 = 0.0076;                % Rate Ca unbnd from act     (1/ms) 
    K_mr2 = 0.084;                 % Rate Ca unbnd from inact   (1/ms) 
    % Alpha1-adrenoceptor activation and IP3 formation (Bennett et al. 2005) 
    k_rG = 1.75e-7;                % Receptor recycling rate    (1/ms) 
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    xi_G = 0.85;                   % Frac of mobile receptors   (unitless) 
    R_TG = 2e4;                    % Total number of recptors   (# recpetprs) 
    k_pG = 0;                      % Recept phos rate NE desens (1/ms) 
    K_1G = 0.01;                   % Unphos recept dissoc const (mM) 
    k_eG = 6e-6;                   % Receptor endocytosis rate  (1/ms) 
    K_2G = 0.2;                    % Phos recept dissoc const   (mM) 
    k_aG = 0.17e-3;                % G-protein activation rate  (1/ms) 
    G_TG = 1e5;                    % Tot # G-protein molecules  (# molecules) 
    k_dG = 1.5e-3;                 % G-protein deactiv rate     (1/ms) 
    alpha_G = 2.781e-8;            % Eff signal gain param      (1/ms) 
    K_cG = 0.4e-3;                 % Ca-PLC dissoc constant     (mM) 
    gamma_G = 1e-15*N_Avo*Vol_i;   % Conv of # PIP2 to concen   (mM) 
    k_degG = 1.25e-3;              % IP3 degradation rate       (1/ms) 
    r_rG = 0.015e-3;               % PIP2 replenishment rate    (1/ms) 
    PIP2_T = 5e7;                  % Total # PIP2 molecules     (# molecules) 
    % sGC activation and cGMP formation (Condorelli 2001, Tsoukias 2004, Yang 2005) 
    V_cGMPmax = 1.26e-7;           % Max cGMP formation rate    (mM/ms) 
    k_2sGC = 0.64e-5;              % sGC full act E3 NOind form (1/ms) 
    k_3sGC =4.2;%0.24;%{ 4.2;                 % sGC full act E3 NOdep form (1/(ms*mM)) 
    k_m1sGC =15e-3;%{50e-3;               % sGC part act E2 dissoc     (1/ms) 
    k_DsGC = 0.4e-3;               % sGC full act E3 NOdep diss (1/ms) 
    k_m2sGC = 0.1e-6;              % sGC full act E3 NOind diss (1/ms) 
    k_1sGC = 2e3;%{0.14e3; %{2e3                % sGC part act E2 form       (1/(ms*mM)) 
    k_DrsGC = 0.1e-3;              % cGMP inv max tau form rate (1/ms) 
    k_pdecGMP = 0.0695e-3;         % cGMP PDE cat hydrol rate   (1/ms) 
    K_mpde = 1e-3;                 % cGMP PDE cat Micaelis cnst (mM) 
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    % Ionic balances 
    Sbar_CM = 0.1;                 % Calmodulin concen          (mM) 
    K_dCM = 2.60e-4;               % Calmodulin-Ca dissoc const (mM) 
    Bbar_F = 0.1;                  % Other Ca buffers concen    (mM) 
    K_dB = 5.298e-4;               % Other buff-Ca dissoc const (mM) 
    % ODE solver parameters 
    ode15s_OptsVSME = odeset(...   % Setting ode15s ptions for VSME steady state 
       'RelTol',1.0e-4, ...        %  Set relative tolerance 
       'AbsTol',1.0e-8);           %  Set absolute tolerance 
    % Calculation of ICs from minimal set of specified ICs 
    V_m0 = -59.4;                                  % Intial Vm                  (mV) 
    d_L0 = 1 / (1 + exp(-V_m0/8.3));               % Calc L-type Ca d gate      (uls) 
    f_L0 = 1 / (1 + exp((V_m0+42)/9.1));           % Calc L-type Ca f gate      (uls) 
    Ca_i0 = 68.0e-6;                               % Initial cyto Ca concen     (mM) 
    NO_0 = 1e-12;                                  % Initial NO concen          (mM) 
    cGMP_i0 = 0;                                   % Initial cGMP concen        (mM)%{%{%{%{%{was 0.2e-3 
    R_NO0 = NO_0 / (NO_0 + 0.2e-3);                % Calc BKCa NO reg factor    (uls)also tried 0.5e-3 
switching from 0.2e-3 to 0.025e-3%{%{%{%{%{%{%{%{%{ 
    R_cGMP0 = (cGMP_i0^2) / ...                    % Calc BKCa cGMP reg factor  (uls) 
               ((cGMP_i0^2) + ((0.55e-3)^2)); 
    V_50KCa0 = (-41.7 * log10(Ca_i0)) - ...        % Calc BKCa half activation  
                 128.2 - (dV_50KCaNO*R_NO0) - ...  %  membrane voltage          (mV) 
                 (dV_50KCacGMP*R_cGMP0); 
    p_f0 = 1 / (1 + exp(-(V_m0-V_50KCa0)/18.25));  % Calc BKCa fast p gate      (uls) 
    p_s0 = 1 / (1 + exp(-(V_m0-V_50KCa0)/18.25));  % Calc BKCa slow p gate      (uls) 
    p_K0 = 1 / (1 + exp(-(V_m0+11)/15));           % Calc V-dep K var p gate    (uls) 
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    q_10 = 1 / (1 + exp((V_m0+40)/14));            % Calc V-dep K fix q1 gate   (uls) 
    q_20 = 1 / (1 + exp((V_m0+40)/14));            % Calc V-dep K fix q2 gate   (uls) 
    h_IP30 = K_inhIP3 / (Ca_i0+K_inhIP3);          % Calc IP3 recept h gate     (uls) 
    R_supSG0 = R_TG * xi_G;                        % Calc unphos NE recept #    (uls) 
    IP3_0 = 0;                                     % Initial cyto IP2 concen    (mM) 
    PIP2_0 = PIP2_T - ((1 + (k_degG/r_rG)) ...     % Calc cyto PIP2 # moleec    (uls) 
              * gamma_G * IP3_0); 
    r_hG0 = (k_degG * gamma_G * IP3_0) / PIP2_0;   % Calc Hydrol rate PIP2     (1/ms) 
    G_0 = (r_hG0*(K_cG+Ca_i0)) / (alpha_G*Ca_i0);  % Calc act G protein in PM  (uls) 
    deltaG_0 = (k_dG * G_0) / ...                  % Calc ratio act lig unbnd  (uls) 
                 (k_aG * (G_TG - G_0));            %  to lig bnd receptors 
    % Assigning all ICs into vector to use to start solution of ODEs 
    x0_VSME(1) = d_L0;             % Init L-type Ca act prob, d_L       (unitless) 
    x0_VSME(2) = f_L0;             % Init L-type Ca inact prob, f_L     (unitless) 
    x0_VSME(3) = p_f0;             % Init Ca-act K fast gate prob, p_f  (unitless) 
    x0_VSME(4) = p_s0;             % Init Ca-act K slow gate prob, p_s  (unitless) 
    x0_VSME(5) = p_K0;             % Init K_V p activ gate prob, p_K    (unitless) 
    x0_VSME(6) = q_10;             % Init K_V q fast activ prob, q_1    (unitless) 
    x0_VSME(7) = q_20;             % Init K_V q slow activ prob, q_2    (unitless) 
    x0_VSME(8) = 0;                % Init SOC act gate prob, P_SOC      (unitless) 
    x0_VSME(9) = h_IP30;           % Init IP3 act gate prob, h_IP3      (unitless) 
    x0_VSME(10)  = 0.66;           % Init SR uptake Ca concen, Ca_u     (mM) 
    x0_VSME(11)  = 0.57;           % Init SR release Ca concen, Ca_r    (mM) 
    x0_VSME(12) = 0.0033;          % Init RyR w/ act Ca bnd, R_10       (unitless) 
    x0_VSME(13) = 4e-6;            % Init RyR w/ act-inact Ca bnd, R_11 (unitless) 
    x0_VSME(14) = 0.9955;          % Init RyR w/ inact Ca bnd, R_01     (unitless) 
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    x0_VSME(15) = R_supSG0;        % Init # unphos surf recept, R_supSG (#) 
    x0_VSME(16) = 0;               % Init # phos surf recept, R_supSPG  (#) 
    x0_VSME(17) = G_0;             % Init # sctive G protein, G         (#) 
    x0_VSME(18)  = 0;              % Init cyto IP3 concen, IP3          (mM) 
    x0_VSME(19) = PIP2_0;          % Init # cyto PIP2 molecules, PIP2   (#) 
    x0_VSME(20) = 0;               % Init rate of cGMP form, V_cGMP     (mM/ms) 
    x0_VSME(21) = 0;               % Init cyto cGMP concen, cGMP_i      (mM) 
    x0_VSME(22)  = Ca_i0;          % Init cyto Ca concen, Ca_i          (mM) 
    x0_VSME(23)  = 8.4;            % Init cyto Na concen, Na_i          (mM) 
    x0_VSME(24)  = 140.0;          % Init cyto K concen, K_i            (mM) 
    x0_VSME(25)  = 59.4;           % Init cyto Cl concen, Cl_i          (mM) 
    x0_VSME(26)  = V_m0;           % Init membrane potential, V_m       (mV) 
    % Optimization parameters 
    fmc_OptsVSME = ....                 % Grab default settings 
           optimset('fmincon');  
    fmc_OptsVSME.Algorithm = ...        % Set algorithm type 
                 'active-set'; 
    fmc_OptsVSME.Display = 'iter';      % Set display content 
    fmc_OptsVSME.TolFun = 1e-6;        % Set tolerance on function 
    fmc_OptsVSME.TolCon = 1e-6;        % Set tolerance on bound constraints 
    fmc_OptaVSME.MaxFunEvals = 600;     % Set maximum number of functional evals 
    fmc_OptsVSME.MaxIter = 200;         % Set maximum number of iterations 
    % Fixed parameter structure 
    VSME_FPValues = {F R T RT FRT N_Avo C_m A_m z_K z_Na z_Ca z_Cl ... 
            Ca_e Na_e K_e Cl_e Vol_i Vol_Ca Vol_SRu Vol_SRr P_VOCC ... 
            N_BKCa tau_pf tau_ps dV_50KCaNO dV_50KCacGMP P_BKCa ... 
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            g_Kv tau_q1 tau_q2 g_Kleak K_NSC d_NSCmin PNa_NSC PK_NSC ... 
            PCa_NSC gCa_SOC gNa_SOC K_SOC tau_SOC g_ClCa R_ClcGMPmin ... 
            n_ClCa K_ClCa n_ClcGMP K_ClcGMP Ibar_PMCA K_mPMCA g_NCX ... 
            d_NCX gamma_NCX Ibar_NaK n_HKe K_dKe n_HNai Na_dNai Q_10 ... 
            L_NaKCl Ibar_IP3 K_IP3 K_actIP3 k_onIP3 K_inhIP3 ... 
            Ibar_SERCA K_mup tau_tr R_leak tau_rel CSQNbar K_CSQN ... 
            K_r1 K_r2 K_mr1 K_mr2 k_rG xi_G R_TG k_pG K_1G k_eG ... 
            K_2G k_aG G_TG k_dG alpha_G K_cG gamma_G k_degG r_rG ... 
            PIP2_T V_cGMPmax k_2sGC k_3sGC k_m1sGC k_DsGC k_m2sGC ... 
            k_1sGC k_DrsGC k_pdecGMP K_mpde Sbar_CM K_dCM Bbar_F ... 
            K_dB ode15s_OptsVSME deltaG_0}; 
    VSME_FPFields = {'F' 'R' 'T' 'RT' 'FRT' 'N_Avo' 'C_m' 'A_m' 'z_K' 'z_Na' ... 
            'z_Ca' 'z_Cl' 'Ca_e' 'Na_e' 'K_e' 'Cl_e' 'Vol_i' 'Vol_Ca' ... 
            'Vol_SRu' 'Vol_SRr' 'P_VOCC' 'N_BKCa' 'tau_pf' 'tau_ps' ... 
            'dV_50KCaNO' 'dV_50KCacGMP' 'P_BKCa' 'g_Kv' 'tau_q1' 'tau_q2' ... 
            'g_Kleak' 'K_NSC' 'd_NSCmin' 'PNa_NSC' 'PK_NSC' 'PCa_NSC' ... 
            'gCa_SOC' 'gNa_SOC' 'K_SOC' 'tau_SOC' 'g_ClCa' 'R_ClcGMPmin' ... 
            'n_ClCa' 'K_ClCa' 'n_ClcGMP' 'K_ClcGMP' 'Ibar_PMCA' 'K_mPMCA' ... 
            'g_NCX' 'd_NCX' 'gamma_NCX' 'Ibar_NaK' 'n_HKe' 'K_dKe' 'n_HNai' ... 
            'Na_dNai' 'Q_10' 'L_NaKCl' 'Ibar_IP3' 'K_IP3' 'K_actIP3' ... 
            'k_onIP3' 'K_inhIP3' 'Ibar_SERCA' 'K_mup' 'tau_tr' 'R_leak' ... 
            'tau_rel' 'CSQNbar' 'K_CSQN' 'K_r1' 'K_r2' 'K_mr1' 'K_mr2' ... 
            'k_rG' 'xi_G' 'R_TG' 'k_pG' 'K_1G' 'k_eG' 'K_2G' 'k_aG' 'G_TG' ... 
            'k_dG' 'alpha_G' 'K_cG' 'gamma_G' 'k_degG' 'r_rG' 'PIP2_T' ... 
            'V_cGMPmax' 'k_2sGC' 'k_3sGC' 'k_m1sGC' 'k_DsGC' 'k_m2sGC' ... 
            'k_1sGC' 'k_DrsGC' 'k_pdecGMP' 'K_mpde' 'Sbar_CM' 'K_dCM' ... 
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            'Bbar_F' 'K_dB' 'ode15s_OptsVSME' 'deltaG_0'}; 
    VSME_FPStruct = cell2struct(VSME_FPValues,VSME_FPFields,2); 
    % Load all fixed parameters in one cell array of structures 
    FixPStruct_Cell = cell(3,1); 
    FixPStruct_Cell{1} = VMech_FPStruct; 
    FixPStruct_Cell{2} = XB_FPStruct; 
    FixPStruct_Cell{3} = VSME_FPStruct; 
     
 
%% 
********************************************************************************** 
%   Act/Ca Xbridge Fit for  S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
 
%     Using system of ODEs solving for VSM crossbridge dynamics in the steady 
%     state so the steady state VSM cytosolic Ca2+ levels can be determined 
%     as a function of VSM activation 
    t_Start = 0;                                    % Starting time of SS calc  (s) 
    t_End = 60;                                     % Ending time of SS calc    (s) 
 
    Cai_Min = 0.010;                                % Min cyto Ca concen        (uM) 
    Cai_Max = 1.500;                                % Max cyto Ca concen        (uM) 
    Cai_Grid = 100;                                 % Grid of cyto Ca range  
    Cai_Disc = logspace(log10(Cai_Min), ...         % Discretized Cai domain    (uM) 
                  log10(Cai_Max),Cai_Grid); 
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    t_Out = cell(Cai_Grid,1);                       % Preallocating cell arrays 
    x_Out = cell(Cai_Grid,1);                       %  and activation matrix 
    Act_Sim = zeros(Cai_Grid,1); 
     
    for i = 1:Cai_Grid                              % Calculate SS act at each Ca_i 
        Ca_i = Cai_Disc(i); 
        XBdXdt_Hndl = @(t,x) dXdT_VSMXB ...         % Setting crossbridge function 
            (t,x,Ca_i,XB_FPStruct);                 %  handle of system of ODEs 
        [t_Out{i},x_Out{i}] = ode15s( ...           % ODE solution over time domain 
            XBdXdt_Hndl,[t_Start t_End], ... 
            x0_XB,ode15s_OptsXB); 
        Act_Sim(i) =(x_Out{i}(end,3) + ...         % Calculate activation 
            x_Out{i}(end,4)) / AMpAM_Max; 
    end 
 
    XBDyn_tSim = t_Out;                             % Store XB time vector 
    XBDyn_SVSim = x_Out;                            % Store XB state variables 
    CaiAct_Sim = [Cai_Disc' Act_Sim];               % Store SS Cai and VSM Act 
     
    % Optimized crossbridge parameter structure 
    XB_SimValues = {XBDyn_tSim XBDyn_SVSim CaiAct_Sim}; 
    XB_SimFields = {'XBDyn_tSim' 'XBDyn_SVSim' 'CaiAct_Sim'}; 
    XB_SimStruct = cell2struct(XB_SimValues,XB_SimFields,2); 
     
    % Calling fmincon to optimize the fit to the steady state  
    % activation with Hill function equation 
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    K_AInit = 1;                                    % Setting the initial 
    n_Init = 0.1;                                   %  free parameter values 
    p_XB(1) = K_AInit; 
    p_XB(2) = n_Init;     
 
    pHill_LowB(1) = 0;                              % Setting the lower and 
    pHill_LowB(2) = 0;                              %  upper bounds for the 
    pHill_UpB(1) = 1.6;                             %  impulse function fit 
    pHill_UpB(2) = 20; 
     
    XBOF_Hndl = @(p_XB) VSMXB_ObjFun ...            % Setting crossbridge objective 
        (p_XB,CaiAct_Sim);                          %  function handle 
    p_XB = fmincon(XBOF_Hndl,p_XB,[], ...           % Optimization call for 
        [],[],[],pHill_LowB,pHill_UpB, ...          %  the Hill function fit 
        [],fmc_OptsXB);  
            
    K_AOpt = p_XB(1);                               % Optimized free parameter 
    n_Opt = p_XB(2);                                %  values  
     
    % Optimized crossbridge parameter structure 
    XB_OPValues = {K_AOpt n_Opt}; 
    XB_OPFields = {'K_AOpt' 'n_Opt'}; 
    XB_OPStruct = cell2struct(XB_OPValues,XB_OPFields,2); 
     
     
%% 
********************************************************************************** 
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%   Save Prev OptP for      S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
 
%     Building the cell array conatining the previously optimized parameters 
%     which will be used in the final optimization 
    OptPStruct_Cell = cell(2,1); 
    OptPStruct_Cell{1} = VMech_OPStruct; 
    OptPStruct_Cell{2} = XB_OPStruct; 
     
     
%% 
********************************************************************************** 
%   Opt VSME params for     S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
***********************************************************************************     
 
    Num_Models =1;%{2; %{9;                                             % # models to try 
     
          pVSME_Opt = [6.997 82.245 4.161]; 
 
 
%% 
********************************************************************************** 
%   Figures for             S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
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%     Simulated myogenic response of each model variant in turn 
%     disp(' ') 
%     for i = 1:Num_Models 
        Model_Flag = 1; 
%         DispStrg = ['Simulating channel variant ' num2str(i)]; 
%         disp(DispStrg) 
        x0_In = x0_VSME;                                        % Load ICs 
%         if (Model_Flag == 4 || Model_Flag == 5)                 % Ohmic channels 
%             x0_In(27) = 0.50;                                   % Add extra IC 
%         end 
        SingVess_SFSIIit(it_num,pVSME_Opt,Model_Flag,x0_In, ...  
                         FixPStruct_Cell,OptPStruct_Cell) 
 
    toc 
end 
                
 
%% 
********************************************************************************** 
%  End of Script            S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
%  References for           S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
% 
%   Bund SJ 
%   Spontaneously hypertensive rat resistance artery structure related to myogenic 
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%   and mechanical properties. 
%   Clinical Science 101:385-393, 2001. 
%    
%   Carlson BE and Secomb TW. 
%   A theoretical model for the myogenic response based on the length-tension  
%   characteristics of vascular smooth muscle. 
%   Microcirculation 12:327-338, 2005. 
% 
%   Hai CM and Murphy RA. 
%   Cross-bridge phosphorylation and regulation of latch state in smooth muscle. 
%   American Journal of Physiology, Cell Physiology 254:C99-106, 1988.     
% 
%   Koenigsberger M, Sauser R, Beny J-L and Meister J-J. 
%   Effects of arterial wall stress on vasomotion. 
%   Biophysical Journal 91:1663-1674, 2006. 
% 
%   Kapela A, Bewerianos A and Twoukias NM. 
%   A mathematical model of Ca2+ dynamics in rat mesenteric smooth muscle cell: 
%   agonist and NO simulation. 
%   Journal of Theoretical Biology 253:238-260, 2008 
% 
%   Condorelli P, George SC. 
%   In Vivo control of soluble guanylate cyclase activation by nitric 
%   oxide: a kinetic analysis. 
%   Biophysical Journal 80: 2110-2119, 2001 
% 
404	  
	  
% 
*********************************************************************************** 
%  Modification Log of      S I N G L E   V E S S E L   M Y O G E N I C   R E S P  
% 
*********************************************************************************** 
%   18 May     2010 --> Developed code integrating the passive/myogenic fits to  
%                        experimental data, Hai and Murphy crossbridge model and  
%                        the Kapela et al. vascular smooth muscle ephys model 
%   10 June    2010 --> 3 parameter fits for stress activated Ca and Na channels  
%                        integrated into code and sucessfully fit 
%    1 October 2010 --> Edited the XB simulation and fit code in Step 2 and  
%                        broke out the XB simulation and fit plot as a separate 
%                        function.  Finished fully commenting code. 
%   18 January 2011 --> Added the nine different channel configurations and enabled 
%                        the input of initial guesses, log scaled optimization, 
%                        and lower and upper parameter bounds through a single  
%                        matrix.  Added the Vm plot at the end of the figure section 
%    5 April   2011 --> Trimmed out all the optimization code except that for the  
%                        determination of the Hill fit to VSM crossbridge activation 
%                        and left in the functions to plot out Figure 4 or 5 and 6 
%                        in the paper 
%    2 June    2011 --> Final edits and comments 
%    2 October 2013 --> Final additions and comments by Patrick Kirby 
%    (modification of original code) 
% 
*********************************************************************************** 
 
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{% 
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%%  SingVess_VmCaNaPanel - 3 panel of simulated Vm, cytosolic Ca2+ and Na+ 
% 
*********************************************************************************** 
%         S T E A D Y - S T A T E   M E M B R A N E   P O T E N T I A L ,    
%         C Y T O S O L I C   C a 2 +   A N D   C Y T O S O L I C   N a +   
%           S I M U L A T I O N   F I G U R E   F O R   P O S S I B L E  
%               S T R E S S   C O N T R O L L E D   C H A N N E L S 
% 
*********************************************************************************** 
% 
%   This function plots a figure comparing the simulated steady-state membrane  
%   potential, cytosolic Ca2+ and cytosolic Na+ for the six possible stress- 
%   controlled channel model variations as identified by successful fits to the  
%   myogenic data.  In the Bund data fits these model variants are: 
% 
%       Model 1 --> Stress control of NSC Ca2+ conductance 
%       Model 2 --> Stress control of NSC Na+ conductance 
%       Model 4 --> Stress control of Ohmic Ca2+ channel conductance 
%       Model 5 --> Stress control of Ohmic Na+ channel conductance 
%       Model 6 --> Stress control of L-type Ca2+ gating voltage 
%       Model 7 --> Stress control of L-type Ca2+ conductance 
%    
%   The function usage is as follows: 
% 
%     SingVess_VmCaNaanel(GoodMod_Fits,LineCS,FixPStructCell) 
%      
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%     where for input GoodMod_Fits is a vector containing the model variants that  
%     generate a successful myogenic response, LineCS is a cell containing the  
%     color and style of the lines in the figure and FixPStructCell is structure  
%     containing all the fixed parameters loaded in the main function.  The output 
%     is the figure on the display and saved in the folder. 
%    
%   Model originally created on     31 March 2011 
%   Model last modfied on            5 April 2011 
% 
%   Developed by        Brian Carlson 
%                       Computational Bioengineering Group 
%                       Biotechnology and Bioengineering Center 
%                       Medical College of Wisconsin 
% 
%   COPYRIGHT AND REQUEST FOR ACKNOWLEDGMENT OF USE:    
%   Copyright (C) 2011 Medical College of Wisconsin.  This software was developed 
%   by the Computational Bioengineering Group, Director D.A. Beard, Director,  
%   Department of Physiology and Biotechnology and Bioengineering Center, Medical  
%   College of Wisconsin, Milwaukee, WI. 53226. Software may be copied for use by  
%   academic institutions so long as these copyright rights are acknowledged.   
%   Commercial use requires a license. 
% 
%   This software was developed with support from NSF grant EFRI 0735903.  
%   Please cite this grant in any publication for which this software is used  
%   and send an email with the citation and, if possible, a PDF file of the paper  
%   to: becarlson@mcw.edu. 
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% 
% 
*********************************************************************************** 
 
%% 
********************************************************************************** 
%  Start of Function       S I N G L E   V E S S E L   V m   C a   N a   P A N E L 
% 
*********************************************************************************** 
 
    function  SingVess_VmCaNaPaneledNE(GoodMod_Fits,FixPStruct_Cell,OptPStruct_Cell) 
     
%% 
********************************************************************************** 
%  Loading Params for      S I N G L E   V E S S E L   V m   C a   N a   P A N E L 
% 
*********************************************************************************** 
 
%     Unpack the vessel wall mechanics data and fixed parameters 
    VMech_FPStruct = FixPStruct_Cell{1}; 
    MesFem_Flag = VMech_FPStruct.MesFem_Flag;           % Sesenteric or femoral data 
    Myo_Data = VMech_FPStruct.Myo_Data;                 % Myogenic response data 
    VMech_OPStruct = OptPStruct_Cell{1};        % Get structure out of cell 
    D100 = VMech_OPStruct.D100_Opt;             % Dpass at 100 mmHg            (um) 
    Title_String= {' NSC \sigma C Na^+ cond'}; 
    Model_Strgs = { '[NE]=10 x 10^-^9mM'... 
                '[NE]=1 x 10^-^6 mM' ... 
               ' [NE]=10 x 10^-^6 mM'  ... 
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               ' [NE]=20 x 10^-^6 mM' ... 
               ' [NE]=40 x 10^-^6 mM' ... 
               ' [NE]=80 x 10^-^6 mM'... 
               ' [NE]=100 x 10^-^6' ... 
               ' [NE]=200 x 10^-^6'}; 
            
%     Model_Strgs2 = { '[NO]=10 x 10^-^1^5mM_Pas'... 
%                ' [NO]=1 x 10^-^9mM Pass' ... 
%                ' [NO]=1 x 10^-^6mM Pass'... 
%                ' [NO]=10 x 10^-^6^5mM Act'... 
%                ' [NO]=50 x 10^-^6mM Act' ... 
%                ' [NO]=400 x 10^-^6mM Act'}; 
%     {' NSC \sigma C Ca^{2+} cond' ... 
%                    ' NSC \sigma C Na^+ cond' ... 
%                    ' NSC \sigma C gate V_m ' ... 
%                    ' Supp Ca^{2+} \sigma C cond' ... 
%                    ' Supp Na^+ \sigma C cond' ... 
%                    ' L-type Ca^{2+} \sigma C gate V' ... 
%                    ' L-type Ca^{2+} \sigma C cond'}; 
                  
            
%% 
********************************************************************************** 
%   Run Simulations for    S I N G L E   V E S S E L   V m   C a   N a   P A N E L 
% 
*********************************************************************************** 
  %function SingVess_VmCaNaPanel(GoodMod_Fits,LineCS,FixPStruct_Cell)           
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%     Figure showing good model fits SS Vm with pressure 
    ScrSize = get(0,'ScreenSize');                      % Getting screen size 
    SimPan = figure('Position', ...                     % Positioning the figure 
        [ScrSize(3)/30 ScrSize(4)/25 ...                %  on the screen 
        ScrSize(3)/1.05 ScrSize(4)/2.75]); 
     
    Num_GoodModFits = size(GoodMod_Fits,1);             % Number of good myo fits 
    Num_Model_Strgs = 8; 
     
   figure(3) 
    ModelFit_MatFile = cell(1,1);                       % Preallocation 
    Legend_Strgs = cell(Num_Model_Strgs,1);%{cell(Num_GoodModFits,1); 
   % for i = 1:Num_GoodModFits                           % Step through each good fit 
        Model_Flag = 2; 
        ModelFit_MatFile{1} = ['SingVess_Model' ...     % .mat file name to be used 
            num2str(Model_Flag) '.mat'];                %  later 
        load(ModelFit_MatFile{1}) 
       %{ plot(PSim_SS,VmSim_SS,LineCS{i},...             % Plot simulation curve 
        %{    'LineWidth',3)  
         plot(PSim_SS(:,1),VmSim_SS(:,1),'-k',PSim_SS(:,2),... 
             VmSim_SS(:,2),'--k',PSim_SS(:,3),VmSim_SS(:,3),'ko',... 
             PSim_SS(:,4),VmSim_SS(:,4),'kx',PSim_SS(:,5),... 
             VmSim_SS(:,5),'k*',PSim_SS(:,6),VmSim_SS(:,6),'-.k',...             % Plot simulation curve 
            PSim_SS(:,7),VmSim_SS(:,7),'g', PSim_SS(:,8),VmSim_SS(:,8),'r-','LineWidth',1)  
        hold on 
        for j=1:Num_Model_Strgs 
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        Legend_Strgs{j} = Model_Strgs{j};   
        end 
        %{Legend_Strgs{i} = Model_Strgs{Model_Flag};      % Create legend strings 
          
   %{ end 
    set(gca,'FontSize',14,'Box','off')                  % Increase font size on axes 
    XLim_Min = 0 * min(Myo_Data(:,1));                  % Forcing limits on  
    XLim_Max = 1.25 * max(Myo_Data(:,1));               %  pressure axis 
    xlim([XLim_Min XLim_Max]) 
    legend(Legend_Strgs,0,'FontSize',10)                 % Draw legend 
    legend('boxoff') 
    ylabel('Membrane Potential (mV)','FontSize',16, ... % Y labels on figure 
           'FontWeight','bold')      
    xlabel('Pressure (mmHg)','FontSize',16, ...         % X labels on figure 
            'FontWeight','bold') 
         
    figure(4) 
    ModelFit_MatFile = cell(2,1);                       % Preallocation 
   %{ Legend_Strgs = cell(Num_GoodModFits,1); 
 %{   for i = 1:Num_Model_Strgs;%{Num_GoodModFits                           % Step through each good fit 
        Model_Flag =2;%{ GoodMod_Fits(i); 
        ModelFit_MatFile{1} = ['SingVess_Model' ...     % .mat file name to be used 
            num2str(Model_Flag) '.mat'];                %  later 
        load(ModelFit_MatFile{1}) 
        %{plot(PSim_SS,Cai_SS*1e3,LineCS{i},...           % Plot simulation curve 
           %{ 'LineWidth',3)  
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         plot(PSim_SS(:,1),Cai_SS(:,1).*1e3,'-k',PSim_SS(:,2),... 
             Cai_SS(:,2).*1e3,'--k',PSim_SS(:,3),Cai_SS(:,3).*1e3,'ko',... 
             PSim_SS(:,4),Cai_SS(:,4).*1e3,'kx',PSim_SS(:,5),... 
             Cai_SS(:,5).*1e3,'k*',PSim_SS(:,6),Cai_SS(:,6).*1e3,'-.k',......           % Plot simulation curve 
            PSim_SS(:,7),Cai_SS(:,7).*1e3,'g', PSim_SS(:,8),Cai_SS(:,8).*1e3,'r-','LineWidth',1)  
        hold on 
       %{ Legend_Strgs{i} = Model_Strgs{Model_Flag};      % Create legend strings 
        for j=1:Num_Model_Strgs 
        Legend_Strgs{j} = Model_Strgs{j};   
        end 
  %{  end 
    set(gca,'FontSize',14,'Box','off')                  % Increase font size on axes 
    XLim_Min = 0 * min(Myo_Data(:,1));                  % Forcing limits on  
    XLim_Max = 1.25 * max(Myo_Data(:,1));               %  pressure axis 
    xlim([XLim_Min XLim_Max]) 
    if (MesFem_Flag == 1) 
        ylim([0 1]) 
    else 
        ylim([0 1]) 
    end 
    legend(Legend_Strgs,0,'FontSize',10)                 % Draw legend 
    legend('boxoff') 
    ylabel('Cytosolic Ca^{2+} (\muM)', ...              % Y labels on figure 
            'FontSize',16,'FontWeight','bold')      
    xlabel('Pressure (mmHg)','FontSize',16, ...         % X labels on figure 
            'FontWeight','bold') 
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   figure(5) 
        ModelFit_MatFile = cell(1,1);                       % Preallocation 
  %{  Legend_Strgs = cell(Num_GoodModFits,1); 
   %{ for i = 1:Num_Model_Strgs;%{Num_GoodModFits                           % Step through each good fit 
        Model_Flag = 2;%{GoodMod_Fits(i); 
        ModelFit_MatFile{1} = ['SingVess_Model' ...     % .mat file name to be used 
            num2str(Model_Flag) '.mat'];                %  later 
        load(ModelFit_MatFile{1}) 
        plot(PSim_SS(:,1),Nai_SS(:,1),'-k',PSim_SS(:,2),... 
             Nai_SS(:,2),'--k',PSim_SS(:,3),Nai_SS(:,3),'ko',... 
             PSim_SS(:,4),Nai_SS(:,4),'kx',PSim_SS(:,5),... 
             Nai_SS(:,5),'k*',PSim_SS(:,6),Nai_SS(:,6),'-.k',.........               % Plot simulation curve 
             PSim_SS(:,7),Nai_SS(:,7),'g', PSim_SS(:,8),Nai_SS(:,8),'r-','LineWidth',1)  
       %{ plot(PSim_SS,Nai_SS,LineCS{i},...               % Plot simulation curve 
       %{     'LineWidth',1)  
        hold on 
        %{Legend_Strgs{i} = Model_Strgs{Model_Flag};      % Create legend strings 
        for j=1:Num_Model_Strgs 
        Legend_Strgs{j} = Model_Strgs{j};   
        end 
   %{ end 
    set(gca,'FontSize',14,'Box','off')                  % Increase font size on axes 
    XLim_Min = 0 * min(Myo_Data(:,1));                  % Forcing limits on  
    XLim_Max = 1.25 * max(Myo_Data(:,1));               %  pressure axis 
    xlim([XLim_Min XLim_Max]) 
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    ylabel('Cytosolic Na^+ (mM)','FontSize',16, ...     % Y labels on figure 
           'FontWeight','bold')      
    xlabel('Pressure (mmHg)','FontSize',16, ...         % X labels on figure 
            'FontWeight','bold') 
    legend(Legend_Strgs,0,'FontSize',10)                 % Draw legend 
    legend('boxoff') 
    
%     figure(6) 
%         ModelFit_MatFile = cell(1,1);                       % Preallocation 
%   %{  Legend_Strgs = cell(Num_GoodModFits,1); 
%    %{ for i = 1:Num_Model_Strgs;%{Num_GoodModFits                           % Step through each good 
fit 
%         Model_Flag = 2;%{GoodMod_Fits(i); 
%         ModelFit_MatFile{1} = ['SingVess_Model' ...     % .mat file name to be used 
%             num2str(Model_Flag) '.mat'];                %  later 
%         load(ModelFit_MatFile{1}) 
%         plot(PSim_SS(:,1),Sigma_Passn(:,1),'-k',PSim_SS(:,4),Sigma_Passn(:,4),'--k',... 
%              PSim_SS(:,8),Sigma_Passn(:,8),'-.k',PSim_SS(:,1),Act_SS(:,1).*Sigma_MaxActn(:,1),'-r',... 
%             PSim_SS(:,4),Act_SS(:,4).*Sigma_MaxActn(:,4),'--r',... 
%             PSim_SS(:,8),Act_SS(:,8).*Sigma_MaxActn(:,8),'-.r','LineWidth',1)  
%        %{ plot(PSim_SS,Nai_SS,LineCS{i},...               % Plot simulation curve 
%        %{     'LineWidth',1)  
%         hold on 
%         %{Legend_Strgs{i} = Model_Strgs{Model_Flag};      % Create legend strings 
%         for z=1:6 
%         Legend_Strgs2{z} = Model_Strgs2{z};   
%         end 
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%          
%    %{ end 
%     set(gca,'FontSize',14,'Box','off')                  % Increase font size on axes 
%     XLim_Min = 0 * min(Myo_Data(:,1));                  % Forcing limits on  
%     XLim_Max = 1.25 * max(Myo_Data(:,1));               %  pressure axis 
%     xlim([XLim_Min XLim_Max]) 
%     ylabel('Stress (kPa)','FontSize',16, ...     % Y labels on figure 
%            'FontWeight','bold')      
%     xlabel('Pressure (mmHg)','FontSize',16, ...         % X labels on figure 
%             'FontWeight','bold') 
%     legend(Legend_Strgs2,0,'FontSize',9)                 % Draw legend 
%     legend('boxoff') 
%    %{ title(Title_String) 
%     
%      figure(7) 
%         ModelFit_MatFile = cell(1,1);                       % Preallocation 
%   %{  Legend_Strgs = cell(Num_GoodModFits,1); 
%    %{ for i = 1:Num_Model_Strgs;%{Num_GoodModFits                           % Step through each good 
fit 
%         Model_Flag = 2;%{GoodMod_Fits(i); 
%         ModelFit_MatFile{1} = ['SingVess_Model' ...     % .mat file name to be used 
%             num2str(Model_Flag) '.mat'];                %  later 
%         load(ModelFit_MatFile{1}) 
%         plot(DSim_SS(:,1)./D100,Sigma_Passn(:,1),'-k',DSim_SS(:,4)./D100,Sigma_Passn(:,4),'--k',... 
%              DSim_SS(:,8)/D100,Sigma_Passn(:,8),'-
.k',DSim_SS(:,1)./D100,Act_SS(:,1).*Sigma_MaxActn(:,1),'-r',... 
%             DSim_SS(:,4)./D100,Act_SS(:,4).*Sigma_MaxActn(:,4),'--r',... 
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%             DSim_SS(:,8)./D100,Act_SS(:,8).*Sigma_MaxActn(:,8),'-.r','LineWidth',1)  
%        %{ plot(PSim_SS,Nai_SS,LineCS{i},...               % Plot simulation curve 
%        %{     'LineWidth',1)  
%         hold on 
%         %{Legend_Strgs{i} = Model_Strgs{Model_Flag};      % Create legend strings 
%         for z=1:6 
%         Legend_Strgs2{z} = Model_Strgs2{z};   
%         end 
%          
%    %{ end 
%     set(gca,'FontSize',14,'Box','off')                  % Increase font size on axes 
%     XLim_Min = 0 * min(Myo_Data(:,1));                  % Forcing limits on  
%     XLim_Max = 1.25 * max(DSim_SS(:,1)./D100);               %  pressure axis 
%     xlim([XLim_Min XLim_Max]) 
%     ylabel('Stress (kPa)','FontSize',16, ...     % Y labels on figure 
%            'FontWeight','bold')      
%     xlabel('Normalized circumferential length (L/L_0)','FontSize',16, ...         % X labels on figure 
%             'FontWeight','bold') 
%     legend(Legend_Strgs2,0,'FontSize',9)                 % Draw legend 
%     legend('boxoff') 
%    %{ title(Title_String) 
     
    drawnow                                             % Draw now and save an eps 
    set(gcf,'PaperPositionMode','auto') 
    print -depsc SimPanelFig.eps 
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    end 
         
 
%% 
********************************************************************************** 
%  End of Function         S I N G L E   V E S S E L   V m   C a   N a   P A N E L 
% 
*********************************************************************************** 
%  Modification Log of    S I N G L E   V E S S E L   V m   C a   N a   P A N E L 
% 
*********************************************************************************** 
%   16 January 2011 --> Created function 
%   18 January 2011 --> Commented code 
%    5 April   2011 --> Made a 1x3 panel and then changed name of fucntion from 
%                        SingVess_VmPlot to reflect this.   
% 
*********************************************************************************** 
 
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{% 
 
%%  VSMAct_ObjFun - Objective function to fit VSM activation as a function of Ca_i  
% 
*********************************************************************************** 
%           O B J E C T I V E   F U N C T I O N   U S E D   T O   F I T 
%            V S M   A C T I V A T I O N   A S   F U N C T I O N   O F 
%                 C Y T O S O L I C   C A L C I U M   L E V E L S 
% 
*********************************************************************************** 
% 
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%   This function takes the simulated steady state data from the Hai and Murphy  
%   model of crossbridge activation as a function of cytosolic Ca2+ and estimates  
%   it with a Hill function.  The root mean squared difference between the  
%   simulated data and the estimate is calculated here.  The main script calls 
%   this with an optimization function to give the best fit of the Hill function 
%   estimate to the simulated steady state response.  This Hill function  
%   approximation is used in the remainder of the code instead of running the  
%   system of ODEs to steady state each time the activation for a given cytosolic 
%   Ca2+ level is needed.   
% 
%   The function usage is as follows: 
% 
%       Res = VSMXB_ObjFun(p,CaiAct_Sim) 
% 
%       where for input p is set of parameter values currently being optimized  
%       and CaiAct_Sim a matrix of cytosolic Ca2+ levels and their correponding  
%       simulated steady-state VSM activation values.  The output, Res, is the  
%       root mean squared residual error that is being minimized to find the  
%       optimized parameter values. 
% 
%   Model originally created on     26 May     2010 
%   Model last modfied on            1 October 2010 
% 
%   Developed by        Brian Carlson 
%                       Computational Bioengineering Group 
%                       Biotechnology and Bioengineering Center 
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%                       Medical College of Wisconsin 
% 
%   COPYRIGHT AND REQUEST FOR ACKNOWLEDGMENT OF USE:    
%   Copyright (C) 2011 Medical College of Wisconsin.  This software was developed 
%   by the Computational Bioengineering Group, Director D.A. Beard, Director,  
%   Department of Physiology and Biotechnology and Bioengineering Center, Medical  
%   College of Wisconsin, Milwaukee, WI. 53226. Software may be copied for use by  
%   academic institutions so long as these copyright rights are acknowledged.   
%   Commercial use requires a license. 
% 
%   This software was developed with support from NSF grant EFRI 0735903.  
%   Please cite this grant in any publication for which this software is used  
%   and send an email with the citation and, if possible, a PDF file of the paper  
%   to: becarlson@mcw.edu. 
% 
% 
*********************************************************************************** 
 
%% 
********************************************************************************** 
%  Start of Function     V S M   X B R I D G E   O B J E C T  F U N C T I O N 
% 
*********************************************************************************** 
 
    function Res = VSMXB_ObjFun(p,CaiAct_Sim) 
     
%     Extracting parameters and data point values   
    K_A = p(1);                                         % 50% activation Ca_i 
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    n = p(2);                                           % Hill exponent 
    Cai_i = CaiAct_Sim(:,1);                            % Vector of cytosolic Ca 
    Act_i = CaiAct_Sim(:,2);                            % Vector of VSM activation 
    Num_SimPts = size(CaiAct_Sim,1);                    % Number of simulated points 
     
%     Estimating the VSM activation with the Hill function 
    Act_Fit = (Cai_i.^n) ./ ((K_A^n) + (Cai_i.^n));     % Hill function calc of Act 
     
%     Calculating the root mean squared error     
    SSEAct_DataSim = sum((Act_Fit - Act_i).^2);         % Act sum sqr error  
    Res = (SSEAct_DataSim / Num_SimPts)^0.5;            % Act norm RMS error 
     
%     Visualization of the current optimized estimate to simulation points 
    close all 
    ScrSize = get(0,'ScreenSize');                          % Get screen size 
    figure('Position',[2*ScrSize(3)/3.1 ScrSize(4)/2.1 ...  % Position figure 
                        ScrSize(3)/3 ScrSize(4)/2]) 
    semilogx(Cai_i,Act_i,'ob', ...                          % Simulation points 
             'MarkerSize',9,'LineWidth',2) 
    hold on 
    semilogx(Cai_i,Act_Fit,'-r','LineWidth',1.5)            % Hill func estimate 
    set(gca,'FontSize',10,'FontWeight','demi')              % Set axes font specs 
    xlabel('Cytsolic Ca, Ca_i (\muM)',... 
            'FontSize',12,'FontWeight','bold') 
    ylabel('VSM activation, A', ... 
            'FontSize',14,'FontWeight','bold') 
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    legend('Simulation points','Hill function fit', ... 
           'Location','SouthEast')          
    title('Hill Function Estimation of VSM Activation', ... 
           'FontSize',14,'FontWeight','bold') 
    pause(0.25)                                             % Slight pause to view 
      
    end 
    
%% 
********************************************************************************** 
%  End of Function       V S M   X B R I D G E   O B J E C T  F U N C T I O N 
% 
*********************************************************************************** 
%  Modification Log of   V S M   X B R I D G E   O B J E C T  F U N C T I O N 
% 
*********************************************************************************** 
%   26 May     2010 --> Created function and fully commented code 
%    1 October 2010 --> Eliminated the alternate impulse function fit to the 
%                       VSM activation as a function of cytosolic Ca, vectorized 
%                       and fully commented the code and also added the fit  
%                       visualization figure. 
% 
*********************************************************************************** 
 
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{% 
 
%%      XBSim_Plot - Generates dynamic and steady state Xbridge figure 
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% 
*********************************************************************************** 
%           C R O S S B R I D G E   D Y N A M I C S   A N D   S T E A D Y 
%                S T A T E   O P T I M I Z A T I O N    F I G U R E 
% 
*********************************************************************************** 
% 
%   This function plots out the VSM corssbridge dynamics as defined by the Hai and 
%   Murphy 4-state  model and then shows the steady state results and the fit to  
%   the results.   
% 
%   The function usage is as follows: 
% 
%       XBSim_Plot(XB_SimStruct,XB_OPStruct) 
% 
%       where for input XB_SimStruct is the structure containing the simulation of 
%       the VSM crossbrige dynamics as simulated and constructed in the main  
%       script and XB_OPStruct is the structure containing the optimized parameter  
%       values for the VSM crossbridge response to Ca2+.  The output, D, is the 
%       generated figure. 
% 
%   Model originally created on     1 October 2010 
%   Model last modfied on           2 October 2010 
% 
%   Developed by        Brian Carlson 
%                       Computational Bioengineering Group 
%                       Biotechnology and Bioengineering Center 
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%                       Medical College of Wisconsin 
% 
%   COPYRIGHT AND REQUEST FOR ACKNOWLEDGMENT OF USE:    
%   Copyright (C) 2011 Medical College of Wisconsin.  This software was developed 
%   by the Computational Bioengineering Group, Director D.A. Beard, Director,  
%   Department of Physiology and Biotechnology and Bioengineering Center, Medical  
%   College of Wisconsin, Milwaukee, WI. 53226. Software may be copied for use by  
%   academic institutions so long as these copyright rights are acknowledged.   
%   Commercial use requires a license. 
% 
%   This software was developed with support from NSF grant EFRI 0735903.  
%   Please cite this grant in any publication for which this software is used  
%   and send an email with the citation and, if possible, a PDF file of the paper  
%   to: becarlson@mcw.edu. 
% 
% 
*********************************************************************************** 
 
%% 
********************************************************************************** 
%  Start of Function       V S M   C R O S S B R I G E   S I M   P L O T 
% 
*********************************************************************************** 
    function XBSim_Plot(XB_SimStruct,XB_OPStruct) 
   
 
%     Unpack the structures storing simulation data and fit parameters     
    XBDyn_tSim = XB_SimStruct.XBDyn_tSim;                       % Time of dynamics 
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    XBDyn_SVSim = XB_SimStruct.XBDyn_SVSim;                     % State variables 
    Cai_Disc = XB_SimStruct.CaiAct_Sim(:,1);                    % SS cytosolci Ca2+  
    Act_Sim = XB_SimStruct.CaiAct_Sim(:,2);                     % SS VSM activation 
     
    K_AOpt = XB_OPStruct.K_AOpt;                                % Optim K_A for XB 
    n_Opt = XB_OPStruct.n_Opt;                                  % Optim n for XB 
     
    Cai_Grid = size(Cai_Disc,1);                                % Find discret grid 
     
%     Estimating the VSM activation with the Hill function 
    Act_Fit = (Cai_Disc.^n_Opt) ./ ...                          % Hill function 
            ((K_AOpt^n_Opt) + (Cai_Disc.^n_Opt));               %  calc of VSM act 
 
%     Figure showing fit to VSM crossbridge simulation 
    ScrSize = get(0,'ScreenSize'); 
    figure('Position',[ScrSize(3)/30 ScrSize(4)/25 ... 
                        ScrSize(3)/1.5 ScrSize(4)/1.15]) 
    suptitle('Crossbridge Dynamics and Steady State VSM Activation') 
                     
    subplot(3,2,1)                                              % M to steady state 
    for i = 2:Cai_Grid-1 
        hold on 
        plot(XBDyn_tSim{i},XBDyn_SVSim{i}(:,1),'-b') 
    end 
    hold on 
    plot(XBDyn_tSim{1},XBDyn_SVSim{1}(:,1),'-g','LineWidth',3) 
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    plot(XBDyn_tSim{Cai_Grid},XBDyn_SVSim{Cai_Grid}(:,1),'-r','LineWidth',3) 
    ylabel('Fraction free dephos myosin, M') 
     
    subplot(3,2,2)                                              % Mp to steady state 
    for i = 2:Cai_Grid-1 
        hold on 
        plot(XBDyn_tSim{i},XBDyn_SVSim{i}(:,2),'-b') 
    end 
    hold on 
    plot(XBDyn_tSim{1},XBDyn_SVSim{1}(:,2),'-g','LineWidth',3) 
    plot(XBDyn_tSim{Cai_Grid},XBDyn_SVSim{Cai_Grid}(:,2),'-r','LineWidth',3) 
    ylabel('Fraction free phos myosin, Mp') 
     
    subplot(3,2,3)                                              % AMp to steady state 
    for i = 2:Cai_Grid-1 
        hold on 
        plot(XBDyn_tSim{i},XBDyn_SVSim{i}(:,3),'-b') 
    end 
    hold on 
    plot(XBDyn_tSim{1},XBDyn_SVSim{1}(:,3),'-g','LineWidth',3) 
    plot(XBDyn_tSim{Cai_Grid},XBDyn_SVSim{Cai_Grid}(:,3),'-r','LineWidth',3) 
    xlabel('Time, t (s)') 
    ylabel('Fraction attached phos myosin, AMp') 
     
    subplot(3,2,4)                                             % AM to steady state 
    for i = 2:Cai_Grid-1 
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        hold on 
        plot(XBDyn_tSim{i},XBDyn_SVSim{i}(:,4),'-b') 
    end 
    hold on 
    plot(XBDyn_tSim{1},XBDyn_SVSim{1}(:,4),'-g','LineWidth',3) 
    plot(XBDyn_tSim{Cai_Grid},XBDyn_SVSim{Cai_Grid}(:,4),'-r','LineWidth',3) 
    xlabel('Time, t (s)') 
    ylabel('Fraction attached dephos myosin, AM') 
     
    subplot(3,2,[5 6])                                         % SS act as a 
    semilogx(Cai_Disc,Act_Sim,'ob')                            %  function of 
    hold on                                                    %  cytosolic Ca 
    semilogx(Cai_Disc,Act_Fit,'-r')                            %  and compare to  
    xlabel('Cytsolic Ca, Ca_i (\muM)')                         %  the two optimized 
    ylabel('VSM activation, A')                                %  fits 
     
    drawnow 
 
    end 
 
 
%% 
********************************************************************************** 
%  End of Function         V S M   C R O S S B R I G E   S I M   P L O T 
% 
*********************************************************************************** 
%  Modification Log of     V S M   C R O S S B R I G E   S I M   P L O T 
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% 
*********************************************************************************** 
%    1 October 2010 --> Created function by breaking out from script 
%    2 October 2010 --> Cleaned up and fully commented code 
% 
*********************************************************************************** 
 
%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{%{% 
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